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Chapter 8  Discussions  
 
The rationale for Shared Decision Making (SDM) in healthcare has already been 
discussed in details at the beginning of this thesis (Chapter 1).  Observed variations 
in healthcare service provision and uptake, along with the gradual shift from a 
paternalistic to a more collaborative patient-clinician relationship, have fostered the 
development of SDM.  Glover’s classical study on tonsillectomy rates among school 
children (Glover 2008) is one the earliest of research efforts in demonstrating these 
variations, and over eight decades onwards these variations have remained 
commonplace globally.  These variations can either be warranted or unwarranted, 
with the latter referring to variations in the utilisation of healthcare services which 
cannot be explained by variations in patient illness and preferences.  The occurrence 
of unwarranted healthcare variations can be attributed to shortfalls in effective care 
and patient safety, preference-sensitive care and supply-sensitive care.   
Urinary diversion after radical cystectomy is a type of preference-sensitive care, 
where legitimate options (conduit and neobladder) exist but evidence for the 
superiority of one option over the other(s) is insufficient; this leaves the best diversion 
option being the one that is most congruent with patient preferences.  As the 
literature and this thesis have elucidated to, there remains many questions on how 
preference-sensitive healthcare decisions such as that concerning this thesis are 
made, with particular uncertainties around how patients form their preferences.  The 
application of SDM aims at counteracting the potential drivers for unwarranted 
healthcare variations already identified by the relevant body of research, with some 
clear evidence of success.  Some of these drivers are pertinent to choice of urinary 
diversion, which will be discussed later in the chapter. 
This chapter discusses the main findings concerning this thesis, which were 
generated from the cross analyses of the findings drawn from the three research 
components: SWPHO-BAUS Radical Cystectomy Dataset Analysis (SWPHO-BAUS 
Analysis), Needs Assessment Questionnaire Survey and Qualitative Interviews. 
 
 8.1 Variations in neobladder use within the UK is notable and potentially 
unwarranted 
Variations in neobladder use after radical cystectomy exist even among the few large 
academic centres renowned for their expertise in this urinary diversion procedure 
(range of neobladder use = 39.1 – 74%), and the overall neobladder use among 
these centres was noticeably higher when compared to that recorded for the wider 
populations e.g. that from the Swedish Registry and the US SEER Database 
reported neobladder use as 9 - 19% (Hatumann et al 2013; Gore et al 2006; Chapter 
1).  SWPHO-BAUS analysis conducted for this thesis demonstrated an even lower 
rate of neobladder use of 6.4% for the UK.  In most cases within the UK, the 
consultant surgeon who performs radical cystectomy also usually performs the 
urinary diversion procedure after cystectomy; he/she is also the clinician who offers 
the options of urinary diversion and initiates relevant discussions with the patient 
concerned, with input from the Multidisciplinary Team (MDT) (Chapter 1).   
The author hereby does not intend to be repetitive and overlabour on the findings for 
the SWPHO-BAUS analysis, their plausible explanations and the limitations of the 
analysis itself, as these have been covered in detail in the relevant results chapter 
(Chapter 4).  The focus of this section is to discuss the implications of the analysis’ 
findings, in the context of the whole thesis.   As mentioned before, the analysis 
agreed with other studies investigating into the potential predictors for neobladder 
use (Gore et al 2006; Hounsome et al 2013), in that age and male gender were 
independently associated with higher neobladder use; and in contrast, deprivation 
status was not associated with neobladder use whilst pre-operative disease stage 
was only weakly associated (Chapter 4 Sections 4.2.1 and 4.2.2).  Such disparities 
were likely to be caused by difference in study sample size and scale used for 
measuring deprivation.  The impact of radical cystectomy caseload on neobladder 
use was not assessed in the analysis but according to the other studies the caseload 
predicted a higher neobladder use (Gore et al 2006; Hounsome et al 2013); as 
explained before, the author felt that due to the issue of poor cystectomy case 
capture by the SWPHO-BAUS rendered the test of association between cystectomy 
caseload and neobladder use imprecise.  The extra time and financial resources 
demanded for more accurately assessing this association was outside the resource 
confines of the research concerning this thesiserefore, on balance the author did not 
investigate into the association between radical cystectomy caseload and neobladder 
use.  , investigating the association between neobladder use and cystectomy 
caseload with the SWPHO-BAUS Dataset data would be unlikely to yield a 
meaningful finding.  
A strength of this analysis was that it investigated  the association between 
neobladder use and several patient pre-operative clinical characteristics which had 
not been studied by the other studies but been widely considered as absolute and 
relative contraindications for neobladder in the literature, including clinical guidelines  
(Chapter 1); these included pre-operative renal function, fitness for surgery, 
radiotherapy and urinary continence status; better renal function, higher level of 
fitness for surgery and radiotherapy-naivety and complete continence of urine were 
also independently associated with higher neobladder use (Chapter 4 Sections 4.2.2. 
and 4.2.3).  The analysis reflected that the UK-based surgeons adopted the research 
evidence to a certain extent, when considering the eligibility of a patient for having a 
choice between conduit and neobladder.  Whilst the author was aware of the nested, 
hierarchical nature of the data (i.e. consultant-within- centres-within-cancer networks) 
and the potential interactions among patient characteristics (e.g. advancing age with 
decreased level of fitness), such were not incorporated into the analysis.  This was 
due to the analysis’ remit to only show trends of association between neobladder use 
and a range of patient characteristics, rather than identifying independent predictors 
for neobladder use.  As a result the author considered the univariate analysis 
conducted for this analysis was already fit for purpose.     
Another strength of this analysis was that it demonstrated notable variations in 
neobladder use across all the three healthcare organisational levels (consultant, 
centre and cancer networks), even after all the patient characteristics were held 
constant and random effects contributed by the organisational level itself was 
considered (i.e. residual variation; Chapter 4 Section 4.3).  The strongest evidence 
for the presence of this variation was at the consultant level (Chapter 4 Section 4.3).  
As mentioned before, this might signify that there was large variation in individual 
consultants’ beliefs in which patient would be suitable for neobladder and therefore, 
how they selected and counselled patients for neobladder.  At the centre level, the 
homogenisation of professional opinion on neobladder use might have been present 
and subsequently resulted in a more subtle evidence of variation in neobladder use.  
Some cancer networks might have a much higher concentration higher volume 
centres than the others, hence the evidence for variation in neobladder use among 
cancer networks had once again become more obvious.   
A mentioned in the relevant results chapter (Chapter 4 Section 4.4), before 
undertaking the actual analysis it was already known that the data of the SWPHO-
BAUS dataset were of compromised quality, mainly due to the dataset’s poor case 
capture for radical cystectomy.  There was also a notable proportion of cases with 
unknown diversion method (Chapter 3) excluded from the analysis.  These data 
quality related issues further exacerbated the problems of imprecision and decreased 
power of the analysis, and such were common to the Hounsome’s study (Hounsome 
et al 2013) which also used the dataset.  Nonetheless, as mentioned SWPHO-BAUS 
Dataset was considered the best available resource for investigating variation in 
neobladder use within UK on a population scale, for the reasons detailed in Methods 
(Chapter 3).  HES was a much more comprehensive dataset for radical cystectomy, 
but for the associated diversion it was only coded for conduit; there was no existent 
ICD-10 code for neobladder or any other diversion type, and the time, administrative 
and financial resources required to identify from all the cystectomy cases associated 
specifically with neobladder were unavailable.  Therefore, in order to obtain a more 
accurate idea about variation in neobladder use within the UK, efforts need to be 
invested in improving the quality of the relevant data. 
Before discussing the plausible reasons for the residual regional variations of the 
magnitudes demonstrated by the analysis, it is helpful to revisit the equation for 
geographical variation in healthcare postulated by Mulley and colleagues (Mulley et 
al 2012), based on their study on a number of other studies on variations in 
healthcare intervention delivery and uptake across a diverse range of healthcare 
settings: 
VTOT approx. = VDD-WTD + VPM  (Mulley et al 2012, p. 20) 
VTOT stands for total geographical variation for a given healthcare intervention, 
whereas VDD-WTD and VPM stand for variation in clinicians’ opinions on the intervention 
and variation in the misdiagnosis in patient preferences respectively; Mulley et al 
further asserted that the variation in aggregate health states (‘patient illness’) and 
that created by accurate patient preferences for intervention-related outcomes were 
so small which would not have contributed much to VTOT, thus omitted from the 
equation.   
To put the above equation in the thesis’ context, VDD-WTD would likely to have been 
large due to the lack of available strong evidence which demonstrated the superiority 
of neobladder over conduit in terms of outcomes available on the comparative merits 
(both clinical and Health-related Quality of Life, HRQoL), and vice versa.  However, 
the author believes that there would have been several other factors suggested as 
contributory to preference-sensitive surgical care in the literature, which were also 
operational in the equation and contributed to VTOT (Birkmeyer et al 2013).  These 
factors included the surgeon’s willingness to refer on for expertise (i.e. to another 
surgeon/centre with expertise in neobladder) and environmental factors in the 
National Health Service (NHS) including technology diffusion (adoption of neobladder 
at surgeon and organisational level), local training frameworks, supply of surgeons 
who perform neobladder and the regulatory frameworks (e.g. cancer waiting time 
targets). 
Since the introduction of neobladder as an alternative urinary diversion to conduit in 
the 1990s (Studer et al 1996; Hautmann et al 1997), there has been no level one 
evidence available; the only formalised guideline/clinical consensus on urinary 
diversion in the context of radical cystectomy to-date was published by the European 
Association of Urology in 2013 (Hautmann et al 2013), which had largely drawn upon 
the Level 2-3 evidence.  There were numerous studies on the outcomes of conduit 
and neobladder scattered in the literature, but most of these were small to moderate 
sized retrospective, single institution series (Lee et al 2014; Nabi et al 2005, Sogni et 
al 2008, Hautmann et al 2007, 2013).  The evidence for longer term follow-up was 
also lacking for neobladder, with the longest period of 10 years for neobladder (Jin et 
al 2012; Nam et al 2013; Osawa et al 2013). Another issue with the available 
evidence on the two urinary diversion was that the study populations of those studies 
comparing the outcomes of conduit with that of neobladder (or other diversion) were 
not demographically matched, which have made the results less precise and 
convincing (Nabi et al 2005; Somani et al 2009).   
As indicated by Brouwers and colleagues (Brouwers et al 2009), ‘the potential 
benefits of clinical practice guidelines are only as good as the quality of clinical 
practice guidelines’.  Undoubtedly, the quality of research evidence encompassed 
within the guidelines has direct bearing their uptake.  However, as elucidated by 
knowledge translation (KT) research, the quality of evidence alone cannot drive 
forward its uptake, but is also dependent on the development process of the 
evidence, its perceived messages to its users, and also the factors related to its 
application against the users’ perceived clinical practice norms and contexts (Palda 
et al 2007; Grimshaw et al 2004, 2006; Grol et al 1998, 2001).  Knowledge 
Translation is defined as: 
“a dynamic and iterative process that includes the synthesis, dissemination, 
exchange and ethically sound application of knowledge to improve health, 
provide more effective health services and products and strengthen the health 
care system” (CIHR) 
With the current uncertainties surrounding the quality of evidence on neobladder, 
clinicians’ opinions on the relative merits of neobladder and therefore patient 
suitability for neobladder are bound to vary.  One may expect neobladder use will 
increase as the quality of the relevant supporting evidence for its use accumulates.  
However, the subsequent uptake of neobladder will also be dependent on the other 
considerations mentioned above with KT research, along with those factors 
contributing to variation in surgical care previously mentioned above e.g. supply of 
surgeons performing neobladder and the regulatory frameworks (cancer waiting 
times).  Even with the unequivocal proof that neobladder is the superior diversion 
method and an encouraging clinical environment for its use, the uptake of neobladder 
may not increase. 
Relative to the conduit, neobladder is an innovation and this fact in itself can hamper 
the progress of its own uptake in clinical practice.  This situation concerns the areas 
of technology diffusion and local training frameworks and looking to the body of KT 
research, it may be explained by humans’ inherent nature to adhere to the familiar 
and become complacent with satisfactory results thus stop seeking for improvements 
(Van de Ven 1985; March and Simon 1958).  Conduit is arguably a technically 
simpler procedure with a simpler recovery and care routine (perhaps from more of 
clinicians’ perspective), and it has accrued an abundance of outcome data supporting 
its use over time; it is therefore understandable why some clinicians (especially 
surgeons) instinctively favour conduit.  Adoption of neobladder by a surgeon into 
his/her surgical practice may start with an open mind to innovation in general, but its 
actual use in clinical practice may only be materialised after substantial training in the 
procedure, backed by a track record of satisfactory outcomes and patient 
satisfaction, being backed by a supportive local clinical environment e.g. trained 
nursing staffs on the wards and high dependency units, a relaxed local cancer 
waiting time target and a local organisational culture which would endorse innovation 
(Denis et al 2001; Robert et al 2009; York Consortium 2009; Akenroye 2012).  There 
are multiple higher level organisational factors suggested in the literature which 
would have hampered the uptake of neobladder, ranging from financial prioritisation 
to lack of formal, systematic approach which would foster the uptake (Robert et al 
2009; York Consortium 2009). 
Referring back to Mulley’s equation for variation in healthcare (Mulley et al 2012), 
one of its elements yet to be discussed is VPM (variation in the misdiagnosis in patient 
preferences outcomes).  The degree of variation in neobladder use observed at each 
organisational level would unlikely to have been due to genuine differences in 
accurately diagnosed patient preferences in the choice of urinary diversion, given 
how widespread the problem of patient preference misdiagnosis is, particularly in the 
case of preference-sensitive decision making (which the choice between conduit and 
neobladder is).  A Cochrane review (Stacey et al 2014) demonstrated how the use of 
patient decision aids (PDAs) had significantly improved patient knowledge and 
clarified values relating to intervention outcomes, thus helped addressing patient 
preference misdiagnosis across a wide range of preference-sensitive healthcare 
decisions.  As far as the author is concerned, the body of work concerning this thesis 
is the only research attempt to explore into the decision making process concerning 
urinary diversion after radical cystectomy; furthermore, there is no patient decision 
support or PDA for the choice between conduit and neobladder after radical 
cystectomy.  A lack of understanding on how patient formed their preferences over 
their diversion options is implicated here and therefore makes patient preferences 
being accurately ascertained unlikely. 
The author also considers that both variation in clinicians’ beliefs and attitudes 
towards neobladder and that in patient preference misdiagnosis are large; these 
variations together with those factors contributing to preference-sensitive surgical 
care aforementioned, had culminated the variation in neobladder use of such 
magnitudes in the UK.  More importantly, as stated before such variations may 
potentially be unwarranted and should be rectified.   
As discussed in details in Chapter 1 (Introduction),  SDM is the potential remedy for 
unwarranted variations in healthcare; prior to rectifying the observed variations in 
neobladder use in UK with SDM, an understanding of the decision making process 
concerning the choice of urinary diversion in today’s NHS is necessary.  Through 
conducting a needs assessment of this decision making process with mixed 
methods, the author gained insights into some of the decisional needs required to be 
addressed; such insights can subsequently afford pragmatic implantation of SDM in 
the DM process, which should in time reduce the unwarranted variation in 
neobladder use within the UK.  The following sections contain discussions on further 
main findings from the needs assessment i.e. the remaining bulk of the research 
concerning this thesis, generated from cross-interpretations of the findings from the 
quantitative needs assessment survey and the qualitative semi-structured interviews. 
 
8.2 Gaps in patient knowledge for choice in urinary diversion after radical 
cystectomy exist 
An element for making a quality healthcare decision by the ideals of SDM is the 
acquisition of an optimal amount of relevant information.  The surgeons are the main 
and perhaps the very first source of information on urinary diversion for patients 
awaiting radical cystectomy, and the information may be enhanced further through 
encounters with the specialist nurses and individuals outside the responsible clinical 
team, as well as exposure to supplemental information materials in assorted formats 
(Chapter 6, Sections 6.2 – 6.4; Chapter 7 Sections 7.2 – 7.4).  Before further 
discussions on the knowledge gap demonstrated by this thesis’ work, it is perhaps 
useful to state that it was outside the remit of the work undertaken for this thesis to 
evaluate what constituted the optimal/the minimal level of relevant knowledge 
required for a making a quality decision on diversion by SDM standards; neither did 
this work aim to formally investigate into what would constitute relevant patient 
knowledge for this decision, or to formally assess the level of patient knowledge.  A 
number of decisional quality (DQ) measurement tools are available though, some of 
which include a formal assessment of the level of patient knowledge specific to a 
healthcare decision (Sepucha and Fowler 2013; Chapter 1).  To date there is no such 
a DQ measurement tool available for the decision on urinary diversion after radical 
cystectomy.   
What the research conducted for this thesis provided was a broad overview on 
patients’ knowledge acquired for the choice of urinary diversion after radical 
cystectomy.  From the survey and interview findings, there was certainly room for 
enhancement of this patient knowledge.  Although the overall level of patient 
satisfaction with information in relation to both diversion methods was high (Chapter 
5, Section 5.1.2) and in general the clinicians would inform their patients very often if 
not every time, about the information relevant to both diversion methods; however, 
not ALL patients who encountered the choice of diversion were very satisfied and 
clinicians did not necessarily inform their patients every time about all the information 
areas relevant to each diversion methods.  This situation is unacceptable according 
to the ideals of SDM.  
With specific regards to the patient survey, not every patient respondent reported 
maximum level of satisfaction with all information areas discussed for each of the two 
diversion options.  Moreover, the percentages of very satisfied or satisfied patients 
vary among different information areas for a given specific diversion option; there 
was also a discrepancy in the percentage of very satisfied or satisfied patients 
between the two diversion options for each information area (Chapter 5, Section 
5.1.2).  Also of note was that, for both diversion options, benefits, risks and course of 
recovery were the three information areas with the highest percentages of very 
satisfied or satisfied patients; on the other hand, employment/retirement, leisure/sport 
and sex were the topics with the fewest for conduit patients; as for the neobladder 
patients, peer support rather than employment/retirement had become one of the 
three information areas with the fewest very satisfied or satisfied patients.  Such 
findings indicated that the clinicians might have placed more emphasis on more 
clinically-orientated topics such as benefits, risks and course of recovery; this 
argument was supported by the fact that these three information areas were 
incidentally the ones well-covered (covered every time/very often) by the highest 
percentages of clinicians (Chapter 5, Section 5.2.2).  As discussed later, 
employment/retirement and leisure/sports are among the many important 
considerations in the choice of diversion from patients’ perspective (Chapter 6, 
Section 6.5.3 ‘Bob’, ‘Ed’, ‘Jim’ and ‘Dave’).  Information provision and discussion with 
patients on these two areas (and indeed on all the other areas listed in the survey 
and any other ones concerning individual patients) should not be trivialised or 
ignored.  The topic of sex was associated with the fewest patients who were very 
satisfied or satisfied.  Furthermore, sex is a significant part of peoples’ normality, and 
surgery which would lead to a significant change to body image (conduit with the 
formation of a urostomy) may also have a significant consequent impact on sexual 
life.  The literature has largely focussed on the inter-relationships between bowel 
stomas, body image and impact on sexuality and sexual life (Sharpe et al 2011, 
Black 2004, Manderson 2005, Brown and Randle 2005) but one can deduce that  
many of these findings would still hold true if urostomy was researched into. 
For any one topic discussed for one of the two diversion option, some patients bound 
to be more satisfied than the others with the topic-specific information provided; 
instead of labouring over how many unsatisfied as opposed to satisfied patients there 
were, a more constructive question to ask here is why should some patients be less 
satisfied?  Two plausible reasons for this were offered by the interview data; one 
being the perceived insufficiency in the amount and depth of information for a more 
informed, less biased comparison of the relative merits and disadvantages of the two 
diversion options (Chapter 6, Section 6.5.3 p. 30 ‘George’; p.31 ‘Tony’); the other 
being patient dissatisfaction with the delivery of information, which may include timing 
and languages used, and the perceived clinicians’ manners in which the information 
was provided (Chapter 6, Section 6.5.3 p. 30 ‘George’).  Another possible reason for 
reduced satisfaction was that the information provided was perceivably negative e.g. 
undesirable outcome of urinary incontinence when discussing about risks.  Statistical 
testing (Wilcoxon test, Chapter 5 Tables 5 and 6) did not demonstrate any significant 
difference in the level of satisfaction between the two diversions across all topics, but 
this could be due to artefacts associated with analysing with a relatively small study 
population.   
Perhaps a more worrisome finding from the survey was that there were few instances 
where certain topics were not discussed for either diversion option (Chapter 5, 
Section 5.1 Tables 3 and 4).  There was no further elaboration on the reasons for 
such in the surveys or the interviews.  Some assumptions can be made here.  
Patients might not recall having discussed these topics with their responsible clinical 
team, and that the responsible clinicians in the team (the surgeons and the nurses) 
assuming that each other have already covered the topics without checking with the 
patient (Chapter 7, p.14 ‘Oscar’ and ‘Donna’).  The lack of communication between 
the surgeons and the nurses and clarity over each other roles can lead to patient 
misinformation, as well as patients’ overall satisfaction with their care (Moret et al 
2008). 
With specific regards to the clinician survey, information coverage (by percentages 
and Wilcoxon test) was higher for conduit than for neobladder.  This could be 
secondary to the differential roles among the clinician respondents; for instance, 
11.9% of the nurse respondents (Chapter 5, Section 5.2.2 p. 23) declared that they 
were stoma nurse specialists, hence it was outside their remits to discuss with 
patients about neobladder; some of the nurse and surgeon respondents might have 
under/or not discussed about neobladder as they might have delegated the task to 
their colleagues who have the expertise in the procedure.  However, of course there 
remains the possibility that the surgeon and nurse respondents assumed that each 
other have already covered topics about neobladder.  It was also interesting to note 
that nurse respondents reported not only better coverage for all topics for both 
diversion, but particularly so for topics concerning post-discharge care and patient’s 
psycho-social wellbeing e.g. body appearances better than the surgeons 
respondents (Chapter 5,Section 5.2.2, Tables 5 and 6); this again could be due to the 
perceived roles of the nurse respondents, and due to their roles they were given 
more time in their organisation with the patients, to ensure coverage of these issues; 
moreover, perhaps nurses were trained to be more holistic in their approach to 
patient care, especially during consultations? (Stein 1967, 1990; Sweet and Norman 
1995; Hughes 1988) 
The variation in the level of satisfaction reported for each information area discussed 
for the respective diversion option might also be attributed to the variation in patient 
satisfaction with the amount and quality of that information (e.g. depth and 
readability) (Coulter et al 1999, Godolphin 2001) and the manner in which information 
was delivered (Weiman 1998).  Another potential explanation was that some patients 
were experiencing regrets from negative outcomes related to certain information 
areas discussed, which led to reported dissatisfaction with the corresponding 
information; association between post-decisional regrets from negative treatment 
outcomes and dissatisfaction with the corresponding treatment-related information 
had been established in the literature (Sheehan et al 2007, Vogel et al 2007). 
Nonetheless, patients are not necessarily well informed even all the topics were 
discussed every time and they were maximally satisfied with the corresponding 
information, as exemplified by the qualitative interview data (Chapter 6, Section 
6.2.1.2 ‘George’, ‘Martin’, ‘Carol’, ‘Dave’; Section 6.5.1 ‘Martin, ‘Steve’, ‘Wife of Fred’, 
‘Greg’, ‘Pete’; Section Section 6.5.3 ‘Dave’, ‘Tony’).  Preparing patients well for 
participation in SDM in terms of knowledge is much beyond simply providing them (if 
not overwhelming them) with an abundance of relevant, accurate information.  
Patients have varying individual information needs; and in order for patients to make 
a quality decision by SDM standards, they need to retain, understand and be 
encouraged to use the information to address their personal values and preferences 
(Joseph-Williams et al 2013).  Unfortunately, information concerning the choice of 
diversion is complex and large in amount; and by nature humans are not good at 
dealing with complexity, remembering and reflecting complex information (Johnson 
1983; Van da Ven 1983).  Therefore, to ensure the utility of patient knowledge 
especially in the choice of urinary diversion after radical cystectomy can be a real 
challenge.  Given the gravity of the decision to individual patients, clinicians should 
endeavour to enhance the level of relevant patient knowledge and its utility.  Some of 
the clinicians interviewed reported a number of ways to improve patient knowledge, 
including having more than one clinician delivering information related to the 
diversion options, over separate consultations (Chapter 7. Section 7.2.1, ‘Nancy’, 
‘Linda’, ‘Helen’); using an aide-memoire documenting the information discussed 
during the consultation (Chapter 7, Section 7.2.1, ‘Sue’) and the use of supplemental 
information resources, which is discussed further below.   Some clinicians also 
reported assessing patient knowledge for the choice, but this was conducted 
informally (e.g. asking patients if they understood about certain recovery routines, 
clarifying with patients their questions related to the diversion options) (Chapter 7 
Section 7.2.1, ‘Linda’, ‘Helen’).  A formal assessment tool of patient knowledge may 
ensure the comprehensiveness and accuracy of patient knowledge acquired for 
choice.  Indeed, the interview data highlighted multiple instances where patients were 
misinformed and this would in turn lead to a choice of diversion based on biased and 
if not, erroneous ideas (for example Chapter 6 Sections 6.5.2, ‘Martin’, ‘Ken’, ‘Steve’, 
‘Wife of Fred, ‘Pete’),  Another way reported by the clinicians interviewed to enhance 
patient knowledge in the context of urinary diversion after radical cystectomy was to 
provide them with realistic benefits and risks associated with each of the two 
diversion procedures concerned, with the aid of demonstrative appliances, former 
patients’ experiences and by making clear to patients about local outcomes 
associated with each of the two diversion procedures (Chapter 6 Section 6.2.2 ‘Mike’, 
‘Steve’, ‘Ed’, ‘Arlene’; Chapter 7 Section 7.2.1 ‘Kumar’, ‘Freda’, ‘Nancy’, ‘Donna’).   
 
8.3 Use of supplemental information materials may help enhancing patient 
knowledge and therefore promoting SDM in practice  
Supplemental information materials differ in their authorship, readership, format and 
quality.  In terms of authorship, this ranges from professional bodies to laymen.  
However, the main emphasis should be on quality rather than authorship, and 
authorship does not necessarily confer quality.  No assessment into the commonly 
used information materials was made, as this was outside the remit of the research 
concerning this thesis.  According to the patients and clinicians interviewed, such 
materials could not replace a face-to-face patient-clinician and/or patient-former 
patient encounters, where information regarding diversion options was provided 
and/or exchanged (Chapter 6 Section 6.4, ‘Tony’ and ‘Brian’; Chapter 7 Section 7.4 
‘Ena’).  Nonetheless, when selected and used appropriately these supplemental 
information materials could be invaluable for making a quality decision on which 
diversion to proceed with, in accordance to SDM ideals (Chapter 7 Section 7.4 ‘Bob’s 
wife’ and ‘Tony’).  The quality of these materials may be judged on many domains 
(layout, readability, language used etc.); there are already numerous evaluative 
scales available, such as EQIP and DISCERN (Moult et al 2004; Charnock et al 
1999).  In the context of SDM, many supplemental information materials are of poor 
quality (Goldophin 2001; Coulter 1999), with the common pitfalls of lacking in 
relevant or including biased information on treatment options and patronising 
language  (Chapter 6, 6.4 ‘Sharon’ and ‘Pete’).   
The layout of the information material can also lead to biased information provision, 
particularly when there is more than one healthcare option, as illustrated by the 
interviews; for instance, the ‘well presented, nicely packaged’ commercialised 
information/training pack for urostomy (Chapter 7 Section 7.4 ‘Freda’, ‘Oscar’)and 
separated information booklets for each corresponding diversion, hence no side-by-
side comparison of the information about the two diversion options available (Chapter 
6 Section 6.4 ‘Pete’).   
Overall the current literature is supportive for the use of supplemental information 
materials (Shepherd et al 2008) in healthcare decision making, but it also advises 
that their use should be coupled with due considerations on individual patient 
characteristics, such as education and literacy level, ethnic and cultural background 
and the nature of the decision (e.g. urgent versus non-urgent; surgery versus medical 
therapy).  Another consideration regarding the use of these materials is the timing of 
their provision to patients.  This consideration is also applicable to the use of patient 
decision support such as PDAs.   Some clinicians interviewed reported concerns 
over exacerbating patient’s anxiety when providing the relevant materials too early 
i.e. before the consultation when the issue of urinary diversion would be mentioned 
(Chapter 7, Section 7.4 ‘Jane’).  Indeed, there are ambiguities over the optimal timing 
of administration of supplemental information materials/PDAs in the literature, which 
indicates a need for further research into this area. 
Supplemental information materials also vary in formats, and there bound to be 
varying personal preferences over format.  In general, as demonstrated by the 
survey, the written format was reported as very helpful or helpful by the greatest 
number of clinician and patient respondents (Chapter 5 Section 5.2.4).  The variation 
in personal preference over format could be secondary to availability, access and 
user-friendliness.  Availability issue was raised with the materials in both the 
DVDs/Video and Audio formats, by both the patients and clinicians surveyed 
(Chapter 5 Sections 5.1.4 and 5.2.4).    It was also interesting to note that 
significantly more nurse respondents found DVDs/Videos and Audios very helpful or 
helpful.  This could be due to their relative familiarity with the access and use of 
materials in these formats.  In the interviews some clinicians expressed the view that 
patients of older age and lower socio-economic class might not find more 
technologically based information materials requiring helpful (Chapter 7 Section 7.4, 
‘Niran’, ‘Freda’); this could be due to stereotyping on some clinicians’ part, but there 
was also evidence in the interview supporting the clinicians’ views (Chapter 6 Section 
6.4 ‘Bill’ – no access to Internet due to his socio-economic circumstances).   
The written format was seemingly the most favoured format, perhaps due to the ease 
to navigate (Chapter 6, Section 6.3 ‘Bob’s wife’) and relatively lower cost for 
production.  In the ideal world, a given supplemental information material should be 
available in all formats; but in a healthcare system where financial resources in 
particular are rationed, and the best format would probably be the most cost-effective 
format.  The data also demonstrated that both patients and clinicians were generally 
less enthusiastic about the use of internet information, and this could be due to their 
concerns over information quality and credibility (Chapter 6 6.4 ‘Jim’; Chapter 7 
Section 7.4 ‘Nancy’, ‘Niran’).    Internet information in general is of varying quality 
(Eyesenbach et al 2002); uncontrolled access to Internet information can negatively 
impact on clinician-patient relationship, with patients having erroneous pre-
conceptions about their healthcare options, making the discussions around these 
options with their clinicians challenging; extra time and efforts might need to be 
afforded by the clinicians to clarify patients’ misconceptions prior to making the 
relevant healthcare decision (McMullan 2006; Murray 2003); as put across by one 
clinician interviewee’s perspective, the use of internet information by patients had 
translated in a ‘logistical nightmare’ (Chapter 7 Section 7.4 ‘Nancy’).  A more robust 
system co-developed by patients and clinicians such as NHS Choices is required for 
the decision concerning urinary diversion after radical cystectomy, to evaluate the 
quality and utility of supplemental information materials which could be relevant to 
the decision; as a result recommendations can be made to patients facing the choice 
of diversion, to make the best use of the best available materials. 
When asked about the preferred future format for a purposely-constructed decision 
support for the choice of diversion after radical cystectomy, most of the respondents 
(both patients and clinicias) in the survey once again chose the written format 
(Chapter 5 Sections 5.1.7 and 5.2.11).  No one chose Audios perhaps due to the 
concern over the lack of visual prompts.  Nonetheless, a combination of different 
formats should be considered, as indicated by the respondents (Chapter 5 Sections 
5.1.7 and 5.2.11) 
Another point to be made is that a distinction needs to be drawn between 
supplemental information leaflets and formal decision support e.g. PDAs; the former 
is for informed decision making, whilst the latter for SDM; and the difference between 
informed decision making and SDM is that the latter incorporate knowledge and 
clarified personal preferences in reaching a healthcare decision (Elwyn et al 2010).  
Indeed, conflation about informed decision making and SDM is still commonplace, as 
demonstrated by the patients and clinicians involved in this research and in other 
healthcare contexts (Marteau 2009).  This issue needs to be urgently addressed 
which would otherwise hasten the progress of SDM implementation in the decision 
concerning this thesis and in general. 
 
 
 
8.4 Surgeon’s opinion trumps patient’s choice of urinary diversion 
The title of the seminal paper by Cathy Charles (Charles et al 1997), ‘Shared 
decision-making in the medical encounter: what does it mean? (or it takes at least 
two to tango)’, in itself implied that at least two parties should be involved with each 
other in a collaborative fashion, in order  to reach a healthcare decision .  However, it 
appeared that in the decision regarding the choice of urinary diversion after radical 
cystectomy within UK, the tango was dominated by the surgeons who would perform 
the operation.  In the UK’s context, there should be three fundamental parties 
involved in the decision, including the operating surgeons, the counselling specialist 
nurses and the patients.  However, it is usual practice for the operating surgeon to 
make the initial decision whether the patient is suitable for either diversion options 
holds the initial discussion with the patient about the choice of diversion. 
With reference to Chapter 1 (Introduction) and the earlier discussions on variation in 
neobladder use (Chapter 9 Section 9.1), there remain many uncertainties over which 
of the diversion options is superior, confounded by some ambiguities over the contra-
indications to formation of neobladder.  Within the confines of the current evidence, it 
can be challenging for the operating surgeons to decide which patient would be 
eligible for choice i.e. having a choice between conduit and neobladder and variation 
in surgeons’ opinion over choice eligibility is to be expected.  The interview data 
suggested that surgeons’ concerns over anticipated clinical outcomes associated 
with neobladder drove the surgeons’ decision on whether a patient would be suitable 
for a choice, and the factors considered by the surgeons in their determination of a 
patient’s eligibility for choice could categorised into that related to 1) patient 
characteristics and 2) surgeon and organisational characteristics.  Patient 
characteristics include age, medical fitness, as well as the perceived patient’s 
motivation and physical capacity to care for neobladder, whereas surgeon and 
organisational characteristics include surgeons’ and the organisations’ set up 
(Chapter 6 Section 6.2.1.3 ‘Steve’; Chapter 7 Sections 7.1.1 and 7.1.2). 
As in the literature (Hautmann et al 2013, Lee et al 2014) old age per se was not an 
absolute contraindication but there are potential associations between advancing age 
and negative outcomes of neobladder.  For instance, the elderly are generally less 
medically fit, with deteriorated level of eye-hand co-ordination and possible existing 
cognitive impairment, which hampers the progress of achieving a functional 
neobladder with a set of complicated initial care routine (Chapter 1, Section 1.1.4).  
Overall the outcomes in the more elderly patients selected for neobladder, 
particularly those concerning the functions of the neobladder, remain highly 
debatable.  In the literature there is evidence that good outcomes can be achieved in 
octogenerians (Sogni et al 2008; Saika et al 2008; Hautmann et al 2011; Taneka et al 
2009; Kassoul et al 2010), but these studies were conducted in pioneering high 
volume centres for neobladder, with high volume surgeons and vigorous, regimented 
peri-operative care arrangements and experienced clinical staff supporting  
neobladder use; neobladder patients from these centres also tend to be of higher risk 
of developing negative outcomes in the current clinical attitude  (elderly/female/more 
co-morbidities).  Therefore, the generally reserved attitude among clinicians 
(particularly the operating surgeons) towards offering more elderly patients 
neobladder in addition to conduit is perhaps understandable (Chapter 7 Section 7.1 
‘William’, ‘Niran’, ‘James’).  Accrued good surgical outcomes and experience with the 
surgeon and his/her organisation can boost the surgeon’s confidence in the 
neobladder operation, leading to changing thresholds in patient selection for 
neobladder e.g. operating in older patients (Chapter 7 Section 7.1 ‘William’, ‘Niran’).  
However, the interview data suggested that some of the more experienced surgeons 
oversaw patient’s chronological age and look for other indicators for the suitability of 
neobladder (Chapter 7 Section 7.1 ‘William’), but it remains unclear how many of the 
surgeons would adopt this attitude.  Indeed in the literature, some authors raised the 
importance to focus on medical fitness rather than chronological age of a patient, 
when considering his/her suitability for having a choice between neobladder and 
conduit (Lee et al 2014). 
Another point for discussion regarding age was that some of the clinicians 
interviewed reported ambivalence towards advancing age when considered offering 
of neobladder.  As mentioned above, good outcomes with neobladder were 
achievable with patients who are more elderly at the time of the operation, but these 
outcomes were reported in pioneering centres with the expertise on neobladder.  
Perhaps a more interesting question to ask would be: what would happen to now the 
younger, fitter neobladder patients when they have become older and frailer, 
physically and/or mentally incapable to manage their neobladder and complications?  
This is a largely unanswered question due to lack of longer-term follow-up data on 
neobladder as mentioned above.  Some clinicians may hold a rather sceptical 
outlook on long term outcomes on neobladder – as one of the surgeons interviewed 
expressed, ‘we could storing up a whole load of problems’ (Chapter 7 Section 7.1 
‘Karl). 
With regards to outcomes of neobladder, there bound to be variations among 
different surgeons and centres as discussed above.  During the discussions 
regarding diversion options, the surgeon’s disclosure of personal versus literature 
based outcomes is contributory to both informed decision making and SDM.  This 
disclosure concerns the quality of patient knowledge which would inevitably impact 
on the quality of the decision over diversion, in SDM terms.  The interview data 
suggested that some surgeons interviewed were honest about their own outcomes to 
their patients (Chapter 7 Section 7.2 ‘Kumar’, ‘James’) and were willing to refer 
patients to their colleagues in another centre with more expertise in neoladder.  
However, there were no data suggesting how the discussions regarding local 
outcomes and referral were materialised.  Moreover, some of the surgeons 
interviewed reported that their patients did not take to the referral for the neobladder 
procedure in another centre, even when offered (Chapter 7 Section 7.2.2, ‘James’); 
this was only in partial agreement with the current evidence (Robertson and Dixon 
2009; Dixon et al 2010), which showed nearly half of the patients who were provided 
with the choice between local and non-local providers for specialist input, would 
accept the latter.  Also of note was that the more elderly or and educated patients 
were shown to be more willing and ready to take on non-local providers, whereas 
those who were without access to a car were less likely to do so.  The underlying 
reasons for uptake of out-of-area referral for a healthcare service (including choice of 
diversion) may be dependent on the nature of the referral, the relative specialism and 
quality related to the service offered, age and socio-economic circumstances of 
individual patients.  Such circumstances may become barriers to accessing higher 
quality healthcare in another location, and are potentially modifiable at an 
organisational level e.g. subsidising patient and family transport.  There is also the 
question of whether patient’s value in staying with the same clinician (surgeon) and 
attitudes towards access to own family/social network would impact on the uptake of 
out-of-area referral.  There has been some evidence some patients prefer to stay 
with the clinicians with whom they have an established trustful relationship, 
regardless of the clinicians’ ability to offer the best quality of healthcare by clinical 
outcome measures (Conner-Spady et al 2008).   A clinician’s (surgeon’s) willingness 
to refer may also depend on the adoption of ‘practice-makes-perfect’ versus selective 
referral systems (Luft et al 1987).  A surgeon who wishes to build up his/her 
neobladder practice may be less inclined to refer patients to centres with higher 
practice; however, this must be balanced against important, ethical considerations 
such as the acceptability of complication figures, given that literature has already 
considered a proportional relationship between neobladder outcomes and case-
volume of a surgeon and/or a centre.  This poses a ‘Catch-22’ situation, where 
patients choosing to undergo the neobladder procedure may be better served in the 
hands of high volume surgeons/centres, but inexperienced surgeons/centres need to 
increase case volume in order to improve outcomes.  Whether the patient’s locality 
has the appropriate level of clinical support would also influence a surgeon’s decision 
in offering neobladder (Chapter 7 Section 7.1 ‘Peter’). 
Whilst there is evidence to guide the surgeons on patient selection for neobladder 
based on measurable patient characteristics such as age, medical fitness, there are 
no objective measures on motivation to care for neobladder.  In the literature ‘lack of 
motivation to care for neobladder’ is considered as an absolute contra-indication for 
neobladder (Lee et al 2014) but assessment of this by the clinicians, as the interview 
data indicate, is somewhat subjective and at times based on the patient’s outer 
appearances and lifestyle (e.g. alcoholism) (Chapter 7 Section 7.1, ‘Anil’, ‘Emma’, 
‘James’).  A patient who is deemed under-motivated by the clinicians may not have 
been offered the choice and actively persuaded to elect for conduit instead.  An 
interesting view by a surgeon interviewed about motivation was that, motivation is 
required to care for either diversion, if a patient is not engaged then he/she unlikely to 
look after any of the diversion well (Chapter 7 Section 7.1 ‘Oscar’).  However, the 
consequences of not looking after neobladder well would be potentially life-
threatening (neobladder rupture) particularly when the patient is hypercontinent, and 
patient safety is perhaps the main concern of many clinicians in their judgement if a 
patient is suitable for neobladder, as well as conduit (Chapter 7 Section 7.1 ‘Jane’ 
and ‘Ena’). 
 
8.5 Inter-professional relationship influences the choice of diversion  
Further data from this research indicated that although the surgeon and nurse 
respondents generally acknowledged each other’s positive impact on the decision 
making process, (Chapter 5 Section 5.1.3), their inter-professional dynamics had not 
always been harmonious (Chapter 7 7.2.1 ‘Peter’, ‘Freda’, ‘Emma’).  Given that the 
level of inter-professional collaboration is proportional to patient outcomes (Larson 
1999; Baggs et al 1999; Frank 2009), it is imperative to identify factors and strategies 
for sustaining a constructive relationship between the surgeons and the nurses, in 
and outside the realm of SDM.  Sometimes disagreement and negotiation between 
the two professional parties are necessary for patients’ best interest, and from the 
perspective of some of the nurses interviewed, their surgeon colleagues tended to 
have a prior preference over which diversion they wished their patients to proceed 
with; subsequently the surgeons framed their information provision around the 
diversion options to patients, mooted their idea of the preferred diversion in patients’ 
mind (Chapter 6 Section 6.2.1 ‘Terry’, ‘Steve’, ‘Ed’; Chapter 7 Section 7.1 ‘William’ 
and  Section 7.2.1 ‘Emma’).  Some patients would then conform to the surgeon’s 
wish against the backdrop of power imbalance in the doctor-patient relationship.  
Some of the nurses interviewed reported addressing this power imbalance to a 
certain extent, by their advocating patient’s views and preferences in the decision 
regarding diversion to their surgeon colleagues (Chapter 7 Section 7.2.1 ‘Nancy’).  
With reference to the SDM literature, trust of patients in their doctors, patients 
undervaluing their own knowledge as well as their wish to be viewed as ‘good 
patients’ (by conforming to doctors and not asking questions or providing their own 
opinions) were the main patient reported barriers to SDM (Joseph-Williams et al 
2013).  The experience of surgeons may also play a role in SDM in the context of this 
decision regarding diversion. Some of the nurses interviewed reported of their 
struggles with having their opinions acknowledged regarding their patients’ 
preferences and professional views on patients’ suitability for diversion, particularly 
with the older and/or more experienced surgeons (Chapter 7 Section 7.2.1, ‘Freda).  
This can be linked to the literature finding that the younger and/or less experienced 
surgeons were apprehensive of their older, more experienced trainers in participating 
in SDM, from their training experience with them (Zenuer et al 2014). 
 
 
 
8.6 Others outside the responsible clinical team are also influential in the 
decision making process 
Many patients who were involved in this research reported the input from both the 
responsible clinical team and those outside the team as helpful in decision making 
process.  Interestingly, among those patient respondents who selected their 
responsible clinicians as helpful, approximately half of them selected both their 
surgeons and nurses with another 41% only selecting their surgeons (Chapter 5 
Section 5.1.3). This in part highlighted once again the power imbalance in the 
patient-doctor relationship. 
With regards to the others outside the responsible clinical team, both the clinicians 
and patients involved in this research reported spouse, former patients and family 
members/relatives/friends as helpful in the decision making process (Chapter 5 
Sections 5.1.3 and 5.2.3; Chapter 6 Sectios 6.3.1 and 6.3.2).  The interview data 
suggested that spouse and family members helped to enhance patient knowledge 
relevant for the decision on diversion through knowledge clarification, helping 
patients to retain information and obtaining additional relevant information with use of 
technology and social network (Chapter 6 Section 6.3.1 ‘Ian’, ‘Terry’, ‘Carol’).  
Therefore, spousal and family input should not be underestimated; for certain health 
conditions such as that for dementia and end of life care, it was clear from the 
relevant research that involvement of spouse, family and carers were imperative for 
good decision making in patient care (Simnoff 2013). 
With particular regards to spousal influence – it is not a new subject in medical 
decision making (Miller et al 2014).  From the interview data, some of the spousal 
interactions constituted negotiated decision making (Chapter 6 section 6.3.1 ‘Steve’, 
‘Mike’s wife; Chapter 7 Section 7.3 ‘Sue’ ‘Norman’), but in other cases the spouse 
kept quiet in order to minimise his/her influences on the patient’s decision (Chapter 6 
Section 6.3.1 ‘Mike’s wife).  Spousal involvement is frequently studied in the research 
on the impact of bowel stoma.  It is well known that the decision to undergo stoma 
forming surgery places significant physical and emotional demands on the spouse; 
furthermore, spousal support, both physical and psychosocial, is central to stoma 
patients’ recovery (Mansson et al 1991; Altschuler et al 2009; Persson 2004) and 
certainly impacts on spousal intimacy (Burnham et al 1977; Manderson 2005; 
Danielson et al 2013).  The effects of stoma formation on spousal relationship are 
profound, and some research evidence demonstrated that this relationship would be 
modified to a certain extent, with gender role re-negotiations between the spouses, in 
an attempt to preserve the known ‘normality’ before surgery (Manderson 2005). 
Another group of influential individuals outside the responsible clinical team are the 
former patients.  As suggested by the interview data, they can provide lived 
experiences but whether such are facilitative for decision making in the context of 
SDM remains debatable experiences (Chapter 6 Section 6.3.2 ‘Martin’, ‘Ed’, ‘Jim’ and 
‘Mike’).  Some of the clinicians interviewed raised the question of which former 
patients should be put in touch with the pre-operative patients, with concerns over 
some of the former patients providing unrealistic pictures and biased opinions about 
the diversion they were living with (Chapter 7 7.3 ‘Norman’).  Those clinicians 
interviewed and in support of pre-operative encounters with former patients reported 
that pre-operative patients should be exposed to both conduit and neobladder 
patients, with or without complications in order to get a more balanced comparison of 
the two diversion options (Chapter 7 7.3 ‘Niran’).  Nonetheless, there is currently no 
guidance on but what constitutes a balanced view and how to objectively obtain such 
a view.  For instance, how many former patients and what kind of former patients 
should a pre-operative patients meet?  Should the pre-operative and the former 
patients be matched demographically and/or socioeconomically?  These are just a 
couple of the many questions to be answered in the matter of using former patients’ 
stories in the contexts of this research and SDM.  
In current literature, the use of patient stories in formal decision support e.g. PDAs is 
contentious as no guidelines on how to select patient stories, and the use of patient 
stories in itself can be in tension with the central ideals of SDM, with regards to 
provision of unbiased patient information (Butow 2005).  Furthermore, the use of 
patient stories runs the danger of patients fixating to the former patient’s experiences 
rather than the underlying message regarding risks and benefits (Chaiken 1980).  
The impact of patient stories may also depend on their persuasiveness, and 
‘vividness’ increased pervasiveness.  Emotional interest, proximity and concreteness 
of information all lend information its credibility and vividness thus pervasiveness, but 
it is difficult to assess these mediators for pervasiveness a variety of scales are 
available for use.  Another criticism regarding the use of patient stories is that, often 
hypothetical scenarios with normal populations are used to construct these stories; 
such varied in length and most of these stories did not provide guidance on how to 
make a good decision in SDM terms (Winterbottom et al 2008). 
 
8.7 Current decision making process regarding diversion options has 
incorporated some features of SDM 
Some data of this research indicated that some features of SDM had already been 
incorporated into the current pre-operative consultation procession for urinary 
diversion after radical cystectomy.  Firstly, holding more than one consultation with 
patients about the diversion; Secondly, nurses and surgeons were consulting with 
patients, with engagement of other individuals outside the responsible clinical team 
(Chapter 7 Section 7.2.1 ‘Linda’, ‘ Abigail’, ‘Nancy’, ‘Donna’, Section 7.3);  these two 
features of consultation process realise the theory of distributed healthcare decision 
making (Rapley 2008), where a decision is made over several consultations over 
time, with encounters with different parties and different technologies employed to 
reach the decision.  Moreover, some of the clinicians interviewed reported explicitly 
asking the patients to explain their choice, in order to elicit and understand their 
preferences.  (Chapter 7 Section 7.2.1, ‘Nancy’, ‘Linda’).  However, it is unclear from 
the data how systematic and comprehensive the clinicians are in their attempts to 
elicit patients’ preferences.  One of the surgeons interviewed also reported asking his 
patients to defer in confirming decision over which diversion to proceed with (Chapter 
7 Section 7.2.1 ‘Norman’).  Afterall, in the literature explicitly asking patients to defer 
decision for a more detailed consideration over option available to them is pertinent 
to SDM (Makoul and Clayman 2006, Stigglebout 2012). 
Pre-operative patient education on the care routines for each diversion can facilitate 
SDM in the context of urinary diversion after radical cystectomy.  The education is 
usually delivered by the nurses, which includes a simulated life with urostomy and 
idea about and/or experience of intermittent self-catheterisation (ISC); it helps 
managing patients’ expectations about living with either diversion and allows a more 
realistic comparison between the two diversion options (Chapter 6 Section 6.2.2; 
Chapter 7 Section ).  Moreover, as discussed previously, teaching patients about 
urostomy care and ISC also provide patients the chance to adjust to these care 
routines.  In all, pre-operative patient education on diversion care routines can 
enhance patient’s readiness to participate in the decision making process, more in 
accordance to the standards of SDM (Measuring SDM NHS right Care 2012).  
The advantages of teaching ISC are as outlined above, and there is a variation in 
how ‘hands-on’ the teaching is as delivered by the nurses.  Some of the nurses 
interviewed reported certain circumstances where they felt justified for not asking 
patients to physically perform ISC competently before surgery, for instance significant 
lower urinary tract symptoms from the bladder cancer and the propensity to bleed 
from the cancer lesion (Chapter 7 Section 7.2.1 ‘Helen’).  There were instances 
where ISC was not taught or even mentioned at all, and the reasons were perhaps 
less justifiable, which included the lack of time to fit in teaching session before 
surgery and the perceived low risk for the need of ISC from local experience 
(Chapter 7, Section 7.2.1 ‘Stephen’ and ‘Helen’ ).  Patients undergoing neobladder 
might have underestimated the risk of requiring ISC, as well as the physical and 
mental challenges of ISC, should it become a necessity (Chapter 6 Section 6.1.2 
‘Bill’). 
 
8.8 Patients choose the diversion which is expected to best match with their 
known normality 
As suggested by the interview data, patients consider a number of factors in 
choosing a diversion and their deliberation can in part shaped by the information 
provided by their responsible clinicians (Chapter 6 Sections 6.2.1, 6.4, 6.5; Chapter 7 
Section 7.2).  They demonstrated a tendency to choose the diversion which would 
cause the least anticipated disruption to their known normality.  This normality 
includes body image, being free or significantly debilitated from complications from 
surgery, survival through surgery, work life and hobby, and intimacy. 
With specific regards to external body appearance, the interview data suggested that 
an individual patient’s self-perceived level of acceptancewith the presence of a stoma 
was very much implicated in the choice between conduit and neobladder (Chapter 6 
Section 6.5.1 ‘Ian’, ‘Bill’, ‘Sharon’; Section 6.5.3 ‘Ken’, ‘Ed’ ).   The issue of stigma 
related to stoma has long been known in the literature (Sontag et al 1977, 
MacDonald et al 1988, Briggs et al 1977); and among those who live with a stoma, 
they often experience a major shift in body image (Slater 1992, Jenks et al 1997, 
Persson and Helstrom 2002, Nordstrom and Nyman 1991), negative impact on 
sexual life they are often in tension with managing their public and private self (Kelly 
1992; Helman 1995).  Those who perceive themselves as being able to successfully 
conceal the stoma when presenting their public self would perhaps be more open to 
the idea of conduit, with balancing of personal values on other outcomes related to 
each of the diversion option (Chapter 6 6.5.1 ‘Ian’, ‘Bill’, ‘Sharon).  Coping strategies 
employed are often surrounding concealment, for instance, with clothing (Chapter 6 
6.5.1 ‘Sharon’) (Helman 2005) but even with successful concealment, a sense of 
having a secret, ‘looking normal but not being so’ and the worry about being ridiculed 
often remain (Kelly 1991 and 1992).  Indeed, with time many people living with a 
stoma reported psycho-social adjustments to life with a stoma over time, and the 
level of self-care and amount of social support are the main predictors of the cope 
level of person living with a stoma (Knowles et al 2014; Brown and Rendall 2005).   
Another main consideration is urinary incontinence.  However, as suggested by the 
interview data, what underlies the impact of urinary incontinence on choice of 
diversion is again, stigma and its management.  It is well known in the literature that 
urinary incontinence can significantly impact on patients’ quality of life, partly due to 
perceived stigma (Paterson 2000; Bradway 2003; Heintz et al 2013; Avery et al 
2013).  It is interesting to note that some of the interviewed patients suggested 
varying confidence with managing incontinence/staying dry with each respective 
diversion option (Chapter 6 Section 6.5.3 ‘Sharon’, ‘Bill’). 
Apart from pelvic floor exercise, intermittent self-catheterisation (ISC) is another 
means to control urinary incontinence for neobladder.  As discussed before, ISC is 
an invasive procedure and some patients may be so overwhelmed by the idea of ISC 
and therefore did not even deliberate further on neobladder (Chapter 6 Section 6.5.3 
‘George’, ‘Dave’).  Apart from the apparent physical discomfort caused by the act of 
ISC, the sense of fear and embarrassment of performing ISC (Chapter 6 Section 
6.5.3 ‘Ken’, ‘Ed’) are often associated with ISC (Achterberg et al 2008; Logan et al 
2008).  However, there is also evidence in the literature that thorough education and 
support from the healthcare professionals would help patients cope with ISC better 
(Ramm et al 2011; Shaw et al 2013).  However, as implicated by the interview data, 
there were other patient considerations about the potential need for ISC and these 
were more practical-based, such as that the impact of ISC on work and hobby, and 
sleep quality (Chapter 6 Section 6.5.3 ‘Bob’, ‘Jim’, ‘Dave’). 
Living with a stoma and having long-term urinary incontinence are akin to having 
‘visible chronic conditions’, and such would invoke two initial responses: automatic 
disclosure or covering.  With the former, some individuals may become genuinely 
unconcerned about being discredited by having a stoma or leakage, whilst the others 
silently suffering from stress then either isolate themselves or concealed themselves 
(Joachim and Acorn 2000).  Perhaps patients’ anticipated psycho-social acceptance  
with stoma and urinary leakage are what lies beneath the choice of diversion. 
Other issues considered by patients, as highlighted by the interview data, included 
the surgeon’s/hospital’s experience with a given diversion method, length of 
operation and their perceived risks and their significance of the respective diversion 
method (Chapter 6, Section 6.2.1.2).  As discussed previously, how patients consider 
their options is largely dependent on their interactions with the responsible clinical 
team and those outside the team; and from such interactions knowledge specific to 
the diversions was gained but unfortunately, not all patients would necessarily be 
well informed to make the decision on diversion. 
 
8.9 Support for patients to participate in shared decision making for the choice 
of diversion can be improved 
In this research, many patients reported feeling very supported in the decision 
making process and only one patient reported not being involved to the point desired 
(Chapter 5 Section 5.1.5 and 5.1.8); however, it remains undetermined what the level 
of discrepancy was between patient preferred and perceived level of involvement, 
which in retrospect was a design deficit with the patient needs assessment survey 
(see further discussion in limitations in the next chapter).  In the literature, there is a 
wide variation in patients’ desired level of participation in decision making and the 
dependent factors are age, sex and the nature of the clinical problem (Robinson and 
Thomson 2001; Levinson et al 2004; Tariman et al 2009).  Therefore, it is difficult to 
generalise patients’ preferred level of participation in healthcare decision making.  All 
clinician respondents who answered the question regarding preferred level of patient 
involvement in the survey reported preferring some input from the patients; this 
finding contrasted with the reported views of some of the clinicians interviewed, who 
stated that the ultimate decision rests with them based on good clinical practice 
(Chapter 7 Section 7.5.1 ‘Jane’, ‘Stephen’); however, sometimes clinicians’ perceived 
best interests for patients do not match with what patients desired, as highlighted by 
the East Kilbride vs Montgomery case (The Supreme Court March 2015) where the 
diabetic mother was not made aware of the material risks of vaginal delivery versus 
that of Caesarian section in her case, and SDM is in fact a medico-legal 
requirements in both the UK and in other parts of the world.   
In parts of the survey and in the interview process, the Control Preference Scale 
(CPS) was used to elicit clinician and patient control over the ownership of the choice 
of urinary diversion after radical cystectomy.  When reflecting on the survey design, it 
could have been more useful to ask both patients and clinicians respectively 
preferred and perceived control, to allow for more detailed population-based 
comparison between these two types of control, within each group and between 
groups.  In the interview process, as mentioned in Chapters 6 and 7, CPS was 
mainly used to elicit patients’ and clinicians’ views on patient engagement and SDM 
relating to choice of diversion and in general.  After its design and validation, CPS 
has been frequently used as a proxy measure of patients/clinicians reported control 
over a healthcare decision in certain research settings.  However, it has been 
adapted for but not necessarily validated for use in research settings or in real clinical 
contexts.  Moreover, many different methods for administration have been described 
and there is no consensus on the best method so far (Degner et al 1997, Singh et al 
2010, Politi et al 2013).  There is also some recent evidence showing that the level of 
engagement in a decision making process does not necessarily equate the level of 
control over the decision i.e. ‘deliberation versus determination’ (Elwyn et al 2010; 
Levinson et al 2005; Mazur et al 1997).   
Lastly, when asked about their views about how to increase engagement in the 
decision making process, especially for those who seemingly did not wish to engage, 
both patients and clinicians volunteered some views which indicated conflation 
between informed decision making and SDM (Chapter 6 Section 6.6.2 ‘George’, 
‘Tony’, ‘Ken’; ‘Chapter 7 Section 7.5 ‘Emma’, ‘Peter’), and the main solution proposed 
being providing patient more and/or in-depth information regarding the 
diversion/healthcare options.  Several years ago it was evident that even among the 
academics in the field of SDM there were confusions between the two concepts 
(Whitney et al 2003, Moumjid et al 2007); however more recently, the distinction 
between SDM and informed decision has become clearer.  With SDM, information 
exchange is a two-way process, with an emphasis of patients realising, and 
vocalising their preferences to their clinicians after being informed; on the other hand, 
informed decision making patients are informed by the healthcare professionals, but 
there is no explicit patient preferences discussions and the flow of information tends 
to be one way, from the clinicians to the patients (Marteau 2009).  When designing a 
future decision support for the choice of diversion or any other healthcare decision 
making contexts, it is important to clarify with the potential users for the decision 
support about their understanding of SDM and provide further training on application 
of SDM as appropriate. 
The next chapter concerns the limitations of individual components of this research, 
as well as conclusions and implications for clinical practice and future research. 
  
Chapter 9 Limitations and Conclusions 
 
9.1 Limitations 
9.1.1 SWPHO-BAUS Radical Cystectomy Dataset Analysis 
The main limitations of this analysis have already been discussed in details in the 
corresponding results chapter (Chapter 4).  Without being too repetitive, these were primarily 
concerned with data quality and included: 
 Poor case-capture of radical cystectomy and therefore the power and precision 
of the analysis were compromised 
 Further loss of cases for analysis due to non-specification of diversion used, 
thus further impairing the overall power and precision of the analysis 
 Smaller sample size than that used in a later, similar analysis drawing from the 
same dataset (Hounsome et al 2013) and therefore less powerful statistically 
and generalizable in comparison 
As discussed before, the author considered it a shared responsibility to improve the quality of 
data of this analysis between clinicians and the designated public bodies (i.e. SWPHO and 
HES).  The surgeons volunteered their data for the SWPHO dataset and a more robust local 
data support and audit system to ensure complete, accurate data entry.  On the other hand, 
there is an urgent need to assign codes to distinguish one diversion procedure from another, 
not only for research but also the overall need for clinical governance. 
 
9.1.2 Needs Assessment Survey  
Given the time and administrative resource constraints on this research, the patient sample 
for this survey was a convenient sample drawn from the OTIS study, which included two of 
the centres from which the patient interviewees were recruited .  As a result, inevitably a small 
number of the patient respondents in the survey were probably also the patient interviewees.  
As for the clinician survey, access to the eligible clinician respondents was dependent on the 
voluntary and at times, paid help from the administrators for the relevant professional bodies 
(BAUS, BAUN and WCET UK).  The administrators were not able to identify the clinicians 
who were involved with radical cystectomy and diversion due to a combination of lack of time 
and information for the identification; on the other hand, the time and financial costs for 
accurate identification of eligible clinicians were simply prohibitively high.  As a result, the 
author was reliant on the clinicians to self-identify themselves as eligible for the survey and 
  
volunteered to respond.  Moreover, like all self-reporting surveys there exists the inherent 
non-response, recall and non-truth reporting biases and the latter two are difficult to control. 
Another limitation of the survey was concerned its question design.  There were issues which 
were not highlighted by the pilot of the survey.  In the patient survey, some of the items for 
questions related satisfaction with knowledge provision by clinicians could be more detailed 
(e.g. explaining what constituted ‘daily care’ and ‘sexual matters’).  Moreover, it should be 
noted satisfaction was a very superficial surrogate marker for information quality and this was 
reflected by the interview data. With regards to the clinician survey, frequency of discussion 
was a very rough and partial measure of quality of the information provided by the clinicians.  
The question regarding additional information material was a ‘double-question’ in that, it was 
asking about the availability as well as perceived usefulness.  This was perhaps confusing for 
some respondents, leading to a high non-response rate when compared to that for the other 
questions in the survey.  It was probably more useful to ask two separate questions, with the 
first one asking about availability and the second one asking about the level of usefulness.  
Regarding the questions on patient perceived support and feeling when encountering choice, 
perhaps it would have been more efficient by combining the two questions with the use of the 
Decisional Conflict Scale (O’ Connor et al 1995).  Finally, the question on perceived 
engagement in the decision was somewhat leading.  As debated in the discussion chapter, a 
perhaps more useful way to ask patients about their level of engagement in the decision 
making process was to ask about preferred and perceived level of engagement in the 
process; the corresponding questions regarding patient engagement could then be put to the 
clinicians (in the clinician survey only preferred level of patient engagement was asked); in 
this way the responses from patients and from clinicians could be compared, and discrepancy 
in preferred and perceived engagement between the these two groups could be determined. 
 
9.1.3 Qualitative interviews 
The data collected during the interviews were accounts of the respondents’ experiences with, 
and views about, the decision making process concerning the choice of urinary diversion after 
radical cystectomy.  These accounts were representation of truth but not necessarily the 
actual truth.  Recall issues and the author’s identity outside research (as a clinician) were also 
implicated in the accounts provided by the respondents.   
The author explored with the respondents the information provided during the pre-operative 
consultation(s) on the choice of urinary diversion; however, the data collected on knowledge 
provision were primarily descriptions of the information provided to the patients rather than 
the information exchange between the patients and clinicians.  To capture more detailed, 
realistic record of the information provided and exchanged during the consultation, as well as 
  
the manner in which the consultation was conducted, ethnographic study methods (e.g. real 
time documentation of direct observation by writing or audiovisual recording) could be 
employed.  However, ethnographic study would not have been able to gain the breadth of 
information collected by the semi-structured interviews conducted.  Since the research 
concerning this thesis was exploratory in nature, and given the potential wide variation in the 
experience and views of the respondents, the interview method was selected.  
The author was also a novice qualitative researcher.  During the interviewing process, 
although there were opportunities to explore issues pertinent to the decision making process, 
some of these were not necessarily followed through by the author due to her lack of 
experience in qualitative interviewing and awareness.  These missed opportunities were 
particularly apparent during some of her earlier interviews. However, through working with the 
experienced research associate colleague, the author had much benefited from reflecting on 
the data during data discussion sessions, and subsequently was able to refine the questions 
asked and more responsive to the cues provided by the respondents, in order to explore 
issues related to the decision making process further in the later interviews.  The author and 
the research associate were different in professional background, but the difference provided 
much stimulus for insightful discussions on the data and therefore, was a great advantage 
rather than a limitation to this research. 
 
9.1.4 Timing of research components 
Timing of research components (or the non-synchrony of such) was not a limitation per se, 
but its implications should be given further considerations.  The literature review and the 
SWPHO-BAUS dataset analysis were conducted independently; the analysis was intended to 
take place at more or less at the same time as the review and early on in the overall research 
process, but due to the time required to obtain approval from both SWPHO and BAUS, the 
analysis took place later than expected.  Nonetheless, this delay would not have impacted 
much on explaining the decision making process concerned, since these two components 
were intended to individually add insights into the decision making process.   
 
On the other hand, the patient needs assessment questionnaire meant the responses from 
that could not be fully utilised to inform the development of the qualitative semi-structured 
interview schedules, nor to refine the questions to be asked at later interviews.  This was 
because the ethics and organisational approvals were only obtained after the interview 
process had been well underway; the questions asked during the patient interviews could 
have been more precise, insightful and relevant to the decision making process and the 
  
potential improvement which could be made, against the ideals of SDM.  However, the 
situation had to be accepted as it would be inappropriate to ask recruited patients to wait for 
an excessively long period of time before their interviews were scheduled. 
 
9.2 Conclusions 
This research, with the use of mixed methodology and methods, achieved its aim to better 
understand the decision making process concerning urinary diversion after radical cystectomy 
in the UK in SDM terms.  Several decisional needs were highlighted and these were 
concerned with knowledge and expectations, values, as well as support and resources; 
furthermore, the potential challenges in and solutions for satisfying such needs were 
suggested.  With regards to the specific objectives of this research: 
9.2.1 To describe the variation of neobladder use in the UK 
As demonstrated by the findings of the SWPHO-BAUS Dataset Analysis (Chapter 4), even 
after holding constant all the differences in the demographic and clinical characteristics 
between the patients, and allowing for the random variation in neobladder use that existed 
between surgeons, centres and cancer networks, the magnitude of the residual variation in 
the use was still unexpectedly high at each of these three organisational levels.  This evoked 
the question if the variation was largely unwarranted and could not be explained by the 
differences in aggregate patient health state and accurately determined patient preference for 
each of the two diversion methods studies (conduit and neobladder).  The findings from the 
dataset analysis provided the ground for the further research query presented in this thesis, 
into how the said decision making process ‘measured up’ against the SDM ideals. 
 
 
9.2.2 To gain insights into the decisional needs for choosing urinary diversion after 
radical cystectomy in the UK 
The Ottawa Decision Support Framework (ODSF) introduced several decisional needs to be 
addressed, in order to make a quality healthcare decision.  In this research, knowledge and 
support for decision making were the key ones to be improved on.  Transfer of knowledge 
relevant to the decision concerning urinary diversion after radial cystectomy remained largely 
unidirectional, from the clinicians to the patients.  In particular, the responsible surgeons 
appeared to be the gatekeepers of the clinical information relevant to the decision; 
furthermore, the power imbalance in the surgeon-patient relationship was strongly implicated 
in not only the amount and type of clinical information provided, but also the manner in which 
  
the information was transmitted to the patients.  There were clear instances where the 
patients were misinformed and in general, the clinicians did not have formalised systems in 
place to check patients’ knowledge for the decision, nor that to elicit patients’ values and 
preferences for the choice of diversion. 
 
The surgeons and nurses worked together in counselling patients before their cystectomy and 
diversion, but the ways in which they collaborate can be more co-ordinated.  For instances, 
some surgeons and nurses had never observed each other’s consultations and this would 
risk overwhelming patients with the information, providing patients with contradictory 
information, or not providing patients with certain information, as both the surgeons and 
nurses would assume this information had been covered by each other.  There were also 
signs of tension in the dynamics between the surgeons and nurses which might affect 
constructive discussions about patients’ choice of diversion.  Moreover, at times nurses’ 
feedback on patients’ views appeared to be undervalued by the surgeons, and this would 
hamper quality decision making. 
 
Other individuals such as spouse and families could also be facilitative in the decision making 
process, mainly through additional information gathering and clarification.  The discussions 
between patients, their spouses and families could also stimulate patient to further deliberate 
about their preferences for choice of diversion.  With regards to former patients, they could 
certainly provide valuable lived experiences with each of the two diversion options, but like 
elsewhere in the literature the value of patient stories in SDM terms is still a largely debatable 
subject.  Moreover, there was a shortage of former neobladder patients to provide post-
operative experiences.  
 
The quality of additional information materials for diversion remains unknown as no formal 
assessment has been made to date.  However, from the research findings, these would not 
replace face-to-face discussions on choice of diversion and individuals generally prefer those 
in printed formats; both clinicians and patients were guarded about the use of web-based 
information materials primarily due to their dubious quality and access.  There was also an 
inclination from the clinicians to produce and use local information materials based on local 
performance data.    
 
In general, both the patients and clinicians were supportive of the idea of having SDM and a 
future decision support; however, on further exploration regarding their understanding of SDM 
and how to enhance the current decision making process, there was conflation between 
‘informed decision making’ and ‘shared decision making’, where both the patients and 
  
clinicians stated increasing the amount and depth of information would translate into better 
quality decision making.  
 
 
9.2.3 To understand the aspects taken into account by patients when they were 
choosing a method of urinary diversion after radical cystectomy        
The patients interviewed in this research reported multiple aspects which they would take into 
account when choosing between conduit and neobladder.  These aspects were largely 
shaped by the information they acquired mainly from surgeons, but also from the nurses, 
spouses and families, former patients and additional information materials.  The aspects 
which the patients deliberated over constitute their normality, and the research findings 
suggested that the patients would choose whichever one diversion method would cause the 
least anticipated disruption to their known normality. 
Body image, the length, complexity and caseload of the diversion procedure, as well as 
management of urinary incontinence were all given due considerations by the patients 
interviewed.  Stigma was strongly implicated in the patients’ deliberation over the shift of body 
image and management of urinary incontinence.  With regards to conduit, the patients 
debated over their own anticipated success of concealment of the urostomy bag and urinary 
leakage, and the impact of the presence of the urostomy on their relationship with the outside 
world.  Urinary leakage itself is held with many negative connotations by the society, and the 
patients’ enthusiasm to remain ‘noticeably’ dry was evident in this research.    Linked closely 
to urinary incontinence management was toileting routines, and in turns these routines were 
associated with both stigma and daily life pragmatics.  Stigma associated with toileting 
routines was particularly prominent among the male patients; to some of them emptying their 
urostomy bag in the public toilets was more acceptable then performing intermittent self-
catheterisation (ISC).  The invasive nature of ISC was also sufficiently off-putting for some 
patients to give up on the idea of neobladder, but as the interview data further suggested, 
pre-operative education of ISC could help patient to adjust and be more prepared about ISC.  
Potential interference with hobby and work associated with each of the two diversion options’ 
care routines was also considered by the patients interviewed.  Intimacy issue was expected 
to be an important factor but the discussions around this were very limited.  This was 
probably because the issue was not explored meaningfully with the patients, rather than the 
patients not considering intimacy as an issue in the choice of diversion.   
 
9.3 Implications for clinical practice and research 
9.3.1 Research evidence on outcomes of neobladder 
  
Clearly the clinical evidence on neobladder as the better alternative diversion option to 
conduit requires to be strengthened, as to better guide the clinicians to discuss with their pre-
cystectomy patients who among them would be suitable to have a choice between the two 
diversion options.  More quality evidence is required on both clinical and health-related quality 
of life outcomes.  Whilst accepting that conducting randomised controlled trial comparing 
conduit and neobladder would be impossible, due to ethical implications, then perhaps the 
academic and clinician communities can focus on generating the next best level evidence, via 
multi-centred, prospective studies on neobladder. 
 
9.3.2 Enhancing patient knowledge relevant for the choice of diversion 
As already discussed, some of the interviewed patients appeared to be misinformed and 
made their choice of diversion based on misinformation.  On the other hand, what constitutes 
a relevant information base for making the choice of diversion has not been formally studied.  
It would be beneficial to patient knowledge enhancement if the patients, their spouses and 
families, and their responsible clinical team (the surgeons and nurses) hold a multidisciplinary 
focus group to discuss what information and its depth would be the minimum required for 
making the choice.  The findings from such discussions could inform the development of a 
formal decision support specific to the choice of diversion after radical cystectomy, specific to 
the healthcare context of UK/other countries.  Furthermore, these findings can also aid the 
development of a decisional quality measurement tool specific to this decision on urinary 
diversion, used for evaluation of the impact on decisional quality with the use of the future 
decision support (e.g. Patient Decision Aid - PDA).  A validated decision support can provide 
not only relevant, quality information for the choice of diversion, but can also elicit patient 
preferences and values consciously for the choice.  Of course, there are various shapes and 
forms of decision support, from decision coaching to PDAs. 
The existing additional information materials used are numerous and of varying quality.  
Research efforts should be afforded into assessing the quality of these materials and improve 
if necessary.  Tailoring of information materials for local population use is also important, with 
the incorporation of information on local outcomes of the respective diversion option.  How to 
tailor information materials for local patient populations should again be a joint research 
venture between the local clinicians and patients.  Just as with the additional information 
materials, when to administer a decision support is crucial to its uptake and its function in 
enhancing the quality of decision; this would pose as another area of research in the 
implementation of a future decision support specific to the decision on urinary diversion. 
 
  
9.3.3 Knowledge is not power – enhancing patient engagement in the decision making 
process 
Even the patients are armed with all the information required for making the choice of urinary 
diversion, SDM may still not be truly ‘worked’ into the decision making process.  As informed 
by the research findings, there was much need to ensure the patient, their families and 
responsible clinicians all have a common understanding on what SDM really means and its 
benefits.  The clinicians, especially the surgeons, should also be made further aware of their 
‘power of suggestions’ – patients’ choice of diversion is largely based on the information 
provided by them.  Observational study of patient-clinician encounter may highlight to the 
clinicians how their presence and the way they transmit the information would impact on the 
overall decision making process; and as a result, the clinicians may learn of certain ways of 
communications would foster unbiased information transmission and patient engagement in 
the consultation process, where the patients are empowered to voice their preferences and 
values.   
Furthermore, formal training of clinicians in assessing individual patients’ knowledge and 
information needs at each encounter is also much needed.  There is also a need to 
encourage a dialogue between the surgeons and nurses to understand each other’s roles and 
challenges faced, so that their information provision during their consultation can be more 
streamlined and coherent.  An enhanced dialogue among specialist nurses of varying roles 
(e.g. stoma nurses and continence advisers) may also achieve the same benefits. 
The patients should also be encouraged to engage in the decision making process more in 
line with the SDM ideals.  There has already been some general efforts by the NHS and other 
organisations such as the Health Foundation, with their ‘Ask 3 Questions’ campaign, in order 
to put the message across to patients that it is perfectly acceptable and desirable to ask 
questions regarding their healthcare decision.  Amidst the gravity of cancer diagnosis and the 
urgency to perform surgery to clear the disease, both the patients and clinicians must be 
reminded of the importance in investing the time in information exchange rather information 
provision: the clinicians provide the information relevant to the diversion option and 
acknowledge patients’ preferences, and the patients provide feedback to their clinicians on 
their understanding of the diversion options. 
Lastly, there is evidence that outcomes of neobladder are satisfactory in centres experienced 
with the procedure, and this is perhaps due to a combination of accrued surgical expertise, 
experienced ward care and follow-up care at home.  Performing neobladders in these 
experienced centres only is perhaps justifiable, but efforts must be made at the local level to 
offer patients the choice to be referred to an experienced centre for the surgery.  On an 
  
organisational level, resources should also be put in place to aid patients who wish to 
undergo neobladder in another centre throughout their treatment journey. 
The author believed that the body of research presented in this thesis demonstrated the need 
for further improvement in the current decision making process concerning urinary diversion 
after radical cystectomy in UK’s healthcare context, in terms of the ideals of SDM.  There 
were observed uncertainties how well patients were informed about the choice of diversion 
and the power imbalance, mainly between patients and their responsible surgeons.  
Moreover, the research also highlighted how the process may be improved and the potential 
challenges encountered in the improvement process.  Along with the identified aspects which 
the patients considered in the choice of diversion, this research represents the groundwork 
for the construction and implementation of a formal decision support for improving the said 
decision making process, as to ultimately improve the quality of the decision. 
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Appendix 2 – Patient Questionnaire 
 
  
 
 
 
OTIS Additional Questionnaire 
 
 
A SURVEY OF PATIENTS’ VIEWS ON DECISION 
SUPPORT FOR CHOOSING URINE DRAINAGE 
(DIVERSION) METHOD WITH  
BLADDER REMOVAL  
 
 
 
 
 
 
 
 
 
PLEASE READ THIS PAGE CAREFULLY FIRST 
 
  
 
Background:  
 
Patients may undergo bladder removal surgery for various conditions, such as 
bladder cancer.  After the bladder is removed, there are different methods to drain 
urine away from the body (urine diversion).  The two main urinary diversion methods 
are:  
 
1) Urostomy (Ileal Conduit): 
 
Urine drains through an opening on the tummy - 'Urostomy', into an external bag 
which needs to be changed regularly. 
 
2) Substitute Bladder (Neobladder): 
 
An artificial bladder is made from some of your bowel.  This can store urine, which 
is like a normal bladder and you can empty it by straining or with the help from 
inserting a thin tube (catheter). 
 
Sometimes a patient is offered only one method of diversion due to clear reasons 
such as concerns about medical fitness and disease involvement with the waterpipe 
(‘urethra’).  However, at other times a patient is suitable for either diversion method.  
Each of the two methods above can affect an individual patient differently and making 
the choice between the two can be difficult.   We would like to develop more support 
to help our patients in the future to choose the diversion method that best suits them. 
  
This survey will help us to do this.  Thank you very much for your involvement.   
ALL SURVEY RESPONSES WILL BE KEPT ANONYMOUS AND 
CONFIDENTIAL 
  
SECTION I - TO START WITH PLEASE TELL US MORE ABOUT 
YOURSELF 
 
 
1. How many months and/or years ago did you have your bladder removal surgery?  
(Please specify): 
 
  ___ MONTHS  ___ YEARS 
 
 
2. When you had your bladder removal surgery, which age group did you belong to?  
(Please choose one response with a tick []): 
 
 39 years or less  
 40-49 years 
 50-59 years 
 60-69 years 
 70 years or more 
 
 
3. Are you: (Please choose one response with a tick [] 
 
 Male   
 Female  
 
 
4. Which method of urine diversion did you have along with bladder removal?  
(Please choose one response with a tick []): 
 
 Urostomy (ileal conduit) 
 Substitute Bladder (Neobladder) 
 
 
  
5. Were both urine diversion methods (Urostomy and Substitute Bladder) available to 
you before you went into hospital for bladder removal surgery?  (Please choose 
one response with a tick []) 
 
 YES  PLEASE GO TO THE NEXT QUESTION (QUESTION 6). 
 
 NO   
PLEASE GO TO THE LAST PAGE 
(QUESTION 18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SECTION II - INFORMATION AND SUPPORT BEFORE YOUR 
SUGERY 
6. Information on Urostomy:  
 
How satisfied were you with the information given about Urostomy by your surgeon 
and his/her team before your surgery? (Please choose one response for each 
information area with a tick []): 
             Level of 
Satisfaction 
                        
 
Information 
Area 
 
Very 
Satisfied 
 
Satisfied Neutral Unsatisfied 
Very 
Unsatisfied 
No Information 
Provided 
Benefits              
Complications/Risks             
Course of recovery             
Peer support 
(groups/individual)             
Daily care after surgery             
Appliances (e.g. bags, 
catheters)             
Employment/Retirement             
Leisure activities/Sports             
Body appearance after 
surgery             
Sexual matters             
  
 
7. Information on Substitute Bladder:  
 
How satisfied were you with the information given about Substitute Bladder by 
your surgeon and his/her team before your surgery?  (Please choose one 
response with a tick [] for each information area): 
 
 
             Level of 
Satisfaction 
                        
 
Information 
Area 
 
Very 
Satisfied 
 
Satisfied Neutral Unsatisfied 
Very 
Unsatisfied 
No 
Information 
Provided 
Benefits 
             
Complications/Risks 
            
Course of recovery  
            
Peer support 
(groups/individual)             
Daily care after surgery 
            
Appliances (e.g. bags, 
catheters)             
Employment/Retirement 
            
Leisure activities/Sports 
            
Body appearance after 
surgery             
Sexual matters 
            
  
8. Would you have liked information on any other areas?  (Please choose a 
response with a tick []): 
 Yes.  (Please comment further): 
 
________________________________________________________ 
 
________________________________________________________ 
 
________________________________________________________ 
 
________________________________________________________ 
 No. 
 
9. Thinking back, who helped you to make the choice of urine diversion method?  
(Please tick [] as many options as applicable): 
 
 Surgeon 
 Specialist Nurse/Stoma Nurse 
 Spouse 
 Other family members/friends 
 Other patients who had gone through similar surgery  
 Patient Support Groups 
 Others (Please state relationship/role/profession):  
  
 ________________________________________________________ 
 
10. Was there anyone else who could have helped you, if available, to make the 
choice of urine diversion method? (Please choose a response with a tick []): 
 
 Yes (Please state relationship/role/profession): 
 
  _________________________________________________________ 
 No 
  
11. How helpful were the following information materials to you when you were 
making the choice of urine diversion method?  (Please choose one response 
with a tick [] for each material).   
 
 
 
 
12. Any other materials you would have liked to have, to help you reach the choice of 
urine diversion?  (Please choose a response with a tick []): 
 
 Yes (Please state material type):  
 
  ____________________________________________________  
          
 No 
 
 
             Level of  
             Helpfulness 
                        
Materials 
 
 
 
Very 
Helpful 
Helpful Neutral 
Not 
particularly 
helpful 
Not 
helpful at 
all 
Don't know 
- material  
was not 
available 
to me 
Internet (Websites) 
 
            
Leaflets/Booklets 
 
            
DVDs/Videos             
Audio CDs             
Other (Please state below): 
 
_________________________ 
 
            
  
13. Overall, how supported did you feel in the process of reaching the choice of 
urine diversion method?  (Please choose one response with a tick []): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Very supported 
 
Supported Neutral Unsupported 
Totally 
unsupported 
          
  
14. When you faced having to choose between the urine diversion methods, how did 
you feel? (Please tick [] as many options as applicable): 
 
 Positive 
 
 Relieved 
 
 Distressed/Upset 
 
 Worried what could go wrong with each choice 
 
 Worried about the impact of each choice on yourself or people close to 
you (significant others) 
 
 Wondering what would be important to you in life after surgery 
 
 Wavering between the choices  
 
 Wanted to delay the decision 
 
 Physically stressed (tense muscles, racing heartbeat, lost sleep etc.) 
 
 Other (Please comment further): 
 
________________________________________________________ 
 
________________________________________________________ 
 
 
  
  
15. We are hoping to build support material which provides information on both 
urine diversion methods and highlights the opinions each individual patient may 
have.  This will then help patients in the future to choose a urine diversion 
method with their bladder removal surgery like you had to do. Which formats of 
decision support material would you prefer most? (Please choose one response 
with a tick [] ): 
 
 Internet (Websites) 
 
 Booklet 
 
 DVD/Videos 
 
 Audio tapes/CDs 
 
 Others (can be combination of above, please state):  
 
 
  _________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SECTION III - MAKING THE DECISION ON URINE DIVERSION 
METHOD 
 
16. Were you involved as much as you would have liked, in reaching a decision on 
the urine diversion method to proceed with?  
 
(Please choose one response and mark with a []): 
 Yes                       PLEASE GO TO THE LAST PAGE (QUESTION 18).  
 
 No                           PLEASE GO TO NEXT QUESTION (QUESTION 17). 
 
 
17. Thinking back, how involved would you have liked to have been, in reaching a 
decision on the urine diversion method to proceed with?  
 
(Please choose the one response that best describes how you would have liked 
the decision made with a tick []): 
 I would have liked to make the decision about which urine diversion 
method I would have. 
 
 
 I would have liked to make the final decision about the urine diversion 
method after seriously considering the opinion from my surgeon’s and 
his/her team.            
 
 
 I would have liked to share with my surgeon along with his/her team the 
responsibility for deciding which urine diversion method was best for me. 
 
 I would have liked my surgeon and his/her team made the final decision on 
which urine diversion method would be used, but seriously considered my 
opinion. 
 
 I would have liked to leave all decisions regarding urine diversion method 
to my surgeon and his/her team.       
 
 
 
  
18. Any additional comments? 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
 
 
THANK YOU VERY MUCH!  PLEASE RETURN THIS QUESTIONNAIRE IN THE PRE-
PAID ENVELOPE PROVIDED 
 
 
 
 
 
 
  
Appendix 3 – Clinician Questionnaire 
 
 
  
 
 
 
  
 
 
 
  
 
 
  
 
  
  
 
  
 
 
  
 
 
  
 
  
  
  
 
 
 
  
Appendix 4 – HES Non-Disclosure Agreement 
 
Appendix C1: HES Non-Disclosure Agreement Form - 
Sensitive tabulations  
This form is appropriate for requesting tabulations of HES data that are sensitive. For example, the table may 
contain consultant level data or have small numbers, which cannot be suppressed in the normal manner, in 
the cells. 
 Organisation: Institute of Health and Society, Newcastle University 
Responsible lead contact: Susan Wong 
Data custodian (senior officer): Richard Thomson  
HES reference (for HES Team use):  
Project: Choosing urinary drainage procedure with cystectomy for bladder cancer 
(please provide a description of the intended project and how you propose to use and/or publish the 
analysis of the HES data – publication of the raw data is prohibited) 
 
The aim of the project entitled above is to improve the decision making process for patients who 
were choosing between two options of urinary drainage procedure, namely ileal conduit diversion 
and orthotopic neobladder, to proceed along with radical cystectomy (surgical bladder removal) for 
bladder cancer.  In order to demonstrate regional variation in the UK in the usage of each mentioned 
drainage option, and any demographic and/or clinical factors which might be associated with such 
variation, the dataset owned by the British Association of Urological Surgeons (BAUS) and managed 
by SWPHO has been obtained for further analysis.  On closer examination of this dataset, however, 
the question of case capture was posed.  The HES data to be requested this time is for identifying 
instances of unsatisfactory degree of capture, by comparing the total numbers of radical cystectomy 
registered by the BAUS/SWPHO dataset and that by HES.  Instances of unsatisfactory case capture in 
the BAUS/SWPHO dataset are to be excluded for further analysis. 
Only the analysis of the BAUS/SWPHO data aided by the HES data to be requested will be published.   
 HES data to be provided:  
(attach an example outline or sketch of the table required if possible/appropriate)  
 
For each trust/provider, the number of radical cystectomy for bladder cancer undertaken in per 
year, from 2004 to End of July 2010 inclusive. 
Sensitivities:  
(retain or delete as appropriate to the data required)  
 
Consultant team data: 
 Pseudonymised consultant code is unpublished and must not be released in any way that 
may enable the identification of individual consultants. 
  Should identifiable consultant data (ie the raw GMC code, not anonymised) be investigated, 
which will only be provided in case of justifiable concern about outcomes, the consultant(s) 
concerned should be made aware that this is happening.  
  
 
 
Patients must not be identified:  
 Patient information from HES must not be used to identify (or recognise) individual patients 
and must be handled with proper regard to the confidentiality of individuals.  
 Any published HES figure(s) at a local level must be based on no fewer than 6 cases or else 
suppressed (eg replaced with an asterisk, with a note “* in this table means a figure 
between 1 and 5”. Zero is allowed). Low-level analyses might facilitate the identification of 
individual patients, especially with local knowledge. Care should be taken to ensure that 
values may not be more closely calculated by differencing from sub-totals. For practical 
purposes, any geographic reference smaller than Strategic Health Authority should be 
considered local 
 
 Deaths data:  
 HES data cannot be used to determine the cause of death of a patient while in hospital. 
Deaths recorded on the HES database are classified according to the main diagnosis for 
which the patient was being treated during their stay in hospital, and may not necessarily be 
the underlying cause of death. The Office for National Statistics (ONS) collects information 
on the cause of death, wherever it occurs, based on the death certificate, and should be the 
source of data for analyses on cause of death. 
 
 I agree:  
 that there is a business need for this work requiring data with the sensitivities indicated 
above.  
  to abide by the instructions given against the sensitivities.  
 that the data will be stored with proper safeguards to prevent unauthorised access. Note: 
This condition is subject to unannounced site inspections by The NHS Information Centre for 
health and social care (The NHS IC) staff to ensure that measures are satisfactory.  
 that the work will not be used for other purposes without the permission of the HES team.  
  that the data will not be copied or transferred to any third party without the written 
consent of the HES Team. Note: output based on the data may be shared provided it abides 
by the rules above.  
  to give prior notice of intention to publish HES data to the HES Team and where feasible 
provide a copy of the published work. Any published work containing HES data must 
acknowledge the source: “Hospital Episode Statistics, The NHS Information Centre for health 
and social care”.  
 to inform the HES Team immediately if custodianship of the data should change.  
 
Signed __ __ ______________________  
 
Name _Susan Wong_________________________  
 
Date _20.09.12_________________________  
 
 
HES Information Governance:  
 
Email: information.governance@ic.nhs.uk  
  
Tel: 0113 254 7054  
Fax: 0113 254 7299  
 
Please complete and return this form to the address above or fax it. The HES data can only be 
sent once the signed agreement is received. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix 5 – Case Capture 
  
 
Sum of COUNT Column Labels Column Labels
Row Labels 2004 2005 2006 2007 2008 2009 2010 (blank) Grand Total Subtotal 2004-2009 2004 2005 2006 2007 2008 2009 2010 (blank) Grand Total Subtotal 2004-2009 Case Capture 2004-2009
AINTREE UNIVERSITY HOSPITAL NHS FOUNDATION TRUST 7 3 3 3 16 16 No Entry 0 0 0.0%
NULL 1 3 2 2 8 8 0 0 0.0%
UNIVERSITY HOSPITAL AINTREE                                                                                                                                                                                                                                    6 1 1 8 8 0 0 0.0%
AIREDALE NHS FOUNDATION TRUST 3 4 7 7 0 0 0 0 0 0 2 2 0 0.0%
AIREDALE NHS TRUST                                                                                                                                                                                                                                             3 4 7 7 0 0 0.0%
ASHFORD AND ST PETER'S HOSPITALS NHS FOUNDATION TRUST 15 15 15 27 19 25 20 136 116 No Entry 0 0 0.0%
NULL 15 9 20 3 47 47 0 0 0.0%
ST PETER'S HOSPITAL                                                                                                                                                                                                                                            6 15 7 16 25 20 89 69 0 0 0.0%
BARKING  HAVERING AND REDBRIDGE UNIVERSITY HOSPITALS NHS TRUST 9 12 6 9 11 10 5 62 57 0 0 0.0%
KING GEORGE HOSPITAL                                                                                                                                                                                                                                           5 8 6 9 11 10 5 54 49 2 1 0 0 0 0 0 3 3 6.1%
NULL 3 4 7 7 0 0 0.0%
OLDCHURCH HOSPITAL                                                                                                                                                                                                                                             1 1 1 0 0 0.0%
BARNET AND CHASE FARM HOSPITALS NHS TRUST 14 12 11 6 10 11 11 75 64 14 14 16 6 6 9 2 67 65 101.6%
BARNET HOSPITAL                                                                                                                                                                                                                                                13 9 22 22 0 0 0.0%
CHASE FARM HOSPITAL                                                                                                                                                                                                                                            3 11 6 10 11 11 52 41 0 0 0.0%
EDGWARE HOSPITAL                                                                                                                                                                                                                                               1 1 1 0 0 0.0%
BARTS AND THE LONDON NHS TRUST 8 2 10 10 No Entry 0 0 0.0%
ST BARTHOLOMEW'S HOSPITAL                                                                                                                                                                                                                                      8 2 10 10 0 0 0.0%
BASILDON AND THURROCK UNIVERSITY HOSPITALS NHS FOUNDATION TRUST 2 9 1 12 12 0 0 0.0%
BASILDON UNIVERSITY HOSPITAL                                                                                                                                                                                                                                   2 9 1 12 12 0 1 1 4 0 0 0 6 6 50.0%
BEDFORD HOSPITAL NHS TRUST 8 8 8 No Entry 0 0 0.0%
NULL 8 8 8 0 0 0.0%
BLACKPOOL TEACHING HOSPITALS NHS FOUNDATION TRUST 6 8 6 1 2 1 24 24 0 0 0.0%
BLACKPOOL VICTORIA HOSPITAL                                                                                                                                                                                                                                    6 8 3 1 1 19 19 7 0 0 0 0 0 0 7 7 36.8%
NULL 3 2 5 5 0 0 0.0%
BOLTON NHS FOUNDATION TRUST 8 3 5 7 1 24 24 0 0 0 0 1 0 0 1 1 4.2%
NULL 8 3 5 7 1 24 24 0 0 0.0%
BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST 16 14 17 20 20 20 12 119 107 12 12 13 9 20 17 1 84 83 77.6%
NULL 16 14 17 20 20 20 12 119 107 0 0 0.0%
BRIGHTON AND SUSSEX UNIVERSITY HOSPITALS NHS TRUST 6 7 13 16 17 28 9 96 87 0 0 0.0%
NULL 6 7 13 16 11 53 53 0 0 0.0%
ROYAL SUSSEX COUNTY HOSPITAL                                                                                                                                                                                                                                   6 28 9 43 34 0 1 0 1 9 18 5 34 29 85.3%
Bromley Hospitals NHS Trust 4 8 3 4 19 19 0 1 0 0 0 0 0 1 1 5.3%
NULL 4 8 3 4 19 19 0 0 0.0%
BUCKINGHAMSHIRE HEALTHCARE NHS TRUST 9 10 14 16 17 9 3 78 75 1 8 1 0 0 0 0 10 10 13.3%
NULL 8 2 10 10 0 0 0.0%
STOKE MANDEVILLE HOSPITAL                                                                                                                                                                                                                                      1 1 2 2 0 0 0.0%
WYCOMBE HOSPITAL                                                                                                                                                                                                                                               8 14 16 16 9 3 66 63 0 0 0.0%
CALDERDALE AND HUDDERSFIELD NHS FOUNDATION TRUST 2 6 13 6 27 27 0 0 0.0%
CALDERDALE ROYAL HOSPITAL                                                                                                                                                                                                                                      1 1 1 0 0 0.0%
HUDDERSFIELD ROYAL INFIRMARY                                                                                                                                                                                                                                   2 5 3 10 10 0 0 0 3 0 1 0 4 4 40.0%
NULL 10 6 16 16 0 0 0.0%
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST 17 35 41 43 50 46 25 257 232 No Entry 0 0 0.0%
ADDENBROOKE'S HOSPITAL                                                                                                                                                                                                                                         17 35 41 43 50 46 25 257 232 0 0 0.0%
CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST 1 1 6 28 6 42 36 No Entry 0 0 0.0%
MANCHESTER ROYAL INFIRMARY                                                                                                                                                                                                                                     1 6 28 6 41 35 0 0 0.0%
NULL 1 1 1 0 0 0.0%
CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST 1 1 1 No Entry 0 0 0.0%
NULL 1 1 1 0 0 0.0%
CHESTERFIELD ROYAL HOSPITAL NHS FOUNDATION TRUST 6 6 6 0 1 4 3 4 3 0 15 15 250.0%
CHESTERFIELD ROYAL HOSPITAL                                                                                                                                                                                                                                    6 6 6 0 0 0.0%
CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST 10 11 24 27 38 26 15 151 136 12 18 15 14 37 23 2 121 119 87.5%
SUNDERLAND ROYAL HOSPITAL                                                                                                                                                                                                                                      10 11 24 26 38 26 15 150 135 0 0 0.0%
UNIVERSITY HOSPITAL OF NORTH DURHAM                                                                                                                                                                                                                            1 1 1 0 0 0 0 0 1 0 1 1 100.0%
COLCHESTER HOSPITAL UNIVERSITY NHS FOUNDATION TRUST 4 7 8 14 14 21 14 82 68 0 0 0.0%
COLCHESTER GENERAL HOSPITAL                                                                                                                                                                                                                                    4 7 8 14 14 21 14 82 68 2 0 0 0 1 0 0 3 3 4.4%
COUNTESS OF CHESTER HOSPITAL NHS FOUNDATION TRUST 5 4 2 1 12 12 No Entry 0 0 0.0%
NULL 5 4 2 1 12 12 0 0 0.0%
COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST 5 11 3 19 19 No Entry 0 0 0.0%
NULL 2 2 2 0 0 0.0%
STANLEY PRIMARY CARE CENTRE                                                                                                                                                                                                                                    5 11 1 17 17 0 0 0.0%
CROYDON HEALTH SERVICES NHS TRUST 6 6 3 15 15 No Entry 0 0 0.0%
NULL 6 6 3 15 15 0 0 0.0%
DARTFORD AND GRAVESHAM NHS TRUST 6 10 16 4 4 1 41 40 No Entry 0 0 0.0%
DARENT VALLEY HOSPITAL                                                                                                                                                                                                                                         6 10 16 4 4 1 41 40 0 0 0.0%
DERBY HOSPITALS NHS FOUNDATION TRUST 10 12 22 25 30 22 16 137 121 9 11 29 29 24 20 0 122 122 100.8%
ROYAL DERBY HOSPITAL                                                                                                                                                                                                                                           10 12 22 25 30 22 16 137 121 0 0 0.0%
DONCASTER AND BASSETLAW HOSPITALS NHS FOUNDATION TRUST 19 18 15 4 56 56 21 21 17 5 0 0 1 65 64 114.3%
DONCASTER ROYAL INFIRMARY                                                                                                                                                                                                                                      19 18 15 4 56 56 0 0 0.0%
DORSET COUNTY HOSPITAL NHS FOUNDATION TRUST 2 1 3 3 0 0 0.0%
DORSET COUNTY HOSPITAL                                                                                                                                                                                                                                         2 1 3 3 1 1 1 1 0 0 0 4 4 133.3%
EAST AND NORTH HERTFORDSHIRE NHS TRUST 10 12 4 12 4 5 13 60 47 No Entry 0 0 0.0%
LISTER HOSPITAL                                                                                                                                                                                                                                                10 12 4 12 4 5 13 60 47 0 0 0.0%
EAST CHESHIRE NHS TRUST 2 2 2 No Entry 0 0 0.0%
MACCLESFIELD DISTRICT GENERAL HOSPITAL                                                                                                                                                                                                                         2 2 2 0 0 0.0%
EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST 14 13 9 16 11 15 3 81 78 No Entry 0 0 0.0%
KENT & CANTERBURY HOSPITAL                                                                                                                                                                                                                                     14 13 9 16 11 15 3 81 78 0 0 0.0%
EAST LANCASHIRE HOSPITALS NHS TRUST 12 18 10 8 9 8 11 76 65 0 0 0.0%
BLACKBURN HOSPITALS                                                                                                                                                                                                                                            3 7 6 8 1 25 25 0 0 0.0%
BURNLEY HOSPITALS                                                                                                                                                                                                                                              9 11 4 24 24 0 0 0.0%
ROYAL BLACKBURN HOSPITAL                                                                                                                                                                                                                                       8 8 11 27 16 0 0 0.0%
EAST SUSSEX HEALTHCARE NHS TRUST 9 15 15 22 12 22 8 103 95 1 1 3 4 11 0 0 20 20 21.1%
CONQUEST HOSPITAL                                                                                                                                                                                                                                              2 5 6 13 13 0 0 0.0%
EASTBOURNE DISTRICT GENERAL HOSPITAL                                                                                                                                                                                                                           7 10 9 22 12 22 8 90 82 0 0 0.0%
EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST 12 6 1 19 19 No Entry 0 0 0.0%
EPSOM HOSPITAL                                                                                                                                                                                                                                                 10 1 11 11 0 0 0.0%
NULL 1 1 1 0 0 0.0%
ST HELIER HOSPITAL                                                                                                                                                                                                                                             1 6 7 7 0 0 0.0%
FRIMLEY PARK HOSPITAL NHS FOUNDATION TRUST 3 2 5 5 No Entry 0 0 0.0%
FRIMLEY PARK HOSPITAL                                                                                                                                                                                                                                          3 2 5 5 0 0 0.0%
GEORGE ELIOT HOSPITAL NHS TRUST 7 6 5 18 18 No Entry 0 0 0.0%
GEORGE ELIOT HOSPITAL - ACUTE SERVICES                                                                                                                                                                                                                         7 5 5 17 17 0 0 0.0%
NULL 1 1 1 0 0 0.0%
GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST 19 15 24 25 27 24 12 146 134 No Entry 0 0 0.0%
CHELTENHAM GENERAL HOSPITAL                                                                                                                                                                                                                                    11 14 23 25 27 24 12 136 124 0 0 0.0%
GLOUCESTERSHIRE ROYAL HOSPITAL                                                                                                                                                                                                                                 8 1 1 10 10 0 0 0.0%
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST 1 1 2 4 2 No Entry 0 0 0.0%
GREAT ORMOND STREET HOSPITAL CENTRAL LONDON SITE                                                                                                                                                                                                               2 2 0 0 0 #DIV/0!
NULL 1 1 2 2 0 0 0.0%
GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST 5 2 7 7 1 7 0 1 0 0 0 9 9 128.6%
NULL 5 2 7 7 0 0 0.0%
Greenwich Healthcare NHS Trust 3 3 3 4 13 13 No Entry 0 0 0.0%
NULL 3 3 3 4 13 13 0 0 0.0%
GUY'S AND ST THOMAS' NHS FOUNDATION TRUST 14 7 14 31 30 34 20 150 130 0 0 1 9 8 22 16 56 40 30.8%
GUY'S HOSPITAL                                                                                                                                                                                                                                                 14 7 14 31 30 33 20 149 129 0 0 0.0%
ST THOMAS' HOSPITAL                                                                                                                                                                                                                                            1 1 1 0 0 0.0%
HAMPSHIRE HOSPITALS NHS FOUNDATION TRUST 3 1 4 4 5 9 1 0 0 0 0 15 15 375.0%
NULL 3 1 4 4 0 0 0.0%
HARROGATE AND DISTRICT NHS FOUNDATION TRUST 7 3 2 12 12 No Entry 0 0 0.0%
HARROGATE DISTRICT HOSPITAL                                                                                                                                                                                                                                    7 3 2 12 12 0 0 0.0%
HEART OF ENGLAND NHS FOUNDATION TRUST 25 25 11 16 17 5 8 107 99 No Entry 0 0 0.0%
HEARTLANDS HOSPITAL                                                                                                                                                                                                                                            17 21 11 16 17 5 8 95 87 0 0 0.0%
NULL 8 4 12 12 0 0 0.0%
HEATHERWOOD AND WEXHAM PARK HOSPITALS NHS FOUNDATION TRUST 15 9 15 3 1 2 3 48 45 No Entry 0 0 0.0%
NULL 2 1 2 3 8 5 0 0 0.0%
WEXHAM PARK HOSPITAL                                                                                                                                                                                                                                           15 9 15 1 40 40 0 0 0.0%
HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST 13 16 13 19 36 38 15 150 135 0 0 0.0%
CASTLE HILL HOSPITAL                                                                                                                                                                                                                                           13 16 13 19 36 38 15 150 135 14 15 12 13 16 1 0 71 71 52.6%
IMPERIAL COLLEGE HEALTHCARE NHS TRUST 20 25 33 19 28 50 24 199 175 0 0 0.0%
NULL 20 25 33 19 27 38 22 184 162 0 0 0.0%
ST MARY'S HOSPITAL (HQ)                                                                                                                                                                                                                                        1 12 2 15 13 0 0 0 0 0 0 1 1 0 0.0%
IPSWICH HOSPITAL NHS TRUST 5 8 4 15 2 34 34 5 0 0 0 0 0 0 5 5 14.7%
NULL 5 8 4 15 2 34 34 0 0 0.0%
JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST 7 2 8 1 1 2 21 21 0 0 0.0%
JAMES PAGET UNIVERSITY HOSPITAL                                                                                                                                                                                                                                7 2 8 1 18 18 9 5 0 0 0 0 0 14 14 77.8%
NULL 1 2 3 3 0 0 0.0%
KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST 5 5 1 1 12 12 0 0 0.0%
KETTERING GENERAL HOSPITAL                                                                                                                                                                                                                                     1 1 2 2 0 1 0 1 0 0 0 2 2 100.0%
NULL 5 5 10 10 0 0 0.0%
KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST 4 4 7 5 20 20 No Entry 0 0 0.0%
KING'S COLLEGE HOSPITAL (DENMARK HILL)                                                                                                                                                                                                                         4 4 7 5 20 20 0 0 0.0%
KINGSTON HOSPITAL NHS TRUST 5 4 4 5 18 18 No Entry 0 0 0.0%
KINGSTON HOSPITAL NHS TRUST                                                                                                                                                                                                                                    5 4 4 5 18 18 0 0 0.0%
LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST 7 11 14 8 22 13 16 91 75 0 0 0.0%
NULL 10 8 22 13 16 69 53 0 0 0.0%
ROYAL PRESTON HOSPITAL                                                                                                                                                                                                                                         7 11 4 22 22 7 8 3 8 6 11 3 46 43 195.5%
LEEDS TEACHING HOSPITALS NHS TRUST 18 21 9 11 22 27 23 131 108 0 0 0.0%
ST JAMES'S UNIVERSITY HOSPITAL                                                                                                                                                                                                                                 18 21 9 11 22 27 23 131 108 0 0 0 0 0 4 1 5 4 3.7%
LUTON AND DUNSTABLE HOSPITAL NHS FOUNDATION TRUST 4 5 2 3 7 4 25 25 No Entry 0 0 0.0%
LUTON & DUNSTABLE HOSPITAL                                                                                                                                                                                                                                     1 1 1 0 0 0.0%
NULL 3 5 2 3 7 4 24 24 0 0 0.0%
MAIDSTONE AND TUNBRIDGE WELLS NHS TRUST 11 8 9 4 12 13 10 67 57 0 0 0.0%
KENT & SUSSEX HOSPITAL                                                                                                                                                                                                                                         9 9 9 2 0 0 0 0 0 0 2 2 22.2%
MAIDSTONE DISTRICT GENERAL HOSPITAL                                                                                                                                                                                                                            8 9 4 12 13 10 56 46 0 0 0.0%
NULL 2 2 2 0 0 0.0%
MEDWAY NHS FOUNDATION TRUST 17 18 17 15 14 18 12 111 99 No Entry 0 0 0.0%
MEDWAY MARITIME HOSPITAL                                                                                                                                                                                                                                       5 5 0 0 0 #DIV/0!
NULL 17 18 17 15 14 18 7 106 99 0 0 0.0%
MID CHESHIRE HOSPITALS NHS FOUNDATION TRUST 11 11 11 7 1 41 41 No Entry 0 0 0.0%
LEIGHTON HOSPITAL                                                                                                                                                                                                                                              11 11 11 7 1 41 41 0 0 0.0%
MID ESSEX HOSPITAL SERVICES NHS TRUST                                     14 17 9 2 1 43 43 No Entry 0 0 0.0%
BROOMFIELD HOSPITAL                                                                                                                                                                                                                                            13 9 2 1 25 25 0 0 0.0%
NULL 14 4 18 18 0 0 0.0%
MID YORKSHIRE HOSPITALS NHS TRUST 25 21 12 18 19 14 15 124 109 0 0 0.0%
NULL 12 2 14 14 0 0 0.0%
PINDERFIELDS GENERAL HOSPITAL                                                                                                                                                                                                                                  25 20 16 19 14 15 109 94 0 0 0 0 0 2 14 16 2 2.1%
PONTEFRACT GENERAL INFIRMARY                                                                                                                                                                                                                                   1 1 1 0 0 0.0%
MILTON KEYNES HOSPITAL NHS FOUNDATION TRUST 1 1 1 0 0 0.0%
MILTON KEYNES HOSPITAL                                                                                                                                                                                                                                         1 1 1 0 1 0 0 0 0 0 1 1 100.0%
NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST 15 23 16 21 30 40 22 167 145 0 0 0.0%
NORFOLK & NORWICH UNIVERSITY HOSPITAL                                                                                                                                                                                                                          15 23 16 21 30 40 22 167 145 0 0 0 0 0 0 7 7 0 0.0%
NORTH BRISTOL NHS TRUST 35 39 44 72 68 55 33 346 313 18 22 26 53 37 41 0 197 197 62.9%
SOUTHMEAD HOSPITAL                                                                                                                                                                                                                                             35 39 44 72 68 55 33 346 313 0 0 0.0%
NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST 2 2 2 0 0 0.0%
NORTH MIDDLESEX HOSPITAL                                                                                                                                                                                                                                       2 2 2 0 0 1 0 0 0 0 1 1 50.0%
NORTH TEES AND HARTLEPOOL NHS FOUNDATION TRUST 1 1 2 2 No Entry 0 0 0.0%
NULL 1 1 1 0 0 0.0%
UNIVERSITY HOSPITAL OF NORTH TEES                                                                                                                                                                                                                              1 1 1 0 0 0.0%
NORTH WEST LONDON HOSPITALS NHS TRUST 6 5 10 9 5 35 35 No Entry 0 0 0.0%
CENTRAL MIDDLESEX HOSPITAL                                                                                                                                                                                                                                     1 1 1 0 0 0.0%
NORTHWICK PARK HOSPITAL                                                                                                                                                                                                                                        6 4 10 9 5 34 34 0 0 0.0%
NORTHAMPTON GENERAL HOSPITAL NHS TRUST 10 8 9 19 22 22 11 101 90 No Entry 0 0 0.0%
NORTHAMPTON GENERAL HOSPITAL (ACUTE)                                                                                                                                                                                                                           10 8 9 2 18 11 58 47 0 0 0.0%
NULL 17 22 4 43 43 0 0 0.0%
NORTHERN DEVON HEALTHCARE NHS TRUST 5 1 6 6 0 0 0.0%
NORTH DEVON DISTRICT HOSPITAL                                                                                                                                                                                                                                  5 1 6 6 4 1 1 10 4 3 0 23 23 383.3%
NORTHERN LINCOLNSHIRE AND GOOLE HOSPITALS NHS FOUNDATION TRUST 5 7 9 5 26 26 No Entry 0 0 0.0%
DIANA  PRINCESS OF WALES HOSPITAL                                                                                                                                                                                                                              2 1 3 3 0 0 0.0%
SCUNTHORPE GENERAL HOSPITAL                                                                                                                                                                                                                                    3 7 8 5 23 23 0 0 0.0%
Nottingham City Hospital NHS Trust 28 26 8 62 62 0 0 0.0%
NULL 28 26 8 62 62 0 0 0.0%
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST 20 14 20 21 11 86 75 0 0 0.0%
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST - CITY CAMPUS                                                                                                                                                                                                        20 14 20 21 11 86 75 28 18 28 22 6 11 7 120 113 150.7%
OXFORD UNIVERSITY HOSPITALS NHS TRUST 14 8 14 15 13 21 14 99 85 0 0 0.0%
CHURCHILL HOSPITAL                                                                                                                                                                                                                                             14 8 14 15 13 21 14 99 85 10 0 0 0 0 0 0 10 10 11.8%
PENNINE ACUTE HOSPITALS NHS TRUST 8 5 10 11 21 55 55 No Entry 0 0 0.0%
NORTH MANCHESTER GENERAL HOSPITAL                                                                                                                                                                                                                              4 2 5 9 14 34 34 0 0 0.0%
ROCHDALE INFIRMARY                                                                                                                                                                                                                                             1 1 1 0 0 0.0%
ROYAL OLDHAM HOSPITAL                                                                                                                                                                                                                                          3 3 5 2 7 20 20 0 0 0.0%
PETERBOROUGH AND STAMFORD HOSPITALS NHS FOUNDATION TRUST 9 3 12 12 No Entry 0 0 0.0%
EDITH CAVELL HOSPITAL                                                                                                                                                                                                                                          9 3 12 12 0 0 0.0%
PLYMOUTH HOSPITALS NHS TRUST 5 6 18 15 20 27 13 104 91 0 0 0.0%
DERRIFORD HOSPITAL                                                                                                                                                                                                                                             5 6 1 13 20 27 13 85 72 1 4 3 0 4 15 0 27 27 37.5%
NULL 17 2 19 19 0 0 0.0%
PORTSMOUTH HOSPITALS NHS TRUST 29 24 20 29 29 19 17 167 150 0 12 13 12 15 14 2 68 66 44.0%
QUEEN ALEXANDRA HOSPITAL                                                                                                                                                                                                                                       1 8 17 26 9 0 0 0.0%
ST MARY'S HOSPITAL                                                                                                                                                                                                                                             29 24 20 29 28 11 141 141 0 0 0.0%
ROYAL BERKSHIRE NHS FOUNDATION TRUST 19 13 27 27 39 30 22 177 155 No Entry 0 0 0.0%
ROYAL BERKSHIRE HOSPITAL                                                                                                                                                                                                                                       19 13 27 27 39 30 22 177 155 0 0 0.0%
ROYAL CORNWALL HOSPITALS NHS TRUST 5 1 6 6 0 0 0.0%
ROYAL CORNWALL HOSPITAL (TRELISKE)                                                                                                                                                                                                                             5 1 6 6 4 0 2 1 4 0 0 11 11 183.3%
ROYAL DEVON AND EXETER NHS FOUNDATION TRUST 12 18 14 29 32 30 15 150 135 0 0 0.0%
NULL 12 10 22 22 0 0 0.0%
ROYAL DEVON & EXETER HOSPITAL (WONFORD)                                                                                                                                                                                                                        12 18 2 19 32 30 15 128 113 0 0 0 0 5 15 0 20 20 17.7%
ROYAL FREE LONDON NHS FOUNDATION TRUST 8 5 4 2 19 19 No Entry 0 0 0.0%
ROYAL FREE HOSPITAL                                                                                                                                                                                                                                            8 5 4 2 19 19 0 0 0.0%
ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST 2 11 11 10 23 22 12 91 79 0 0 0.0%
NULL 2 8 10 10 0 0 0.0%
ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST                                                                                                                                                                                                  14 2 16 16 0 0 0.0%
THE ROYAL LIVERPOOL UNIVERSITY HOSPITAL                                                                                                                                                                                                                        3 11 10 9 20 12 65 53 0 0 0 10 29 21 0 60 60 113.2%
ROYAL UNITED HOSPITAL BATH NHS TRUST 8 4 12 12 No Entry 0 0 0.0%
ROYAL UNITED HOSPITAL                                                                                                                                                                                                                                          8 4 12 12 0 0 0.0%
ROYAL WEST SUSSEX NHS TRUST 5 4 2 1 12 12 6 4 5 2 0 1 0 18 18 150.0%
NULL 5 4 2 1 12 12 0 0 0.0%
SALFORD ROYAL NHS FOUNDATION TRUST 2 3 5 7 15 12 4 48 44 4 3 1 5 5 1 0 19 19 43.2%
MACCLESFIELD DISTRICT GENERAL HOSPITAL (SRFT)                                                                                                                                                                                                                  2 3 5 7 12 29 29 0 0 0.0%
NULL 3 12 15 15 0 0 0.0%
SALFORD ROYAL                                                                                                                                                                                                                                                  4 4 0 0 0 #DIV/0!
SALISBURY NHS FOUNDATION TRUST 9 1 10 7 6 2 4 39 35 0 0 0.0%
SALISBURY DISTRICT HOSPITAL                                                                                                                                                                                                                                    9 1 10 7 6 2 4 39 35 11 2 10 5 8 5 4 45 41 117.1%
SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST 12 2 1 15 15 0 0 0.0%
CITY HOSPITAL                                                                                                                                                                                                                                                  4 1 1 6 6 0 0 0.0%
SANDWELL GENERAL HOSPITAL                                                                                                                                                                                                                                      8 1 9 9 1 1 0 0 1 1 0 4 4 44.4%
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST 20 28 18 26 43 46 31 212 181 0 0 0.0%
NORTHERN GENERAL HOSPITAL                                                                                                                                                                                                                                      1 1 2 2 0 0 0.0%
ROYAL HALLAMSHIRE HOSPITAL                                                                                                                                                                                                                                     19 27 18 26 43 46 31 210 179 0 1 0 0 0 3 2 6 4 2.2%
SHERWOOD FOREST HOSPITALS NHS FOUNDATION TRUST 4 5 5 4 18 18 No Entry 0 0 0.0%
KING'S MILL HOSPITAL                                                                                                                                                                                                                                           4 5 5 4 18 18 0 0 0.0%
SHREWSBURY AND TELFORD HOSPITAL NHS TRUST 11 14 16 15 10 19 6 91 85 0 0 0.0%
ROYAL SHREWSBURY HOSPITAL                                                                                                                                                                                                                                      11 14 16 15 10 19 6 91 85 0 0 0 0 0 2 1 3 2 2.4%
SOUTH DEVON HEALTHCARE NHS FOUNDATION TRUST 4 1 6 11 11 0 0 0.0%
NULL 3 3 3 0 0 0.0%
TORBAY HOSPITAL                                                                                                                                                                                                                                                4 1 3 8 8 0 1 0 0 1 3 0 5 5 62.5%
SOUTH TEES HOSPITALS NHS FOUNDATION TRUST 23 18 11 10 24 23 16 125 109 No Entry 0 0 0.0%
NULL 10 10 24 5 49 49 0 0 0.0%
RUTSON HOSPITAL                                                                                                                                                                                                                                                23 18 1 18 6 66 60 0 0 0.0%
THE JAMES COOK UNIVERSITY HOSPITAL                                                                                                                                                                                                                             10 10 0 0 0 #DIV/0!
SOUTH TYNESIDE NHS FOUNDATION TRUST 7 6 13 13 No Entry 0 0 0.0%
SOUTH TYNESIDE DISTRICT HOSPITAL                                                                                                                                                                                                                               7 6 13 13 0 0 0.0%
SOUTH WARWICKSHIRE NHS FOUNDATION TRUST 4 4 5 13 13 0 0 0.0%
WARWICK HOSPITAL                                                                                                                                                                                                                                               4 4 5 13 13 6 3 1 0 0 0 0 10 10 76.9%
SOUTHEND UNIVERSITY HOSPITAL NHS FOUNDATION TRUST 6 10 18 16 13 21 15 99 84 4 8 18 18 18 14 1 81 80 95.2%
SOUTHEND HOSPITAL                                                                                                                                                                                                                                              6 10 18 16 13 21 15 99 84 0 0 0.0%
SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST 4 5 6 5 1 21 21 4 5 8 6 3 3 0 29 29 138.1%
ORMSKIRK & DISTRICT GENERAL HOSPITAL                                                                                                                                                                                                                           4 4 8 8 0 0 0.0%
SOUTHPORT & FORMBY DISTRICT GENERAL HOSPITAL                                                                                                                                                                                                                   1 6 5 1 13 13 0 0 0.0%
ST GEORGE'S HEALTHCARE NHS TRUST 6 20 17 16 10 15 11 95 84 No Entry 0 0 0.0%
ST GEORGES AT ST HELIER HOSPITAL                                                                                                                                                                                                                               6 20 17 2 45 45 0 0 0.0%
ST GEORGE'S HOSPITAL (TOOTING)                                                                                                                                                                                                                                 14 10 15 11 50 39 0 0 0.0%
ST HELENS AND KNOWSLEY HOSPITALS NHS TRUST 3 2 5 2 12 12 0 0 0.0%
WHISTON HOSPITAL                                                                                                                                                                                                                                               3 2 5 2 12 12 1 0 2 1 3 0 0 7 7 58.3%
STOCKPORT NHS FOUNDATION TRUST 5 13 15 21 26 19 26 125 99 No Entry 0 0 0.0%
NULL 5 12 17 17 0 0 0.0%
STOCKPORT NHS FOUNDATION TRUST                                                                                                                                                                                                                                 1 15 21 26 19 26 108 82 0 0 0.0%
SURREY AND SUSSEX HEALTHCARE NHS TRUST 11 3 9 10 5 10 48 48 No Entry 0 0 0.0%
EAST SURREY HOSPITAL                                                                                                                                                                                                                                           11 3 2 9 2 27 27 0 0 0.0%
NULL 7 1 3 10 21 21 0 0 0.0%
THE CHRISTIE NHS FOUNDATION TRUST 12 19 10 11 9 5 5 71 66 0 0 0.0%
NULL 12 19 10 11 3 55 55 0 0 0.0%
THE CHRISTIE                                                                                                                                                                                                                                                   6 5 5 16 11 0 0 1 0 0 0 0 1 1 9.1%
THE DUDLEY GROUP NHS FOUNDATION TRUST 7 4 11 11 No Entry 0 0 0.0%
RUSSELLS HALL HOSPITAL                                                                                                                                                                                                                                         7 4 11 11 0 0 0.0%
THE HILLINGDON HOSPITALS NHS FOUNDATION TRUST 4 4 8 8 0 0 0.0%
HILLINGDON HOSPITAL                                                                                                                                                                                                                                            2 4 6 6 3 2 4 6 0 0 0 15 15 250.0%
NULL 2 2 2 0 0 0.0%
THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST 35 46 38 48 51 40 23 281 258 0 0 0.0%
FREEMAN HOSPITAL                                                                                                                                                                                                                                               35 46 38 48 51 40 23 281 258 38 45 39 46 58 43 0 269 269 104.3%
THE PRINCESS ALEXANDRA HOSPITAL NHS TRUST 3 3 1 7 7 0 0 0.0%
PRINCESS ALEXANDRA HOSPITAL                                                                                                                                                                                                                                    3 3 1 7 7 0 6 0 5 5 3 1 20 19 271.4%
THE QUEEN ELIZABETH HOSPITAL  KING'S LYNN  NHS FOUNDATION TRUST 6 5 5 1 17 17 No Entry 0 0 0.0%
THE QUEEN ELIZABETH HOSPITAL                                                                                                                                                                                                                                   6 5 5 1 17 17 0 0 0.0%
THE ROTHERHAM NHS FOUNDATION TRUST 3 6 10 1 20 20 0 0 0.0%
ROTHERHAM DISTRICT GENERAL HOSPITAL                                                                                                                                                                                                                            3 6 10 1 20 20 7 0 0 0 0 0 0 7 7 35.0%
THE ROYAL BOURNEMOUTH AND CHRISTCHURCH HOSPITALS NHS FOUNDATION TRUST 13 9 15 12 9 13 17 88 71 0 0 0.0%
CHRISTCHURCH HOSPITAL                                                                                                                                                                                                                                          1 1 1 0 0 0.0%
NULL 12 1 13 13 0 0 0.0%
ROYAL BOURNEMOUTH GENERAL HOSPITAL                                                                                                                                                                                                                             13 9 3 10 9 13 17 74 57 9 6 2 3 7 1 0 28 28 49.1%
THE ROYAL MARSDEN NHS FOUNDATION TRUST 12 10 18 21 22 20 12 115 103 0 0 0.0%
NULL 14 8 16 2 40 40 0 0 0.0%
THE ROYAL MARSDEN HOSPITAL (LONDON)                                                                                                                                                                                                                            12 10 4 13 6 18 12 75 63 0 0 0 0 0 1 0 1 1 1.6%
THE ROYAL WOLVERHAMPTON NHS TRUST 4 12 10 11 18 20 10 85 75 0 0 0.0%
NEW CROSS HOSPITAL                                                                                                                                                                                                                                             17 20 10 47 37 11 15 17 16 19 13 5 96 91 245.9%
NULL 4 12 10 11 1 38 38 0 0 0.0%
THE WHITTINGTON HOSPITAL NHS TRUST 3 3 6 6 No Entry 0 0 0.0%
THE WHITTINGTON HOSPITAL                                                                                                                                                                                                                                       3 3 6 6 0 0 0.0%
UNITED LINCOLNSHIRE HOSPITALS NHS TRUST 16 12 10 10 16 10 7 81 74 0 0 0.0%
LINCOLN COUNTY HOSPITAL                                                                                                                                                                                                                                        7 8 9 13 8 7 52 45 0 0 0.0%
PILGRIM HOSPITAL                                                                                                                                                                                                                                               9 12 2 1 3 2 29 29 10 10 0 0 0 0 0 20 20 69.0%
UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST 8 4 10 5 7 15 8 57 49 0 0 0.0%
MIDDLESEX HOSPITAL                                                                                                                                                                                                                                             8 3 11 11 0 0 0.0%
UNIVERSITY COLLEGE HOSPITAL                                                                                                                                                                                                                                    1 10 5 7 15 8 46 38 7 8 0 0 0 0 0 15 15 39.5%
UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE NHS TRUST 16 21 22 18 18 9 6 110 104 0 7 9 1 1 5 3 26 23 22.1%
CITY GENERAL HOSPITAL                                                                                                                                                                                                                                          16 21 7 44 44 0 0 0.0%
NORTH STAFFORDSHIRE ROYAL INFIRMARY                                                                                                                                                                                                                            15 18 18 9 6 66 60 0 0 0.0%
UNIVERSITY HOSPITAL OF SOUTH MANCHESTER NHS FOUNDATION TRUST 2 2 8 12 19 13 9 65 56 No Entry 0 0 0.0%
NULL 2 2 8 12 19 2 45 45 0 0 0.0%
WYTHENSHAWE HOSPITAL                                                                                                                                                                                                                                           11 9 20 11 0 0 0.0%
UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST 17 11 21 17 18 13 10 107 97 0 0 0.0%
NULL 2 2 2 0 0 0.0%
SOUTHAMPTON GENERAL HOSPITAL                                                                                                                                                                                                                                   15 11 21 17 18 13 10 105 95 14 0 25 2 0 8 6 55 49 51.6%
UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST 10 13 12 19 20 19 14 107 93 0 0 0.0%
QUEEN ELIZABETH HOSPITAL                                                                                                                                                                                                                                       10 13 12 19 20 19 14 107 93 13 0 0 1 23 16 2 55 53 57.0%
UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST 3 2 1 1 7 7 0 0 0.0%
BRISTOL ROYAL INFIRMARY                                                                                                                                                                                                                                        3 2 1 1 7 7 8 4 0 1 0 1 1 15 14 200.0%
UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST 5 5 8 15 21 11 10 75 65 No Entry 0 0 0.0%
UNIVERSITY HOSPITAL (COVENTRY)                                                                                                                                                                                                                                 5 5 8 15 21 11 10 75 65 0 0 0.0%
UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST 20 14 16 8 22 17 14 111 97 0 0 0.0%
LEICESTER GENERAL HOSPITAL                                                                                                                                                                                                                                     20 14 16 8 22 17 14 111 97 9 10 6 12 25 22 4 88 84 86.6%
UNIVERSITY HOSPITALS OF MORECAMBE BAY NHS FOUNDATION TRUST 6 9 10 4 29 29 No Entry 0 0 0.0%
FURNESS GENERAL HOSPITAL                                                                                                                                                                                                                                       4 6 6 3 19 19 0 0 0.0%
ROYAL LANCASTER INFIRMARY                                                                                                                                                                                                                                      2 3 4 1 10 10 0 0 0.0%
WALSALL HEALTHCARE NHS TRUST 3 2 1 6 6 No Entry 0 0 0.0%
MANOR HOSPITAL                                                                                                                                                                                                                                                 3 2 1 6 6 0 0 0.0%
WEST HERTFORDSHIRE HOSPITALS NHS TRUST 13 14 13 11 9 9 69 69 0 0 0.0%
HEMEL HEMPSTEAD HOSPITAL                                                                                                                                                                                                                                       1 1 1 3 0 1 1 3 2 0 10 10 1000.0%
WATFORD GENERAL HOSPITAL                                                                                                                                                                                                                                       13 14 13 10 9 9 68 68 0 0 0 0 0 1 0 1 1 1.5%
WEST SUFFOLK NHS FOUNDATION TRUST 7 7 7 No Entry 0 0 0.0%
NULL 7 7 7 0 0 0.0%
WESTERN SUSSEX HOSPITALS NHS TRUST 1 2 3 1 0 0 0.0%
ST RICHARD'S HOSPITAL                                                                                                                                                                                                                                          1 1 0 6 4 4 2 0 0 0 16 16 #DIV/0!
WORTHING HOSPITAL                                                                                                                                                                                                                                              1 1 2 1 0 0 0.0%
WESTON AREA HEALTH NHS TRUST                                                                                                                                                                                                                                   1 1 1 0 0 0.0%
WESTON GENERAL HOSPITAL                                                                                                                                                                                                                                        1 1 1 0 0 0 0 1 0 0 1 1 100.0%
WHIPPS CROSS UNIVERSITY HOSPITAL NHS TRUST 4 5 11 12 15 12 8 67 59 No Entry 0 0 0.0%
WHIPPS CROSS UNIVERSITY HOSPITAL                                                                                                                                                                                                                               4 5 11 12 15 12 8 67 59 0 0 0.0%
WINCHESTER AND EASTLEIGH HEALTHCARE NHS TRUST 4 8 2 14 14 No Entry 0 0 0.0%
ROYAL HAMPSHIRE COUNTY HOSPITAL                                                                                                                                                                                                                                4 8 2 14 14 0 0 0.0%
WIRRAL UNIVERSITY TEACHING HOSPITAL NHS FOUNDATION TRUST 12 3 6 9 12 12 8 62 54 0 0 0.0%
ARROWE PARK HOSPITAL                                                                                                                                                                                                                                           12 3 6 9 12 12 8 62 54 0 0 6 12 10 8 11 47 36 66.7%
WORCESTERSHIRE ACUTE HOSPITALS NHS TRUST 12 12 14 23 17 15 12 105 93 0 0 0.0%
ALEXANDRA HOSPITAL                                                                                                                                                                                                                                             12 12 14 23 17 15 12 105 93 13 1 4 0 1 4 0 23 23 24.7%
WORTHING AND SOUTHLANDS HOSPITALS NHS TRUST 5 4 11 5 2 1 28 28 No Entry 0 0 0.0%
NULL 5 4 11 5 2 1 28 28 0 0 0.0%
WRIGHTINGTON  WIGAN AND LEIGH NHS FOUNDATION TRUST 4 1 4 9 9 No Entry 0 0 0.0%
NULL 4 1 5 5 0 0 0.0%
ROYAL ALBERT EDWARD INFIRMARY                                                                                                                                                                                                                                  4 4 4 0 0 0.0%
WYE VALLEY NHS TRUST 3 2 3 8 8 0 0 0.0%
HEREFORD COUNTY HOSPITAL                                                                                                                                                                                                                                       3 2 3 8 8 5 3 3 0 0 1 0 12 12 150.0%
YORK TEACHING HOSPITAL NHS FOUNDATION TRUST 13 12 12 17 4 58 58 0 0 0.0%
YORK HOSPITALS NHS TRUST HQ                                                                                                                                                                                                                                    13 12 12 17 4 58 58 2 0 0 0 0 0 0 2 2 3.4%
(blank) 0 #DIV/0!
(blank) 0 #DIV/0!
Grand Total 1176 1163 1193 1212 1301 1260 790 8095 7305 385 343 357 364 439 414 105 2407 2302 31.5%
32.7% 29.5% 29.9% 30.0% 33.7% 32.9% 13.3% 29.7% 31.5%
*If only include centre with total 50% or greater case capture another  355 cases lost to analysis
  
Appendix 6 – Patient Interview Information Sheet 
 
 
INFORMATION SHEET FOR PATIENTS 
 
[Study site: 1] 
[Unique identification number:            ] 
 
Decision making about bladder removal for cancer – 
An interview study 
 
We would like to invite you to take part in a research study. Before you decide we 
would like to explain why the research is being done and what it would involve. 
Please take time to read this information and discuss it with others if you wish. 
Please ask us if anything is not clear or if you would like more information. At the end 
of this leaflet you will find details on how to contact us.  
 
Part 1 tells you the purpose of this study and what will happen if you take part: 
 
 Why is the research being done?  
 Why have I been asked to take part? 
 Do I have to take part? 
 What will happen if I agree to take part? 
 Will I receive any expenses or payments?  
 What are the possible risks and benefits of taking part? 
 Will my taking part in the study be kept confidential? 
 
Part 2 gives you more detailed information about the conduct of the study:  
 
 What will happen if I change my mind about taking part? 
 Will my taking part in the study be kept confidential? 
 Will my General Practitioner (GP) be informed if I take part? 
 What will happen to the results of the study? 
 Who is organising and funding the research?  
 Who has reviewed the study?  
 
  
 What happens next? 
 How to contact us? 
 
 
Part 1: Purpose of this study and what will happen if you take part 
 
Why is the research being done? 
 
This study is part of a wider research project to develop a decision aid to help 
patients choose the method for draining urine after the bladder has been removed 
for cancer.  Currently, there are two options of urinary drainage when the bladder is 
removed: 
 
3) Urostomy (also known ileal conduit diversion): 
 
In this approach urine drains through an opening on the tummy (stoma) into an 
external bag which needs to be changed regularly. 
 
4) Substitute bladder (orthotopic neobladder): 
 
In this approach an artificial bladder is made from some of your bowels.  This can 
store urine, which like a normal bladder and you can then drain the urine by straining 
or inserting a thin tube (catheter). 
Each approach can affect patients differently and making the choice can be difficult.  
How people choose between the two approaches is poorly understood. This study is 
led by Dr Susan Wong, Professor Richard Thomson, Dr Catherine Exley and 
Professor Robert Pickard.  
 
This part of the study involves individual interviews to explore how doctors, nurses 
and patients make this choice.  The findings of the interviews will help us design a 
decision aid to help patients and their healthcare professionals make better informed 
choices. 
 
 
 
Why have I been asked to take part? 
  
 
You have been asked because you are about to have bladder surgery for cancer, 
and you may have been involved in making a decision about the method of draining 
urine. 
 
Do I have to take part? 
 
Taking part in an interview is entirely voluntary it is up to you to decide whether to 
take part. If you agree to take part, we will obtain your consent at the time of the 
interview. You are free to refuse to take part in this study, without giving a reason 
and without your medical care or legal rights being affected. If you do not want to be 
involved your decision will be treated with respect and entirely without prejudice.  
 
What will happen if I agree to take part? 
 
If you agree, our research team at Newcastle University will be in touch to arrange 
an interview time with you.  Interviews will take place face-to-face with a researcher 
from our team.  Notes may also be taken during the interview by the researcher.  
Each interview will last for about an hour and be recorded by an audio-recorder.  We 
will meet you at a time and place that suits you, for example at your home.  You are 
welcome to have someone with you during the discussion e.g. a family member or a 
friend.  Should your companion clearly express the wish to be interviewed, we will 
ask him/her to sign a consent form prior to proceeding with the interview. 
 
Before the interview starts, the researcher will answer any questions you may have 
about the study and will ask you to sign a consent form.  During the interview, you 
may be asked questions on: 
 
 How you chose the method of draining urine. 
 Your views on the information provided by doctors and nurses, how much you 
were involved and the support available when you were making the choice 
above. 
 What might better help a patient to make this choice. 
 
 
 
 
We will also ask if we can keep your contact details for taking part in further studies 
in the future to:  
  
 
1) Discuss the findings from the interviews. 
 
2)  Discuss ways to incorporate the findings into a decision aid.  
 
Personal contact details will be held confidentially and securely, and will be held only 
to contact you to ask if you would take part in a future study. You will again be able 
to choose to help or not if approached again. 
 
Will I receive any expenses or payments?  
 
The research team will pay you any out of pocket travel expenses if you provide us 
with a receipt. 
 
What are the possible risks of taking part? 
 
Every effort will be made to ensure your comfort and well-being during the interview. 
If you become tired we will take a break and ask you if you would like to continue.  
 
It is possible that some of the topics in the interview may be difficult or upsetting. You 
do not have to talk about those topics if you do not want to. If you would like to 
discuss any distressing or upsetting issues further, we can inform a member of the 
clinical team at Freeman Hospital, Newcastle-upon-Tyne who is responsible for your 
care with your permission. Please remember that you are free to stop taking part in 
the interview at anytime, and this will not affect your current or future treatment or 
your legal rights. 
 
Should you raise issues of concerns demonstrated in your care, we will encourage 
you to bring this to the attention of your local Patient Advice and Liaison Services 
(PALS) and the managerial level in charge of your hospital team.  We will provide the 
relevant contact details if necessary.  If you prefer not to approach your hospital 
directly, we can suggest the use of National Patient Safety Agency (NPSA) system.  
You can also ask us to raise your concerns to the relevant parties on your behalf, if 
you prefer.  When clear unprofessional practice has been demonstrated by your 
team, it is in our duty as the research team to report this to the director of research 
governance at the hospital trust involved and the General Medical Council. 
What are the possible benefits of taking part? 
  
 
Whilst there may be no personal benefit to you in taking part, the findings may help 
improve the ways the choices that patients make in future.  
 
Will my taking part in the study be kept confidential? 
 
YES - All information about your participation in the study will be strictly confidential. 
More details on confidentiality are included in Part 2 of this leaflet. 
 
This completes Part 1 of this information leaflet. If the information in Part 1 has 
interested you and you are considering participation, please read the additional 
information in Part 2 before making any decision.  
 
 
 
Part 2: Detailed information about the conduct of the study 
 
What will happen if I change my mind about taking part? 
 
If you agree to be interviewed but later decide that you don’t want to, please contact a 
member of our research team using the details at the end of this leaflet, quoting your 
unique identification number that is printed at the top of the first page of this leaflet. 
 
You are also free to leave the interview at any time, without giving a reason and 
without your medical care or legal rights being affected. At this point we can also 
destroy any information you have provided in the interview, but we will ask for your 
permission to continue to use the information that we have collected up until the 
point you leave the interview. However, once we have typed up and anonymised 
(your name and any identifying particulars will not be included) the information 
collected in the interview it will not be possible to delete the contribution of one 
participant without losing other potentially important information.   
 
Will my taking part in the study be kept confidential? 
 
YES.  We will not share details of your participation in the study with anyone outside 
the research team.  Your name or any other information that could identify you will 
not appear in any reports, publications or presentations based on findings from the 
study.  After the interview has finished, all data (audio-recordings and notes) will be 
typed up and anonymised (your name and any identifying particulars will not be 
included).  The recording of the interview will be destroyed once it is typed up and 
checked for accuracy.  Any direct quotes from participants who take part in the 
interviews would only be quoted as coming from “a participant” or a participant with a 
certain label, like “one participant [patient] said.”   
  
 
In accordance with Newcastle University’s policy, the computer files generated from 
the interviews will be stored in password protected university computer network.  Any 
paper versions of interview data (including notes taken at the interview) will be 
anonymised, and will be kept in a locked filing cabinet in the Institute of Health and 
Society at Newcastle University, and will only be available to members of the 
research team.  The paper and computer files of the information collected in the 
interviews will be held by Newcastle University for 10 years then securely destroyed. 
 
Will my General Practitioner (GP) be informed if I take part? 
 
We will not contact your GP regarding your participation in the study. 
 
What will happen to the results of the study? 
 
We will publish the findings in a report and scientific journals, and present them at 
scientific meetings. Any information that could potentially identify you will not be 
included in any report or publication.  
 
Who is organising and funding the research?  
 
The sponsor of the research is Newcastle University and Newcastle upon Tyne 
Hospitals NHS Foundation Trust. The study is also part of a wider educational 
research project funded by the National Institute of Health Research (NIHR). 
 
Who has reviewed the study?  
 
This study has been reviewed and given favourable opinion by the Newcastle & 
North Tyneside Research Ethics Committee 2. 
 
What happens next?  
 
If you would like to take part, please give your contact details on the reply slip of the 
invitation letter enclosed and return it in the self-addressed envelope.  We will 
contact you by phone to arrange for the interview. We will explain the study and 
answer any questions you may have about the study.  On the day of the interview, 
  
you will be asked to sign a consent form and we will clarify any queries you have 
related to the study.  
 
How to contact us 
 
If you have any concerns about the study, or would like more information, please 
contact a member of the study team: 
 
 
Dr Susan Wong (Clinical Research Associate)    
Telephone: 0191 2223818 
Email: s.wong@ncl.ac.uk 
    
Dr Mabel Lie (Research Associate)  
Telephone: 0191 2225874 
Email: m.l.s.lie@ncl.ac.uk 
 
 
Alternatively, please contact your local Patient Advice and Liaison Services (PALS) if 
you have other concerns or complaints about the study: 
 
Freepost:  RLTC-SGHH-EGXJ 
       North of Tyne PALS 
                 The Old Stables 
                 Grey’s Yard 
                 Morpeth 
                 Northumberland 
                 NE61 1QD  
 
Freephone:  0800 032 0202  
 
Lastly, for more independent advice, you may wish to contact: 
 
Urostomy Association 
18 Foxglove Avenue 
Uttoxeter 
Staffordshire 
ST14 8UN 
 
Telephone: 01889 563191 
Registered Charity no: 1131072 
  
 
Thank you for taking the time to read this information. 
 
Mr. Mark Johnson 
Consultant Urological Surgeon 
Telephone:  0191 2231030 
 
Department of Urology,  
Freeman Hospital, 
Newcastle upon Tyne 
NE7 7DN 
 
  
Appendix 7 – Patient Interview Invitation 
 
LETTER OF INVITATION: PATIENTS  
 
[Date of Letter:            ] 
 
Dear [                                         ] 
 
The urology team at Freeman Hospital, Newcastle-upon-Tyne who has been looking after you and our research team 
based in the Institute of Health and Society at Newcastle University would like to invite you, as a patient who is about 
to undergo bladder removal surgery and may have been involved in making a decision about the method of urine 
drainage, to take part in this interview study. 
 
Decision making about bladder removal for cancer - An interview study 
 
Our study is part of a larger research project named ‘Designing Decision Aid to Facilitate Choice of Urinary Drainage 
Procedure after Cystectomy for Bladder Cancer’.  This part of the project is led by  
Dr Susan Wong, Professor Richard Thomson, Dr Catherine Exley and Professor Robert Pickard.  
 
We aim to hold interviews with patients and healthcare professionals, in order to identify the aspects taken into 
account by both groups when choosing a urine drainage method with bladder removal for cancer.  The findings from 
the interviews will be used to build decision aid to help patients to choose the most individually suitable urine drainage 
method.  Your participation will involve an individual face-to-face interview with a researcher from our team. 
 
Attached is an information sheet about this study which sets out in more detail what your involvement would entail, 
and why the study is being done. If you are interested in participating, please complete and return the reply slip below 
by post using the self-addressed envelope enclosed.  Please note that participation in this study is entirely voluntary 
and you are free to refuse to take part, without giving a reason and without your medical care or legal rights being 
affected. 
 
If you have any questions or would like any further details, please do not hesitate to contact us.  
 
Yours sincerely, 
 
  
 
Dr Susan Wong (Clinical Research Associate)  
Telephone: 0191 2223818 
Email: s.wong@ncl.ac.uk 
 
Dr Mabel Lie (Research Associate) 
Telephone: 0191 2225874 
Email: m.l.s.lie@ncl.ac.uk 
 
Institute of Health & Society 
Baddiley-Clark Building 
Newcastle University 
Richardson Road 
Newcastle upon Tyne 
NE2 4AX  
 
           Enc. Reply Slip 
 
 ------------------------------------------------------------------------------------------------------------- 
 
I am willing to participate in the study, however I understand that I am free to withdraw from the 
study at any time and with no reason. I understand a researcher will contact me to arrange a 
suitable time and place for the interview. 
 
 
Name: ______________________________________ 
 
Signature: ___________________________________ 
 
Contact details (work): (email, telephone or other) 
 
____________________________________________ 
 
____________________________________________ 
 
____________________________________________ 
 
 
Mr. Mark Johnson 
Consultant Urological Surgeon 
Telephone:  0191 2231030 
 
Department of Urology,  
Freeman Hospital, 
Newcastle upon Tyne 
NE7 7DN 
 
  
PATIENTS: CONSENT FORM  (Appendix 8) 
 
Site Number: [1]                                         
Participant Identification Number: [            ] 
 
Decision making about bladder removal for cancer - 
An interview study 
 
Name of Researcher(s):                 Please initial 
each box  
 
1. I confirm that I have read and understood the information sheet dated  
5th August, 2010 (Version 1.2) for the above study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily.  
 
2. I understand that my participation in the face-to-face interview is voluntary and that 
I am free to withdraw my participation at any time without giving any reason, 
without my medical or legal rights being affected.  
 
3. I understand that data collected during the study will be looked at by individuals 
from the research team based at Newcastle University, and that all information will 
remain anonymous and confidential, and that no personal information will be used 
which may identify me in the final report or scientific publications.  
 
4. I agree to allow the researcher to audio-record the interview. I understand that 
anything that can personally identify me will be removed from the typed transcripts 
of the interview, and that the transcripts will be used for qualitative analysis. 
 
5. I understand that once transcribed, the audio-recordings will be destroyed and 
transcripts stored in locked files in accordance with the Data Protection Act.  
6. I agree to my contact details being recorded on password protected computers 
located in the Institute of Health and Society at Newcastle University for the 
purposes of inviting me to participate in further related studies such as survey, and 
communicating study results.  
 
7. I agree to take part in the above study.  
 
 
 
Name of Participant                                 Date                                     Signature  
 
 
Name of Person                                       Date                                     Signature 
Taking Consent:  
 
When completed: 1 copy for staff member; 1 copy for researcher file 
 
 
 
 
 
 
 
 
  
Appendix 9 – Recruited Patients for Interview: Characteristics 
 
 
 
 
 
Interviewer ID SiteName StudyPatientID Degner Choice StudyEntryDate StudyEntryTime RunningTotal Gender DOB Age Ethnicity Pre-/Post-op Time to/from op Diversion Type Interview Location
1 FRH FP1 1 15/11/2010 2pm 1 M 68 White British Post 2 years 10 months Conduit Home
1 FRH FP2 3 23/11/2010 1pm 2 F 54 White British Post 1 year 6 months Neobladder FRH
1 FRH FP3 4 18/01/2011 11.30am 3 M 59 White British Post 1 year 4 months Conduit Home
1 FRH FP4 4 24/01/2011 2pm 4 M 67 White British Post 2 months Conduit Home
2 FRH FP5 A 18/02/2011 2pm 5 M 68 White British Post 2 years 2 months Conduit Home
2 FRH FP7 A/B 23/02/2011 11am 7 F 62 White British Post 1 year 3 months Neobladder Home
2 SRH SP1 A 02/03/2011 1pm 11 M 58 White British Post 6 months Conduit Home
2 FRH FP6 A but C 08/03/2011 3pm 6 F 60 White British Post 2 years 7 months Conduit Home
1 FRH FP8 4 08/03/2011 2pm 8 M 70 White British Post 1 year Conduit Home
1 FRH FP10 2 11/03/2011 4pm 10 M 53 White British Post 1 year 2 months Neobladder Home
1 FRH FP9 5 11/03/2011 2pm 9 M 65 White British Post 11 months Conduit Home
1 SRH SP2 2 15/03/2011 1pm 13 M 58 White British Post 3 months Conduit Home
1 SRH SP3 3 - SP3; 2 - Wife 16/03/2011 2pm 12 M 54 White British Post 4 months Conduit Home
2 JCUH JP1 B 26/04/2011 3pm 14 M 72 White British Pre 2 weeks before Neobladder Home
1 FRH FP11 2 (actual); 2 (ideal) 21/07/2011 11am 15 M Early 50s White British Pre 5 days Conduit Home
2 JCUH JP1 (2) 08/08/2011 3pm 17 M 72 White British Post 3 months Neobladder Home
2 JCUH JP2 08/08/2011 11am 16 M 47 White British Post 3 months Neobladder Home
2 FRH FP12 04/10/2011 3pm 18 M 63 White British Post 3 months Conduit Home
1 FRH FP13 2 (actual); 2 (ideal) 28/10/2011 3pm 20 F 56 White British Pre 5 days Conduit FRH
1 RHH RP1 02/11/2011 2pm 21 M 51 North African British Pre 2 days Neobladder Home
1 SRH SP4 2 03/11/2011 2pm 19 F 71 White British Post 6 months Conduit Home
1 RHH RP2 15/11/2011 2pm 22 M 67 White British Post 4 months Conduit Home
1 RHH RP3 22/11/2011 11am 23 M 59 White British Post 5 months Conduit Home
1 RHH RP4 30/11/2011 11am 27 M 69 White British Post 1 year 2 months Neobladder Home
1 RHH RP5 2 (actual); 2 (ideal) 30/11/2011 2pm 28 M 63 White British Pre 6 days Conduit Home
1 JCUH JP3 25/01/2012 3.30pm 27 M Mid 60s White British Pre 2.5 weeks before Conduit Home
1 RHH RP6 26/01/2012 11am 24 M 64 White British Post 4 months Conduit Home
1 RHH RP7 31/01/2012 11am 25 M 53 White British Post 4 months Neobladder Home
  
Appendix 10 – Clinician Interview Information Sheet 
 
 
INFORMATION SHEET FOR CLINICIANS 
 
[Study site: 1] 
[Unique identification number:            ] 
 
Decision making about urinary diversion with radical cystectomy 
for cancer - An interview study 
 
We would like to invite you to take part in a research study. Before you decide we 
would like to explain why the research is being done and what it would involve. 
Please take time to read this information and discuss it with others if you wish. 
Please ask us if anything is not clear or if you would like more information. At the end 
of this leaflet you will find details on how to contact us.  
 
Part 1 tells you the purpose of this study and what will happen if you take part: 
 
 Why is the research being done?  
 Why have I been asked to take part? 
 Do I have to take part? 
 What will happen if I agree to take part? 
 Will I receive any expenses or payments?  
 What are the possible risks and benefits of taking part? 
 Will my taking part in the study be kept confidential? 
 
Part 2 gives you more detailed information about the conduct of the study:  
 
 What will happen if I change my mind about taking part? 
 Will my taking part in the study be kept confidential? 
 Will my General Practitioner (GP) be informed if I take part? 
 What will happen to the results of the study? 
 Who is organising and funding the research?  
 Who has reviewed the study?  
 
  
 What happens next? 
 How to contact us? 
 
 
Part 1: Purpose of this study and what will happen if you take part 
 
Why is the research being done? 
 
This study is part of a wider research project to develop a decision aid to help 
patients choose the urinary diversion method after radical cystectomy for cancer.  
Currently, the two methods of diversion most commonly offered are ileal conduit 
diversion and orthotopic neobladder reconstruction.   Each method can affect 
patients differently and making the choice can be difficult.  How patients choose 
between the two approaches is poorly understood.  This study is led by Dr Susan 
Wong, Professor Richard Thomson, Dr Catherine Exley and Professor Robert 
Pickard.  
 
This part of the study involves individual, interviews to explore how healthcare 
professionals and patients make this choice.  The findings of the interviews will help 
us design a decision aid to help patients and their healthcare professionals make 
better informed choices. 
 
Why have I been asked to take part? 
 
You have been asked because you are a healthcare professional involved in the 
decision making about urinary diversion when radical cystectomy is performed for 
bladder cancer. 
 
Do I have to take part? 
 
Taking part in an interview is entirely voluntary it is up to you to decide whether to 
take part. If you agree to take part, we will obtain your consent at the time of the 
interview. You are free to refuse to take part in this study, without giving a reason 
and without your employment or legal rights being affected. If you do not want to be 
involved in this study your decision will be treated with respect and entirely without 
prejudice.  
 
 
  
What will happen if I agree to take part? 
 
If you agree, our research team at Newcastle University will be in touch with you 
again to arrange for an interview, and ask you to assist in recruiting patients for 
interviews.  We will communicate with you on a separate occasion regarding the 
details of patient recruitment.  
 
Interviews will take place face-to-face with a researcher from our team.  Notes may 
also be taken during the interview by the researcher.  Each interview will last for 
about an hour and be recorded by an audio-recorder.  We will meet you at a time 
and place within your work premise that suits you.   
 
Before the interview starts, the researcher will answer any questions you may have 
about the study and will ask you to sign a consent form.  During the interview, you 
may be asked questions on: 
 
 Aspects you considered in selecting a urinary diversion method for a patient 
when radical cystectomy is performed for cancer. 
 Your experience on communication and engagement with patients, when 
deciding which urinary diversion to proceed with in the context of radical 
cystectomy.  
 What may help you and a patient to decide on the urinary diversion to adopt. 
 
 
We will also ask if we can keep your contact details for taking part in further studies 
in the future to:  
 
 1) Discuss the findings from the interviews. 
 
2)  Discuss ways to incorporate the findings into a decision aid.  
 
Personal contact details will be held confidentially and securely, and will be held only 
to contact you to ask if you would take part in a future study. You will again be able 
to choose to help or not if approached again. 
Will I receive any expenses or payments?  
 
There will be no financial incentive for taking part in the research.  
  
What are the possible risks of taking part? 
 
Every effort will be made to ensure your comfort and well-being during the interview. 
If you become tired we will take a break and ask you if you would like to continue.  
 
It is possible that taking part in an interview may raise some potentially controversial 
issues or may cause you to recall distressing experiences from your clinical work.  
 
What are the possible benefits of taking part? 
 
Whilst there may be no personal benefit to you in taking part, the findings may help 
improve the ways the choices that patients make in future.  
 
Will my taking part in the study be kept confidential? 
 
YES - All information about your participation in the study will be strictly confidential. 
More details on confidentiality are included in Part 2 of this leaflet. 
 
This completes Part 1 of this information leaflet. If the information in Part 1 has 
interested you and you are considering participation, please read the additional 
information in Part 2 before making any decision.  
 
 
Part 2: Detailed information about the conduct of the study 
 
What will happen if I change my mind about taking part? 
 
If you agree to participate (interview and patient recruitment) but later decide that you 
no longer wish to, please contact a member of our research team using the details at 
the end of this leaflet, quoting your unique identification number that is printed at the 
top of the first page of this leaflet. 
 
You are also free to leave the interview at any time, without giving a reason and 
without your medical care or legal rights being affected. At this point we can also 
destroy any information you have provided in the interview, but we will ask for your 
permission to continue to use the information that we have collected up until the 
point you leave the interview. However, once we have typed up and anonymised 
(your name and any identifying particulars will not be included) the information 
collected in the interview it will not be possible to delete the contribution of one 
participant without losing other potentially important information.   
 
  
Will my taking part in the study be kept confidential? 
 
YES.  We will not share details of your participation in the study with anyone outside 
the research team.  Your name or any other information that could identify you will 
not appear in any reports, publications or presentations based on findings from the 
study.  After the interview has finished, all data (audio-recordings and notes) will be 
typed up and anonymised (your name and any identifying particulars will not be 
included).  The recording of the interview will be destroyed once it is typed up and 
checked for accuracy.  Any direct quotes from participants who take part in the 
interviews would only be quoted as coming from “a participant” or a participant with a 
certain label, like “one participant [surgeon/nurse] said.”   
 
In accordance with Newcastle University’s policy, the computer files generated from 
the interviews will be stored in password protected university computer network.  Any 
paper versions of interview data (including notes taken at the interview) will be 
anonymised, and will be kept in a locked filing cabinet in the Institute of Health and 
Society at Newcastle University, and will only be available to members of the 
research team.  The paper and computer files of the information collected in the 
interviews will be held by Newcastle University for 10 years then securely destroyed. 
 
What will happen to the results of the study? 
 
We will publish the findings in a report and scientific journals, and present them at 
scientific meetings. Any information that could potentially identify you will not be 
included in any report or publication.  
 
Who is organising and funding the research?  
 
The sponsor of the research is Newcastle University and Newcastle upon Tyne 
Hospitals NHS Foundation Trust. The study is also part of a wider educational 
research project funded by the National Institute of Health Research (NIHR). 
 
Who has reviewed the study?  
 
This study has been reviewed and given favourable opinion by Newcastle & North 
Tyneside Research Ethics Committee 2. 
 
 
  
What happens next?  
 
If you agree to take part, please provide your contact details (e-mail address and 
contact telephone number) via e-mail, or on the reply slip of the invitation letter 
enclosed and return the slip by post.  A member of our research team will soon 
contact you by phone to arrange for an interview to take place. We will explain the 
study and answer any questions you may have about the study.  Before we proceed 
with the interview on the day, you will be asked to sign a consent form and we will 
clarify any queries you have related to the study.  
 
How to contact us 
 
If you have any concerns about the study, or would like more information, please 
contact a member of the study team: 
 
Dr Susan Wong (Clinical Research Associate)    
Telephone: 0191 2223818 
Email: s.wong@ncl.ac.uk 
    
Dr Mabel Lie (Research Associate)  
Telephone: 0191 2225874 
Email: m.l.s.lie@ncl.ac.uk 
 
Thank you for taking the time to read this information. 
 
 
 
 
 
 
 
 
 
 
 
 
Mr. Mark Johnson 
Consultant Urological Surgeon 
Telephone:  0191 2231030 
 
Department of Urology,  
Freeman Hospital, 
Newcastle upon Tyne 
NE7 7DN 
 
  
Appendix 11 – Clinician Interview Invitation 
 
 
 
 
Research Team 
Susan S W Wong - NIHR Research Fellow 
Cath Exley - Senior Lecturer 
Robert Pickard - Professor of Urology 
Richard Thomson - Professor of Public health 
 
Dear [               ] 
 
 
RE: A questionnaire survey of clinicians’ views on decision support for 
choosing between ileal conduit and orthotopic neobladder with radical 
cystectomy 
 
We are a group of researchers based at the Institute of Health & Society, Newcastle 
University, and in conjunction with the Oncology Section of BAUS, would like to 
invite you to participate in this short questionnaire survey.  It is a self-completed, 
web-based survey and is part of a wider research project, which aims to develop 
formal support for bladder cancer patients who will undergo radical cystectomy to 
help them make a choice between ileal conduit and orthotopic neobladder) that best 
suits them.  You have been invited since you are a urologist involved in the decision 
making about urinary diversion when radical cystectomy is performed for bladder 
cancer.  The survey takes 15-20 minutes to complete and it asks your views on the 
current support you have available for helping patients make the choice of diversion, 
and potential ways to improve the support.   
We understand that sometimes a patient is suitable for only one of the two diversion 
options mentioned because of patient health or cancer factors; at other times 
however, a patient can be a candidate for either option. In the latter case, choosing 
the most suitable diversion on an individual level can be a difficult process for both 
the patient concerned and his/her responsible clinicians.  To date, little is known 
about this choice-making process.  The findings from this survey and other 
components of the project including qualitative interviews and workshops will inform 
the content of the decision support we are going to develop.   
At the end of the survey there is a brief introduction to the subsequent interview 
study and you will have the opportunity to express your interest in taking part as an 
independent healthcare professional. 
Please note that participation in this survey is entirely voluntary.  Should you decide 
to participate, please follow the link below and follow the instructions. 
http://www.surveymonkey.com/s/XKFN57M 
 
  
The survey is hosted on the password-protected SurveyMonkeyTM system and all 
data collected will be automatically anonymised.  Only participants who indicate their 
interest in taking part in the interview phase will be identifiable by giving their e mail 
address.  Any publication generated from the survey will therefore report on 
aggregate data only and no individual respondents will be identified.   
Thank you ever so much for your time, and if you have any queries please do not 
hesitate to contact us. 
 
Kind Regards, 
 
 
Susan S W Wong (Clinical Research Associate) 
Telephone:  
0191 222 3818 (Work) 
 
Email: s.wong@ncl.ac.uk 
 
Address: 
Institute of Health & Society 
Baddiley-Clark Building 
Newcastle University 
Richardson Road 
Newcastle upon Tyne 
NE2 4AX 
 
 
 
 
 
 
 
 
 
 
 
 
  
CLINICIANS: CONSENT FORM (Appendix 12: Local)                
Site Number: [1]                                           
Participant Identification Number: [            ]  
 
Decision making about urinary diversion with radical cystectomy for cancer - 
An interview study 
 
Name of Researcher(s):                 Please initial 
each box  
 
8. I confirm that I have read and understand the information sheet dated 4th June, 
2010 (Version 1.1) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.  
 
9. I understand that my participation in the face-to-face interview is voluntary and that 
I am free to withdraw my participation at any time without giving any reason, 
without my employment or legal rights being affected.  
 
10. I understand that data collected during the study will be looked at by individuals 
from the research team based at Newcastle University, and that all information will 
remain anonymous and confidential, and that no personal information will be used 
which may identify me in the final report or scientific publications.  
 
11. I agree to allow the researcher to audio-record the interview. I understand that 
anything that can personally identify me will be removed from the typed transcripts 
of the interview, and that the transcripts will be used for qualitative analysis. 
 
12. I understand that once transcribed, the audio-recordings will be destroyed and 
transcripts stored in locked files in accordance with the Data Protection Act.  
13. I agree to my contact details being recorded over on password protected 
computers located in the Institute of Health and Society at Newcastle University 
for the purposes of inviting me to participate in further related studies such as 
validation workshop, and communicating study results.  
 
14. I agree to take part in the above study.  
 
 
 
Name of Participant                                 Date                                     Signature  
 
 
Name of Person                                       Date                                     Signature 
Taking Consent:  
 
 
When completed: 1 copy for staff member; 1 copy for researcher file 
 
 
 
 
 
 
 
 
  
 
          CLINICIANS: CONSENT FORM (Appendix 13: Non-Local) 
Site Number: [4]                                           
Participant Identification Number: [            ]  
 
Decision making about urinary diversion with radical cystectomy for cancer - 
An interview study 
 
Name of Researcher(s):                 Please initial 
each box  
 
15. I confirm that I have read and understand the information sheet dated 4th June, 
2010 (Version 1.1) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.  
 
16. I understand that my participation in the face-to-face interview is voluntary and that 
I am free to withdraw my participation at any time without giving any reason, 
without my employment or legal rights being affected.  
 
17. I understand that data collected during the study will be looked at by individuals 
from the research team based at Newcastle University, and that all information will 
remain anonymous and confidential, and that no personal information will be used 
which may identify me in the final report or scientific publications.  
 
18. I agree to allow the researcher to audio-record the interview. I understand that 
anything that can personally identify me will be removed from the typed transcripts 
of the interview, and that the transcripts will be used for qualitative analysis. 
 
19. I understand that once transcribed, the audio-recordings will be destroyed and 
transcripts stored in locked files in accordance with the Data Protection Act.  
20. I agree to my contact details being recorded over on password protected 
computers located in the Institute of Health and Society at Newcastle University 
for the purposes of inviting me to participate in further related studies such as 
validation workshop, and communicating study results.  
 
21. I agree to take part in the above study.  
 
 
 
Name of Participant                                 Date                                     Signature  
 
 
Name of Person                                       Date                                     Signature 
Taking Consent:  
 
When completed: 1 copy for staff member; 1 copy for researcher file 
 
 
 
 
 
 
 
 
  
Appendix 14 – Recruited Clinicians for Interview: Characteristics (Local) 
 
 
 
 
 
 
 
 
 
 
StudyClinicianID Degner Choice 1 Degner Choice 2 StudyEntryDate StudyEntryTime RunningTotal Gender Seniority Ethnicity Surgeon/Specialist 
Nurse
Interview Location
FC1 3 3 23/11/2010 10am 1 F White British SN FRH
C1 4 2 08/12/2010 1pm 2 F White British SN Wansbeck General
C2 4 3 13/01/2011 2pm 3 F White British SN FRH
FC2 C B 14/01/2011 2pm 4 M White British Surgeon FRH
FC3 2 2 03/02/2011 1pm 5 F White British SN Home
FC4 B A 10/02/2011 9am 6 M White British Surgeon FRH
FC5 B/C B 14/02/2011 11am 7 M Asian British Surgeon FRH
SC1 C B 02/03/2011 3.30 pm 8 M White British Surgeon SRH
JC2 4 3 07/03/2011 4pm 9 M White British Surgeon JCUH
JC1 B A 23/03/2011 2.30pm 10 F White British Surgeon JCUH
JC3 Scale not used Scale not used 13/04/2011 10.30pm 11 F White British Surgeon JCUH
SC2 E A 31/08/2011 11am 12 F White British SN SRH
JC4 B B 05/09/2011 2pm 13 F White British SN JCUH
RC1 B B 06/12/2011 10am 14 M White British Surgeon
RC2 B A 06/12/2011 2pm 15 F White British SN
RC3 B B 13/02/2012 2pm 16 M Non-white British Surgeon
  
Appendix 14 – Recruited Clinicians for Interview: Characteristics (Non- Local: Surgeons) 
 
 
  
 
  
Appendix 14 – Recruited Clinicians for Interview: Characteristics (Non- Local: Nurses) 
 
  
 
Gender Age Yrs of Experience No. Cystectomy 
counselled last yr
IC counselled ON counselled Region Degner Add Comments Date Info sent Date Reminder Participation Y/N Consent Hardcopy prior 
to Interview Y/N
Date and Time Interview Interviewer Degner 1 Degner 2
Female 38 0 to 5 years 3 999 999 Guernsey I would prefer to leave the 
decision about the diversion 
to my patient
I think it is important that the patient is given all 
the required information from the different 
Specialists but ultimately, the Surgeon and the 
patient need to discuss which option is going to 
have the best outcome for them and their future 
needs.  Also, the Surgeon has a lot more 
considerations to think about regarding the 
patients performance status.
08.09.11 N/A Y N/N3. Card sent. 10.10.11, 11am SW B ?:
Female 46 6 to 10 years 16 10 6 Slough I would prefer to leave the 
decision about the diversion 
to my patient
When I first counsel patients re the pros & cons 
of each form of surgery, there seems to be a lack 
of awareness from them relating to the possible 
complications of neo-bladder surgery - e.g. 
possibility of incontinence or need for self-
catheterisation. I don't really feel that I should 
be the first person they hear this information 
from. Having a urostomy does sometimes seem 
to be presented to patients as a less favourable 
option by their surgeon. I would certainly prefer 
it if their surgeon gave them a more balanced 
view of both types of surgery before they came 
to see me, especially since my initial contact with 
them is sometimes only a week or two before 
their operation. This leaves patients with very 
little time to make an informed decision - 
especially if they then wish to make contact with 
former patients to hear their experiences first.
08.09.11 N/A Y N/N2.  Consent sent by ML. 13.10.11, 3.15pm ML A ?
Female 51 6 to 10 years 10 10 0 Tooting I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
sometimes we are told that a patient is deciding 
between diversion options, but has never been 
referred to us as the stoma nurses. I do not feel 
that they have been given enough information 
on ileal conduit, if they have not met us to make 
a fully informed choice.
08.09.11 23.09.11 e-mailed.  Need 
post.
Y N/N5
Female 48 11 to 15 years 8 6 2 I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
Pt must be the one to decide but for some the 
practicalities of option may not be suitable to all 
and at this point I would want the pt to think 
hard about the decision understanding all that is 
involved.
08.09.11 23.09.11
Female 59 over 20 years 6 5 1 W. Sussex I would prefer to leave the 
decision about the diversion 
to my patient
We must leave the final decision to the patient 
having talked about all the risks, benefits etc.
08.09.11 23.09.11
Female 55 over 20 years 22 15 6 London I would prefer that my patient 
and I make the decision about 
the diversion jointly
999 08.09.11 23.09.11 N/N4.  Consent and card sent. 5pm, 24.09.11 SW ? ?
Female 45 6 to 10 years 10 5 5 Brighton I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
it is important that pts have the information and 
your experence in order for them to make a 
decision for them
08.09.11 23.09.11 e-mailed with WCET 
UK in error.  Need post.
Female 55 6 to 10 years 28 25 3 Belfast I would prefer that my patient 
and I make the decision about 
the diversion jointly
I have found that there is quite some 
inconsistency in the information available 
reagarding post-operative and discharge care for 
patients with neobladder reconstruction.  
Therefore a more balanced view and 
information would be helpful
08.09.11 23.09.11
Female 45 16 to 20 years Approx. 50 35 15 Swansea I would prefer to leave the 
decision about the diversion 
to my patient
999 08.09.11 23.09.11 Y N/N6.  Consent sent 08.11.11. 08.11.11, 2pm.                01792 
703526
SW B B
Female 50 11 to 15 years 10 3 7 Manchester I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999 08.09.11 N/A Y N/N1. Card sent. 24.10.11, 2pm SW B B
Female 33 0 to 5 years Approx. 15 Approx. 15 4 I would prefer to leave the 
decision about the diversion 
to my patient
I provide all the advantages and disadvantages of 
the procedure, providing leaflets and booklets 
and visual aids and when I provided all the facts 
would leave the decision with my patient and be 
there to support them in whatever they choose
08.09.11 23.09.11
Male 37 11 to 15 years 12 11 1 I would prefer to leave the 
decision about the diversion 
to my patient
999 08.09.11 23.09.11
Female 46 6 to 10 years 32 26 3 I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999 29.09.11 18.10.11
Female 46 16 to 20 years 12 to 15 12 to 15 8 I would prefer to leave the 
decision about the diversion 
to my patient (If medically fit 
enough for neobladder)
Some patients do not have a choice of 
neobladder as the operation is longer; if not fit 
so would not get to choose
29.09.11.  Prefers post. 18.10.11. Posted
Female 45 6 to 10 years 4 4 999 I would prefer to leave the 
decision about the diversion 
to my patient
Patient to make own decision after information 
given for informed decision by patient
29.09.11 18.10.11
Female 51 11 to 15 years 12 12 999 I would prefer to leave the 
decision about the diversion 
to my patient
999 29.09.11 18.10.11 N (as hospital does not 
perform radical cystectomy 
anymore)
Female 49 11 to 15 years 10 10 999 I would prefer that my patient 
and I make the decision about 
the diversion jointly
To ensure the patient is fully informed befor they 
make a decision
29.09.11 18.10.11 Y N/N8
Female 47 16 to 20 years 22 15 5 (2 Neo + Mitrofanoff) London I would prefer to leave the 
decision about the diversion 
to my patient
To previous question I would leave the choice to 
the pa tients once they have had an opportunity 
to be provided with information on all options.
16.11.11 N/A Y N/N7. Consent sent 28.11.11 10 am, 28.11.11 SW B B
  
Appendix 15 – Interview Guides: Patients 
 
Decision making about bladder removal for cancer – 
An interview study 
 
Patient interview schedule 
 
Introductory 
 
1. Introduce researcher and purpose of the study. 
 
2. Obtain written consent to proceed and to audio-record the interview conversation. 
 
3. Remind interviewee about confidentiality, anonymity and disposal of all interview 
information, according to University’s regulations and Data Protection Act (1998). 
 
4. Remind Interviewee that they are free to stop or withdraw at anytime. 
 
 
Questions 
 
1. I understand you had a chat with your surgeon before going into hospital for the bladder 
removal surgery.  Can you recall what was covered with your surgeon during the chat? 
 
 Probe:  
 
 About bladder removal 
 About urinary drainage (urine diversion) 
 The option(s) of diversion methods mentioned 
 About talking with Specialist Nurses after seeing the surgeon 
 
(If only one method mentioned, stress that sometimes for clear reasons e.g. the location of 
the bladder growth, concerns for medical fitness etc. a patient is not suitable for other 
methods.  Then mention otherwise there would have been two urine diversion methods 
available: urostomy and neobladder) 
 
2. How did you feel when you when you were advised that the bladder should be removed? 
 
  
3. When you were faced with two choices of urine diversion methods, how did you feel?  
(For patients with two choices only). 
 
4. When you were choosing/if you had a chance to choose between the options of urine 
diversion methods, what did/would you take into account? 
 
 Probe: 
 
 Benefits (survival)/Risks (recurrence), complications 
 Recovery, rehabilitation, self-help groups, follow-up 
 Daily management, supplies, care arrangements 
 Impact on significant others 
 Work, leisure/sports/travel 
 Self-identity, body image, sexual matters 
 Likelihood of disease progression 
 Impact on overall quality of life 
 The most important factor to the patient 
 Rank most important/least important factors 
 
5. What did you think of the information given to you about your surgery by your surgeon 
and his/her team? 
 
 Probe: 
 
 What information, the amount and helpfulness of information on bladder removal 
and/or diversion(s) 
 Information given should cover all the factors stated above, in Question 2. 
 Any additional information the patient would like 
 Anything now known would have been beneficial to know before the surgery? 
 
6. Were there any materials you came across before your surgery that were helpful? 
 
 Probe: 
 
 Leaflets/booklets, DVDs, Audio-CDs etc. 
 Anything the patient would have liked to have. 
 Where did the patient get the information. 
 
7. Who helped you/ to choose between the urine diversion methods? 
 
 Probe: 
 
 Surgeon/Specialist Nurses/Spouse/Family/Friends/Others 
 Who were the most helpful/influential? 
 Who would you have preferred help or more help from? 
  
 
 
8. We are trying to encourage future patients like yourself have more say, when it comes to 
deciding on management/treatments.  How important do you think this is?  What do you 
think can help with this? 
 
9. Also, we are trying to build some material helping future patients to choose a diversion 
method that best suits them when the diseased bladder is to be removed.  Do you have 
any suggestions?   (Probe: format and the way the material should be used) 
 
10. How involved did you feel in the whole discussion about your surgery? 
 
11.  How involved would you prefer to be (Flashcard)? 
 
Use  Degner Control Preference Scale: 
 I would prefer to make the decision about which urine 
diversion method I would have.           
 
 I would prefer to make the final decision about the urine 
diversion method after seriously considering the opinion 
from my surgeon’s and his/her team.                                              
 
 I would prefer my surgeon along with his/her team and I 
shared the responsibility for deciding which urine 
diversion method was best for me.                                            
 
 I would prefer my surgeon and his/her team made the final 
decision on which urine diversion method would be used, 
but seriously considered my opinion.                                            
 
 I would prefer to leave all decisions regarding urine 
diversion method to my surgeon and his/her team.            
       
 If patient feels not as involved as he/she would have liked, 
ask how much he/she would prefer. 
 
12. How do you feel about your surgery now (for post-surgery patients only) 
 
 Probe:  
 
  
 Overall satisfaction, regrets, level of cope etc. 
 Would make the same decision again?  If not , why not? 
 
13. Are there any other issues you would like to mention? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix 15 – Interview Guides: Clinicians - Surgeons 
 
Decision making about urinary diversion with radical cystectomy 
for cancer - An interview study 
 
Clinician (Surgeon) interview schedule 
 
Introductory 
 
5. Introduce researcher and purpose of the study. 
 
6. Obtain written consent to proceed and to audio-record the interview conversation. 
 
7. Remind interviewee about confidentiality, anonymity and disposal of all interview 
information, according to University’s regulations and Data Protection Act (1998). 
 
8. Remind Interviewee that they are free to stop or withdraw at anytime. 
 
 
Questions 
 
14. To begin with, can you tell me something about yourself?  How long have you been a 
consultant? 
 
15. What is your experience of performing/observing ileal conduits and neobladders so far? 
 
16. What is your experience of being involved in decisions about urinary diversions with 
radical cystectomy?  What would you say was the level of your involvement? 
 
(Encourage surgeon to provide examples) 
  
17. How do you decide on the urinary diversions to offer?  (Probe: how to decide to offer one 
or both diversions) 
 
 Probe: 
 
 Which diversion recommended most often and why. 
  
 Try to elicit clinical and non-clinical characteristics for the above, including 
time required for each procedure. 
 
18. You have mentioned the following factors in your decision (list factors) - which would you 
say is the most important/least important? 
 
 
 
 
 
19. What is your typical pre-surgery chat with a patient undergoing radical cystectomy with 
urinary diversion like? 
 
 Probe 
 
 Any companions?  
 Topics covered 
 Level of input from patient and his/her companions?  Use Degner Control Preference 
Scale (CPS) for patient (P). (Flashcard) 
 
 P made the decision about which urine diversion method P would have.           
 P made the final decision about the urine diversion method after seriously considering 
the opinion from surgeon’s and his/her team.                                              
 
 Surgeon along with his/her team and P shared the responsibility for deciding which 
urine diversion method was best for me.                                            
 
 Surgeon and his/her team made the final decision on which urine diversion method 
would be used, but seriously considered P’s opinion.                                            
 
 P left all decisions regarding urine diversion method to surgeon and his/her team.        
    
 
 What are some of the reactions you get from the patient and his/her company when 
you tell them about bladder removal and the diversion(s)?  
 
20. What information do you give a pre-cystectomy patient, on the cystectomy itself and the 
diversion(s)? 
 
21. Are any materials given to a pre-cystectomy patient in your practice?  If so, what are 
they?  What do you think of their usefulness? 
 
 Probe: 
 
  
 Leaflets/booklets, DVDs, Audio-CDs etc. 
 The amount and helpfulness of these materials. 
 
22. Who else are influential in helping the patient to reach a decision in the choice between 
the two diversion options? 
 
 Probe: 
 
 Specialist Nurses/Spouse/Family/Friends/Others 
 (Of those you have mentioned, who have you found to have been most 
influential?  -  Can be asked with Question 3) 
 What do you think of their role and level of involvement? 
 
 
 
23. What do you prefer in terms of involvement, when deciding which urine diversion method 
to proceed with?  (For patients suitable for both diversion methods) (Flashcard) 
 
 Use Degner CPS adapted for Clinicians: 
 
I would prefer to leave the decision about the diversion to my patient 
 
I would prefer that my patient makes the decision about the diversion, after seriously 
considering my opinion 
 
I would prefer that my patient and I make the decision about the diversion jointly. 
 
I would prefer to make the decision about the diversion, after seriously considering my 
patient's opinion. 
 
I would prefer to make the decision about the diversion. 
 
24. Do you think it is a good idea to encourage future cystectomy (radical) patients who are 
suitable for both diversion methods to have more say in deciding on the diversion 
method to go with.   
 
 Probe: 
 
 If yes, what could facilitate this? 
 If not, why not? 
 
  
25. Also, we are trying to develop some material helping future patients to choose a 
diversion method that best suits them when the diseased bladder is to be removed.  Do 
you have any suggestions?  (Probe: format and the way the material should be used) 
 
26. Are there any other issues you would like to mention? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix 15 – Interview Guides: Clinicians - Nurses 
 
Decision making about urinary diversion with radical cystectomy 
for cancer - An interview study 
 
Clinician (Specialist Nurse) interview schedule 
 
Introductory 
 
9. Introduce researcher and purpose of the study. 
 
10. Obtain written consent to proceed and to audio-record the interview conversation. 
 
11. Remind interviewee about confidentiality, anonymity and disposal of all interview 
information, according to University’s regulations and Data Protection Act (1998). 
 
12. Remind Interviewee that they are free to stop or withdraw at anytime. 
 
 
Questions 
 
27. To start, can you tell me something about yourself: fpr examplehow long have you been 
a specialist nurse? 
 
28. What has your experience been of counselling radical cystectomy patients so far? 
 
29. Have you been involved in decisions about urinary diversions with radical cystectomy?  If 
so how?   
 
(Encourage specialist nurse to provide examples) 
 
 
30. Has a patient changed his/her mind about the diversion to proceed with, after speaking 
to you? 
  
  
31. Say you have a patient who is to undergo radical cystectomy with urinary diversion.  How 
would you advise him/her? (Probe: about patients with and without both choices of 
diversion) 
 
 
32. You have mentioned the following factors in the advice you give  (name them) - which 
would you say is the most important? 
 
 
33. How do you see your role in helping patients reach a decision? 
 
34. How do most patients see your role? And how does the consultant see your role? 
 
35. What is your typical pre-surgery chat with a patient undergoing radical cystectomy with 
urinary diversion like? 
 
 Probe 
 
 Any companions?  
 Topics covered 
 Usual level of input from patient and his/her companions?  Use Degner Control 
Preference Scale (CPS) for patient (P). (Flashcard) 
 
 P makes the decision about which urine diversion method P would have.     
 
 P makes the final decision about the urine diversion method after seriously 
considering the opinion from surgeon’s and his/her team.                                              
 
 Surgeon along with his/her team and P shares the responsibility for deciding which 
urine diversion method was best for me.                                            
 
 Surgeon and his/her team makes the final decision on which urine diversion method 
would be used, but seriously considered P’s opinion.                                            
 
 P leaves all decisions regarding urine diversion method to surgeon and his/her team.        
    
 
8. From your experience, what have been some of the reactions of your patients and their 
company when you discuss with them about bladder removal and the diversion(s)?  
 
36.  What information do you give a pre-cystectomy patient, on the  cystectomy itself 
and the diversion(s)? 
 
37.  Are any materials given to a pre-cystectomy patient in your practice?  If so, what are 
they?  What do you think of their usefuleness? 
  
 
 Probe: 
 
 Leaflets/booklets, DVDs, Audio-CDs etc. 
 The amount and helpfulness of these materials. 
 
38. Who else are helpful/influential to the patient in reaching a decision regarding the choice 
between the two diversion options? 
 
 Probe: 
 
 Surgeon/Spouse/Family/Friends/Others 
 (Of those you have mentioned, who have you found to have been most 
helpful/influential?  -  Can be asked with Question 3) 
 
39. If it was down to you alone, how involved would you prefer to be when deciding on the 
urine diversion method to proceed with? (For patients suitable for both diversion 
methods) 
 
 Probe: 
 
 Use Degner CPS adapted for Clinicians (Flashcard): 
 
I would prefer to leave the decision about the diversion to my patient 
 
I would prefer that my patient makes the decision about the diversion, after seriously 
considering my opinion 
 
I would prefer that my patient and I make the decision about the diversion jointly. 
 
I would prefer to make the decision about the diversion, after seriously considering my 
patient's opinion. 
 
I would prefer to make the decision about the diversion. 
 
40. Do you think it is a good idea to encourage future cystectomy (radical) patients who are 
suitable for both diversion methods to have more say in deciding on the diversion 
method to go with.   
 
 Probe: 
 
 If yes, what could facilitate this? 
  
 If not, why not? 
 
41. Also, we are trying to build some material helping future patients to choose a diversion 
method that best suits them when the diseased bladder is to be removed.  Do you have 
any suggestions?  (Probe: format and the way the material should be used) 
 
42. Are there any other issues you would like to mention? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix 16 – SWPHO Dataset Analysed 
 
 
Px ID Cons ID Centre Centre ID (HES) Centre CaseloadCentre Caseload Network ID (HES) Network Caseload Network Caseload Sex Age Indication Diversion 
1 1 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 999 Muscle invasive TCC Ileal Conduit
2 1 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 74 Muscle invasive TCC Ileal Conduit
3 1 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 48 Muscle invasive TCC Ileal Conduit
4 1 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 72 Primary CIS Ileal Conduit
5 1 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 F 81 Muscle invasive TCC Ileal Conduit
6 1 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 59 Muscle invasive TCC Orthotopic
7 1 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 45 Muscle invasive TCC Orthotopic
8 2 (Ashington) 1 9 36 405 M 62 Muscle invasive TCC Ileal Conduit
9 2 (Ashington) 1 9 36 405 M 69 Muscle invasive TCC Ileal Conduit
10 2 (Ashington) 1 9 36 405 F 77 Uncontrolled superficial disease Orthotopic
11 2 (Ashington) 1 9 36 405 M 63 Muscle invasive TCC Ileal Conduit
12 2 Cumberland Infirmary; West Cumberland Hospital17 1 36 405 F 65 Muscle invasive TCC Ileal Conduit
13 2 Freeman Hospital 23 258 36 405 M 77 Muscle invasive TCC Ileal Conduit
14 2 Freeman Hospital 23 258 36 405 M 68 Primary adenocarcinoma Ileal Conduit
15 2 Freeman Hospital 23 258 36 405 M 77 Muscle invasive TCC Ileal Conduit
16 2 Freeman Hospital 23 258 36 405 M 79 Muscle invasive TCC Ileal Conduit
17 2 Freeman Hospital 23 258 36 405 M 999 Muscle invasive TCC Ileal Conduit
18 2 Freeman Hospital 23 258 36 405 F 75 Muscle invasive TCC Ileal Conduit
19 2 Freeman Hospital 23 258 36 405 M 72 Salvage after radiotherapy Ileal Conduit
20 2 Freeman Hospital 23 258 36 405 M 59 Muscle invasive TCC Ileal Conduit
21 2 Freeman Hospital 23 258 36 405 M 999 Uncontrolled superficial disease Ileal Conduit
22 2 Freeman Hospital 23 258 36 405 F 76 Muscle invasive TCC Ileal Conduit
23 2 Freeman Hospital 23 258 36 405 M 75 Uncontrolled superficial disease Ileal Conduit
24 2 Freeman Hospital 23 258 36 405 M 67 Muscle invasive TCC Ileal Conduit
25 2 Freeman Hospital 23 258 36 405 M 66 Uncontrolled superficial disease Ileal Conduit
26 2 Freeman Hospital 23 258 36 405 M 66 Uncontrolled superficial disease Ileal Conduit
27 2 Freeman Hospital 23 258 36 405 F 70 Uncontrolled superficial disease Ileal Conduit
28 2 Freeman Hospital 23 258 36 405 M 999 Muscle invasive TCC Ileal Conduit
29 2 Freeman Hospital 23 258 36 405 M 62 Muscle invasive TCC Ileal Conduit
30 2 Freeman Hospital 23 258 36 405 M 63 Muscle invasive TCC Ileal Conduit
31 2 Freeman Hospital 23 258 36 405 F 55 Uncontrolled superficial disease Ileal Conduit
32 2 Freeman Hospital 23 258 36 405 M 70 Muscle invasive TCC Ileal Conduit
33 2 Freeman Hospital 23 258 36 405 M 74 Muscle invasive TCC Ileal Conduit
34 2 Freeman Hospital 23 258 36 405 M 67 Uncontrolled superficial disease Ileal Conduit
35 2 Freeman Hospital 23 258 36 405 M 67 Muscle invasive TCC Ileal Conduit
36 2 Freeman Hospital 23 258 36 405 F 76 Muscle invasive TCC Ileal Conduit
37 2 Freeman Hospital 23 258 36 405 M 79 Primary CIS Ileal Conduit
38 2 Freeman Hospital 23 258 36 405 F 62 Uncontrolled superficial disease Ileal Conduit
39 2 Freeman Hospital 23 258 36 405 M 72 Uncontrolled superficial disease Ileal Conduit
40 2 Freeman Hospital 23 258 36 405 F 61 Muscle invasive TCC Ileal Conduit
41 2 Freeman Hospital 23 258 36 405 M 80 Muscle invasive TCC Ileal Conduit
42 2 Freeman Hospital 23 258 36 405 M 79 Muscle invasive TCC Ileal Conduit
43 2 Freeman Hospital 23 258 36 405 F 80 Uncontrolled superficial disease Ileal Conduit
44 2 Freeman Hospital 23 258 36 405 M 76 Muscle invasive TCC Ileal Conduit
45 2 Freeman Hospital 23 258 36 405 M 77 Muscle invasive TCC Ileal Conduit
46 2 Freeman Hospital 23 258 36 405 M 61 Muscle invasive TCC Ileal Conduit
47 2 Freeman Hospital 23 258 36 405 M 73 Muscle invasive TCC Ileal Conduit
48 2 Freeman Hospital 23 258 36 405 F 74 Muscle invasive TCC Ileal Conduit
49 2 Freeman Hospital 23 258 36 405 M 59 Squamous cell Ca Orthotopic
  
 
 
 
50 2 Freeman Hospital 23 258 36 405 M 70 Muscle invasive TCC Ileal Conduit
51 2 Freeman Hospital 23 258 36 405 M 56 Muscle invasive TCC Ileal Conduit
52 2 Freeman Hospital 23 258 36 405 M 64 Muscle invasive TCC Ileal Conduit
53 2 Freeman Hospital 23 258 36 405 M 72 Muscle invasive TCC Ileal Conduit
54 2 Freeman Hospital 23 258 36 405 M 50 Muscle invasive TCC Ileal Conduit
55 2 Freeman Hospital 23 258 36 405 F 69 Muscle invasive TCC Ileal Conduit
56 2 Freeman Hospital 23 258 36 405 M 70 Uncontrolled superficial disease Ileal Conduit
57 2 Freeman Hospital 23 258 36 405 M 75 Muscle invasive TCC Ileal Conduit
58 2 Freeman Hospital 23 258 36 405 M 81 Muscle invasive TCC Ileal Conduit
59 2 Freeman Hospital 23 258 36 405 M 70 Muscle invasive TCC Orthotopic
60 2 Freeman Hospital 23 258 36 405 M 73 Uncontrolled superficial disease Orthotopic
61 2 Freeman Hospital 23 258 36 405 M 999 Muscle invasive TCC Ileal Conduit
62 2 Freeman Hospital 23 258 36 405 M 83 Salvage after radiotherapy Ileal Conduit
63 2 Freeman Hospital 23 258 36 405 M 54 Muscle invasive TCC Ileal Conduit
64 2 Freeman Hospital 23 258 36 405 M 49 Primary adenocarcinoma Ileal Conduit
65 2 Freeman Hospital 23 258 36 405 M 64 Uncontrolled superficial disease Ileal Conduit
66 2 Freeman Hospital 23 258 36 405 M 68 Uncontrolled superficial disease Ileal Conduit
67 2 Freeman Hospital 23 258 36 405 M 67 Muscle invasive TCC Ileal Conduit
68 2 Freeman Hospital 23 258 36 405 M 79 Muscle invasive TCC Ileal Conduit
69 2 Freeman Hospital 23 258 36 405 M 60 Muscle invasive TCC Orthotopic
70 2 Freeman Hospital 23 258 36 405 M 52 Uncontrolled superficial disease Ileal Conduit
71 2 Freeman Hospital 23 258 36 405 M 72 Muscle invasive TCC Ileal Conduit
72 2 Freeman Hospital 23 258 36 405 M 58 Muscle invasive TCC Ileal Conduit
73 2 Freeman Hospital 23 258 36 405 F 62 Muscle invasive TCC Ileal Conduit
74 2 Freeman Hospital 23 258 36 405 M 73 Uncontrolled superficial disease Ileal Conduit
75 2 Freeman Hospital 23 258 36 405 F 75 Uncontrolled superficial disease Ileal Conduit
76 2 Freeman Hospital 23 258 36 405 F 51 Uncontrolled superficial disease Ileal Conduit
77 2 Freeman Hospital 23 258 36 405 M 76 Primary adenocarcinoma Orthotopic
78 2 Freeman Hospital 23 258 36 405 M 61 Muscle invasive TCC Ileal Conduit
79 2 Freeman Hospital 23 258 36 405 F 48 Muscle invasive TCC Orthotopic
80 2 Freeman Hospital 23 258 36 405 F 74 Uncontrolled superficial disease Ileal Conduit
81 2 Freeman Hospital 23 258 36 405 F 68 Uncontrolled superficial disease Orthotopic
82 2 Freeman Hospital 23 258 36 405 M 63 Muscle invasive TCC Ileal Conduit
83 2 Freeman Hospital 23 258 36 405 M 72 Uncontrolled superficial disease Ileal Conduit
84 2 Freeman Hospital 23 258 36 405 M 69 Uncontrolled superficial disease Ileal Conduit
85 2 Freeman Hospital 23 258 36 405 M 57 Muscle invasive TCC Orthotopic
86 2 Freeman Hospital 23 258 36 405 M 48 Muscle invasive TCC Orthotopic
87 2 Freeman Hospital 23 258 36 405 F 71 Uncontrolled superficial disease Ileal Conduit
88 2 Freeman Hospital 23 258 36 405 M 70 Muscle invasive TCC Ileal Conduit
89 2 Freeman Hospital 23 258 36 405 M 70 Muscle invasive TCC Ileal Conduit
90 2 Freeman Hospital 23 258 36 405 M 58 Primary adenocarcinoma Ileal Conduit
91 2 Freeman Hospital 23 258 36 405 M 999 Muscle invasive TCC Ileal Conduit
92 2 Freeman Hospital 23 258 36 405 M 74 Muscle invasive TCC Ileal Conduit
93 2 Freeman Hospital 23 258 36 405 M 80 Uncontrolled superficial disease Ileal Conduit
94 2 Freeman Hospital 23 258 36 405 F 71 Uncontrolled superficial disease Ileal Conduit
95 2 Freeman Hospital 23 258 36 405 M 71 Muscle invasive TCC Ileal Conduit
96 2 Freeman Hospital 23 258 36 405 M 76 Uncontrolled superficial disease Ileal Conduit
97 2 Freeman Hospital 23 258 36 405 M 78 Uncontrolled superficial disease Orthotopic
98 2 Freeman Hospital 23 258 36 405 M 76 Uncontrolled superficial disease Ileal Conduit
99 2 Freeman Hospital 23 258 36 405 M 65 Muscle invasive TCC Ileal Conduit
  
 
 
 
100 2 Freeman Hospital 23 258 36 405 F 76 Squamous cell Ca Ileal Conduit
101 2 Freeman Hospital 23 258 36 405 M 60 Muscle invasive TCC Orthotopic
102 2 Freeman Hospital 23 258 36 405 F 60 Muscle invasive TCC Ileal Conduit
103 2 Freeman Hospital 23 258 36 405 F 999 Uncontrolled superficial disease Ileal Conduit
104 2 Freeman Hospital 23 258 36 405 M 53 Uncontrolled superficial disease Ileal Conduit
105 2 Freeman Hospital 23 258 36 405 M 57 Uncontrolled superficial disease Orthotopic
106 2 Freeman Hospital 23 258 36 405 M 69 Uncontrolled superficial disease Ileal Conduit
107 2 Freeman Hospital 23 258 36 405 M 61 Muscle invasive TCC Ileal Conduit
108 2 Freeman Hospital 23 258 36 405 M 76 Muscle invasive TCC Ileal Conduit
109 2 Freeman Hospital 23 258 36 405 M 60 Muscle invasive TCC Ileal Conduit
110 2 Freeman Hospital 23 258 36 405 M 61 Muscle invasive TCC Ileal Conduit
111 2 Freeman Hospital 23 258 36 405 M 999 Muscle invasive TCC Ileal Conduit
112 2 Freeman Hospital 23 258 36 405 M 67 Uncontrolled superficial disease Ileal Conduit
113 2 Freeman Hospital 23 258 36 405 M 78 Uncontrolled superficial disease Ileal Conduit
114 2 Freeman Hospital 23 258 36 405 M 77 Muscle invasive TCC Ileal Conduit
115 2 Freeman Hospital 23 258 36 405 M 61 Muscle invasive TCC Ileal Conduit
116 2 Freeman Hospital 23 258 36 405 M 68 Muscle invasive TCC Ileal Conduit
117 2 Freeman Hospital 23 258 36 405 F 71 Sarcoma Ileal Conduit
118 2 Freeman Hospital 23 258 36 405 M 61 Uncontrolled superficial disease Ileal Conduit
119 2 Freeman Hospital 23 258 36 405 F 73 Muscle invasive TCC Ileal Conduit
120 2 Freeman Hospital 23 258 36 405 M 72 Muscle invasive TCC Ileal Conduit
121 3 North Bristol NHSTrust (Southmead) 37 313 28 351 M 70 Muscle invasive TCC Ileal Conduit
122 3 North Bristol NHSTrust (Southmead) 37 313 28 351 M 62 Other Ileal Conduit
123 4 Hillingdon Hospital 28 6 21 6 F 58 Squamous cell Ca Ileal Conduit
124 4 Hillingdon Hospital 28 6 21 6 F 62 999 Ileal Conduit
125 5 Hereford Hospitals NHS Trust 27 8 29 31 M 56 Muscle invasive TCC Ileal Conduit
126 6 Basildon Hospital 6 12 38 164 F 69 Muscle invasive TCC Ileal Conduit
127 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 79 Primary CIS Ileal Conduit
128 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 57 Muscle invasive TCC Ileal Conduit
129 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 72 Muscle invasive TCC Ileal Conduit
130 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 72 Primary CIS Ileal Conduit
131 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 58 Muscle invasive TCC Ileal Conduit
132 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 76 Muscle invasive TCC Ileal Conduit
133 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 50 Muscle invasive TCC Ileal Conduit
134 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 62 Muscle invasive TCC Orthotopic
135 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 47 Muscle invasive TCC Ileal Conduit
136 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 73 Muscle invasive TCC Ileal Conduit
137 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 52 Uncontrolled superficial disease Ileal Conduit
138 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 65 Muscle invasive TCC Ileal Conduit
139 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 68 Primary CIS Ileal Conduit
140 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 68 Uncontrolled superficial disease Ileal Conduit
141 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 999 Muscle invasive TCC Ileal Conduit
142 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 79 Muscle invasive TCC Ileal Conduit
143 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 77 Muscle invasive TCC Ileal Conduit
144 7 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 72 Squamous cell Ca Ileal Conduit
145 8 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 F 62 999 Orthotopic
146 8 New Cross Hospital 35 37 35 226 M 56 999 Orthotopic
147 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 F 69 Muscle invasive TCC Ileal Conduit
148 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 75 Muscle invasive TCC Ileal Conduit
149 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 66 Secondary adenocarcinoma Ileal Conduit
  
 
 
 
150 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 72 Muscle invasive TCC Ileal Conduit
151 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 F 82 999 Ileal Conduit
152 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 69 Uncontrolled superficial disease Ileal Conduit
153 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 74 Muscle invasive TCC Ileal Conduit
154 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 82 Uncontrolled superficial disease Ileal Conduit
155 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 82 999 Ileal Conduit
156 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 999 Uncontrolled superficial disease Orthotopic
157 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 78 Muscle invasive TCC Ileal Conduit
158 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 71 Muscle invasive TCC Orthotopic
159 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 F 61 999 Ileal Conduit
160 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 84 999 Ileal Conduit
161 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 76 999 Ileal Conduit
162 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 56 999 Orthotopic
163 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 56 Uncontrolled superficial disease Orthotopic
164 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 85 Muscle invasive TCC Ileal Conduit
165 8 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 61 Muscle invasive TCC Ileal Conduit
166 8 Royal Cornwall Hospital 50 6 26 205 M 68 Muscle invasive TCC Orthotopic
167 8 Sandwell District General Hospital 62 9 11 102 M 74 Muscle invasive TCC Ileal Conduit
168 8 Sandwell District General Hospital 62 9 11 102 M 32 Primary adenocarcinoma Orthotopic
169 9 Rotherham District General Hospital 47 20 8 261 M 68 Muscle invasive TCC Ileal Conduit
170 9 Rotherham District General Hospital 47 20 8 261 F 57 Muscle invasive TCC Ileal Conduit
171 9 Rotherham District General Hospital 47 20 8 261 M 61 Muscle invasive TCC Ileal Conduit
172 9 Rotherham District General Hospital 47 20 8 261 F 65 Muscle invasive TCC Ileal Conduit
173 9 Rotherham District General Hospital 47 20 8 261 M 58 Muscle invasive TCC Ileal Conduit
174 9 Rotherham District General Hospital 47 20 8 261 M 58 Muscle invasive TCC Ileal Conduit
175 9 Royal Liverpool University Hospital 54 53 3 140 F 71 Muscle invasive TCC Ileal Conduit
176 9 Royal Liverpool University Hospital 54 53 3 140 M 54 Other Ileal Conduit
177 9 Royal Liverpool University Hospital 54 53 3 140 M 69 Muscle invasive TCC Ileal Conduit
178 9 Royal Liverpool University Hospital 54 53 3 140 F 55 Muscle invasive TCC Orthotopic
179 9 Royal Liverpool University Hospital 54 53 3 140 F 71 Other Ileal Conduit
180 9 Royal Liverpool University Hospital 54 53 3 140 M 65 Muscle invasive TCC Ileal Conduit
181 9 Royal Liverpool University Hospital 54 53 3 140 M 46 999 Ileal Conduit
182 9 Royal Liverpool University Hospital 54 53 3 140 F 999 999 Ileal Conduit
183 9 Royal Liverpool University Hospital 54 53 3 140 F 60 Muscle invasive TCC Ileal Conduit
184 9 Royal Liverpool University Hospital 54 53 3 140 M 77 999 Ileal Conduit
185 9 Royal Liverpool University Hospital 54 53 3 140 M 74 Uncontrolled superficial disease Ileal Conduit
186 9 Royal Liverpool University Hospital 54 53 3 140 M 73 Other Ileal Conduit
187 9 Royal Liverpool University Hospital 54 53 3 140 M 56 Muscle invasive TCC Ileal Conduit
188 9 Royal Liverpool University Hospital 54 53 3 140 M 71 Muscle invasive TCC Ileal Conduit
189 9 Royal Liverpool University Hospital 54 53 3 140 M 39 Muscle invasive TCC Ileal Conduit
190 9 Royal Liverpool University Hospital 54 53 3 140 M 48 Primary adenocarcinoma Ileal Conduit
191 9 Royal Liverpool University Hospital 54 53 3 140 M 72 Muscle invasive TCC Ileal Conduit
192 9 Royal Liverpool University Hospital 54 53 3 140 M 66 Muscle invasive TCC Ileal Conduit
193 9 Royal Liverpool University Hospital 54 53 3 140 M 63 Muscle invasive TCC Ileal Conduit
194 9 Southport & Ormskirk NHS Trust 66 21 3 140 M 75 Muscle invasive TCC Ileal Conduit
195 9 Southport & Ormskirk NHS Trust 66 21 3 140 F 70 Salvage after radiotherapy Ileal Conduit
196 9 Southport & Ormskirk NHS Trust 66 21 3 140 M 73 Muscle invasive TCC Ileal Conduit
197 9 Whiston Hospital 80 12 3 140 M 59 Muscle invasive TCC Ileal Conduit
198 9 Whiston Hospital 80 12 3 140 M 60 Muscle invasive TCC Ileal Conduit
199 9 Whiston Hospital 80 12 3 140 M 71 Other Ileal Conduit
  
 
 
 
200 9 Whiston Hospital 80 12 3 140 M 60 Muscle invasive TCC Ileal Conduit
201 9 Whiston Hospital 80 12 3 140 F 68 Muscle invasive TCC Ileal Conduit
202 10 Walsgrave Hospital 76 9 12 22 M 74 Salvage after radiotherapy Ileal Conduit
203 10 Walsgrave Hospital 76 9 12 22 M 66 Muscle invasive TCC Ileal Conduit
204 10 Walsgrave Hospital 76 9 12 22 M 65 Muscle invasive TCC Ileal Conduit
205 11 University College Hospital London 72 38 22 118 F 45 Primary CIS Orthotopic
206 11 University College Hospital London 72 38 22 118 M 61 Uncontrolled superficial disease Ileal Conduit
207 12 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 999 82 Muscle invasive TCC Ileal Conduit
208 12 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 M 63 Uncontrolled superficial disease Ileal Conduit
209 12 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 F 62 Muscle invasive TCC Ileal Conduit
210 12 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 M 69 Muscle invasive TCC Ileal Conduit
211 12 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 F 75 Primary CIS Ileal Conduit
212 12 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 M 74 Muscle invasive TCC Ileal Conduit
213 12 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 999 68 Muscle invasive TCC Ileal Conduit
214 12 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 M 78 Muscle invasive TCC Ileal Conduit
215 12 Watford General Hospital 78 68 20 69 M 75 Salvage after radiotherapy Ileal Conduit
216 13 Airedale General Hospital 2 7 6 384 M 83 Salvage after radiotherapy Ileal Conduit
217 13 Airedale General Hospital 2 7 6 384 M 72 Muscle invasive TCC Ileal Conduit
218 13 Bradford Royal Infirmary 7 107 6 384 M 65 Muscle invasive TCC Ileal Conduit
219 13 Bradford Royal Infirmary 7 107 6 384 M 73 Muscle invasive TCC Ileal Conduit
220 13 Bradford Royal Infirmary 7 107 6 384 F 75 Squamous cell Ca Ileal Conduit
221 13 Bradford Royal Infirmary 7 107 6 384 F 76 Muscle invasive TCC Ileal Conduit
222 13 Bradford Royal Infirmary 7 107 6 384 M 73 Primary CIS Ileal Conduit
223 13 Bradford Royal Infirmary 7 107 6 384 F 61 Muscle invasive TCC Ileal Conduit
224 13 Bradford Royal Infirmary 7 107 6 384 F 65 Muscle invasive TCC Ileal Conduit
225 13 Bradford Royal Infirmary 7 107 6 384 M 83 Muscle invasive TCC Ileal Conduit
226 13 Bradford Royal Infirmary 7 107 6 384 M 999 Muscle invasive TCC Ileal Conduit
227 13 Bradford Royal Infirmary 7 107 6 384 F 66 Squamous cell Ca Ileal Conduit
228 13 Bradford Royal Infirmary 7 107 6 384 F 66 Muscle invasive TCC Ileal Conduit
229 13 Bradford Royal Infirmary 7 107 6 384 M 80 Muscle invasive TCC Ileal Conduit
230 13 Bradford Royal Infirmary 7 107 6 384 M 70 Muscle invasive TCC Ileal Conduit
231 13 Bradford Royal Infirmary 7 107 6 384 F 72 Muscle invasive TCC Ileal Conduit
232 13 Bradford Royal Infirmary 7 107 6 384 M 65 Muscle invasive TCC Ileal Conduit
233 13 Bradford Royal Infirmary 7 107 6 384 M 43 Squamous cell Ca Ileal Conduit
234 13 Bradford Royal Infirmary 7 107 6 384 M 55 Squamous cell Ca Ileal Conduit
235 13 Bradford Royal Infirmary 7 107 6 384 M 59 Muscle invasive TCC Ileal Conduit
236 13 Bradford Royal Infirmary 7 107 6 384 M 66 Muscle invasive TCC Ileal Conduit
237 13 Bradford Royal Infirmary 7 107 6 384 M 58 Muscle invasive TCC Orthotopic
238 13 Bradford Royal Infirmary 7 107 6 384 F 75 Salvage after radiotherapy Ileal Conduit
239 13 Bradford Royal Infirmary 7 107 6 384 M 61 Muscle invasive TCC Ileal Conduit
240 13 Bradford Royal Infirmary 7 107 6 384 M 63 Muscle invasive TCC Ileal Conduit
241 13 Bradford Royal Infirmary 7 107 6 384 M 64 Uncontrolled superficial disease Ileal Conduit
242 13 Bradford Royal Infirmary 7 107 6 384 M 77 Muscle invasive TCC Ileal Conduit
243 13 Bradford Royal Infirmary 7 107 6 384 M 78 Muscle invasive TCC Ileal Conduit
244 13 Bradford Royal Infirmary 7 107 6 384 M 74 Muscle invasive TCC Ileal Conduit
245 13 Huddersfield Royal Infirmary 28 10 6 384 M 71 Muscle invasive TCC Ileal Conduit
246 13 Huddersfield Royal Infirmary 28 10 6 384 M 72 Muscle invasive TCC Ileal Conduit
247 13 Huddersfield Royal Infirmary 28 10 6 384 M 62 Muscle invasive TCC Ileal Conduit
248 14 Southampton General Hospital 64 95 31 307 M 63 Uncontrolled superficial disease Ileal Conduit
249 14 Southampton General Hospital 64 95 31 307 F 999 Muscle invasive TCC Ileal Conduit
  
 
 
 
250 14 Southampton General Hospital 64 95 31 307 M 73 Uncontrolled superficial disease Ileal Conduit
251 14 Southampton General Hospital 64 95 31 307 F 999 Salvage after radiotherapy Ileal Conduit
252 14 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
253 14 Southampton General Hospital 64 95 31 307 M 999 Uncontrolled superficial disease Ileal Conduit
254 14 Southampton General Hospital 64 95 31 307 F 999 Muscle invasive TCC Ileal Conduit
255 14 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
256 14 Southampton General Hospital 64 95 31 307 F 999 Muscle invasive TCC Ileal Conduit
257 14 Southampton General Hospital 64 95 31 307 M 999 Squamous cell Ca Ileal Conduit
258 14 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
259 14 Southampton General Hospital 64 95 31 307 M 999 Other Ileal Conduit
260 14 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
261 14 Southampton General Hospital 64 95 31 307 M 70 Uncontrolled superficial disease Ileal Conduit
262 15 New Cross Hospital 35 37 35 226 M 75 Muscle invasive TCC Ileal Conduit
263 15 New Cross Hospital 35 37 35 226 M 71 Uncontrolled superficial disease Ileal Conduit
264 15 New Cross Hospital 35 37 35 226 F 61 Squamous cell Ca Ileal Conduit
265 15 New Cross Hospital 35 37 35 226 M 60 Muscle invasive TCC Ileal Conduit
266 15 New Cross Hospital 35 37 35 226 M 62 Muscle invasive TCC Ileal Conduit
267 15 New Cross Hospital 35 37 35 226 M 64 Muscle invasive TCC Ileal Conduit
268 15 New Cross Hospital 35 37 35 226 F 47 Squamous cell Ca Ileal Conduit
269 15 New Cross Hospital 35 37 35 226 F 71 Muscle invasive TCC Ileal Conduit
270 15 New Cross Hospital 35 37 35 226 M 64 Muscle invasive TCC Ileal Conduit
271 15 New Cross Hospital 35 37 35 226 M 65 Other Ileal Conduit
272 15 New Cross Hospital 35 37 35 226 F 72 Muscle invasive TCC Ileal Conduit
273 15 New Cross Hospital 35 37 35 226 M 76 Uncontrolled superficial disease Ileal Conduit
274 15 New Cross Hospital 35 37 35 226 M 70 Muscle invasive TCC Ileal Conduit
275 15 New Cross Hospital 35 37 35 226 M 56 Muscle invasive TCC Ileal Conduit
276 15 New Cross Hospital 35 37 35 226 M 46 Muscle invasive TCC Orthotopic
277 15 New Cross Hospital 35 37 35 226 F 61 Uncontrolled superficial disease Ileal Conduit
278 15 New Cross Hospital 35 37 35 226 M 68 Other Ileal Conduit
279 15 New Cross Hospital 35 37 35 226 M 66 Muscle invasive TCC Ileal Conduit
280 15 New Cross Hospital 35 37 35 226 M 55 Muscle invasive TCC Ileal Conduit
281 15 New Cross Hospital 35 37 35 226 F 61 Squamous cell Ca Ileal Conduit
282 15 New Cross Hospital 35 37 35 226 M 57 Muscle invasive TCC Ileal Conduit
283 15 New Cross Hospital 35 37 35 226 F 59 Uncontrolled superficial disease Ileal Conduit
284 15 New Cross Hospital 35 37 35 226 M 59 Muscle invasive TCC Ileal Conduit
285 15 New Cross Hospital 35 37 35 226 F 67 Primary CIS Ileal Conduit
286 15 New Cross Hospital 35 37 35 226 F 59 Muscle invasive TCC Ileal Conduit
287 15 New Cross Hospital 35 37 35 226 M 69 Muscle invasive TCC Ileal Conduit
288 15 New Cross Hospital 35 37 35 226 M 54 Uncontrolled superficial disease Ileal Conduit
289 15 New Cross Hospital 35 37 35 226 F 75 Muscle invasive TCC Ileal Conduit
290 15 New Cross Hospital 35 37 35 226 F 69 Muscle invasive TCC Ileal Conduit
291 15 New Cross Hospital 35 37 35 226 F 59 Primary CIS Ileal Conduit
292 15 New Cross Hospital 35 37 35 226 M 61 Muscle invasive TCC Ileal Conduit
293 15 New Cross Hospital 35 37 35 226 M 76 999 Ileal Conduit
294 15 New Cross Hospital 35 37 35 226 M 68 Muscle invasive TCC Ileal Conduit
295 15 New Cross Hospital 35 37 35 226 F 68 Gynaecological Ca Ileal Conduit
296 15 New Cross Hospital 35 37 35 226 M 71 Muscle invasive TCC Ileal Conduit
297 15 New Cross Hospital 35 37 35 226 M 66 Other Ileal Conduit
298 15 New Cross Hospital 35 37 35 226 F 68 Other Ileal Conduit
299 15 New Cross Hospital 35 37 35 226 M 56 Muscle invasive TCC Orthotopic
  
 
 
 
300 15 New Cross Hospital 35 37 35 226 M 47 Muscle invasive TCC Ileal Conduit
301 15 New Cross Hospital 35 37 35 226 F 77 Muscle invasive TCC Ileal Conduit
302 15 New Cross Hospital 35 37 35 226 M 65 Sarcoma Ileal Conduit
303 15 New Cross Hospital 35 37 35 226 F 70 Muscle invasive TCC Ileal Conduit
304 15 New Cross Hospital 35 37 35 226 M 65 Muscle invasive TCC Ileal Conduit
305 16 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 F 38 Muscle invasive TCC Ileal Conduit
306 16 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 76 Primary CIS Ileal Conduit
307 16 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 70 Primary CIS Ileal Conduit
308 16 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 F 64 Primary adenocarcinoma Ileal Conduit
309 16 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 999 Uncontrolled superficial disease Ileal Conduit
310 16 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 57 Primary CIS Ileal Conduit
311 16 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 68 Muscle invasive TCC Ileal Conduit
312 16 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 999 Salvage after radiotherapy Ileal Conduit
313 17 Barnet & Chase Farm Hospital 5 64 22 118 M 70 Muscle invasive TCC Ileal Conduit
314 18 University Hospital of North Stafford 74 104 35 226 M 62 Muscle invasive TCC Ileal Conduit
315 18 University Hospital of North Stafford 74 104 35 226 F 60 Muscle invasive TCC Ileal Conduit
316 18 University Hospital of North Stafford 74 104 35 226 F 999 Other Ileal Conduit
317 18 University Hospital of North Stafford 74 104 35 226 F 52 Salvage after radiotherapy Ileal Conduit
318 18 University Hospital of North Stafford 74 104 35 226 F 73 Muscle invasive TCC Ileal Conduit
319 18 University Hospital of North Stafford 74 104 35 226 M 78 Muscle invasive TCC Ileal Conduit
320 18 University Hospital of North Stafford 74 104 35 226 F 999 Muscle invasive TCC Ileal Conduit
321 18 University Hospital of North Stafford 74 104 35 226 M 76 Uncontrolled superficial disease Ileal Conduit
322 18 University Hospital of North Stafford 74 104 35 226 F 54 Secondary adenocarcinoma Ileal Conduit
323 18 University Hospital of North Stafford 74 104 35 226 M 77 Muscle invasive TCC Ileal Conduit
324 18 University Hospital of North Stafford 74 104 35 226 F 52 Gynaecological Ca Ileal Conduit
325 18 University Hospital of North Stafford 74 104 35 226 F 55 Squamous cell Ca Ileal Conduit
326 18 University Hospital of North Stafford 74 104 35 226 M 56 Muscle invasive TCC Ileal Conduit
327 18 University Hospital of North Stafford 74 104 35 226 F 63 Gynaecological Ca Ileal Conduit
328 18 University Hospital of North Stafford 74 104 35 226 F 60 Muscle invasive TCC Ileal Conduit
329 18 University Hospital of North Stafford 74 104 35 226 M 74 Muscle invasive TCC Ileal Conduit
330 18 University Hospital of North Stafford 74 104 35 226 M 74 Muscle invasive TCC Ileal Conduit
331 19 Royal Bournemouth Hospital 49 57 27 60 F 70 Squamous cell Ca Ileal Conduit
332 19 Royal Bournemouth Hospital 49 57 27 60 M 64 Muscle invasive TCC Ileal Conduit
333 19 Royal Bournemouth Hospital 49 57 27 60 M 66 Muscle invasive TCC Ileal Conduit
334 19 Royal Bournemouth Hospital 49 57 27 60 F 60 Muscle invasive TCC Ileal Conduit
335 19 Royal Bournemouth Hospital 49 57 27 60 M 76 Salvage after radiotherapy Ileal Conduit
336 19 Royal Bournemouth Hospital 49 57 27 60 M 64 Uncontrolled superficial disease Ileal Conduit
337 19 Royal Bournemouth Hospital 49 57 27 60 M 71 Uncontrolled superficial disease Ileal Conduit
338 19 Royal Bournemouth Hospital 49 57 27 60 M 69 Uncontrolled superficial disease Ileal Conduit
339 19 Royal Bournemouth Hospital 49 57 27 60 M 999 Other Ileal Conduit
340 19 Royal Bournemouth Hospital 49 57 27 60 M 65 Muscle invasive TCC Ileal Conduit
341 19 Royal Bournemouth Hospital 49 57 27 60 M 75 Uncontrolled superficial disease Ileal Conduit
342 19 Royal Bournemouth Hospital 49 57 27 60 M 63 Primary CIS Orthotopic
343 19 Royal Bournemouth Hospital 49 57 27 60 M 64 Primary CIS Ileal Conduit
344 19 Royal Bournemouth Hospital 49 57 27 60 M 68 Other Ileal Conduit
345 19 Royal Bournemouth Hospital 49 57 27 60 F 77 Muscle invasive TCC Ileal Conduit
346 19 Royal Bournemouth Hospital 49 57 27 60 M 999 Salvage after radiotherapy Ileal Conduit
347 19 Royal Bournemouth Hospital 49 57 27 60 M 55 Salvage after radiotherapy Ileal Conduit
348 19 Royal Bournemouth Hospital 49 57 27 60 M 69 Muscle invasive TCC Ileal Conduit
349 20 Southampton General Hospital 64 95 31 307 F 80 Squamous cell Ca Ileal Conduit
  
 
 
 
350 20 Southampton General Hospital 64 95 31 307 F 999 Muscle invasive TCC Ileal Conduit
351 20 Southampton General Hospital 64 95 31 307 M 999 Other Ileal Conduit
352 20 Southampton General Hospital 64 95 31 307 M 54 Muscle invasive TCC Ileal Conduit
353 20 Southampton General Hospital 64 95 31 307 F 78 Muscle invasive TCC Ileal Conduit
354 20 Southampton General Hospital 64 95 31 307 M 999 Other Ileal Conduit
355 21 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 69 Sarcoma Ileal Conduit
356 21 Royal Marsden Hospital 55 63 25 63 F 999 Muscle invasive TCC Ileal Conduit
357 22 Southampton General Hospital 64 95 31 307 F 999 Muscle invasive TCC Ileal Conduit
358 22 Southampton General Hospital 64 95 31 307 F 999 Muscle invasive TCC Ileal Conduit
359 22 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
360 22 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
361 999 Bradford Royal Infirmary 7 107 6 384 M 66 Muscle invasive TCC Ileal Conduit
362 999 Bradford Royal Infirmary 7 107 6 384 M 999 Muscle invasive TCC Ileal Conduit
363 999 Bradford Royal Infirmary 7 107 6 384 M 61 Muscle invasive TCC Ileal Conduit
364 999 Bradford Royal Infirmary 7 107 6 384 F 999 Muscle invasive TCC Ileal Conduit
365 999 Bradford Royal Infirmary 7 107 6 384 M 75 Muscle invasive TCC Ileal Conduit
366 999 Bradford Royal Infirmary 7 107 6 384 F 61 Uncontrolled superficial disease Ileal Conduit
367 999 Bradford Royal Infirmary 7 107 6 384 M 44 Squamous cell Ca Ileal Conduit
368 999 Bradford Royal Infirmary 7 107 6 384 M 999 Muscle invasive TCC Ileal Conduit
369 999 Bradford Royal Infirmary 7 107 6 384 M 74 Muscle invasive TCC Ileal Conduit
370 999 Bradford Royal Infirmary 7 107 6 384 M 68 Muscle invasive TCC Ileal Conduit
371 999 Bradford Royal Infirmary 7 107 6 384 M 60 Muscle invasive TCC Ileal Conduit
372 999 Bradford Royal Infirmary 7 107 6 384 M 69 Muscle invasive TCC Ileal Conduit
373 999 Bradford Royal Infirmary 7 107 6 384 M 70 999 Ileal Conduit
374 999 Bradford Royal Infirmary 7 107 6 384 F 72 Muscle invasive TCC Ileal Conduit
375 999 Bradford Royal Infirmary 7 107 6 384 M 69 Muscle invasive TCC Ileal Conduit
376 999 Bradford Royal Infirmary 7 107 6 384 M 64 Muscle invasive TCC Ileal Conduit
377 999 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 72 999 Ileal Conduit
378 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 82 Other Ileal Conduit
379 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 71 Muscle invasive TCC Ileal Conduit
380 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 76 Other Ileal Conduit
381 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 67 Muscle invasive TCC Ileal Conduit
382 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 60 Other Ileal Conduit
383 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 57 Muscle invasive TCC Ileal Conduit
384 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 74 Muscle invasive TCC Ileal Conduit
385 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 73 Muscle invasive TCC Ileal Conduit
386 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 71 Other Ileal Conduit
387 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 66 Muscle invasive TCC Ileal Conduit
388 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 53 Uncontrolled superficial disease Ileal Conduit
389 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 78 Uncontrolled superficial disease Ileal Conduit
390 999 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 79 Other Ileal Conduit
391 999 Derriford Hospital 19 72 26 205 M 66 Primary CIS Ileal Conduit
392 999 Derriford Hospital 19 72 26 205 F 73 Squamous cell Ca Ileal Conduit
393 999 Derriford Hospital 19 72 26 205 M 71 Muscle invasive TCC Ileal Conduit
394 999 Derriford Hospital 19 72 26 205 M 65 Primary CIS Ileal Conduit
395 999 Derriford Hospital 19 72 26 205 M 69 Uncontrolled superficial disease Ileal Conduit
396 999 Derriford Hospital 19 72 26 205 M 76 Other Ileal Conduit
397 999 Derriford Hospital 19 72 26 205 M 67 Uncontrolled superficial disease Ileal Conduit
398 999 Derriford Hospital 19 72 26 205 M 66 Muscle invasive TCC Ileal Conduit
399 999 Derriford Hospital 19 72 26 205 M 70 Uncontrolled superficial disease Ileal Conduit
  
 
 
 
400 999 Guy's & Thomas's Hospital 25 130 24 149 F 999 Muscle invasive TCC Ileal Conduit
401 999 Guy's & Thomas's Hospital 25 130 24 149 M 999 Uncontrolled superficial disease Ileal Conduit
402 999 Guy's & Thomas's Hospital 25 130 24 149 M 999 Uncontrolled superficial disease Ileal Conduit
403 999 Guy's & Thomas's Hospital 25 130 24 149 F 999 Muscle invasive TCC Ileal Conduit
404 999 Guy's & Thomas's Hospital 25 130 24 149 M 999 Uncontrolled superficial disease Ileal Conduit
405 999 Guy's & Thomas's Hospital 25 130 24 149 M 999 Muscle invasive TCC Ileal Conduit
406 999 Guy's & Thomas's Hospital 25 130 24 149 M 999 Muscle invasive TCC Ileal Conduit
407 999 Guy's & Thomas's Hospital 25 130 24 149 F 999 Muscle invasive TCC Ileal Conduit
408 999 Guy's & Thomas's Hospital 25 130 24 149 M 999 Muscle invasive TCC Ileal Conduit
409 999 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 M 77 Salvage after radiotherapy Ileal Conduit
410 999 Leicester General Hospital 33 97 39 345 M 71 Other Ileal Conduit
411 999 Leicester General Hospital 33 97 39 345 F 66 Muscle invasive TCC Ileal Conduit
412 999 Leicester General Hospital 33 97 39 345 M 39 Muscle invasive TCC Orthotopic
413 999 Leicester General Hospital 33 97 39 345 M 46 Muscle invasive TCC Orthotopic
414 999 Leicester General Hospital 33 97 39 345 F 48 Other Ileal Conduit
415 999 New Cross Hospital 35 37 35 226 M 70 Muscle invasive TCC Ileal Conduit
416 999 New Cross Hospital 35 37 35 226 F 70 Salvage after radiotherapy Ileal Conduit
417 999 New Cross Hospital 35 37 35 226 M 74 Muscle invasive TCC Ileal Conduit
418 999 New Cross Hospital 35 37 35 226 M 999 Muscle invasive TCC Ileal Conduit
419 999 New Cross Hospital 35 37 35 226 M 999 Primary adenocarcinoma Ileal Conduit
420 999 New Cross Hospital 35 37 35 226 M 68 Uncontrolled superficial disease Ileal Conduit
421 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 72 999 Ileal Conduit
422 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 79 Muscle invasive TCC Ileal Conduit
423 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 76 Uncontrolled superficial disease Ileal Conduit
424 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 71 Muscle invasive TCC Ileal Conduit
425 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 70 Muscle invasive TCC Ileal Conduit
426 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 57 Uncontrolled superficial disease Ileal Conduit
427 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 82 Muscle invasive TCC Ileal Conduit
428 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 82 Primary CIS Ileal Conduit
429 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 81 Uncontrolled superficial disease Ileal Conduit
430 999 North Bristol NHSTrust (Southmead) 37 313 28 351 F 79 Muscle invasive TCC Ileal Conduit
431 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 69 Sarcoma Ileal Conduit
432 999 North Bristol NHSTrust (Southmead) 37 313 28 351 F 80 Muscle invasive TCC Ileal Conduit
433 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 75 Muscle invasive TCC Ileal Conduit
434 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 72 Uncontrolled superficial disease Ileal Conduit
435 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 82 Muscle invasive TCC Ileal Conduit
436 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 73 999 Ileal Conduit
437 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 59 Uncontrolled superficial disease Ileal Conduit
438 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 72 Muscle invasive TCC Ileal Conduit
439 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 61 Uncontrolled superficial disease Ileal Conduit
440 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 79 Muscle invasive TCC Ileal Conduit
441 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 76 Muscle invasive TCC Ileal Conduit
442 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 70 Muscle invasive TCC Ileal Conduit
443 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 47 Muscle invasive TCC Ileal Conduit
444 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 65 Muscle invasive TCC Ileal Conduit
445 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 64 Muscle invasive TCC Ileal Conduit
446 999 North Bristol NHSTrust (Southmead) 37 313 28 351 F 51 Muscle invasive TCC Ileal Conduit
447 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 77 Muscle invasive TCC Ileal Conduit
448 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 79 Muscle invasive TCC Ileal Conduit
449 999 North Bristol NHSTrust (Southmead) 37 313 28 351 F 71 Salvage after radiotherapy Ileal Conduit
  
 
 
 
450 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 62 Muscle invasive TCC Ileal Conduit
451 999 North Bristol NHSTrust (Southmead) 37 313 28 351 F 58 Muscle invasive TCC Ileal Conduit
452 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 86 Muscle invasive TCC Ileal Conduit
453 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 59 Muscle invasive TCC Ileal Conduit
454 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 68 Muscle invasive TCC Ileal Conduit
455 999 North Bristol NHSTrust (Southmead) 37 313 28 351 F 71 Muscle invasive TCC Ileal Conduit
456 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 74 Muscle invasive TCC Ileal Conduit
457 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 66 Uncontrolled superficial disease Ileal Conduit
458 999 North Bristol NHSTrust (Southmead) 37 313 28 351 F 69 Muscle invasive TCC Ileal Conduit
459 999 North Bristol NHSTrust (Southmead) 37 313 28 351 F 69 Muscle invasive TCC Ileal Conduit
460 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 77 Uncontrolled superficial disease Ileal Conduit
461 999 North Bristol NHSTrust (Southmead) 37 313 28 351 M 71 Uncontrolled superficial disease Ileal Conduit
462 999 Princess Alexandra Hospital, Harlow 44 14 22 118 M 72 Uncontrolled superficial disease Ileal Conduit
463 999 Royal Cornwall Hospital 50 6 26 205 F 74 Muscle invasive TCC Ileal Conduit
464 999 Royal Cornwall Hospital 50 6 26 205 F 76 Muscle invasive TCC Ileal Conduit
465 999 Royal Cornwall Hospital 50 6 26 205 M 55 Muscle invasive TCC Ileal Conduit
466 999 Royal Hampshire County Hospital 53 15 31 307 M 999 Muscle invasive TCC Ileal Conduit
467 999 Royal Hampshire County Hospital 53 15 31 307 M 79 Uncontrolled superficial disease Ileal Conduit
468 999 Royal Hampshire County Hospital 53 15 31 307 M 999 Muscle invasive TCC Ileal Conduit
469 999 Royal Hampshire County Hospital 53 15 31 307 M 999 Muscle invasive TCC Ileal Conduit
470 999 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 F 68 Secondary adenocarcinoma Ileal Conduit
471 999 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 F 73 Muscle invasive TCC Ileal Conduit
472 999 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 69 Muscle invasive TCC Ileal Conduit
473 999 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 F 74 Muscle invasive TCC Ileal Conduit
474 999 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 53 Muscle invasive TCC Ileal Conduit
475 999 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 75 Muscle invasive TCC Ileal Conduit
476 999 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 78 Other Ileal Conduit
477 999 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 64 Muscle invasive TCC Ileal Conduit
478 999 Southampton General Hospital 64 95 31 307 M 999 Salvage after radiotherapy Ileal Conduit
479 999 Southampton General Hospital 64 95 31 307 F 999 Muscle invasive TCC Ileal Conduit
480 999 Southampton General Hospital 64 95 31 307 F 999 999 Ileal Conduit
481 999 Southampton General Hospital 64 95 31 307 M 999 Squamous cell Ca Ileal Conduit
482 999 Southampton General Hospital 64 95 31 307 M 999 Primary CIS Ileal Conduit
483 999 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
484 999 Taunton And Somerset Hospital 69 11 28 351 M 65 Muscle invasive TCC Ileal Conduit
485 999 Taunton And Somerset Hospital 69 11 28 351 M 75 Muscle invasive TCC Ileal Conduit
486 999 University Hospital of North Durham 73 1 36 405 M 67 Other Ileal Conduit
487 999 Yeovil District Hospital 81 19 28 351 M 67 Squamous cell Ca Ileal Conduit
488 23 North Bristol NHSTrust (Southmead) 37 313 28 351 999 79 Muscle invasive TCC Ileal Conduit
489 24 Great Western Hospital, Swindon 24 7 30 167 M 60 Muscle invasive TCC Ileal Conduit
490 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 81 Muscle invasive TCC Ileal Conduit
491 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 64 Salvage after radiotherapy Ileal Conduit
492 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 65 Uncontrolled superficial disease Ileal Conduit
493 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 71 Muscle invasive TCC Ileal Conduit
494 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 65 Uncontrolled superficial disease Orthotopic
495 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 84 999 Ileal Conduit
496 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 53 Muscle invasive TCC Orthotopic
497 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 74 Muscle invasive TCC Ileal Conduit
498 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 77 Uncontrolled superficial disease Ileal Conduit
499 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 72 Muscle invasive TCC Ileal Conduit
  
 
 
 
500 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 62 Muscle invasive TCC Ileal Conduit
501 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 58 Muscle invasive TCC Ileal Conduit
502 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 52 Muscle invasive TCC Ileal Conduit
503 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 64 Muscle invasive TCC Ileal Conduit
504 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 71 999 Ileal Conduit
505 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 56 Muscle invasive TCC Orthotopic
506 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 66 Muscle invasive TCC Orthotopic
507 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 68 Muscle invasive TCC Ileal Conduit
508 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 60 Muscle invasive TCC Orthotopic
509 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 73 Uncontrolled superficial disease Ileal Conduit
510 24 North Bristol NHSTrust (Southmead) 37 313 28 351 999 999 Muscle invasive TCC Orthotopic
511 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 73 Uncontrolled superficial disease Ileal Conduit
512 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 57 Muscle invasive TCC Ileal Conduit
513 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 999 999 Ileal Conduit
514 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 60 Uncontrolled superficial disease Ileal Conduit
515 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 79 Muscle invasive TCC Ileal Conduit
516 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 60 Other Ileal Conduit
517 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 45 Muscle invasive TCC Ileal Conduit
518 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 49 Muscle invasive TCC Ileal Conduit
519 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 72 Squamous cell Ca Ileal Conduit
520 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 62 999 Orthotopic
521 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 74 999 Ileal Conduit
522 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 73 Other Ileal Conduit
523 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 77 Muscle invasive TCC Ileal Conduit
524 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 74 Muscle invasive TCC Ileal Conduit
525 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 65 999 Ileal Conduit
526 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 65 999 Ileal Conduit
527 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 60 Muscle invasive TCC Orthotopic
528 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 72 Salvage after radiotherapy Ileal Conduit
529 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 47 Muscle invasive TCC Orthotopic
530 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 999 Muscle invasive TCC Ileal Conduit
531 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 64 Muscle invasive TCC Ileal Conduit
532 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 70 Muscle invasive TCC Ileal Conduit
533 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 78 Primary CIS Ileal Conduit
534 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 63 Muscle invasive TCC Ileal Conduit
535 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 75 Muscle invasive TCC Ileal Conduit
536 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 67 Other Ileal Conduit
537 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 64 Muscle invasive TCC Ileal Conduit
538 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 79 Muscle invasive TCC Ileal Conduit
539 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 77 Muscle invasive TCC Ileal Conduit
540 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 75 Muscle invasive TCC Ileal Conduit
541 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 78 Salvage after radiotherapy Ileal Conduit
542 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 70 Muscle invasive TCC Ileal Conduit
543 24 North Bristol NHSTrust (Southmead) 37 313 28 351 F 77 Muscle invasive TCC Ileal Conduit
544 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 75 Muscle invasive TCC Ileal Conduit
545 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 72 Muscle invasive TCC Ileal Conduit
546 24 North Bristol NHSTrust (Southmead) 37 313 28 351 M 999 Salvage after radiotherapy Orthotopic
547 24 Taunton And Somerset Hospital 69 11 28 351 M 53 Muscle invasive TCC Orthotopic
548 24 Taunton And Somerset Hospital 69 11 28 351 F 75 Squamous cell Ca Ileal Conduit
549 24 Weston - Super - Mare General Hospital 79 1 28 351 M 72 Muscle invasive TCC Ileal Conduit
  
 
 
 
550 24 Weston - Super - Mare General Hospital 79 1 28 351 F 58 Squamous cell Ca Ileal Conduit
551 24 Yeovil District Hospital 81 19 28 351 F 65 Salvage after radiotherapy Ileal Conduit
552 24 Yeovil District Hospital 81 19 28 351 M 71 Muscle invasive TCC Ileal Conduit
553 24 Yeovil District Hospital 81 19 28 351 M 74 999 Ileal Conduit
554 24 Yeovil District Hospital 81 19 28 351 M 67 Uncontrolled superficial disease Ileal Conduit
555 24 Yeovil District Hospital 81 19 28 351 M 68 Muscle invasive TCC Ileal Conduit
556 24 Yeovil District Hospital 81 19 28 351 M 61 Muscle invasive TCC Ileal Conduit
557 24 Yeovil District Hospital 81 19 28 351 M 76 Muscle invasive TCC Ileal Conduit
558 25 Bromley Hospital 9 19 24 149 M 65 Muscle invasive TCC Ileal Conduit
559 26 Nottingham City Hospital 40 75 39 345 999 999 Gynaecological Ca Ileal Conduit
560 26 Nottingham City Hospital 40 75 39 345 F 41 Gynaecological Ca Ileal Conduit
561 26 Nottingham City Hospital 40 75 39 345 M 999 Uncontrolled superficial disease Ileal Conduit
562 26 Nottingham City Hospital 40 75 39 345 F 75 Squamous cell Ca Ileal Conduit
563 26 Nottingham City Hospital 40 75 39 345 999 999 Muscle invasive TCC Ileal Conduit
564 26 Nottingham City Hospital 40 75 39 345 F 999 Squamous cell Ca Ileal Conduit
565 26 Nottingham City Hospital 40 75 39 345 M 66 Primary CIS Ileal Conduit
566 26 Nottingham City Hospital 40 75 39 345 M 62 Muscle invasive TCC Ileal Conduit
567 26 Nottingham City Hospital 40 75 39 345 999 67 Muscle invasive TCC Orthotopic
568 26 Nottingham City Hospital 40 75 39 345 M 58 Muscle invasive TCC Orthotopic
569 26 Nottingham City Hospital 40 75 39 345 999 999 Muscle invasive TCC Ileal Conduit
570 26 Nottingham City Hospital 40 75 39 345 M 60 Muscle invasive TCC Orthotopic
571 26 Nottingham City Hospital 40 75 39 345 F 61 Muscle invasive TCC Ileal Conduit
572 26 Nottingham City Hospital 40 75 39 345 M 74 Primary CIS Ileal Conduit
573 26 Nottingham City Hospital 40 75 39 345 999 999 Gynaecological Ca Ileal Conduit
574 26 Nottingham City Hospital 40 75 39 345 999 999 Muscle invasive TCC Ileal Conduit
575 26 Nottingham City Hospital 40 75 39 345 M 77 Salvage after radiotherapy Ileal Conduit
576 26 Nottingham City Hospital 40 75 39 345 M 56 Squamous cell Ca Ileal Conduit
577 26 Nottingham City Hospital 40 75 39 345 M 75 Salvage after radiotherapy Ileal Conduit
578 26 Nottingham City Hospital 40 75 39 345 M 999 Salvage after radiotherapy Ileal Conduit
579 26 Nottingham City Hospital 40 75 39 345 M 76 Primary CIS Ileal Conduit
580 26 Nottingham City Hospital 40 75 39 345 M 54 Muscle invasive TCC Ileal Conduit
581 26 Nottingham City Hospital 40 75 39 345 M 71 Muscle invasive TCC Ileal Conduit
582 26 Nottingham City Hospital 40 75 39 345 M 77 Muscle invasive TCC Ileal Conduit
583 26 Nottingham City Hospital 40 75 39 345 M 76 Uncontrolled superficial disease Ileal Conduit
584 26 Nottingham City Hospital 40 75 39 345 999 999 Salvage after radiotherapy Ileal Conduit
585 26 Royal Bolton Hospital NHS Foundation Trust 48 24 2 101.00 M 74 Muscle invasive TCC Ileal Conduit
586 27 Castle Hill Hospital 11 135 7 144 F 999 Muscle invasive TCC Ileal Conduit
587 28 Portsmouth Hospitals NHS Trust 43 150 31 307 999 81 Muscle invasive TCC Ileal Conduit
588 29 Freeman Hospital 23 258 36 405 M 75 Uncontrolled superficial disease Ileal Conduit
589 30 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 65 999 Orthotopic
590 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 62 999 Orthotopic
591 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 76 Muscle invasive TCC Ileal Conduit
592 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 52 999 Orthotopic
593 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 72 Uncontrolled superficial disease Ileal Conduit
594 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 F 71 Muscle invasive TCC Ileal Conduit
595 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 64 Other Ileal Conduit
596 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 53 Muscle invasive TCC Orthotopic
597 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 72 999 Ileal Conduit
598 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 60 Muscle invasive TCC Ileal Conduit
599 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 73 999 Ileal Conduit
  
 
 
 
600 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 77 Muscle invasive TCC Ileal Conduit
601 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 62 Uncontrolled superficial disease Ileal Conduit
602 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 999 999 Ileal Conduit
603 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 77 999 Ileal Conduit
604 30 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 78 Muscle invasive TCC Ileal Conduit
605 31 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 77 Muscle invasive TCC Ileal Conduit
606 31 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 51 Muscle invasive TCC Ileal Conduit
607 31 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 77 Muscle invasive TCC Ileal Conduit
608 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 71 Muscle invasive TCC Ileal Conduit
609 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 73 Other Ileal Conduit
610 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 71 Muscle invasive TCC Ileal Conduit
611 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 76 Other Ileal Conduit
612 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 59 Muscle invasive TCC Ileal Conduit
613 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 80 Muscle invasive TCC Ileal Conduit
614 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 72 Muscle invasive TCC Ileal Conduit
615 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 71 Muscle invasive TCC Ileal Conduit
616 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 56 Muscle invasive TCC Ileal Conduit
617 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 76 Primary CIS Ileal Conduit
618 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 65 Muscle invasive TCC Ileal Conduit
619 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 65 Muscle invasive TCC Ileal Conduit
620 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 77 Muscle invasive TCC Ileal Conduit
621 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 42 Squamous cell Ca Ileal Conduit
622 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 74 Other Ileal Conduit
623 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 79 Muscle invasive TCC Ileal Conduit
624 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 85 Muscle invasive TCC Ileal Conduit
625 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 60 Other Ileal Conduit
626 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 72 Muscle invasive TCC Ileal Conduit
627 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 75 Other Ileal Conduit
628 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 60 Other Ileal Conduit
629 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 57 Other Ileal Conduit
630 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 60 Other Ileal Conduit
631 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 65 Other Ileal Conduit
632 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 61 Primary CIS Ileal Conduit
633 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 67 Primary CIS Ileal Conduit
634 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 58 Other Ileal Conduit
635 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 59 Other Ileal Conduit
636 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 62 Muscle invasive TCC Ileal Conduit
637 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 74 Other Ileal Conduit
638 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 66 Muscle invasive TCC Orthotopic
639 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 69 Muscle invasive TCC Ileal Conduit
640 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 67 Muscle invasive TCC Ileal Conduit
641 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 67 Muscle invasive TCC Ileal Conduit
642 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 74 Squamous cell Ca Ileal Conduit
643 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 77 Other Ileal Conduit
644 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 79 Other Ileal Conduit
645 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 71 Other Ileal Conduit
646 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 79 Salvage after radiotherapy Ileal Conduit
647 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 78 Muscle invasive TCC Ileal Conduit
648 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 78 Muscle invasive TCC Ileal Conduit
649 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 94 Muscle invasive TCC Ileal Conduit
  
 
 
 
650 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 58 Muscle invasive TCC Ileal Conduit
651 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 64 Other Ileal Conduit
652 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 64 Muscle invasive TCC Ileal Conduit
653 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 42 Other Ileal Conduit
654 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 56 Other Ileal Conduit
655 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 67 Other Ileal Conduit
656 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 66 Muscle invasive TCC Ileal Conduit
657 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 76 Muscle invasive TCC Ileal Conduit
658 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 63 Muscle invasive TCC Ileal Conduit
659 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 64 Muscle invasive TCC Ileal Conduit
660 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 62 Muscle invasive TCC Ileal Conduit
661 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 77 Muscle invasive TCC Ileal Conduit
662 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 70 Other Ileal Conduit
663 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 77 Other Ileal Conduit
664 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 77 Muscle invasive TCC Ileal Conduit
665 32 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 79 Muscle invasive TCC Ileal Conduit
666 33 Pilgrim Hospital 41 29 39 345 M 75 Muscle invasive TCC Ileal Conduit
667 33 Pilgrim Hospital 41 29 39 345 M 72 Primary adenocarcinoma Ileal Conduit
668 33 Pilgrim Hospital 41 29 39 345 M 83 Primary CIS Ileal Conduit
669 33 Pilgrim Hospital 41 29 39 345 F 72 Muscle invasive TCC Ileal Conduit
670 33 Pilgrim Hospital 41 29 39 345 M 64 Muscle invasive TCC Ileal Conduit
671 33 Pilgrim Hospital 41 29 39 345 M 77 Primary adenocarcinoma Ileal Conduit
672 33 Pilgrim Hospital 41 29 39 345 M 71 Muscle invasive TCC Ileal Conduit
673 33 Pilgrim Hospital 41 29 39 345 M 73 Other Ileal Conduit
674 33 Pilgrim Hospital 41 29 39 345 M 76 Muscle invasive TCC Ileal Conduit
675 34 Freeman Hospital 23 258 36 405 M 69 Muscle invasive TCC Ileal Conduit
676 35 North Bristol NHSTrust (Southmead) 37 313 28 351 M 75 Muscle invasive TCC Ileal Conduit
677 36 Freeman Hospital 23 258 36 405 F 71 Muscle invasive TCC Ileal Conduit
678 36 Freeman Hospital 23 258 36 405 M 58 Muscle invasive TCC Orthotopic
679 36 Freeman Hospital 23 258 36 405 M 71 Uncontrolled superficial disease Ileal Conduit
680 36 Freeman Hospital 23 258 36 405 M 79 Muscle invasive TCC Ileal Conduit
681 36 Freeman Hospital 23 258 36 405 M 62 Uncontrolled superficial disease Orthotopic
682 36 Freeman Hospital 23 258 36 405 F 76 Muscle invasive TCC Ileal Conduit
683 36 Freeman Hospital 23 258 36 405 M 73 Uncontrolled superficial disease Ileal Conduit
684 36 Freeman Hospital 23 258 36 405 M 74 Muscle invasive TCC Ileal Conduit
685 36 Freeman Hospital 23 258 36 405 F 63 Uncontrolled superficial disease Ileal Conduit
686 36 Freeman Hospital 23 258 36 405 M 73 Muscle invasive TCC Ileal Conduit
687 36 Freeman Hospital 23 258 36 405 F 999 Primary CIS Ileal Conduit
688 36 Freeman Hospital 23 258 36 405 F 74 Muscle invasive TCC Ileal Conduit
689 36 Freeman Hospital 23 258 36 405 M 75 Muscle invasive TCC Ileal Conduit
690 36 Freeman Hospital 23 258 36 405 M 72 Uncontrolled superficial disease Ileal Conduit
691 36 Freeman Hospital 23 258 36 405 M 60 Uncontrolled superficial disease Ileal Conduit
692 36 Freeman Hospital 23 258 36 405 M 66 Muscle invasive TCC Ileal Conduit
693 36 Freeman Hospital 23 258 36 405 M 61 Primary adenocarcinoma Ileal Conduit
694 36 Freeman Hospital 23 258 36 405 M 78 Muscle invasive TCC Ileal Conduit
695 36 Freeman Hospital 23 258 36 405 F 64 Muscle invasive TCC Ileal Conduit
696 36 Freeman Hospital 23 258 36 405 M 71 Uncontrolled superficial disease Ileal Conduit
697 36 Freeman Hospital 23 258 36 405 M 74 Uncontrolled superficial disease Ileal Conduit
698 36 Freeman Hospital 23 258 36 405 M 71 Muscle invasive TCC Ileal Conduit
699 36 Freeman Hospital 23 258 36 405 M 76 Muscle invasive TCC Ileal Conduit
  
 
 
 
700 36 Freeman Hospital 23 258 36 405 F 71 Muscle invasive TCC Ileal Conduit
701 36 Freeman Hospital 23 258 36 405 M 66 Muscle invasive TCC Ileal Conduit
702 36 Freeman Hospital 23 258 36 405 F 74 Uncontrolled superficial disease Ileal Conduit
703 36 Freeman Hospital 23 258 36 405 F 72 Muscle invasive TCC Ileal Conduit
704 36 Freeman Hospital 23 258 36 405 F 68 Muscle invasive TCC Ileal Conduit
705 36 Freeman Hospital 23 258 36 405 F 67 Primary CIS Ileal Conduit
706 36 Freeman Hospital 23 258 36 405 M 57 Uncontrolled superficial disease Orthotopic
707 36 Freeman Hospital 23 258 36 405 M 75 Uncontrolled superficial disease Ileal Conduit
708 36 Freeman Hospital 23 258 36 405 M 61 Muscle invasive TCC Ileal Conduit
709 36 Freeman Hospital 23 258 36 405 F 70 Uncontrolled superficial disease Ileal Conduit
710 36 Freeman Hospital 23 258 36 405 M 69 Muscle invasive TCC Ileal Conduit
711 36 Freeman Hospital 23 258 36 405 M 53 Uncontrolled superficial disease Ileal Conduit
712 36 Freeman Hospital 23 258 36 405 F 67 Muscle invasive TCC Ileal Conduit
713 36 Freeman Hospital 23 258 36 405 F 74 Muscle invasive TCC Ileal Conduit
714 36 Freeman Hospital 23 258 36 405 F 80 Uncontrolled superficial disease Ileal Conduit
715 36 Freeman Hospital 23 258 36 405 M 76 Muscle invasive TCC Ileal Conduit
716 36 Freeman Hospital 23 258 36 405 M 70 Muscle invasive TCC Ileal Conduit
717 36 Freeman Hospital 23 258 36 405 F 71 Muscle invasive TCC Ileal Conduit
718 36 Freeman Hospital 23 258 36 405 M 64 Uncontrolled superficial disease Ileal Conduit
719 36 Freeman Hospital 23 258 36 405 M 62 Uncontrolled superficial disease Ileal Conduit
720 36 Freeman Hospital 23 258 36 405 M 83 Muscle invasive TCC Ileal Conduit
721 36 Freeman Hospital 23 258 36 405 F 78 Primary CIS Ileal Conduit
722 36 Freeman Hospital 23 258 36 405 F 52 Primary adenocarcinoma Orthotopic
723 36 Freeman Hospital 23 258 36 405 M 53 Uncontrolled superficial disease Ileal Conduit
724 36 Freeman Hospital 23 258 36 405 F 78 Squamous cell Ca Ileal Conduit
725 36 Freeman Hospital 23 258 36 405 M 68 Muscle invasive TCC Orthotopic
726 36 Freeman Hospital 23 258 36 405 F 67 Muscle invasive TCC Ileal Conduit
727 36 Freeman Hospital 23 258 36 405 M 74 Muscle invasive TCC Ileal Conduit
728 36 Freeman Hospital 23 258 36 405 M 56 Uncontrolled superficial disease Orthotopic
729 37 Castle Hill Hospital 11 135 7 144 M 71 Salvage after radiotherapy Ileal Conduit
730 37 Castle Hill Hospital 11 135 7 144 M 63 Muscle invasive TCC Ileal Conduit
731 37 Castle Hill Hospital 11 135 7 144 M 72 Salvage after radiotherapy Ileal Conduit
732 37 Castle Hill Hospital 11 135 7 144 F 79 Muscle invasive TCC Ileal Conduit
733 37 Castle Hill Hospital 11 135 7 144 M 61 Muscle invasive TCC Ileal Conduit
734 37 Castle Hill Hospital 11 135 7 144 M 69 Muscle invasive TCC Ileal Conduit
735 37 Castle Hill Hospital 11 135 7 144 M 53 Salvage after radiotherapy Ileal Conduit
736 37 Castle Hill Hospital 11 135 7 144 M 53 Muscle invasive TCC Orthotopic
737 37 Castle Hill Hospital 11 135 7 144 M 76 Muscle invasive TCC Ileal Conduit
738 37 Castle Hill Hospital 11 135 7 144 M 73 Uncontrolled superficial disease Ileal Conduit
739 37 Castle Hill Hospital 11 135 7 144 F 76 Muscle invasive TCC Ileal Conduit
740 37 Castle Hill Hospital 11 135 7 144 M 46 Muscle invasive TCC Ileal Conduit
741 37 Castle Hill Hospital 11 135 7 144 F 58 Uncontrolled superficial disease Ileal Conduit
742 37 Castle Hill Hospital 11 135 7 144 M 79 Muscle invasive TCC Ileal Conduit
743 37 Castle Hill Hospital 11 135 7 144 M 70 Primary CIS Ileal Conduit
744 37 Castle Hill Hospital 11 135 7 144 M 56 Muscle invasive TCC Ileal Conduit
745 37 Castle Hill Hospital 11 135 7 144 M 47 Muscle invasive TCC Ileal Conduit
746 37 Castle Hill Hospital 11 135 7 144 M 79 Salvage after radiotherapy Ileal Conduit
747 37 Castle Hill Hospital 11 135 7 144 M 61 Muscle invasive TCC Ileal Conduit
748 37 Castle Hill Hospital 11 135 7 144 M 59 Uncontrolled superficial disease Ileal Conduit
749 37 Castle Hill Hospital 11 135 7 144 M 58 999 Ileal Conduit
  
 
 
 
750 37 Castle Hill Hospital 11 135 7 144 M 80 Uncontrolled superficial disease Ileal Conduit
751 37 Castle Hill Hospital 11 135 7 144 M 60 Muscle invasive TCC Ileal Conduit
752 37 Scarborough Hospital 63 9 7 144 M 73 Muscle invasive TCC Ileal Conduit
753 38 Bradford Royal Infirmary 7 107 6 384 M 57 Muscle invasive TCC Orthotopic
754 39 Hereford Hospitals NHS Trust 27 8 29 31 M 64 Primary CIS Ileal Conduit
755 39 Hereford Hospitals NHS Trust 27 8 29 31 M 57 Muscle invasive TCC Ileal Conduit
756 39 Hereford Hospitals NHS Trust 27 8 29 31 M 65 Muscle invasive TCC Ileal Conduit
757 39 Hereford Hospitals NHS Trust 27 8 29 31 M 72 Muscle invasive TCC Ileal Conduit
758 39 Hereford Hospitals NHS Trust 27 8 29 31 M 71 Muscle invasive TCC Ileal Conduit
759 39 Hereford Hospitals NHS Trust 27 8 29 31 F 62 Muscle invasive TCC Ileal Conduit
760 39 Hereford Hospitals NHS Trust 27 8 29 31 M 75 Muscle invasive TCC Ileal Conduit
761 39 Hereford Hospitals NHS Trust 27 8 29 31 M 73 Muscle invasive TCC Ileal Conduit
762 39 Hereford Hospitals NHS Trust 27 8 29 31 F 78 Muscle invasive TCC Ileal Conduit
763 40 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 70 Muscle invasive TCC Ileal Conduit
764 40 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 72 Muscle invasive TCC Orthotopic
765 41 Royal Hampshire County Hospital 53 15 31 307 M 86 Muscle invasive TCC Ileal Conduit
766 41 Royal Hampshire County Hospital 53 15 31 307 F 69 Muscle invasive TCC Ileal Conduit
767 41 Royal Hampshire County Hospital 53 15 31 307 M 62 Primary CIS Ileal Conduit
768 41 Royal Hampshire County Hospital 53 15 31 307 M 76 Muscle invasive TCC Ileal Conduit
769 41 Royal Hampshire County Hospital 53 15 31 307 M 69 Muscle invasive TCC Ileal Conduit
770 41 Royal Hampshire County Hospital 53 15 31 307 M 76 Uncontrolled superficial disease Ileal Conduit
771 41 Royal Hampshire County Hospital 53 15 31 307 F 999 Muscle invasive TCC Ileal Conduit
772 41 Royal Hampshire County Hospital 53 15 31 307 M 82 Muscle invasive TCC Ileal Conduit
773 41 Royal Hampshire County Hospital 53 15 31 307 M 64 Muscle invasive TCC Ileal Conduit
774 42 Nottingham City Hospital 40 75 39 345 F 60 Muscle invasive TCC Ileal Conduit
775 42 Nottingham City Hospital 40 75 39 345 M 50 Muscle invasive TCC Ileal Conduit
776 42 Nottingham City Hospital 40 75 39 345 M 66 Muscle invasive TCC Ileal Conduit
777 42 Nottingham City Hospital 40 75 39 345 M 67 Salvage after radiotherapy Ileal Conduit
778 42 Nottingham City Hospital 40 75 39 345 F 79 Muscle invasive TCC Ileal Conduit
779 42 Nottingham City Hospital 40 75 39 345 M 76 Muscle invasive TCC Ileal Conduit
780 42 Nottingham City Hospital 40 75 39 345 M 72 Muscle invasive TCC Ileal Conduit
781 42 Nottingham City Hospital 40 75 39 345 M 75 Muscle invasive TCC Ileal Conduit
782 42 Nottingham City Hospital 40 75 39 345 M 67 Secondary adenocarcinoma Ileal Conduit
783 42 Nottingham City Hospital 40 75 39 345 M 68 Muscle invasive TCC Ileal Conduit
784 42 Nottingham City Hospital 40 75 39 345 F 47 Primary adenocarcinoma Ileal Conduit
785 42 Nottingham City Hospital 40 75 39 345 M 74 Uncontrolled superficial disease Ileal Conduit
786 43 Dorset County Hospital 21 3 27 60 F 68 Muscle invasive TCC Ileal Conduit
787 43 Dorset County Hospital 21 3 27 60 M 63 Muscle invasive TCC Ileal Conduit
788 43 Salisbury District Hospital 61 35 31 307 M 60 Muscle invasive TCC Ileal Conduit
789 43 Salisbury District Hospital 61 35 31 307 M 76 Muscle invasive TCC Ileal Conduit
790 43 Salisbury District Hospital 61 35 31 307 M 67 Muscle invasive TCC Ileal Conduit
791 43 Salisbury District Hospital 61 35 31 307 M 76 Muscle invasive TCC Ileal Conduit
792 43 Salisbury District Hospital 61 35 31 307 M 60 Muscle invasive TCC Ileal Conduit
793 43 Salisbury District Hospital 61 35 31 307 M 61 Muscle invasive TCC Orthotopic
794 43 Salisbury District Hospital 61 35 31 307 M 68 Muscle invasive TCC Ileal Conduit
795 43 Salisbury District Hospital 61 35 31 307 M 75 Muscle invasive TCC Ileal Conduit
796 43 Salisbury District Hospital 61 35 31 307 M 999 Muscle invasive TCC Ileal Conduit
797 43 Salisbury District Hospital 61 35 31 307 M 73 Other Ileal Conduit
798 43 Salisbury District Hospital 61 35 31 307 M 70 Salvage after radiotherapy Ileal Conduit
799 43 Salisbury District Hospital 61 35 31 307 M 69 Muscle invasive TCC Ileal Conduit
  
 
 
 
800 43 Salisbury District Hospital 61 35 31 307 M 69 Muscle invasive TCC Ileal Conduit
801 43 Salisbury District Hospital 61 35 31 307 M 44 Muscle invasive TCC Ileal Conduit
802 43 Salisbury District Hospital 61 35 31 307 F 65 Muscle invasive TCC Ileal Conduit
803 43 Salisbury District Hospital 61 35 31 307 F 61 Other Ileal Conduit
804 43 Salisbury District Hospital 61 35 31 307 F 75 Primary adenocarcinoma Ileal Conduit
805 43 Salisbury District Hospital 61 35 31 307 F 68 Muscle invasive TCC Ileal Conduit
806 43 Salisbury District Hospital 61 35 31 307 M 78 Uncontrolled superficial disease Ileal Conduit
807 43 Salisbury District Hospital 61 35 31 307 M 76 Uncontrolled superficial disease Ileal Conduit
808 43 Salisbury District Hospital 61 35 31 307 M 57 Uncontrolled superficial disease Ileal Conduit
809 43 Salisbury District Hospital 61 35 31 307 M 56 Muscle invasive TCC Ileal Conduit
810 43 Salisbury District Hospital 61 35 31 307 M 76 Other Ileal Conduit
811 43 Salisbury District Hospital 61 35 31 307 M 80 Muscle invasive TCC Ileal Conduit
812 43 Salisbury District Hospital 61 35 31 307 M 81 Salvage after radiotherapy Ileal Conduit
813 43 Salisbury District Hospital 61 35 31 307 M 53 Muscle invasive TCC Ileal Conduit
814 43 Salisbury District Hospital 61 35 31 307 F 73 Muscle invasive TCC Ileal Conduit
815 43 Salisbury District Hospital 61 35 31 307 F 62 Primary adenocarcinoma Ileal Conduit
816 43 Salisbury District Hospital 61 35 31 307 M 63 Muscle invasive TCC Orthotopic
817 43 Salisbury District Hospital 61 35 31 307 M 77 Salvage after radiotherapy Ileal Conduit
818 43 Salisbury District Hospital 61 35 31 307 M 64 Primary CIS Orthotopic
819 43 Salisbury District Hospital 61 35 31 307 M 49 Muscle invasive TCC Ileal Conduit
820 43 Salisbury District Hospital 61 35 31 307 F 75 Muscle invasive TCC Ileal Conduit
821 43 Salisbury District Hospital 61 35 31 307 M 76 Muscle invasive TCC Ileal Conduit
822 43 Salisbury District Hospital 61 35 31 307 M 80 Muscle invasive TCC Ileal Conduit
823 43 Salisbury District Hospital 61 35 31 307 M 69 Secondary adenocarcinoma Ileal Conduit
824 43 Salisbury District Hospital 61 35 31 307 M 65 Salvage after radiotherapy Ileal Conduit
825 43 Salisbury District Hospital 61 35 31 307 F 70 Salvage after radiotherapy Ileal Conduit
826 43 Salisbury District Hospital 61 35 31 307 F 67 Muscle invasive TCC Ileal Conduit
827 43 Salisbury District Hospital 61 35 31 307 M 72 Muscle invasive TCC Ileal Conduit
828 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 71 Squamous cell Ca Ileal Conduit
829 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 63 Muscle invasive TCC Ileal Conduit
830 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 77 Uncontrolled superficial disease Ileal Conduit
831 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 69 Muscle invasive TCC Ileal Conduit
832 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 62 Muscle invasive TCC Ileal Conduit
833 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 73 Muscle invasive TCC Ileal Conduit
834 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 65 Muscle invasive TCC Ileal Conduit
835 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 69 Muscle invasive TCC Ileal Conduit
836 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 69 Uncontrolled superficial disease Ileal Conduit
837 44 Southport & Ormskirk NHS Trust 66 21 3 140 F 65 Muscle invasive TCC Ileal Conduit
838 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 60 Muscle invasive TCC Ileal Conduit
839 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 68 Muscle invasive TCC Ileal Conduit
840 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 72 Muscle invasive TCC Ileal Conduit
841 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 52 Uncontrolled superficial disease Ileal Conduit
842 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 57 Muscle invasive TCC Ileal Conduit
843 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 69 Muscle invasive TCC Ileal Conduit
844 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 73 Muscle invasive TCC Ileal Conduit
845 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 57 Muscle invasive TCC Ileal Conduit
846 44 Southport & Ormskirk NHS Trust 66 21 3 140 F 72 Muscle invasive TCC Ileal Conduit
847 44 Southport & Ormskirk NHS Trust 66 21 3 140 M 58 Uncontrolled superficial disease Ileal Conduit
848 44 Southport & Ormskirk NHS Trust 66 21 3 140 F 55 Muscle invasive TCC Ileal Conduit
849 45 James Paget Hospital 29 18 37 52 F 71 Muscle invasive TCC Ileal Conduit
  
 
 
 
850 45 James Paget Hospital 29 18 37 52 M 63 Muscle invasive TCC Ileal Conduit
851 45 James Paget Hospital 29 18 37 52 M 78 Muscle invasive TCC Ileal Conduit
852 45 James Paget Hospital 29 18 37 52 M 80 Muscle invasive TCC Ileal Conduit
853 45 James Paget Hospital 29 18 37 52 M 81 Muscle invasive TCC Ileal Conduit
854 45 James Paget Hospital 29 18 37 52 M 82 Salvage after radiotherapy Ileal Conduit
855 45 James Paget Hospital 29 18 37 52 M 58 Muscle invasive TCC Ileal Conduit
856 45 James Paget Hospital 29 18 37 52 M 74 Muscle invasive TCC Ileal Conduit
857 45 James Paget Hospital 29 18 37 52 M 68 Muscle invasive TCC Ileal Conduit
858 45 James Paget Hospital 29 18 37 52 F 71 Muscle invasive TCC Ileal Conduit
859 45 James Paget Hospital 29 18 37 52 F 69 Muscle invasive TCC Ileal Conduit
860 45 James Paget Hospital 29 18 37 52 M 72 Muscle invasive TCC Ileal Conduit
861 45 James Paget Hospital 29 18 37 52 M 48 Muscle invasive TCC Ileal Conduit
862 45 James Paget Hospital 29 18 37 52 M 68 Muscle invasive TCC Ileal Conduit
863 46 Whiston Hospital 80 12 3 140 F 71 Salvage after radiotherapy Ileal Conduit
864 47 North Bristol NHSTrust (Southmead) 37 313 28 351 M 84 999 Ileal Conduit
865 47 North Bristol NHSTrust (Southmead) 37 313 28 351 M 83 999 Ileal Conduit
866 47 Weston - Super - Mare General Hospital 79 1 28 351 M 60 999 Ileal Conduit
867 48 Lincoln & Louth NHS Trust 34 8 39 345 F 44 Squamous cell Ca Ileal Conduit
868 48 Lincoln & Louth NHS Trust 34 8 39 345 M 74 Muscle invasive TCC Ileal Conduit
869 48 Lincoln & Louth NHS Trust 34 8 39 345 M 62 Muscle invasive TCC Ileal Conduit
870 48 Lincoln & Louth NHS Trust 34 8 39 345 F 64 Muscle invasive TCC Ileal Conduit
871 48 Lincoln & Louth NHS Trust 34 8 39 345 M 74 Muscle invasive TCC Ileal Conduit
872 49 Portsmouth Hospitals NHS Trust 43 150 31 307 M 74 999 Ileal Conduit
873 49 Portsmouth Hospitals NHS Trust 43 150 31 307 M 75 Muscle invasive TCC Ileal Conduit
874 49 Portsmouth Hospitals NHS Trust 43 150 31 307 M 73 Primary CIS Ileal Conduit
875 49 Portsmouth Hospitals NHS Trust 43 150 31 307 M 59 999 Ileal Conduit
876 50 Guy's & Thomas's Hospital 25 130 24 149 M 62 Uncontrolled superficial disease Ileal Conduit
877 50 Guy's & Thomas's Hospital 25 130 24 149 M 53 Uncontrolled superficial disease Ileal Conduit
878 52 Southampton General Hospital 64 95 31 307 M 73 Muscle invasive TCC Ileal Conduit
879 52 Southampton General Hospital 64 95 31 307 F 86 Muscle invasive TCC Ileal Conduit
880 52 Southampton General Hospital 64 95 31 307 M 84 Muscle invasive TCC Ileal Conduit
881 53 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 77 Muscle invasive TCC Ileal Conduit
882 53 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 69 Squamous cell Ca Ileal Conduit
883 53 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 57 Squamous cell Ca Ileal Conduit
884 53 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 66 Muscle invasive TCC Ileal Conduit
885 53 Alexandra Hospital; Kidderminster General Hospital; Worcester Royal Infirmary3 23 29 31 M 70 Muscle invasive TCC Ileal Conduit
886 54 Colchester General Hospital 16 68 38 164 M 71 Muscle invasive TCC Ileal Conduit
887 54 Colchester General Hospital 16 68 38 164 F 73 Salvage after radiotherapy Ileal Conduit
888 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 67 Salvage after radiotherapy Ileal Conduit
889 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 79 Muscle invasive TCC Ileal Conduit
890 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 71 Muscle invasive TCC Ileal Conduit
891 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 64 Uncontrolled superficial disease Ileal Conduit
892 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 59 Muscle invasive TCC Ileal Conduit
893 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 68 Primary CIS Ileal Conduit
894 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 74 Muscle invasive TCC Ileal Conduit
895 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 66 Muscle invasive TCC Ileal Conduit
896 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 60 Muscle invasive TCC Ileal Conduit
897 55 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 64 Salvage after radiotherapy Ileal Conduit
898 56 Castle Hill Hospital 11 135 7 144 F 75 Muscle invasive TCC Ileal Conduit
899 56 Castle Hill Hospital 11 135 7 144 F 73 Squamous cell Ca Ileal Conduit
  
 
 
 
900 56 Castle Hill Hospital 11 135 7 144 M 66 Muscle invasive TCC Ileal Conduit
901 56 Castle Hill Hospital 11 135 7 144 M 67 Uncontrolled superficial disease Ileal Conduit
902 56 Castle Hill Hospital 11 135 7 144 M 71 Muscle invasive TCC Ileal Conduit
903 56 Castle Hill Hospital 11 135 7 144 F 71 Other Ileal Conduit
904 56 Castle Hill Hospital 11 135 7 144 M 999 Muscle invasive TCC Ileal Conduit
905 56 Castle Hill Hospital 11 135 7 144 F 58 Salvage after radiotherapy Ileal Conduit
906 56 Castle Hill Hospital 11 135 7 144 M 65 Salvage after radiotherapy Ileal Conduit
907 56 Castle Hill Hospital 11 135 7 144 M 66 Muscle invasive TCC Ileal Conduit
908 56 Castle Hill Hospital 11 135 7 144 M 70 Muscle invasive TCC Ileal Conduit
909 56 Castle Hill Hospital 11 135 7 144 M 76 Muscle invasive TCC Ileal Conduit
910 56 Castle Hill Hospital 11 135 7 144 M 78 Salvage after radiotherapy Ileal Conduit
911 56 Castle Hill Hospital 11 135 7 144 M 69 Muscle invasive TCC Ileal Conduit
912 56 Castle Hill Hospital 11 135 7 144 M 66 Muscle invasive TCC Ileal Conduit
913 56 Castle Hill Hospital 11 135 7 144 F 57 Muscle invasive TCC Ileal Conduit
914 56 Castle Hill Hospital 11 135 7 144 M 76 Salvage after radiotherapy Ileal Conduit
915 56 Castle Hill Hospital 11 135 7 144 F 44 Muscle invasive TCC Ileal Conduit
916 56 Scarborough Hospital 63 9 7 144 M 56 Uncontrolled superficial disease Orthotopic
917 56 Scarborough Hospital 63 9 7 144 M 74 Muscle invasive TCC Ileal Conduit
918 56 Scarborough Hospital 63 9 7 144 M 64 Primary CIS Ileal Conduit
919 56 Scarborough Hospital 63 9 7 144 F 53 Muscle invasive TCC Ileal Conduit
920 57 Leicester General Hospital 33 97 39 345 M 71 Muscle invasive TCC Ileal Conduit
921 57 Leicester General Hospital 33 97 39 345 M 60 Muscle invasive TCC Ileal Conduit
922 57 Leicester General Hospital 33 97 39 345 F 60 Salvage after radiotherapy Ileal Conduit
923 57 Leicester General Hospital 33 97 39 345 F 76 Muscle invasive TCC Ileal Conduit
924 57 Leicester General Hospital 33 97 39 345 M 68 Uncontrolled superficial disease Ileal Conduit
925 57 Leicester General Hospital 33 97 39 345 M 69 Muscle invasive TCC Ileal Conduit
926 57 Leicester General Hospital 33 97 39 345 M 74 999 Ileal Conduit
927 57 Leicester General Hospital 33 97 39 345 F 69 Muscle invasive TCC Ileal Conduit
928 57 Leicester General Hospital 33 97 39 345 F 75 Muscle invasive TCC Ileal Conduit
929 57 Leicester General Hospital 33 97 39 345 M 71 Primary CIS Ileal Conduit
930 57 Leicester General Hospital 33 97 39 345 M 75 Salvage after radiotherapy Ileal Conduit
931 57 Leicester General Hospital 33 97 39 345 M 54 Uncontrolled superficial disease Ileal Conduit
932 57 Leicester General Hospital 33 97 39 345 M 77 Salvage after radiotherapy Ileal Conduit
933 57 Leicester General Hospital 33 97 39 345 M 61 Salvage after radiotherapy Ileal Conduit
934 57 Leicester General Hospital 33 97 39 345 M 59 Muscle invasive TCC Ileal Conduit
935 57 Leicester General Hospital 33 97 39 345 M 69 Muscle invasive TCC Ileal Conduit
936 57 Leicester General Hospital 33 97 39 345 M 79 Uncontrolled superficial disease Ileal Conduit
937 57 Leicester General Hospital 33 97 39 345 M 73 Uncontrolled superficial disease Ileal Conduit
938 57 Leicester General Hospital 33 97 39 345 M 74 Other Ileal Conduit
939 57 Leicester General Hospital 33 97 39 345 F 65 Muscle invasive TCC Ileal Conduit
940 57 Leicester General Hospital 33 97 39 345 M 65 Muscle invasive TCC Ileal Conduit
941 57 Leicester General Hospital 33 97 39 345 M 69 Primary CIS Ileal Conduit
942 57 Leicester General Hospital 33 97 39 345 M 75 Salvage after radiotherapy Ileal Conduit
943 57 Leicester General Hospital 33 97 39 345 F 74 Primary CIS Ileal Conduit
944 57 Leicester General Hospital 33 97 39 345 F 70 Uncontrolled superficial disease Ileal Conduit
945 57 Leicester General Hospital 33 97 39 345 M 54 Muscle invasive TCC Ileal Conduit
946 57 Leicester General Hospital 33 97 39 345 M 61 Uncontrolled superficial disease Ileal Conduit
947 57 Leicester General Hospital 33 97 39 345 F 72 Muscle invasive TCC Ileal Conduit
948 57 Leicester General Hospital 33 97 39 345 M 59 Other Ileal Conduit
949 57 Leicester General Hospital 33 97 39 345 M 66 Other Orthotopic
  
 
 
 
950 57 Leicester General Hospital 33 97 39 345 M 72 Uncontrolled superficial disease Orthotopic
951 57 Leicester General Hospital 33 97 39 345 M 62 Muscle invasive TCC Ileal Conduit
952 57 Leicester General Hospital 33 97 39 345 M 64 Muscle invasive TCC Ileal Conduit
953 57 Leicester General Hospital 33 97 39 345 M 66 Muscle invasive TCC Ileal Conduit
954 57 Leicester General Hospital 33 97 39 345 M 69 Uncontrolled superficial disease Ileal Conduit
955 57 Leicester General Hospital 33 97 39 345 M 66 Salvage after radiotherapy Ileal Conduit
956 57 Leicester General Hospital 33 97 39 345 M 72 Salvage after radiotherapy Ileal Conduit
957 57 Leicester General Hospital 33 97 39 345 M 72 Muscle invasive TCC Ileal Conduit
958 58 Kent and Sussex Hospital 30 9 34 9 F 75 Muscle invasive TCC Ileal Conduit
959 58 Kent and Sussex Hospital 30 9 34 9 M 33 Muscle invasive TCC Orthotopic
960 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 57 Muscle invasive TCC Ileal Conduit
961 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 64 Uncontrolled superficial disease Ileal Conduit
962 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 66 Muscle invasive TCC Ileal Conduit
963 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 70 Muscle invasive TCC Ileal Conduit
964 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 62 Muscle invasive TCC Ileal Conduit
965 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 61 Muscle invasive TCC Ileal Conduit
966 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 83 Muscle invasive TCC Ileal Conduit
967 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 72 Muscle invasive TCC Ileal Conduit
968 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 65 Primary CIS Ileal Conduit
969 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 65 Muscle invasive TCC Ileal Conduit
970 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 66 Other Ileal Conduit
971 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 69 Muscle invasive TCC Ileal Conduit
972 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 71 Muscle invasive TCC Ileal Conduit
973 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 57 Muscle invasive TCC Ileal Conduit
974 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 71 Muscle invasive TCC Ileal Conduit
975 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 74 Other Ileal Conduit
976 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 72 Muscle invasive TCC Ileal Conduit
977 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 60 Primary CIS Ileal Conduit
978 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 69 Muscle invasive TCC Ileal Conduit
979 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 74 Muscle invasive TCC Ileal Conduit
980 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 58 Other Ileal Conduit
981 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 80 Uncontrolled superficial disease Ileal Conduit
982 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 60 Muscle invasive TCC Ileal Conduit
983 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 60 Muscle invasive TCC Ileal Conduit
984 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 66 Muscle invasive TCC Ileal Conduit
985 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 67 Uncontrolled superficial disease Ileal Conduit
986 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 64 Salvage after radiotherapy Ileal Conduit
987 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 62 Muscle invasive TCC Ileal Conduit
988 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 62 Muscle invasive TCC Ileal Conduit
989 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 78 Other Ileal Conduit
990 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 65 Primary CIS Ileal Conduit
991 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 72 Muscle invasive TCC Ileal Conduit
992 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 66 Uncontrolled superficial disease Ileal Conduit
993 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 69 Muscle invasive TCC Ileal Conduit
994 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 54 Muscle invasive TCC Ileal Conduit
995 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 68 Primary CIS Ileal Conduit
996 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 59 Muscle invasive TCC Ileal Conduit
997 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 62 Primary CIS Ileal Conduit
998 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 48 Salvage after radiotherapy Ileal Conduit
999 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 51 Muscle invasive TCC Ileal Conduit
  
 
 
 
1000 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 70 Muscle invasive TCC Ileal Conduit
1001 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 77 Muscle invasive TCC Ileal Conduit
1002 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 59 Uncontrolled superficial disease Ileal Conduit
1003 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 71 Muscle invasive TCC Ileal Conduit
1004 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 64 Muscle invasive TCC Ileal Conduit
1005 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 57 Uncontrolled superficial disease Ileal Conduit
1006 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 66 Muscle invasive TCC Ileal Conduit
1007 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 67 Other Ileal Conduit
1008 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 75 Other Ileal Conduit
1009 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 70 Muscle invasive TCC Ileal Conduit
1010 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 60 Muscle invasive TCC Ileal Conduit
1011 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 69 Muscle invasive TCC Ileal Conduit
1012 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 59 Muscle invasive TCC Ileal Conduit
1013 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 60 Other Ileal Conduit
1014 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 74 Muscle invasive TCC Ileal Conduit
1015 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 67 Muscle invasive TCC Ileal Conduit
1016 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 70 Muscle invasive TCC Ileal Conduit
1017 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 69 Uncontrolled superficial disease Ileal Conduit
1018 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 76 Primary CIS Ileal Conduit
1019 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 67 Muscle invasive TCC Ileal Conduit
1020 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 60 Squamous cell Ca Ileal Conduit
1021 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 F 61 Muscle invasive TCC Ileal Conduit
1022 59 Doncaster & Bassetlaw Hospitals NHS Trust 20 56 8 261 M 52 Muscle invasive TCC Ileal Conduit
1023 59 Royal Hallamshire Hospital 52 179 8 261 M 70 Muscle invasive TCC Ileal Conduit
1024 59 Royal Hallamshire Hospital 52 179 8 261 M 69 Muscle invasive TCC Ileal Conduit
1025 59 Royal Hallamshire Hospital 52 179 8 261 F 76 Muscle invasive TCC Ileal Conduit
1026 60 Royal Devon And Exeter Hospital 51 113 26 205 M 65 Uncontrolled superficial disease Ileal Conduit
1027 60 Royal Devon And Exeter Hospital 51 113 26 205 M 70 Uncontrolled superficial disease Ileal Conduit
1028 60 Royal Devon And Exeter Hospital 51 113 26 205 M 56 Muscle invasive TCC Ileal Conduit
1029 60 Royal Devon And Exeter Hospital 51 113 26 205 F 62 Muscle invasive TCC Ileal Conduit
1030 60 Royal Devon And Exeter Hospital 51 113 26 205 M 999 Muscle invasive TCC Ileal Conduit
1031 60 Royal Devon And Exeter Hospital 51 113 26 205 M 65 Muscle invasive TCC Ileal Conduit
1032 60 Royal Devon And Exeter Hospital 51 113 26 205 M 74 Muscle invasive TCC Ileal Conduit
1033 60 Royal Devon And Exeter Hospital 51 113 26 205 F 78 Muscle invasive TCC Ileal Conduit
1034 60 Royal Devon And Exeter Hospital 51 113 26 205 M 65 Muscle invasive TCC Orthotopic
1035 60 Royal Devon And Exeter Hospital 51 113 26 205 F 66 Primary CIS Ileal Conduit
1036 60 Royal Devon And Exeter Hospital 51 113 26 205 M 74 Uncontrolled superficial disease Ileal Conduit
1037 60 Royal Devon And Exeter Hospital 51 113 26 205 F 44 Muscle invasive TCC Ileal Conduit
1038 61 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 62 Muscle invasive TCC Ileal Conduit
1039 61 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 F 81 Muscle invasive TCC Ileal Conduit
1040 61 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 70 Muscle invasive TCC Ileal Conduit
1041 61 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 70 Muscle invasive TCC Ileal Conduit
1042 62 Churchill Hospital 14 85 30 167 M 999 Muscle invasive TCC Ileal Conduit
1043 62 Churchill Hospital 14 85 30 167 F 999 Muscle invasive TCC Ileal Conduit
1044 62 Churchill Hospital 14 85 30 167 F 999 Primary CIS Ileal Conduit
1045 62 Churchill Hospital 14 85 30 167 M 999 Muscle invasive TCC Ileal Conduit
1046 62 Churchill Hospital 14 85 30 167 M 999 Muscle invasive TCC Ileal Conduit
1047 62 Churchill Hospital 14 85 30 167 M 999 Squamous cell Ca Ileal Conduit
1048 62 Churchill Hospital 14 85 30 167 F 999 Squamous cell Ca Ileal Conduit
1049 62 Churchill Hospital 14 85 30 167 M 999 Muscle invasive TCC Ileal Conduit
  
 
 
 
1050 62 Churchill Hospital 14 85 30 167 M 999 Muscle invasive TCC Ileal Conduit
1051 62 Churchill Hospital 14 85 30 167 F 999 Muscle invasive TCC Ileal Conduit
1052 63 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 62 Uncontrolled superficial disease Ileal Conduit
1053 63 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 70 Muscle invasive TCC Ileal Conduit
1054 63 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 74 Uncontrolled superficial disease Ileal Conduit
1055 63 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 60 Muscle invasive TCC Ileal Conduit
1056 63 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 77 Muscle invasive TCC Ileal Conduit
1057 64 Warwick Hospital 77 13 12 22 F 71 Muscle invasive TCC Ileal Conduit
1058 64 Warwick Hospital 77 13 12 22 M 66 Muscle invasive TCC Ileal Conduit
1059 64 Warwick Hospital 77 13 12 22 M 68 Muscle invasive TCC Ileal Conduit
1060 64 Warwick Hospital 77 13 12 22 M 68 Squamous cell Ca Ileal Conduit
1061 64 Warwick Hospital 77 13 12 22 M 74 Muscle invasive TCC Ileal Conduit
1062 64 Warwick Hospital 77 13 12 22 M 71 Other Ileal Conduit
1063 64 Warwick Hospital 77 13 12 22 M 59 Squamous cell Ca Ileal Conduit
1064 64 Warwick Hospital 77 13 12 22 M 68 Muscle invasive TCC Ileal Conduit
1065 64 Warwick Hospital 77 13 12 22 M 55 Muscle invasive TCC Ileal Conduit
1066 64 Warwick Hospital 77 13 12 22 M 77 Muscle invasive TCC Ileal Conduit
1067 65 The Ipswich Hospital 70 34 37 52 M 999 Muscle invasive TCC Ileal Conduit
1068 66 Royal Bournemouth Hospital 49 57 27 60 M 70 Muscle invasive TCC Ileal Conduit
1069 66 Royal Bournemouth Hospital 49 57 27 60 M 77 Muscle invasive TCC Ileal Conduit
1070 66 Royal Bournemouth Hospital 49 57 27 60 M 999 Primary CIS Ileal Conduit
1071 67 Barnet & Chase Farm Hospital 5 64 22 118 M 74 Muscle invasive TCC Ileal Conduit
1072 68 Princess Alexandra Hospital, Harlow 44 14 22 118 F 999 999 Ileal Conduit
1073 68 Princess Alexandra Hospital, Harlow 44 14 22 118 F 73 Uncontrolled superficial disease Ileal Conduit
1074 68 Princess Alexandra Hospital, Harlow 44 14 22 118 M 999 Uncontrolled superficial disease Ileal Conduit
1075 68 Princess Alexandra Hospital, Harlow 44 14 22 118 M 999 Muscle invasive TCC Ileal Conduit
1076 68 Princess Alexandra Hospital, Harlow 44 14 22 118 F 64 Uncontrolled superficial disease Ileal Conduit
1077 69 Victoria Hospital Blackpool 75 19 1 19 999 999 Muscle invasive TCC Ileal Conduit
1078 69 Victoria Hospital Blackpool 75 19 1 19 M 999 Secondary adenocarcinoma Ileal Conduit
1079 69 Victoria Hospital Blackpool 75 19 1 19 M 999 Muscle invasive TCC Ileal Conduit
1080 69 Victoria Hospital Blackpool 75 19 1 19 M 999 Salvage after radiotherapy Ileal Conduit
1081 70 Royal Liverpool University Hospital 54 53 3 140 M 70 Muscle invasive TCC Ileal Conduit
1082 70 Royal Liverpool University Hospital 54 53 3 140 M 67 Primary CIS Ileal Conduit
1083 70 Royal Liverpool University Hospital 54 53 3 140 M 71 Muscle invasive TCC Ileal Conduit
1084 70 Royal Liverpool University Hospital 54 53 3 140 M 999 Muscle invasive TCC Ileal Conduit
1085 70 Royal Liverpool University Hospital 54 53 3 140 F 74 Uncontrolled superficial disease Ileal Conduit
1086 70 Royal Liverpool University Hospital 54 53 3 140 F 67 999 Ileal Conduit
1087 70 Royal Liverpool University Hospital 54 53 3 140 F 70 Muscle invasive TCC Ileal Conduit
1088 70 Royal Liverpool University Hospital 54 53 3 140 F 999 Muscle invasive TCC Ileal Conduit
1089 71 Royal Liverpool University Hospital 54 53 3 140 M 55 Muscle invasive TCC Orthotopic
1090 72 Salford RoyalNHS Foundation Trust 60 44 2 101.00 F 68 Squamous cell Ca Ileal Conduit
1091 73 Royal Bournemouth Hospital 49 57 27 60 M 79 Salvage after radiotherapy Ileal Conduit
1092 73 Royal Bournemouth Hospital 49 57 27 60 F 57 Squamous cell Ca Ileal Conduit
1093 73 Royal Bournemouth Hospital 49 57 27 60 M 70 Muscle invasive TCC Ileal Conduit
1094 73 Royal Bournemouth Hospital 49 57 27 60 M 76 Muscle invasive TCC Ileal Conduit
1095 73 Royal Bournemouth Hospital 49 57 27 60 M 57 Muscle invasive TCC Ileal Conduit
1096 73 Royal Bournemouth Hospital 49 57 27 60 M 69 Muscle invasive TCC Ileal Conduit
1097 74 Walsgrave Hospital 76 9 12 22 M 53 Muscle invasive TCC Ileal Conduit
1098 75 North Bristol NHSTrust (Southmead) 37 313 28 351 M 63 Muscle invasive TCC Ileal Conduit
1099 75 North Bristol NHSTrust (Southmead) 37 313 28 351 M 85 Muscle invasive TCC Ileal Conduit
  
 
 
 
1100 75 North Bristol NHSTrust (Southmead) 37 313 28 351 F 70 Muscle invasive TCC Ileal Conduit
1101 75 Walsgrave Hospital 76 9 12 22 M 75 Sarcoma Ileal Conduit
1102 76 Portsmouth Hospitals NHS Trust 43 150 31 307 M 77 Muscle invasive TCC Ileal Conduit
1103 76 Portsmouth Hospitals NHS Trust 43 150 31 307 F 78 Muscle invasive TCC Ileal Conduit
1104 76 Portsmouth Hospitals NHS Trust 43 150 31 307 M 59 Uncontrolled superficial disease Ileal Conduit
1105 76 Portsmouth Hospitals NHS Trust 43 150 31 307 M 77 Muscle invasive TCC Ileal Conduit
1106 77 Kettering General Hospital 31 2 39 345 F 77 Muscle invasive TCC Ileal Conduit
1107 78 Royal Hampshire County Hospital 53 15 31 307 M 69 Uncontrolled superficial disease Ileal Conduit
1108 78 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
1109 78 Southampton General Hospital 64 95 31 307 M 999 Salvage after radiotherapy Ileal Conduit
1110 78 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
1111 78 Southampton General Hospital 64 95 31 307 M 40 Other Ileal Conduit
1112 78 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
1113 78 Southampton General Hospital 64 95 31 307 F 27 Gynaecological Ca Ileal Conduit
1114 78 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
1115 78 Southampton General Hospital 64 95 31 307 M 999 Primary CIS Ileal Conduit
1116 78 Southampton General Hospital 64 95 31 307 M 999 Uncontrolled superficial disease Ileal Conduit
1117 78 Southampton General Hospital 64 95 31 307 F 999 Gynaecological Ca Ileal Conduit
1118 78 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
1119 78 Southampton General Hospital 64 95 31 307 M 999 Muscle invasive TCC Ileal Conduit
1120 78 Southampton General Hospital 64 95 31 307 F 74 Muscle invasive TCC Ileal Conduit
1121 78 Southampton General Hospital 64 95 31 307 F 999 Muscle invasive TCC Ileal Conduit
1122 78 Southampton General Hospital 64 95 31 307 F 999 Primary CIS Ileal Conduit
1123 79 Hemel Hempstead General Hospital; Mount Vernon & Watford Hospitals26 1 20 69 M 65 Muscle invasive TCC Ileal Conduit
1124 80 Royal Preston Hospital 56 22 2 101.00 M 75 Muscle invasive TCC Ileal Conduit
1125 81 Hereford Hospitals NHS Trust 27 8 29 31 M 76 Uncontrolled superficial disease Ileal Conduit
1126 82 (Ashington) 1 9 36 405 M 76 Muscle invasive TCC Ileal Conduit
1127 82 (Ashington) 1 9 36 405 F 73 Muscle invasive TCC Ileal Conduit
1128 82 (Ashington) 1 9 36 405 F 70 Uncontrolled superficial disease Ileal Conduit
1129 82 (Ashington) 1 9 36 405 M 72 Uncontrolled superficial disease Ileal Conduit
1130 82 (Ashington) 1 9 36 405 999 67 Uncontrolled superficial disease Ileal Conduit
1131 82 Freeman Hospital 23 258 36 405 M 70 Uncontrolled superficial disease Ileal Conduit
1132 82 Freeman Hospital 23 258 36 405 M 61 Muscle invasive TCC Ileal Conduit
1133 82 Freeman Hospital 23 258 36 405 M 59 Muscle invasive TCC Ileal Conduit
1134 82 Freeman Hospital 23 258 36 405 M 42 Uncontrolled superficial disease Ileal Conduit
1135 82 Freeman Hospital 23 258 36 405 M 64 Muscle invasive TCC Ileal Conduit
1136 82 Freeman Hospital 23 258 36 405 M 69 Muscle invasive TCC Ileal Conduit
1137 82 Freeman Hospital 23 258 36 405 F 64 Uncontrolled superficial disease Orthotopic
1138 82 Freeman Hospital 23 258 36 405 M 71 Muscle invasive TCC Ileal Conduit
1139 82 Freeman Hospital 23 258 36 405 F 77 Squamous cell Ca Ileal Conduit
1140 82 Freeman Hospital 23 258 36 405 M 78 Uncontrolled superficial disease Ileal Conduit
1141 82 Freeman Hospital 23 258 36 405 M 78 Uncontrolled superficial disease Ileal Conduit
1142 82 Freeman Hospital 23 258 36 405 M 54 Uncontrolled superficial disease Ileal Conduit
1143 82 Freeman Hospital 23 258 36 405 M 69 Uncontrolled superficial disease Ileal Conduit
1144 82 Freeman Hospital 23 258 36 405 M 51 Uncontrolled superficial disease Ileal Conduit
1145 82 Freeman Hospital 23 258 36 405 M 72 Uncontrolled superficial disease Ileal Conduit
1146 82 Freeman Hospital 23 258 36 405 M 69 Uncontrolled superficial disease Ileal Conduit
1147 82 Freeman Hospital 23 258 36 405 M 78 Muscle invasive TCC Ileal Conduit
1148 82 Freeman Hospital 23 258 36 405 M 57 Uncontrolled superficial disease Ileal Conduit
1149 82 Freeman Hospital 23 258 36 405 F 80 Other Ileal Conduit
  
 
 
 
1150 82 Freeman Hospital 23 258 36 405 M 75 Muscle invasive TCC Ileal Conduit
1151 82 Freeman Hospital 23 258 36 405 M 70 Uncontrolled superficial disease Ileal Conduit
1152 82 Freeman Hospital 23 258 36 405 M 77 Uncontrolled superficial disease Ileal Conduit
1153 82 Freeman Hospital 23 258 36 405 M 69 Primary CIS Ileal Conduit
1154 82 Freeman Hospital 23 258 36 405 M 63 Uncontrolled superficial disease Ileal Conduit
1155 82 Freeman Hospital 23 258 36 405 M 67 Muscle invasive TCC Ileal Conduit
1156 82 Freeman Hospital 23 258 36 405 F 64 Muscle invasive TCC Ileal Conduit
1157 82 Freeman Hospital 23 258 36 405 M 66 Uncontrolled superficial disease Ileal Conduit
1158 82 Freeman Hospital 23 258 36 405 M 66 Muscle invasive TCC Ileal Conduit
1159 82 Freeman Hospital 23 258 36 405 M 69 Muscle invasive TCC Ileal Conduit
1160 82 Freeman Hospital 23 258 36 405 F 72 Muscle invasive TCC Ileal Conduit
1161 82 Freeman Hospital 23 258 36 405 M 75 Muscle invasive TCC Ileal Conduit
1162 82 Freeman Hospital 23 258 36 405 M 999 Uncontrolled superficial disease Ileal Conduit
1163 82 Freeman Hospital 23 258 36 405 F 75 Muscle invasive TCC Ileal Conduit
1164 82 Freeman Hospital 23 258 36 405 M 72 Uncontrolled superficial disease Ileal Conduit
1165 82 Freeman Hospital 23 258 36 405 M 61 Uncontrolled superficial disease Ileal Conduit
1166 82 Freeman Hospital 23 258 36 405 M 57 Uncontrolled superficial disease Ileal Conduit
1167 82 Freeman Hospital 23 258 36 405 M 71 Primary CIS Ileal Conduit
1168 82 Freeman Hospital 23 258 36 405 M 66 Muscle invasive TCC Orthotopic
1169 82 Freeman Hospital 23 258 36 405 F 67 Squamous cell Ca Ileal Conduit
1170 82 Freeman Hospital 23 258 36 405 M 59 Muscle invasive TCC Ileal Conduit
1171 82 Freeman Hospital 23 258 36 405 F 78 Muscle invasive TCC Ileal Conduit
1172 82 Freeman Hospital 23 258 36 405 F 78 Muscle invasive TCC Ileal Conduit
1173 82 Freeman Hospital 23 258 36 405 F 68 Uncontrolled superficial disease Ileal Conduit
1174 82 Freeman Hospital 23 258 36 405 M 76 Muscle invasive TCC Ileal Conduit
1175 82 Freeman Hospital 23 258 36 405 M 78 Muscle invasive TCC Ileal Conduit
1176 82 Freeman Hospital 23 258 36 405 M 72 Muscle invasive TCC Ileal Conduit
1177 82 Freeman Hospital 23 258 36 405 M 79 Uncontrolled superficial disease Ileal Conduit
1178 82 Freeman Hospital 23 258 36 405 M 59 Muscle invasive TCC Ileal Conduit
1179 82 Freeman Hospital 23 258 36 405 M 64 Uncontrolled superficial disease Ileal Conduit
1180 82 Freeman Hospital 23 258 36 405 F 67 Muscle invasive TCC Ileal Conduit
1181 82 Freeman Hospital 23 258 36 405 M 59 Muscle invasive TCC Ileal Conduit
1182 82 Freeman Hospital 23 258 36 405 M 80 Squamous cell Ca Ileal Conduit
1183 82 Freeman Hospital 23 258 36 405 M 76 Muscle invasive TCC Ileal Conduit
1184 82 Freeman Hospital 23 258 36 405 M 72 Muscle invasive TCC Ileal Conduit
1185 82 Freeman Hospital 23 258 36 405 M 63 Muscle invasive TCC Ileal Conduit
1186 82 Freeman Hospital 23 258 36 405 M 61 Uncontrolled superficial disease Ileal Conduit
1187 82 Freeman Hospital 23 258 36 405 M 66 Muscle invasive TCC Ileal Conduit
1188 82 Freeman Hospital 23 258 36 405 F 76 Uncontrolled superficial disease Ileal Conduit
1189 82 Freeman Hospital 23 258 36 405 M 73 Muscle invasive TCC Ileal Conduit
1190 82 Freeman Hospital 23 258 36 405 M 62 Uncontrolled superficial disease Ileal Conduit
1191 82 Freeman Hospital 23 258 36 405 M 63 Muscle invasive TCC Ileal Conduit
1192 82 Freeman Hospital 23 258 36 405 M 61 Uncontrolled superficial disease Ileal Conduit
1193 82 Freeman Hospital 23 258 36 405 F 56 Muscle invasive TCC Ileal Conduit
1194 82 Freeman Hospital 23 258 36 405 F 60 Uncontrolled superficial disease Ileal Conduit
1195 82 Freeman Hospital 23 258 36 405 M 58 Uncontrolled superficial disease Ileal Conduit
1196 82 Freeman Hospital 23 258 36 405 M 66 Primary CIS Ileal Conduit
1197 82 Freeman Hospital 23 258 36 405 M 999 Muscle invasive TCC Ileal Conduit
1198 82 Freeman Hospital 23 258 36 405 M 77 Muscle invasive TCC Ileal Conduit
1199 82 Freeman Hospital 23 258 36 405 M 42 Uncontrolled superficial disease Orthotopic
  
 
 
 
1200 82 Freeman Hospital 23 258 36 405 M 64 Muscle invasive TCC Ileal Conduit
1201 82 Freeman Hospital 23 258 36 405 M 68 Muscle invasive TCC Ileal Conduit
1202 82 Freeman Hospital 23 258 36 405 M 46 Muscle invasive TCC Orthotopic
1203 82 Freeman Hospital 23 258 36 405 M 75 Uncontrolled superficial disease Ileal Conduit
1204 82 Freeman Hospital 23 258 36 405 M 78 Muscle invasive TCC Ileal Conduit
1205 82 Freeman Hospital 23 258 36 405 F 77 Muscle invasive TCC Ileal Conduit
1206 82 Freeman Hospital 23 258 36 405 M 57 Muscle invasive TCC Ileal Conduit
1207 82 Freeman Hospital 23 258 36 405 M 72 Uncontrolled superficial disease Ileal Conduit
1208 82 Freeman Hospital 23 258 36 405 F 58 Muscle invasive TCC Ileal Conduit
1209 82 Freeman Hospital 23 258 36 405 M 74 Muscle invasive TCC Ileal Conduit
1210 82 Freeman Hospital 23 258 36 405 F 73 Muscle invasive TCC Ileal Conduit
1211 82 Freeman Hospital 23 258 36 405 M 74 Uncontrolled superficial disease Ileal Conduit
1212 82 Freeman Hospital 23 258 36 405 M 70 Muscle invasive TCC Ileal Conduit
1213 82 Freeman Hospital 23 258 36 405 M 71 Muscle invasive TCC Ileal Conduit
1214 82 Freeman Hospital 23 258 36 405 F 71 Uncontrolled superficial disease Ileal Conduit
1215 82 Freeman Hospital 23 258 36 405 F 74 Uncontrolled superficial disease Ileal Conduit
1216 82 Freeman Hospital 23 258 36 405 F 71 Muscle invasive TCC Ileal Conduit
1217 82 Freeman Hospital 23 258 36 405 M 58 Muscle invasive TCC Ileal Conduit
1218 82 Freeman Hospital 23 258 36 405 M 67 Uncontrolled superficial disease Ileal Conduit
1219 82 Freeman Hospital 23 258 36 405 M 51 Uncontrolled superficial disease Ileal Conduit
1220 82 Freeman Hospital 23 258 36 405 M 50 Squamous cell Ca Ileal Conduit
1221 82 Freeman Hospital 23 258 36 405 M 69 Uncontrolled superficial disease Ileal Conduit
1222 83 Nottingham City Hospital 40 75 39 345 M 65 Muscle invasive TCC Ileal Conduit
1223 84 Colchester General Hospital 16 68 38 164 M 68 Primary CIS Ileal Conduit
1224 85 York District Hospital 82 58 6 384 M 83 Primary CIS Ileal Conduit
1225 85 York District Hospital 82 58 6 384 M 79 Muscle invasive TCC Ileal Conduit
1226 86 Arrowe Park Hospital 4 54 3 140 M 53 Muscle invasive TCC Orthotopic
1227 87 University College Hospital London 72 38 22 118 M 78 Sarcoma Ileal Conduit
1228 87 University College Hospital London 72 38 22 118 F 66 Primary CIS Ileal Conduit
1229 87 University College Hospital London 72 38 22 118 M 77 Muscle invasive TCC Ileal Conduit
1230 87 University College Hospital London 72 38 22 118 F 57 Muscle invasive TCC Ileal Conduit
1231 87 University College Hospital London 72 38 22 118 M 74 Sarcoma Ileal Conduit
1232 87 University College Hospital London 72 38 22 118 M 60 Muscle invasive TCC Orthotopic
1233 87 University College Hospital London 72 38 22 118 999 999 Muscle invasive TCC Ileal Conduit
1234 87 University College Hospital London 72 38 22 118 F 64 Muscle invasive TCC Orthotopic
1235 88 Guy's & Thomas's Hospital 25 130 24 149 M 999 Muscle invasive TCC Ileal Conduit
1236 88 Guy's & Thomas's Hospital 25 130 24 149 F 47 Muscle invasive TCC Ileal Conduit
1237 88 Guy's & Thomas's Hospital 25 130 24 149 M 71 Muscle invasive TCC Ileal Conduit
1238 88 Guy's & Thomas's Hospital 25 130 24 149 M 999 Muscle invasive TCC Ileal Conduit
1239 88 Guy's & Thomas's Hospital 25 130 24 149 M 64 Muscle invasive TCC Ileal Conduit
1240 88 Guy's & Thomas's Hospital 25 130 24 149 M 64 Uncontrolled superficial disease Ileal Conduit
1241 88 Guy's & Thomas's Hospital 25 130 24 149 M 76 Muscle invasive TCC Ileal Conduit
1242 88 Guy's & Thomas's Hospital 25 130 24 149 M 79 Muscle invasive TCC Ileal Conduit
1243 88 Guy's & Thomas's Hospital 25 130 24 149 M 65 Muscle invasive TCC Ileal Conduit
1244 88 Guy's & Thomas's Hospital 25 130 24 149 M 999 Uncontrolled superficial disease Ileal Conduit
1245 88 Guy's & Thomas's Hospital 25 130 24 149 M 58 Muscle invasive TCC Ileal Conduit
1246 88 Guy's & Thomas's Hospital 25 130 24 149 M 69 Muscle invasive TCC Ileal Conduit
1247 88 Guy's & Thomas's Hospital 25 130 24 149 M 62 Muscle invasive TCC Orthotopic
1248 88 Guy's & Thomas's Hospital 25 130 24 149 M 999 Muscle invasive TCC Ileal Conduit
1249 88 Guy's & Thomas's Hospital 25 130 24 149 M 999 Muscle invasive TCC Ileal Conduit
  
 
 
 
1250 88 Guy's & Thomas's Hospital 25 130 24 149 M 999 Uncontrolled superficial disease Ileal Conduit
1251 88 Guy's & Thomas's Hospital 25 130 24 149 F 58 Primary CIS Orthotopic
1252 88 Guy's & Thomas's Hospital 25 130 24 149 M 999 Uncontrolled superficial disease Ileal Conduit
1253 88 Guy's & Thomas's Hospital 25 130 24 149 M 999 Salvage after radiotherapy Ileal Conduit
1254 88 Guy's & Thomas's Hospital 25 130 24 149 M 999 Salvage after radiotherapy Ileal Conduit
1255 88 Guy's & Thomas's Hospital 25 130 24 149 F 999 Other Ileal Conduit
1256 88 Guy's & Thomas's Hospital 25 130 24 149 M 68 Muscle invasive TCC Ileal Conduit
1257 88 Guy's & Thomas's Hospital 25 130 24 149 M 68 Uncontrolled superficial disease Ileal Conduit
1258 88 Guy's & Thomas's Hospital 25 130 24 149 M 63 Muscle invasive TCC Ileal Conduit
1259 88 Guy's & Thomas's Hospital 25 130 24 149 999 53 Muscle invasive TCC Orthotopic
1260 88 Guy's & Thomas's Hospital 25 130 24 149 F 75 Muscle invasive TCC Ileal Conduit
1261 88 Guy's & Thomas's Hospital 25 130 24 149 M 63 Muscle invasive TCC Ileal Conduit
1262 89 Castle Hill Hospital 11 135 7 144 F 78 Muscle invasive TCC Ileal Conduit
1263 89 Castle Hill Hospital 11 135 7 144 M 61 Muscle invasive TCC Ileal Conduit
1264 89 Castle Hill Hospital 11 135 7 144 F 57 Muscle invasive TCC Ileal Conduit
1265 89 Castle Hill Hospital 11 135 7 144 F 68 Muscle invasive TCC Ileal Conduit
1266 89 Castle Hill Hospital 11 135 7 144 F 73 Muscle invasive TCC Ileal Conduit
1267 89 Castle Hill Hospital 11 135 7 144 F 62 Muscle invasive TCC Ileal Conduit
1268 89 Castle Hill Hospital 11 135 7 144 M 55 Uncontrolled superficial disease Ileal Conduit
1269 89 Castle Hill Hospital 11 135 7 144 M 80 Muscle invasive TCC Ileal Conduit
1270 89 Castle Hill Hospital 11 135 7 144 M 75 Muscle invasive TCC Ileal Conduit
1271 89 Castle Hill Hospital 11 135 7 144 M 73 Primary CIS Ileal Conduit
1272 89 Castle Hill Hospital 11 135 7 144 M 69 Uncontrolled superficial disease Ileal Conduit
1273 89 Castle Hill Hospital 11 135 7 144 M 73 Salvage after radiotherapy Ileal Conduit
1274 89 Castle Hill Hospital 11 135 7 144 F 66 Muscle invasive TCC Ileal Conduit
1275 89 Castle Hill Hospital 11 135 7 144 M 73 Uncontrolled superficial disease Ileal Conduit
1276 89 Castle Hill Hospital 11 135 7 144 M 59 Muscle invasive TCC Ileal Conduit
1277 89 Castle Hill Hospital 11 135 7 144 M 72 Muscle invasive TCC Ileal Conduit
1278 89 Castle Hill Hospital 11 135 7 144 M 62 Uncontrolled superficial disease Ileal Conduit
1279 89 Castle Hill Hospital 11 135 7 144 M 68 Muscle invasive TCC Ileal Conduit
1280 89 Castle Hill Hospital 11 135 7 144 M 67 Uncontrolled superficial disease Orthotopic
1281 89 Castle Hill Hospital 11 135 7 144 F 58 Muscle invasive TCC Ileal Conduit
1282 89 Castle Hill Hospital 11 135 7 144 M 81 Uncontrolled superficial disease Ileal Conduit
1283 89 Castle Hill Hospital 11 135 7 144 F 64 Muscle invasive TCC Ileal Conduit
1284 89 Scarborough Hospital 63 9 7 144 M 68 Uncontrolled superficial disease Ileal Conduit
1285 89 Scarborough Hospital 63 9 7 144 F 63 Salvage after radiotherapy Ileal Conduit
1286 89 Scarborough Hospital 63 9 7 144 M 67 Muscle invasive TCC Ileal Conduit
1287 90 Salford RoyalNHS Foundation Trust 60 44 2 101.00 F 999 Muscle invasive TCC Ileal Conduit
1288 90 Salford RoyalNHS Foundation Trust 60 44 2 101.00 F 75 Muscle invasive TCC Ileal Conduit
1289 90 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 78 Muscle invasive TCC Ileal Conduit
1290 90 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 67 Muscle invasive TCC Ileal Conduit
1291 90 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 72 Muscle invasive TCC Ileal Conduit
1292 90 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 60 Muscle invasive TCC Ileal Conduit
1293 90 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 78 Muscle invasive TCC Ileal Conduit
1294 91 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 69 Muscle invasive TCC Ileal Conduit
1295 92 Lincoln & Louth NHS Trust 34 8 39 345 F 76 Muscle invasive TCC Ileal Conduit
1296 92 Lincoln & Louth NHS Trust 34 8 39 345 M 52 Uncontrolled superficial disease Ileal Conduit
1297 92 Pilgrim Hospital 41 29 39 345 M 70 Muscle invasive TCC Ileal Conduit
1298 92 Pilgrim Hospital 41 29 39 345 M 57 Muscle invasive TCC Ileal Conduit
1299 92 Pilgrim Hospital 41 29 39 345 F 68 Muscle invasive TCC Ileal Conduit
  
 
 
 
1300 92 Pilgrim Hospital 41 29 39 345 M 56 Muscle invasive TCC Ileal Conduit
1301 93 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 67 Primary CIS Ileal Conduit
1302 93 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 73 Muscle invasive TCC Ileal Conduit
1303 93 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 69 Muscle invasive TCC Ileal Conduit
1304 93 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 66 Muscle invasive TCC Ileal Conduit
1305 93 Buckinghamshire Hospitals NHS Trust 10 75 30 167 M 71 Muscle invasive TCC Ileal Conduit
1306 94 Arrowe Park Hospital 4 54 3 140 M 76 Muscle invasive TCC Ileal Conduit
1307 94 Arrowe Park Hospital 4 54 3 140 M 62 Muscle invasive TCC Ileal Conduit
1308 94 Arrowe Park Hospital 4 54 3 140 M 52 Muscle invasive TCC Ileal Conduit
1309 94 Arrowe Park Hospital 4 54 3 140 M 80 Primary adenocarcinoma Ileal Conduit
1310 94 Arrowe Park Hospital 4 54 3 140 F 68 Other Ileal Conduit
1311 94 Arrowe Park Hospital 4 54 3 140 M 61 Muscle invasive TCC Ileal Conduit
1312 94 Arrowe Park Hospital 4 54 3 140 F 63 Primary CIS Ileal Conduit
1313 94 Arrowe Park Hospital 4 54 3 140 M 55 Uncontrolled superficial disease Ileal Conduit
1314 94 Arrowe Park Hospital 4 54 3 140 M 69 Muscle invasive TCC Ileal Conduit
1315 94 Arrowe Park Hospital 4 54 3 140 M 67 Muscle invasive TCC Orthotopic
1316 94 Arrowe Park Hospital 4 54 3 140 M 63 Muscle invasive TCC Ileal Conduit
1317 94 Arrowe Park Hospital 4 54 3 140 M 63 Muscle invasive TCC Ileal Conduit
1318 94 Arrowe Park Hospital 4 54 3 140 F 67 Muscle invasive TCC Ileal Conduit
1319 94 Arrowe Park Hospital 4 54 3 140 M 57 Muscle invasive TCC Ileal Conduit
1320 94 Arrowe Park Hospital 4 54 3 140 F 64 Primary adenocarcinoma Ileal Conduit
1321 94 Arrowe Park Hospital 4 54 3 140 M 58 Muscle invasive TCC Ileal Conduit
1322 94 Arrowe Park Hospital 4 54 3 140 F 72 Muscle invasive TCC Ileal Conduit
1323 94 Arrowe Park Hospital 4 54 3 140 M 76 Muscle invasive TCC Ileal Conduit
1324 94 Arrowe Park Hospital 4 54 3 140 M 56 Muscle invasive TCC Ileal Conduit
1325 94 Arrowe Park Hospital 4 54 3 140 M 69 Uncontrolled superficial disease Ileal Conduit
1326 94 Arrowe Park Hospital 4 54 3 140 F 999 Other Ileal Conduit
1327 94 Arrowe Park Hospital 4 54 3 140 F 65 Uncontrolled superficial disease Ileal Conduit
1328 94 Arrowe Park Hospital 4 54 3 140 F 69 Other Ileal Conduit
1329 94 Arrowe Park Hospital 4 54 3 140 F 68 Muscle invasive TCC Ileal Conduit
1330 94 Arrowe Park Hospital 4 54 3 140 M 53 Muscle invasive TCC Ileal Conduit
1331 94 Arrowe Park Hospital 4 54 3 140 M 60 Muscle invasive TCC Ileal Conduit
1332 94 Arrowe Park Hospital 4 54 3 140 M 66 Muscle invasive TCC Ileal Conduit
1333 94 Arrowe Park Hospital 4 54 3 140 M 52 Squamous cell Ca Ileal Conduit
1334 95 Royal Shrewsbury Hospital 57 85 35 226 M 79 Muscle invasive TCC Ileal Conduit
1335 95 Royal Shrewsbury Hospital 57 85 35 226 M 999 Muscle invasive TCC Ileal Conduit
1336 96 Christie Hospital 13 11 2 101.00 M 75 Muscle invasive TCC Ileal Conduit
1337 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 68 Primary CIS Ileal Conduit
1338 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 75 Squamous cell Ca Ileal Conduit
1339 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 70 Muscle invasive TCC Ileal Conduit
1340 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 F 72 Squamous cell Ca Ileal Conduit
1341 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 F 79 Other Ileal Conduit
1342 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 76 Muscle invasive TCC Ileal Conduit
1343 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 72 Muscle invasive TCC Ileal Conduit
1344 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 F 57 Gynaecological Ca Ileal Conduit
1345 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 70 Muscle invasive TCC Ileal Conduit
1346 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 F 57 Other Ileal Conduit
1347 96 Salford RoyalNHS Foundation Trust 60 44 2 101.00 M 65 Muscle invasive TCC Ileal Conduit
1348 97 Nottingham City Hospital 40 75 39 345 F 80 Muscle invasive TCC Ileal Conduit
1349 97 Nottingham City Hospital 40 75 39 345 M 68 Muscle invasive TCC Ileal Conduit
  
 
 
 
1350 97 Nottingham City Hospital 40 75 39 345 F 999 Primary CIS Ileal Conduit
1351 97 Nottingham City Hospital 40 75 39 345 M 73 Muscle invasive TCC Ileal Conduit
1352 97 Nottingham City Hospital 40 75 39 345 M 999 Muscle invasive TCC Ileal Conduit
1353 97 Nottingham City Hospital 40 75 39 345 F 54 Salvage after radiotherapy Orthotopic
1354 97 Nottingham City Hospital 40 75 39 345 M 60 Muscle invasive TCC Ileal Conduit
1355 97 Nottingham City Hospital 40 75 39 345 F 65 Muscle invasive TCC Ileal Conduit
1356 97 Nottingham City Hospital 40 75 39 345 M 72 Muscle invasive TCC Ileal Conduit
1357 97 Nottingham City Hospital 40 75 39 345 M 67 Primary CIS Ileal Conduit
1358 97 Nottingham City Hospital 40 75 39 345 M 76 Muscle invasive TCC Ileal Conduit
1359 97 Nottingham City Hospital 40 75 39 345 M 60 Primary CIS Orthotopic
1360 97 Nottingham City Hospital 40 75 39 345 M 79 Muscle invasive TCC Ileal Conduit
1361 97 Nottingham City Hospital 40 75 39 345 M 77 Muscle invasive TCC Ileal Conduit
1362 97 Nottingham City Hospital 40 75 39 345 M 62 Primary CIS Ileal Conduit
1363 97 Nottingham City Hospital 40 75 39 345 M 82 Muscle invasive TCC Ileal Conduit
1364 97 Nottingham City Hospital 40 75 39 345 F 72 Muscle invasive TCC Ileal Conduit
1365 97 Nottingham City Hospital 40 75 39 345 F 999 Muscle invasive TCC Ileal Conduit
1366 97 Nottingham City Hospital 40 75 39 345 M 63 Other Orthotopic
1367 97 Nottingham City Hospital 40 75 39 345 M 76 Muscle invasive TCC Ileal Conduit
1368 97 Nottingham City Hospital 40 75 39 345 M 58 999 Ileal Conduit
1369 97 Nottingham City Hospital 40 75 39 345 F 70 Muscle invasive TCC Ileal Conduit
1370 97 Nottingham City Hospital 40 75 39 345 F 56 Uncontrolled superficial disease Ileal Conduit
1371 97 Nottingham City Hospital 40 75 39 345 M 67 Muscle invasive TCC Ileal Conduit
1372 97 Nottingham City Hospital 40 75 39 345 M 999 Muscle invasive TCC Ileal Conduit
1373 97 Nottingham City Hospital 40 75 39 345 F 72 Salvage after radiotherapy Ileal Conduit
1374 97 Nottingham City Hospital 40 75 39 345 M 57 Other Orthotopic
1375 97 Nottingham City Hospital 40 75 39 345 M 51 Muscle invasive TCC Orthotopic
1376 97 Nottingham City Hospital 40 75 39 345 F 76 Muscle invasive TCC Ileal Conduit
1377 97 Nottingham City Hospital 40 75 39 345 F 71 Muscle invasive TCC Ileal Conduit
1378 97 Nottingham City Hospital 40 75 39 345 M 78 Salvage after radiotherapy Ileal Conduit
1379 97 Nottingham City Hospital 40 75 39 345 M 999 Salvage after radiotherapy Ileal Conduit
1380 97 Nottingham City Hospital 40 75 39 345 F 73 Muscle invasive TCC Ileal Conduit
1381 97 Nottingham City Hospital 40 75 39 345 M 55 Muscle invasive TCC Orthotopic
1382 97 Nottingham City Hospital 40 75 39 345 F 46 Muscle invasive TCC Ileal Conduit
1383 97 Nottingham City Hospital 40 75 39 345 M 63 Muscle invasive TCC Ileal Conduit
1384 97 Nottingham City Hospital 40 75 39 345 M 66 Muscle invasive TCC Ileal Conduit
1385 97 Nottingham City Hospital 40 75 39 345 M 75 Other Ileal Conduit
1386 97 Nottingham City Hospital 40 75 39 345 M 54 Muscle invasive TCC Ileal Conduit
1387 97 Nottingham City Hospital 40 75 39 345 M 59 Other Ileal Conduit
1388 97 Nottingham City Hospital 40 75 39 345 M 65 Muscle invasive TCC Ileal Conduit
1389 97 Nottingham City Hospital 40 75 39 345 M 69 Muscle invasive TCC Ileal Conduit
1390 97 Nottingham City Hospital 40 75 39 345 M 72 Primary CIS Ileal Conduit
1391 97 Nottingham City Hospital 40 75 39 345 F 69 Uncontrolled superficial disease Ileal Conduit
1392 97 Nottingham City Hospital 40 75 39 345 M 66 Uncontrolled superficial disease Ileal Conduit
1393 97 Nottingham City Hospital 40 75 39 345 M 74 Muscle invasive TCC Ileal Conduit
1394 97 Nottingham City Hospital 40 75 39 345 F 999 Gynaecological Ca Ileal Conduit
1395 97 Nottingham City Hospital 40 75 39 345 M 64 Primary CIS Ileal Conduit
1396 97 Nottingham City Hospital 40 75 39 345 F 36 Muscle invasive TCC Ileal Conduit
1397 97 Nottingham City Hospital 40 75 39 345 F 74 Muscle invasive TCC Ileal Conduit
1398 97 Nottingham City Hospital 40 75 39 345 M 59 Muscle invasive TCC Ileal Conduit
1399 97 Nottingham City Hospital 40 75 39 345 F 75 Muscle invasive TCC Ileal Conduit
  
 
 
 
1400 97 Nottingham City Hospital 40 75 39 345 M 69 Squamous cell Ca Ileal Conduit
1401 97 Nottingham City Hospital 40 75 39 345 M 65 Primary CIS Orthotopic
1402 97 Nottingham City Hospital 40 75 39 345 F 56 Muscle invasive TCC Ileal Conduit
1403 97 Nottingham City Hospital 40 75 39 345 M 62 Muscle invasive TCC Orthotopic
1404 97 Nottingham City Hospital 40 75 39 345 F 36 Gynaecological Ca Ileal Conduit
1405 97 Nottingham City Hospital 40 75 39 345 M 53 Muscle invasive TCC Ileal Conduit
1406 97 Nottingham City Hospital 40 75 39 345 M 76 Other Ileal Conduit
1407 97 Nottingham City Hospital 40 75 39 345 M 74 Muscle invasive TCC Ileal Conduit
1408 97 Nottingham City Hospital 40 75 39 345 M 81 Muscle invasive TCC Ileal Conduit
1409 97 Nottingham City Hospital 40 75 39 345 F 72 Squamous cell Ca Ileal Conduit
1410 97 Nottingham City Hospital 40 75 39 345 M 74 Uncontrolled superficial disease Ileal Conduit
1411 97 Nottingham City Hospital 40 75 39 345 M 83 Muscle invasive TCC Ileal Conduit
1412 97 Nottingham City Hospital 40 75 39 345 999 70 Primary CIS Ileal Conduit
1413 97 Nottingham City Hospital 40 75 39 345 M 75 Muscle invasive TCC Ileal Conduit
1414 97 Nottingham City Hospital 40 75 39 345 M 76 Primary CIS Ileal Conduit
1415 97 Nottingham City Hospital 40 75 39 345 M 69 Other Ileal Conduit
1416 97 Nottingham City Hospital 40 75 39 345 M 63 Muscle invasive TCC Ileal Conduit
1417 97 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 50 Uncontrolled superficial disease Ileal Conduit
1418 98 Kettering General Hospital 31 2 39 345 M 74 Salvage after radiotherapy Ileal Conduit
1419 99 Royal Liverpool University Hospital 54 53 3 140 M 68 Muscle invasive TCC Ileal Conduit
1420 99 Royal Liverpool University Hospital 54 53 3 140 M 70 Muscle invasive TCC Ileal Conduit
1421 99 Royal Liverpool University Hospital 54 53 3 140 M 999 Salvage after radiotherapy Ileal Conduit
1422 99 Royal Liverpool University Hospital 54 53 3 140 M 65 Muscle invasive TCC Ileal Conduit
1423 99 Royal Liverpool University Hospital 54 53 3 140 F 61 Muscle invasive TCC Ileal Conduit
1424 99 Royal Liverpool University Hospital 54 53 3 140 M 57 Muscle invasive TCC Ileal Conduit
1425 99 Royal Liverpool University Hospital 54 53 3 140 M 71 999 Ileal Conduit
1426 99 Royal Liverpool University Hospital 54 53 3 140 F 71 Muscle invasive TCC Ileal Conduit
1427 99 Royal Liverpool University Hospital 54 53 3 140 M 52 999 Ileal Conduit
1428 99 Royal Liverpool University Hospital 54 53 3 140 M 57 Muscle invasive TCC Ileal Conduit
1429 99 Royal Liverpool University Hospital 54 53 3 140 F 61 Muscle invasive TCC Ileal Conduit
1430 99 Royal Liverpool University Hospital 54 53 3 140 M 71 Muscle invasive TCC Ileal Conduit
1431 99 Royal Liverpool University Hospital 54 53 3 140 M 72 Muscle invasive TCC Orthotopic
1432 99 Royal Liverpool University Hospital 54 53 3 140 M 70 Muscle invasive TCC Ileal Conduit
1433 99 Royal Liverpool University Hospital 54 53 3 140 M 999 Muscle invasive TCC Ileal Conduit
1434 99 Royal Liverpool University Hospital 54 53 3 140 F 72 Muscle invasive TCC Ileal Conduit
1435 99 Royal Liverpool University Hospital 54 53 3 140 M 68 999 Ileal Conduit
1436 99 Royal Liverpool University Hospital 54 53 3 140 M 999 Muscle invasive TCC Ileal Conduit
1437 99 Royal Liverpool University Hospital 54 53 3 140 M 66 Muscle invasive TCC Ileal Conduit
1438 99 Royal Liverpool University Hospital 54 53 3 140 F 78 Muscle invasive TCC Ileal Conduit
1439 99 Southport & Ormskirk NHS Trust 66 21 3 140 M 70 Muscle invasive TCC Ileal Conduit
1440 99 Southport & Ormskirk NHS Trust 66 21 3 140 M 75 Muscle invasive TCC Ileal Conduit
1441 99 Southport & Ormskirk NHS Trust 66 21 3 140 F 64 Muscle invasive TCC Ileal Conduit
1442 99 Southport & Ormskirk NHS Trust 66 21 3 140 M 55 Muscle invasive TCC Orthotopic
1443 99 Southport & Ormskirk NHS Trust 66 21 3 140 M 65 Uncontrolled superficial disease Ileal Conduit
1444 100 Sandwell District General Hospital 62 9 11 102 999 72 Muscle invasive TCC Ileal Conduit
1445 100 Sandwell District General Hospital 62 9 11 102 999 57 Sarcoma Ileal Conduit
1446 101 Pilgrim Hospital 41 29 39 345 F 73 Muscle invasive TCC Ileal Conduit
1447 101 Pilgrim Hospital 41 29 39 345 M 61 Muscle invasive TCC Orthotopic
1448 101 Pilgrim Hospital 41 29 39 345 M 55 Muscle invasive TCC Ileal Conduit
1449 101 Pilgrim Hospital 41 29 39 345 M 69 Muscle invasive TCC Orthotopic
  
 
 
 
1450 101 Pilgrim Hospital 41 29 39 345 M 70 Muscle invasive TCC Ileal Conduit
1451 101 Pilgrim Hospital 41 29 39 345 M 74 Muscle invasive TCC Ileal Conduit
1452 101 Pilgrim Hospital 41 29 39 345 M 63 Muscle invasive TCC Ileal Conduit
1453 102 Derriford Hospital 19 72 26 205 M 50 Muscle invasive TCC Ileal Conduit
1454 102 Derriford Hospital 19 72 26 205 M 69 Muscle invasive TCC Ileal Conduit
1455 102 Derriford Hospital 19 72 26 205 M 74 Uncontrolled superficial disease Ileal Conduit
1456 102 Derriford Hospital 19 72 26 205 999 57 Uncontrolled superficial disease Ileal Conduit
1457 103 Guy's & Thomas's Hospital 25 130 24 149 M 52 Primary CIS Ileal Conduit
1458 104 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 70 Muscle invasive TCC Ileal Conduit
1459 104 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 64 Muscle invasive TCC Ileal Conduit
1460 104 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 67 Muscle invasive TCC Ileal Conduit
1461 104 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 46 Muscle invasive TCC Ileal Conduit
1462 104 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 66 Uncontrolled superficial disease Ileal Conduit
1463 104 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 75 Other Ileal Conduit
1464 104 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 66 Primary CIS Ileal Conduit
1465 104 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 70 Uncontrolled superficial disease Ileal Conduit
1466 104 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 74 Other Ileal Conduit
1467 105 Freeman Hospital 23 258 36 405 M 83 Uncontrolled superficial disease Ileal Conduit
1468 105 Freeman Hospital 23 258 36 405 F 72 Uncontrolled superficial disease Ileal Conduit
1469 105 Freeman Hospital 23 258 36 405 M 70 Uncontrolled superficial disease Orthotopic
1470 105 Freeman Hospital 23 258 36 405 F 75 Muscle invasive TCC Ileal Conduit
1471 105 Freeman Hospital 23 258 36 405 F 58 Muscle invasive TCC Ileal Conduit
1472 105 Freeman Hospital 23 258 36 405 F 65 Uncontrolled superficial disease Ileal Conduit
1473 105 Freeman Hospital 23 258 36 405 M 56 Muscle invasive TCC Ileal Conduit
1474 105 Freeman Hospital 23 258 36 405 M 80 Uncontrolled superficial disease Ileal Conduit
1475 105 Freeman Hospital 23 258 36 405 F 72 Uncontrolled superficial disease Ileal Conduit
1476 105 Freeman Hospital 23 258 36 405 M 63 Muscle invasive TCC Ileal Conduit
1477 105 Freeman Hospital 23 258 36 405 M 58 Muscle invasive TCC Ileal Conduit
1478 107 The Ipswich Hospital 70 34 37 52 F 57 Squamous cell Ca Ileal Conduit
1479 107 The Ipswich Hospital 70 34 37 52 M 74 Muscle invasive TCC Ileal Conduit
1480 107 The Ipswich Hospital 70 34 37 52 M 999 Other Ileal Conduit
1481 107 The Ipswich Hospital 70 34 37 52 F 74 Muscle invasive TCC Ileal Conduit
1482 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 62 Primary CIS Ileal Conduit
1483 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 66 Muscle invasive TCC Ileal Conduit
1484 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 60 Other Ileal Conduit
1485 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 59 Uncontrolled superficial disease Ileal Conduit
1486 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 64 Muscle invasive TCC Ileal Conduit
1487 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 73 Muscle invasive TCC Ileal Conduit
1488 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 72 Muscle invasive TCC Ileal Conduit
1489 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 72 Other Ileal Conduit
1490 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 71 Muscle invasive TCC Ileal Conduit
1491 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 73 Muscle invasive TCC Ileal Conduit
1492 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 74 Muscle invasive TCC Ileal Conduit
1493 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 61 Muscle invasive TCC Ileal Conduit
1494 108 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 76 Muscle invasive TCC Ileal Conduit
1495 109 Royal Sussex County Hospital 58 34 33 129 M 74 999 Ileal Conduit
1496 110 Lincoln & Louth NHS Trust 34 8 39 345 F 77 Muscle invasive TCC Ileal Conduit
1497 111 Pinderfields Hospital 42 94 6 384 M 63 Other Ileal Conduit
1498 111 Pinderfields Hospital 42 94 6 384 M 71 Muscle invasive TCC Ileal Conduit
1499 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 76 Uncontrolled superficial disease Ileal Conduit
  
 
 
 
1500 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 62 Other Ileal Conduit
1501 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 62 Uncontrolled superficial disease Ileal Conduit
1502 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 65 Muscle invasive TCC Ileal Conduit
1503 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 69 Other Ileal Conduit
1504 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 78 Primary CIS Ileal Conduit
1505 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 74 Muscle invasive TCC Ileal Conduit
1506 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 76 Uncontrolled superficial disease Ileal Conduit
1507 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 71 Other Ileal Conduit
1508 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 54 Primary CIS Ileal Conduit
1509 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 65 Other Ileal Conduit
1510 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 71 Muscle invasive TCC Ileal Conduit
1511 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 76 Uncontrolled superficial disease Ileal Conduit
1512 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 62 Muscle invasive TCC Ileal Conduit
1513 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 71 Other Ileal Conduit
1514 112 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 60 Muscle invasive TCC Ileal Conduit
1515 113 East Sussex Hospitals NHS Trust 22 95 33 129 M 68 Muscle invasive TCC Ileal Conduit
1516 113 East Sussex Hospitals NHS Trust 22 95 33 129 M 73 Primary CIS Ileal Conduit
1517 113 East Sussex Hospitals NHS Trust 22 95 33 129 M 76 Muscle invasive TCC Ileal Conduit
1518 113 East Sussex Hospitals NHS Trust 22 95 33 129 M 72 Muscle invasive TCC Ileal Conduit
1519 113 East Sussex Hospitals NHS Trust 22 95 33 129 M 81 Muscle invasive TCC Ileal Conduit
1520 113 East Sussex Hospitals NHS Trust 22 95 33 129 M 71 Muscle invasive TCC Ileal Conduit
1521 113 East Sussex Hospitals NHS Trust 22 95 33 129 F 75 Primary CIS Ileal Conduit
1522 113 East Sussex Hospitals NHS Trust 22 95 33 129 F 999 Muscle invasive TCC Ileal Conduit
1523 113 East Sussex Hospitals NHS Trust 22 95 33 129 F 74 Muscle invasive TCC Ileal Conduit
1524 114 King George Hospital 32 49 23 49 M 51 Muscle invasive TCC Orthotopic
1525 114 King George Hospital 32 49 23 49 M 61 Muscle invasive TCC Orthotopic
1526 115 New Cross Hospital 35 37 35 226 M 82 Muscle invasive TCC Ileal Conduit
1527 115 New Cross Hospital 35 37 35 226 F 40 Gynaecological Ca Ileal Conduit
1528 115 New Cross Hospital 35 37 35 226 M 69 Muscle invasive TCC Ileal Conduit
1529 115 New Cross Hospital 35 37 35 226 M 63 Muscle invasive TCC Ileal Conduit
1530 115 New Cross Hospital 35 37 35 226 M 65 Muscle invasive TCC Ileal Conduit
1531 115 New Cross Hospital 35 37 35 226 M 72 Uncontrolled superficial disease Ileal Conduit
1532 115 New Cross Hospital 35 37 35 226 F 52 Gynaecological Ca Ileal Conduit
1533 115 New Cross Hospital 35 37 35 226 M 72 Muscle invasive TCC Ileal Conduit
1534 115 New Cross Hospital 35 37 35 226 F 54 Muscle invasive TCC Ileal Conduit
1535 115 New Cross Hospital 35 37 35 226 F 70 Muscle invasive TCC Ileal Conduit
1536 115 New Cross Hospital 35 37 35 226 M 71 Muscle invasive TCC Ileal Conduit
1537 115 New Cross Hospital 35 37 35 226 M 68 Muscle invasive TCC Ileal Conduit
1538 115 New Cross Hospital 35 37 35 226 M 62 Muscle invasive TCC Ileal Conduit
1539 115 New Cross Hospital 35 37 35 226 F 65 Uncontrolled superficial disease Ileal Conduit
1540 115 New Cross Hospital 35 37 35 226 M 58 Muscle invasive TCC Ileal Conduit
1541 115 New Cross Hospital 35 37 35 226 M 73 Muscle invasive TCC Ileal Conduit
1542 115 New Cross Hospital 35 37 35 226 M 71 Muscle invasive TCC Ileal Conduit
1543 115 New Cross Hospital 35 37 35 226 F 39 Salvage after radiotherapy Ileal Conduit
1544 115 New Cross Hospital 35 37 35 226 F 63 Gynaecological Ca Ileal Conduit
1545 115 New Cross Hospital 35 37 35 226 M 63 Primary CIS Ileal Conduit
1546 115 New Cross Hospital 35 37 35 226 F 52 Squamous cell Ca Ileal Conduit
1547 115 New Cross Hospital 35 37 35 226 M 67 Muscle invasive TCC Ileal Conduit
1548 115 New Cross Hospital 35 37 35 226 M 60 Primary CIS Ileal Conduit
1549 115 New Cross Hospital 35 37 35 226 F 52 Other Ileal Conduit
  
 
1550 115 New Cross Hospital 35 37 35 226 F 40 Salvage after radiotherapy Ileal Conduit
1551 115 New Cross Hospital 35 37 35 226 M 76 Uncontrolled superficial disease Ileal Conduit
1552 115 New Cross Hospital 35 37 35 226 F 68 Uncontrolled superficial disease Ileal Conduit
1553 115 New Cross Hospital 35 37 35 226 M 66 Muscle invasive TCC Ileal Conduit
1554 115 New Cross Hospital 35 37 35 226 M 74 Muscle invasive TCC Ileal Conduit
1555 115 New Cross Hospital 35 37 35 226 M 72 Muscle invasive TCC Ileal Conduit
1556 115 New Cross Hospital 35 37 35 226 F 68 Salvage after radiotherapy Ileal Conduit
1557 115 New Cross Hospital 35 37 35 226 F 64 Muscle invasive TCC Ileal Conduit
1558 115 New Cross Hospital 35 37 35 226 M 68 Uncontrolled superficial disease Ileal Conduit
1559 115 New Cross Hospital 35 37 35 226 M 68 Muscle invasive TCC Ileal Conduit
1560 115 New Cross Hospital 35 37 35 226 M 62 Muscle invasive TCC Ileal Conduit
1561 115 New Cross Hospital 35 37 35 226 M 67 Uncontrolled superficial disease Ileal Conduit
1562 115 New Cross Hospital 35 37 35 226 M 55 Muscle invasive TCC Ileal Conduit
1563 115 New Cross Hospital 35 37 35 226 M 63 Muscle invasive TCC Ileal Conduit
1564 116 Royal Preston Hospital 56 22 2 101.00 M 69 Other Ileal Conduit
1565 116 Royal Preston Hospital 56 22 2 101.00 M 69 Muscle invasive TCC Ileal Conduit
1566 116 Royal Preston Hospital 56 22 2 101.00 F 48 Squamous cell Ca Orthotopic
1567 116 Royal Preston Hospital 56 22 2 101.00 M 75 Muscle invasive TCC Ileal Conduit
1568 116 Royal Preston Hospital 56 22 2 101.00 M 74 Muscle invasive TCC Ileal Conduit
1569 116 Royal Preston Hospital 56 22 2 101.00 M 72 Muscle invasive TCC Ileal Conduit
1570 116 Royal Preston Hospital 56 22 2 101.00 M 77 Muscle invasive TCC Ileal Conduit
1571 116 Royal Preston Hospital 56 22 2 101.00 F 72 Muscle invasive TCC Ileal Conduit
1572 116 Royal Preston Hospital 56 22 2 101.00 M 51 Muscle invasive TCC Ileal Conduit
1573 116 Royal Preston Hospital 56 22 2 101.00 F 78 Primary CIS Ileal Conduit
1574 116 Royal Preston Hospital 56 22 2 101.00 M 50 Muscle invasive TCC Ileal Conduit
1575 116 Royal Preston Hospital 56 22 2 101.00 M 81 Muscle invasive TCC Ileal Conduit
1576 116 Royal Preston Hospital 56 22 2 101.00 F 80 Muscle invasive TCC Ileal Conduit
1577 116 Royal Preston Hospital 56 22 2 101.00 F 62 Muscle invasive TCC Ileal Conduit
1578 116 Royal Preston Hospital 56 22 2 101.00 M 67 Muscle invasive TCC Ileal Conduit
1579 116 Royal Preston Hospital 56 22 2 101.00 M 69 Primary CIS Ileal Conduit
1580 116 Royal Preston Hospital 56 22 2 101.00 M 64 Muscle invasive TCC Ileal Conduit
1581 116 Royal Preston Hospital 56 22 2 101.00 M 66 Muscle invasive TCC Ileal Conduit
1582 116 Royal Preston Hospital 56 22 2 101.00 F 40 Gynaecological Ca Ileal Conduit
1583 116 Royal Preston Hospital 56 22 2 101.00 M 54 Muscle invasive TCC Orthotopic
1584 116 Royal Preston Hospital 56 22 2 101.00 F 68 Gynaecological Ca Ileal Conduit
1585 116 Royal Preston Hospital 56 22 2 101.00 999 65 Salvage after radiotherapy Ileal Conduit
1586 116 Royal Preston Hospital 56 22 2 101.00 M 81 Muscle invasive TCC Ileal Conduit
1587 116 Royal Preston Hospital 56 22 2 101.00 F 61 Primary CIS Ileal Conduit
1588 116 Royal Preston Hospital 56 22 2 101.00 M 78 Muscle invasive TCC Ileal Conduit
1589 116 Royal Preston Hospital 56 22 2 101.00 M 74 Other Ileal Conduit
1590 116 Royal Preston Hospital 56 22 2 101.00 F 57 Muscle invasive TCC Ileal Conduit
1591 116 Royal Preston Hospital 56 22 2 101.00 F 75 Muscle invasive TCC Ileal Conduit
1592 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 999 Secondary adenocarcinoma Ileal Conduit
1593 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 75 Muscle invasive TCC Ileal Conduit
1594 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 68 Muscle invasive TCC Ileal Conduit
1595 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 F 76 Muscle invasive TCC Ileal Conduit
1596 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 72 Muscle invasive TCC Ileal Conduit
1597 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 F 77 Salvage after radiotherapy Ileal Conduit
1598 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 77 Other Ileal Conduit
1599 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 71 Salvage after radiotherapy Ileal Conduit
1600 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 73 Muscle invasive TCC Ileal Conduit
1601 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 53 Other Ileal Conduit
1602 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 71 Other Ileal Conduit
1603 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 999 56 Muscle invasive TCC Ileal Conduit
1604 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 56 Muscle invasive TCC Ileal Conduit
1605 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 72 Uncontrolled superficial disease Ileal Conduit
1606 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 59 Muscle invasive TCC Ileal Conduit
1607 117 Queen Elizabeth Hospital, B'ham 45 93 11 102 M 65 Muscle invasive TCC Ileal Conduit
1608 118 Leicester General Hospital 33 97 39 345 M 78 Muscle invasive TCC Ileal Conduit
1609 118 Leicester General Hospital 33 97 39 345 M 66 Uncontrolled superficial disease Ileal Conduit
1610 118 Leicester General Hospital 33 97 39 345 M 71 Muscle invasive TCC Ileal Conduit
1611 118 Leicester General Hospital 33 97 39 345 M 76 Salvage after radiotherapy Ileal Conduit
1612 118 Leicester General Hospital 33 97 39 345 M 72 Muscle invasive TCC Ileal Conduit
1613 118 Leicester General Hospital 33 97 39 345 M 49 Squamous cell Ca Orthotopic
1614 118 Leicester General Hospital 33 97 39 345 M 65 Salvage after radiotherapy Ileal Conduit
1615 118 Leicester General Hospital 33 97 39 345 M 60 999 Ileal Conduit
1616 118 Leicester General Hospital 33 97 39 345 F 77 Squamous cell Ca Ileal Conduit
1617 118 Leicester General Hospital 33 97 39 345 M 67 Other Orthotopic
1618 118 Leicester General Hospital 33 97 39 345 M 74 Salvage after radiotherapy Ileal Conduit
1619 118 Leicester General Hospital 33 97 39 345 M 70 Uncontrolled superficial disease Ileal Conduit
1620 118 Leicester General Hospital 33 97 39 345 M 68 Uncontrolled superficial disease Ileal Conduit
1621 118 Leicester General Hospital 33 97 39 345 M 66 Muscle invasive TCC Ileal Conduit
1622 118 Leicester General Hospital 33 97 39 345 M 77 Muscle invasive TCC Ileal Conduit
1623 118 Leicester General Hospital 33 97 39 345 M 60 Uncontrolled superficial disease Orthotopic
1624 118 Leicester General Hospital 33 97 39 345 M 69 Squamous cell Ca Ileal Conduit
1625 118 Leicester General Hospital 33 97 39 345 F 64 Muscle invasive TCC Ileal Conduit
1626 118 Leicester General Hospital 33 97 39 345 M 74 Primary CIS Ileal Conduit
1627 118 Leicester General Hospital 33 97 39 345 M 59 Muscle invasive TCC Ileal Conduit
1628 118 Leicester General Hospital 33 97 39 345 M 69 Muscle invasive TCC Ileal Conduit
1629 118 Leicester General Hospital 33 97 39 345 M 39 Muscle invasive TCC Ileal Conduit
1630 118 Leicester General Hospital 33 97 39 345 M 58 Muscle invasive TCC Ileal Conduit
1631 118 Leicester General Hospital 33 97 39 345 M 57 Uncontrolled superficial disease Ileal Conduit
1632 118 Leicester General Hospital 33 97 39 345 M 69 Muscle invasive TCC Ileal Conduit
1633 118 Leicester General Hospital 33 97 39 345 M 999 Muscle invasive TCC Ileal Conduit
1634 118 Leicester General Hospital 33 97 39 345 M 49 Muscle invasive TCC Ileal Conduit
1635 118 Leicester General Hospital 33 97 39 345 F 54 Muscle invasive TCC Ileal Conduit
1636 118 Leicester General Hospital 33 97 39 345 M 77 Muscle invasive TCC Ileal Conduit
1637 121 Royal Devon And Exeter Hospital 51 113 26 205 F 82 Muscle invasive TCC Ileal Conduit
1638 121 Royal Devon And Exeter Hospital 51 113 26 205 M 54 Muscle invasive TCC Orthotopic
1639 121 Royal Devon And Exeter Hospital 51 113 26 205 M 55 Primary CIS Orthotopic
1640 121 Royal Devon And Exeter Hospital 51 113 26 205 M 79 Salvage after radiotherapy Ileal Conduit
1641 121 Royal Devon And Exeter Hospital 51 113 26 205 M 63 Uncontrolled superficial disease Orthotopic
1642 121 Royal Devon And Exeter Hospital 51 113 26 205 M 69 Muscle invasive TCC Ileal Conduit
1643 121 Torbay Hospital 71 8 26 205 F 48 Muscle invasive TCC Orthotopic
1644 121 Torbay Hospital 71 8 26 205 F 61 Primary adenocarcinoma Orthotopic
1645 121 Torbay Hospital 71 8 26 205 M 60 Muscle invasive TCC Orthotopic
1646 122 Royal Devon And Exeter Hospital 51 113 26 205 M 63 Muscle invasive TCC Orthotopic
1647 122 Royal Devon And Exeter Hospital 51 113 26 205 M 69 Muscle invasive TCC Ileal Conduit
1648 122 Torbay Hospital 71 8 26 205 M 76 Muscle invasive TCC Ileal Conduit
1649 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 70 Muscle invasive TCC Ileal Conduit
1650 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 79 Salvage after radiotherapy Ileal Conduit
1651 123 Southend University Hospital NHS Foundation Trust65 84 38 164 F 63 Muscle invasive TCC Ileal Conduit
1652 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 72 Muscle invasive TCC Ileal Conduit
1653 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 69 Muscle invasive TCC Ileal Conduit
1654 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 75 Muscle invasive TCC Ileal Conduit
1655 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 69 Muscle invasive TCC Ileal Conduit
1656 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 63 Salvage after radiotherapy Ileal Conduit
1657 123 Southend University Hospital NHS Foundation Trust65 84 38 164 F 62 Muscle invasive TCC Ileal Conduit
1658 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 67 Uncontrolled superficial disease Ileal Conduit
1659 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 73 Uncontrolled superficial disease Ileal Conduit
  
 
 
 
1610 118 Leicester General Hospital 33 97 39 345 M 71 Muscle invasive TCC Ileal Conduit
1611 118 Leicester General Hospital 33 97 39 345 M 76 Salvage after radiotherapy Ileal Conduit
1612 118 Leicester General Hospital 33 97 39 345 M 72 Muscle invasive TCC Ileal Conduit
1613 118 Leicester General Hospital 33 97 39 345 M 49 Squamous cell Ca Orthotopic
1614 118 Leicester General Hospital 33 97 39 345 M 65 Salvage after radiotherapy Ileal Conduit
1615 118 Leicester General Hospital 33 97 39 345 M 60 999 Ileal Conduit
1616 118 Leicester General Hospital 33 97 39 345 F 77 Squamous cell Ca Ileal Conduit
1617 118 Leicester General Hospital 33 97 39 345 M 67 Other Orthotopic
1618 118 Leicester General Hospital 33 97 39 345 M 74 Salvage after radiotherapy Ileal Conduit
1619 118 Leicester General Hospital 33 97 39 345 M 70 Uncontrolled superficial disease Ileal Conduit
1620 118 Leicester General Hospital 33 97 39 345 M 68 Uncontrolled superficial disease Ileal Conduit
1621 118 Leicester General Hospital 33 97 39 345 M 66 Muscle invasive TCC Ileal Conduit
1622 118 Leicester General Hospital 33 97 39 345 M 77 Muscle invasive TCC Ileal Conduit
1623 118 Leicester General Hospital 33 97 39 345 M 60 Uncontrolled superficial disease Orthotopic
1624 118 Leicester General Hospital 33 97 39 345 M 69 Squamous cell Ca Ileal Conduit
1625 118 Leicester General Hospital 33 97 39 345 F 64 Muscle invasive TCC Ileal Conduit
1626 118 Leicester General Hospital 33 97 39 345 M 74 Primary CIS Ileal Conduit
1627 118 Leicester General Hospital 33 97 39 345 M 59 Muscle invasive TCC Ileal Conduit
1628 118 Leicester General Hospital 33 97 39 345 M 69 Muscle invasive TCC Ileal Conduit
1629 118 Leicester General Hospital 33 97 39 345 M 39 Muscle invasive TCC Ileal Conduit
1630 118 Leicester General Hospital 33 97 39 345 M 58 Muscle invasive TCC Ileal Conduit
1631 118 Leicester General Hospital 33 97 39 345 M 57 Uncontrolled superficial disease Ileal Conduit
1632 118 Leicester General Hospital 33 97 39 345 M 69 Muscle invasive TCC Ileal Conduit
1633 118 Leicester General Hospital 33 97 39 345 M 999 Muscle invasive TCC Ileal Conduit
1634 118 Leicester General Hospital 33 97 39 345 M 49 Muscle invasive TCC Ileal Conduit
1635 118 Leicester General Hospital 33 97 39 345 F 54 Muscle invasive TCC Ileal Conduit
1636 118 Leicester General Hospital 33 97 39 345 M 77 Muscle invasive TCC Ileal Conduit
1637 121 Royal Devon And Exeter Hospital 51 113 26 205 F 82 Muscle invasive TCC Ileal Conduit
1638 121 Royal Devon And Exeter Hospital 51 113 26 205 M 54 Muscle invasive TCC Orthotopic
1639 121 Royal Devon And Exeter Hospital 51 113 26 205 M 55 Primary CIS Orthotopic
1640 121 Royal Devon And Exeter Hospital 51 113 26 205 M 79 Salvage after radiotherapy Ileal Conduit
1641 121 Royal Devon And Exeter Hospital 51 113 26 205 M 63 Uncontrolled superficial disease Orthotopic
1642 121 Royal Devon And Exeter Hospital 51 113 26 205 M 69 Muscle invasive TCC Ileal Conduit
1643 121 Torbay Hospital 71 8 26 205 F 48 Muscle invasive TCC Orthotopic
1644 121 Torbay Hospital 71 8 26 205 F 61 Primary adenocarcinoma Orthotopic
1645 121 Torbay Hospital 71 8 26 205 M 60 Muscle invasive TCC Orthotopic
1646 122 Royal Devon And Exeter Hospital 51 113 26 205 M 63 Muscle invasive TCC Orthotopic
1647 122 Royal Devon And Exeter Hospital 51 113 26 205 M 69 Muscle invasive TCC Ileal Conduit
1648 122 Torbay Hospital 71 8 26 205 M 76 Muscle invasive TCC Ileal Conduit
1649 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 70 Muscle invasive TCC Ileal Conduit
1650 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 79 Salvage after radiotherapy Ileal Conduit
1651 123 Southend University Hospital NHS Foundation Trust65 84 38 164 F 63 Muscle invasive TCC Ileal Conduit
1652 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 72 Muscle invasive TCC Ileal Conduit
1653 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 69 Muscle invasive TCC Ileal Conduit
1654 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 75 Muscle invasive TCC Ileal Conduit
1655 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 69 Muscle invasive TCC Ileal Conduit
1656 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 63 Salvage after radiotherapy Ileal Conduit
1657 123 Southend University Hospital NHS Foundation Trust65 84 38 164 F 62 Muscle invasive TCC Ileal Conduit
1658 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 67 Uncontrolled superficial disease Ileal Conduit
1659 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 73 Uncontrolled superficial disease Ileal Conduit
  
 
 
 
1660 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 73 Uncontrolled superficial disease Ileal Conduit
1661 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 70 Muscle invasive TCC Ileal Conduit
1662 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 81 Muscle invasive TCC Ileal Conduit
1663 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 77 Salvage after radiotherapy Ileal Conduit
1664 123 Southend University Hospital NHS Foundation Trust65 84 38 164 F 79 Muscle invasive TCC Ileal Conduit
1665 123 Southend University Hospital NHS Foundation Trust65 84 38 164 F 63 Muscle invasive TCC Ileal Conduit
1666 123 Southend University Hospital NHS Foundation Trust65 84 38 164 F 74 Muscle invasive TCC Ileal Conduit
1667 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 72 Muscle invasive TCC Ileal Conduit
1668 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 68 Muscle invasive TCC Ileal Conduit
1669 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 71 Muscle invasive TCC Ileal Conduit
1670 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 65 Primary CIS Ileal Conduit
1671 123 Southend University Hospital NHS Foundation Trust65 84 38 164 M 77 Muscle invasive TCC Ileal Conduit
1672 123 Southend University Hospital NHS Foundation Trust65 84 38 164 F 82 Muscle invasive TCC Ileal Conduit
1673 123 Southend University Hospital NHS Foundation Trust65 84 38 164 F 66 Muscle invasive TCC Ileal Conduit
1674 124 Victoria Hospital Blackpool 75 19 1 19 999 999 Muscle invasive TCC Ileal Conduit
1675 124 Victoria Hospital Blackpool 75 19 1 19 999 999 Muscle invasive TCC Ileal Conduit
1676 124 Victoria Hospital Blackpool 75 19 1 19 999 999 Muscle invasive TCC Ileal Conduit
1677 125 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 65 Muscle invasive TCC Ileal Conduit
1678 125 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 77 Muscle invasive TCC Ileal Conduit
1679 125 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 F 59 Muscle invasive TCC Ileal Conduit
1680 125 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 73 Muscle invasive TCC Ileal Conduit
1681 125 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 63 Muscle invasive TCC Orthotopic
1682 125 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 48 Uncontrolled superficial disease Ileal Conduit
1683 125 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 74 Uncontrolled superficial disease Ileal Conduit
1684 125 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 M 70 Muscle invasive TCC Ileal Conduit
1685 125 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 F 69 Muscle invasive TCC Ileal Conduit
1686 125 North Bristol NHSTrust (Southmead) 37 313 28 351 M 74 Muscle invasive TCC Ileal Conduit
1687 125 North Bristol NHSTrust (Southmead) 37 313 28 351 M 49 Other Ileal Conduit
1688 125 North Bristol NHSTrust (Southmead) 37 313 28 351 M 63 Uncontrolled superficial disease Ileal Conduit
1689 125 North Bristol NHSTrust (Southmead) 37 313 28 351 F 76 Muscle invasive TCC Ileal Conduit
1690 126 Bradford Royal Infirmary 7 107 6 384 F 75 Muscle invasive TCC Ileal Conduit
1691 126 Bradford Royal Infirmary 7 107 6 384 M 74 Muscle invasive TCC Ileal Conduit
1692 126 Bradford Royal Infirmary 7 107 6 384 F 54 Muscle invasive TCC Ileal Conduit
1693 126 Bradford Royal Infirmary 7 107 6 384 M 60 Muscle invasive TCC Ileal Conduit
1694 126 Bradford Royal Infirmary 7 107 6 384 M 70 Muscle invasive TCC Ileal Conduit
1695 126 Bradford Royal Infirmary 7 107 6 384 M 65 Primary CIS Ileal Conduit
1696 126 Bradford Royal Infirmary 7 107 6 384 M 73 Muscle invasive TCC Ileal Conduit
1697 126 Bradford Royal Infirmary 7 107 6 384 F 70 Muscle invasive TCC Ileal Conduit
1698 126 Bradford Royal Infirmary 7 107 6 384 F 74 Muscle invasive TCC Ileal Conduit
1699 126 Bradford Royal Infirmary 7 107 6 384 F 76 Muscle invasive TCC Ileal Conduit
1700 126 Bradford Royal Infirmary 7 107 6 384 M 72 Muscle invasive TCC Ileal Conduit
1701 126 Bradford Royal Infirmary 7 107 6 384 M 67 Muscle invasive TCC Ileal Conduit
1702 126 Bradford Royal Infirmary 7 107 6 384 M 38 Primary adenocarcinoma Orthotopic
1703 126 Bradford Royal Infirmary 7 107 6 384 M 68 Muscle invasive TCC Ileal Conduit
1704 126 Bradford Royal Infirmary 7 107 6 384 M 75 Muscle invasive TCC Ileal Conduit
1705 126 Bradford Royal Infirmary 7 107 6 384 M 61 Primary CIS Orthotopic
1706 126 Bradford Royal Infirmary 7 107 6 384 M 54 Muscle invasive TCC Ileal Conduit
1707 126 Bradford Royal Infirmary 7 107 6 384 M 61 Muscle invasive TCC Ileal Conduit
1708 126 Bradford Royal Infirmary 7 107 6 384 M 85 Salvage after radiotherapy Ileal Conduit
1709 126 Bradford Royal Infirmary 7 107 6 384 M 65 Other Ileal Conduit
  
 
 
 
 
 
 
1710 126 Bradford Royal Infirmary 7 107 6 384 M 31 Muscle invasive TCC Ileal Conduit
1711 126 Bradford Royal Infirmary 7 107 6 384 F 73 Muscle invasive TCC Ileal Conduit
1712 126 Bradford Royal Infirmary 7 107 6 384 M 61 Muscle invasive TCC Ileal Conduit
1713 126 Bradford Royal Infirmary 7 107 6 384 M 62 Muscle invasive TCC Ileal Conduit
1714 126 Bradford Royal Infirmary 7 107 6 384 F 48 Squamous cell Ca Ileal Conduit
1715 126 Bradford Royal Infirmary 7 107 6 384 M 65 Muscle invasive TCC Ileal Conduit
1716 126 Bradford Royal Infirmary 7 107 6 384 M 71 Muscle invasive TCC Ileal Conduit
1717 126 Bradford Royal Infirmary 7 107 6 384 M 77 Muscle invasive TCC Ileal Conduit
1718 126 Bradford Royal Infirmary 7 107 6 384 M 62 Muscle invasive TCC Ileal Conduit
1719 126 Bradford Royal Infirmary 7 107 6 384 M 58 Muscle invasive TCC Orthotopic
1720 126 Bradford Royal Infirmary 7 107 6 384 M 80 Muscle invasive TCC Ileal Conduit
1721 126 Bradford Royal Infirmary 7 107 6 384 F 65 Muscle invasive TCC Ileal Conduit
1722 126 Bradford Royal Infirmary 7 107 6 384 M 76 Squamous cell Ca Ileal Conduit
1723 126 Bradford Royal Infirmary 7 107 6 384 M 53 Muscle invasive TCC Orthotopic
1724 126 Bradford Royal Infirmary 7 107 6 384 M 999 Muscle invasive TCC Orthotopic
1725 126 Bradford Royal Infirmary 7 107 6 384 F 80 Muscle invasive TCC Ileal Conduit
1726 126 Bradford Royal Infirmary 7 107 6 384 M 77 Other Ileal Conduit
1727 126 Huddersfield Royal Infirmary 28 10 6 384 M 67 Muscle invasive TCC Ileal Conduit
1728 127 University College Hospital London 72 38 22 118 M 68 Muscle invasive TCC Ileal Conduit
1729 127 University College Hospital London 72 38 22 118 M 39 Squamous cell Ca Ileal Conduit
1730 128 Walsgrave Hospital 76 9 12 22 F 79 Muscle invasive TCC Ileal Conduit
1731 128 Walsgrave Hospital 76 9 12 22 F 67 Muscle invasive TCC Ileal Conduit
1732 128 Walsgrave Hospital 76 9 12 22 M 81 Muscle invasive TCC Ileal Conduit
1733 129 Chesterfield & North Derbyshire 12 6 8 261 M 51 Squamous cell Ca Ileal Conduit
1734 129 Chesterfield & North Derbyshire 12 6 8 261 F 70 Muscle invasive TCC Ileal Conduit
1735 129 Chesterfield & North Derbyshire 12 6 8 261 F 69 Muscle invasive TCC Ileal Conduit
1736 129 Chesterfield & North Derbyshire 12 6 8 261 M 75 Primary CIS Ileal Conduit
1737 129 Chesterfield & North Derbyshire 12 6 8 261 M 71 Muscle invasive TCC Ileal Conduit
1738 129 Chesterfield & North Derbyshire 12 6 8 261 M 79 Uncontrolled superficial disease Ileal Conduit
1739 129 Chesterfield & North Derbyshire 12 6 8 261 M 66 Uncontrolled superficial disease Ileal Conduit
1740 129 Chesterfield & North Derbyshire 12 6 8 261 M 73 Muscle invasive TCC Ileal Conduit
1741 129 Chesterfield & North Derbyshire 12 6 8 261 M 67 Salvage after radiotherapy Ileal Conduit
1742 129 Chesterfield & North Derbyshire 12 6 8 261 M 65 Muscle invasive TCC Ileal Conduit
1743 129 Chesterfield & North Derbyshire 12 6 8 261 F 65 Muscle invasive TCC Ileal Conduit
1744 129 Chesterfield & North Derbyshire 12 6 8 261 F 76 Uncontrolled superficial disease Ileal Conduit
1745 129 Chesterfield & North Derbyshire 12 6 8 261 M 74 Uncontrolled superficial disease Ileal Conduit
1746 129 Chesterfield & North Derbyshire 12 6 8 261 M 68 Muscle invasive TCC Ileal Conduit
1747 129 Chesterfield & North Derbyshire 12 6 8 261 F 58 Muscle invasive TCC Ileal Conduit
1748 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 52 Uncontrolled superficial disease Ileal Conduit
1749 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 44 Muscle invasive TCC Ileal Conduit
  
 
 
 
1750 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 70 Muscle invasive TCC Ileal Conduit
1751 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 76 Uncontrolled superficial disease Ileal Conduit
1752 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 69 Muscle invasive TCC Ileal Conduit
1753 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 80 Muscle invasive TCC Ileal Conduit
1754 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 80 Squamous cell Ca Ileal Conduit
1755 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 42 Gynaecological Ca Ileal Conduit
1756 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 69 Muscle invasive TCC Ileal Conduit
1757 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 65 Muscle invasive TCC Ileal Conduit
1758 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 77 Primary CIS Ileal Conduit
1759 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 999 Muscle invasive TCC Ileal Conduit
1760 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 68 Muscle invasive TCC Ileal Conduit
1761 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 59 Salvage after radiotherapy Ileal Conduit
1762 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 59 Muscle invasive TCC Orthotopic
1763 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 64 Uncontrolled superficial disease Ileal Conduit
1764 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 71 Squamous cell Ca Ileal Conduit
1765 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 70 Muscle invasive TCC Ileal Conduit
1766 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 55 Salvage after radiotherapy Ileal Conduit
1767 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 56 Uncontrolled superficial disease Ileal Conduit
1768 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 75 Muscle invasive TCC Ileal Conduit
1769 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 67 Muscle invasive TCC Ileal Conduit
1770 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 999 999 Secondary adenocarcinoma Ileal Conduit
1771 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 60 Uncontrolled superficial disease Ileal Conduit
1772 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 70 Muscle invasive TCC Ileal Conduit
1773 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 70 Muscle invasive TCC Ileal Conduit
1774 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 74 Uncontrolled superficial disease Ileal Conduit
1775 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 68 Other Ileal Conduit
1776 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 62 Gynaecological Ca Ileal Conduit
1777 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 61 Uncontrolled superficial disease Ileal Conduit
1778 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 64 Muscle invasive TCC Ileal Conduit
1779 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 78 Muscle invasive TCC Ileal Conduit
1780 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 82 Muscle invasive TCC Ileal Conduit
1781 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 63 Muscle invasive TCC Ileal Conduit
1782 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 61 Muscle invasive TCC Ileal Conduit
1783 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 999 Gynaecological Ca Ileal Conduit
1784 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 78 Muscle invasive TCC Ileal Conduit
1785 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 55 Uncontrolled superficial disease Ileal Conduit
1786 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 76 Muscle invasive TCC Ileal Conduit
1787 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 73 Muscle invasive TCC Ileal Conduit
1788 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 63 Muscle invasive TCC Ileal Conduit
1789 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 69 Muscle invasive TCC Ileal Conduit
1790 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 82 Muscle invasive TCC Ileal Conduit
1791 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 73 Muscle invasive TCC Ileal Conduit
1792 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 72 Uncontrolled superficial disease Ileal Conduit
1793 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 999 Muscle invasive TCC Ileal Conduit
1794 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 63 Muscle invasive TCC Ileal Conduit
1795 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 66 Uncontrolled superficial disease Ileal Conduit
1796 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 70 Uncontrolled superficial disease Ileal Conduit
1797 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 62 Uncontrolled superficial disease Ileal Conduit
1798 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 61 Uncontrolled superficial disease Ileal Conduit
1799 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 63 Muscle invasive TCC Ileal Conduit
  
 
 
 
1800 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 79 Uncontrolled superficial disease Ileal Conduit
1801 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 73 Muscle invasive TCC Ileal Conduit
1802 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 70 Uncontrolled superficial disease Ileal Conduit
1803 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 66 Muscle invasive TCC Ileal Conduit
1804 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 71 Muscle invasive TCC Ileal Conduit
1805 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 77 Muscle invasive TCC Ileal Conduit
1806 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 59 Uncontrolled superficial disease Ileal Conduit
1807 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 59 Other Ileal Conduit
1808 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 61 Squamous cell Ca Ileal Conduit
1809 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 66 Primary CIS Ileal Conduit
1810 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 58 Muscle invasive TCC Ileal Conduit
1811 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 62 Muscle invasive TCC Ileal Conduit
1812 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 68 Muscle invasive TCC Ileal Conduit
1813 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 70 Gynaecological Ca Ileal Conduit
1814 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 63 Muscle invasive TCC Ileal Conduit
1815 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 67 Muscle invasive TCC Ileal Conduit
1816 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 68 Muscle invasive TCC Ileal Conduit
1817 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 74 Uncontrolled superficial disease Ileal Conduit
1818 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 73 Muscle invasive TCC Ileal Conduit
1819 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 83 Uncontrolled superficial disease Ileal Conduit
1820 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 60 Other Ileal Conduit
1821 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 49 Muscle invasive TCC Orthotopic
1822 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 70 Muscle invasive TCC Ileal Conduit
1823 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 75 Muscle invasive TCC Ileal Conduit
1824 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 74 Muscle invasive TCC Ileal Conduit
1825 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 47 Muscle invasive TCC Ileal Conduit
1826 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 69 Uncontrolled superficial disease Ileal Conduit
1827 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 73 Uncontrolled superficial disease Ileal Conduit
1828 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 56 Muscle invasive TCC Orthotopic
1829 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 57 Uncontrolled superficial disease Ileal Conduit
1830 129 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 71 Squamous cell Ca Ileal Conduit
1831 129 Queen's Hospital Burton 46 13 39 345 M 79 Salvage after radiotherapy Ileal Conduit
1832 129 Queen's Hospital Burton 46 13 39 345 M 71 Uncontrolled superficial disease Ileal Conduit
1833 129 Queen's Hospital Burton 46 13 39 345 M 62 Muscle invasive TCC Ileal Conduit
1834 129 Queen's Hospital Burton 46 13 39 345 F 74 Muscle invasive TCC Ileal Conduit
1835 129 Queen's Hospital Burton 46 13 39 345 M 61 Muscle invasive TCC Ileal Conduit
1836 129 Queen's Hospital Burton 46 13 39 345 M 71 Muscle invasive TCC Ileal Conduit
1837 129 Queen's Hospital Burton 46 13 39 345 M 63 Muscle invasive TCC Ileal Conduit
1838 129 Queen's Hospital Burton 46 13 39 345 M 55 Muscle invasive TCC Ileal Conduit
1839 129 Queen's Hospital Burton 46 13 39 345 M 70 Uncontrolled superficial disease Ileal Conduit
1840 129 Queen's Hospital Burton 46 13 39 345 F 68 Muscle invasive TCC Ileal Conduit
1841 129 Queen's Hospital Burton 46 13 39 345 M 67 Uncontrolled superficial disease Orthotopic
1842 129 Queen's Hospital Burton 46 13 39 345 F 73 Uncontrolled superficial disease Ileal Conduit
1843 129 Queen's Hospital Burton 46 13 39 345 M 61 Uncontrolled superficial disease Orthotopic
1844 129 Portsmouth Hospitals NHS Trust 43 150 31 307 F 83 Uncontrolled superficial disease Ileal Conduit
1845 129 Portsmouth Hospitals NHS Trust 43 150 31 307 M 65 Muscle invasive TCC Ileal Conduit
1846 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 61 Muscle invasive TCC Ileal Conduit
1847 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 58 Muscle invasive TCC Ileal Conduit
1848 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 56 Muscle invasive TCC Orthotopic
1849 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 65 Uncontrolled superficial disease Ileal Conduit
  
 
 
 
1850 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 62 Uncontrolled superficial disease Ileal Conduit
1851 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 69 Gynaecological Ca Ileal Conduit
1852 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 30 Gynaecological Ca Ileal Conduit
1853 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 69 Muscle invasive TCC Ileal Conduit
1854 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 68 Other Ileal Conduit
1855 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 73 Other Ileal Conduit
1856 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 72 Muscle invasive TCC Ileal Conduit
1857 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 72 Muscle invasive TCC Ileal Conduit
1858 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 76 Muscle invasive TCC Ileal Conduit
1859 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 999 Muscle invasive TCC Ileal Conduit
1860 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 61 Muscle invasive TCC Ileal Conduit
1861 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 56 Muscle invasive TCC Ileal Conduit
1862 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 64 Muscle invasive TCC Ileal Conduit
1863 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 46 Muscle invasive TCC Ileal Conduit
1864 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 46 Muscle invasive TCC Ileal Conduit
1865 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 70 Muscle invasive TCC Ileal Conduit
1866 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 74 Muscle invasive TCC Ileal Conduit
1867 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 81 Muscle invasive TCC Ileal Conduit
1868 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 69 Muscle invasive TCC Ileal Conduit
1869 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 999 Muscle invasive TCC Ileal Conduit
1870 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 39 Muscle invasive TCC Ileal Conduit
1871 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 69 Other Ileal Conduit
1872 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 68 Primary CIS Ileal Conduit
1873 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 56 Muscle invasive TCC Ileal Conduit
1874 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 45 Muscle invasive TCC Orthotopic
1875 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 61 Muscle invasive TCC Ileal Conduit
1876 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 68 Primary CIS Ileal Conduit
1877 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 72 Muscle invasive TCC Ileal Conduit
1878 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 999 Muscle invasive TCC Ileal Conduit
1879 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 68 Muscle invasive TCC Ileal Conduit
1880 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 79 Muscle invasive TCC Ileal Conduit
1881 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 81 Muscle invasive TCC Ileal Conduit
1882 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 70 Muscle invasive TCC Ileal Conduit
1883 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 75 Muscle invasive TCC Ileal Conduit
1884 130 Portsmouth Hospitals NHS Trust 43 150 31 307 F 68 Muscle invasive TCC Ileal Conduit
1885 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 80 Muscle invasive TCC Ileal Conduit
1886 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 46 Muscle invasive TCC Ileal Conduit
1887 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 70 Muscle invasive TCC Ileal Conduit
1888 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 63 Muscle invasive TCC Ileal Conduit
1889 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 62 Muscle invasive TCC Ileal Conduit
1890 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 76 Muscle invasive TCC Ileal Conduit
1891 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 50 Muscle invasive TCC Ileal Conduit
1892 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 57 Muscle invasive TCC Ileal Conduit
1893 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 72 Muscle invasive TCC Ileal Conduit
1894 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 65 Muscle invasive TCC Ileal Conduit
1895 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 64 Squamous cell Ca Ileal Conduit
1896 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 63 Muscle invasive TCC Orthotopic
1897 130 Portsmouth Hospitals NHS Trust 43 150 31 307 M 79 Muscle invasive TCC Ileal Conduit
1898 130 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 57 Muscle invasive TCC Orthotopic
1899 130 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 74 Muscle invasive TCC Ileal Conduit
  
 
 
 
1900 130 Royal West Sussex NHS Trust, St Richard's Hospital59 12 31 307 M 66 Muscle invasive TCC Ileal Conduit
1901 131 Dorset County Hospital 21 3 27 60 M 65 Salvage after radiotherapy Ileal Conduit
1902 131 Dorset County Hospital 21 3 27 60 M 59 Muscle invasive TCC Ileal Conduit
1903 131 Royal Bournemouth Hospital 49 57 27 60 F 999 Muscle invasive TCC Ileal Conduit
1904 132 North Devon District Hospital 38 6 26 205 M 65 Muscle invasive TCC Ileal Conduit
1905 132 North Devon District Hospital 38 6 26 205 M 53 Muscle invasive TCC Ileal Conduit
1906 132 North Devon District Hospital 38 6 26 205 F 62 Muscle invasive TCC Ileal Conduit
1907 132 North Devon District Hospital 38 6 26 205 M 69 Other Ileal Conduit
1908 132 North Devon District Hospital 38 6 26 205 M 68 999 Orthotopic
1909 133 Castle Hill Hospital 11 135 7 144 M 51 Muscle invasive TCC Ileal Conduit
1910 133 Castle Hill Hospital 11 135 7 144 F 57 Muscle invasive TCC Ileal Conduit
1911 133 Castle Hill Hospital 11 135 7 144 M 69 Muscle invasive TCC Orthotopic
1912 134 King George Hospital 32 49 23 49 F 71 Muscle invasive TCC Ileal Conduit
1913 135 St James's University Hospital 67 108 6 384 M 81 Squamous cell Ca Ileal Conduit
1914 135 St James's University Hospital 67 108 6 384 M 34 Sarcoma Ileal Conduit
1915 135 St James's University Hospital 67 108 6 384 M 70 Uncontrolled superficial disease Ileal Conduit
1916 135 St James's University Hospital 67 108 6 384 F 69 Salvage after radiotherapy Ileal Conduit
1917 135 St James's University Hospital 67 108 6 384 F 65 Muscle invasive TCC Ileal Conduit
1918 136 New Cross Hospital 35 37 35 226 M 52 Muscle invasive TCC Ileal Conduit
1919 137 Royal Preston Hospital 56 22 2 101.00 M 79 Muscle invasive TCC Ileal Conduit
1920 137 Royal Preston Hospital 56 22 2 101.00 M 71 Muscle invasive TCC Orthotopic
1921 137 Royal Preston Hospital 56 22 2 101.00 M 63 Muscle invasive TCC Ileal Conduit
1922 137 Royal Preston Hospital 56 22 2 101.00 M 61 Muscle invasive TCC Ileal Conduit
1923 137 Royal Preston Hospital 56 22 2 101.00 M 56 Other Ileal Conduit
1924 138 Freeman Hospital 23 258 36 405 M 66 Muscle invasive TCC Ileal Conduit
1925 138 Freeman Hospital 23 258 36 405 M 71 Muscle invasive TCC Ileal Conduit
1926 138 Freeman Hospital 23 258 36 405 M 48 Muscle invasive TCC Ileal Conduit
1927 139 Derby Hospitals NHS Foundation Trust 18 121 39 345 F 65 Muscle invasive TCC Ileal Conduit
1928 139 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 63 Muscle invasive TCC Ileal Conduit
1929 139 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 76 Muscle invasive TCC Ileal Conduit
1930 139 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 74 Muscle invasive TCC Ileal Conduit
1931 139 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 72 Muscle invasive TCC Ileal Conduit
1932 139 Derby Hospitals NHS Foundation Trust 18 121 39 345 M 77 Muscle invasive TCC Ileal Conduit
1933 140 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 75 Muscle invasive TCC Ileal Conduit
1934 140 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 74 Muscle invasive TCC Ileal Conduit
1935 140 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 71 Muscle invasive TCC Ileal Conduit
1936 140 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 79 Other Ileal Conduit
1937 140 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 68 Muscle invasive TCC Ileal Conduit
1938 140 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 M 59 Primary CIS Ileal Conduit
1939 140 City Hospitals Sunderland NHS Foundation Trust 15 136 36 405 F 73 Muscle invasive TCC Ileal Conduit
1940 141 University College Hospital London 72 38 22 118 M 999 999 Orthotopic
1941 142 Royal Sussex County Hospital 58 34 33 129 M 60 999 Ileal Conduit
1942 143 Barnet & Chase Farm Hospital 5 64 22 118 M 57 Muscle invasive TCC Ileal Conduit
1943 143 Barnet & Chase Farm Hospital 5 64 22 118 M 999 Salvage after radiotherapy Ileal Conduit
1944 143 Barnet & Chase Farm Hospital 5 64 22 118 M 79 Salvage after radiotherapy Ileal Conduit
1945 143 Barnet & Chase Farm Hospital 5 64 22 118 M 999 Muscle invasive TCC Ileal Conduit
1946 143 Barnet & Chase Farm Hospital 5 64 22 118 M 72 Uncontrolled superficial disease Ileal Conduit
1947 143 Barnet & Chase Farm Hospital 5 64 22 118 M 85 Primary adenocarcinoma Ileal Conduit
1948 143 Barnet & Chase Farm Hospital 5 64 22 118 M 77 Other Ileal Conduit
1949 143 Barnet & Chase Farm Hospital 5 64 22 118 F 72 Muscle invasive TCC Ileal Conduit
  
 
 
 
1950 143 Barnet & Chase Farm Hospital 5 64 22 118 F 64 Muscle invasive TCC Ileal Conduit
1951 143 Barnet & Chase Farm Hospital 5 64 22 118 M 68 Uncontrolled superficial disease Ileal Conduit
1952 143 Barnet & Chase Farm Hospital 5 64 22 118 F 46 Muscle invasive TCC Ileal Conduit
1953 143 Barnet & Chase Farm Hospital 5 64 22 118 M 999 Squamous cell Ca Ileal Conduit
1954 143 Barnet & Chase Farm Hospital 5 64 22 118 M 41 Uncontrolled superficial disease Ileal Conduit
1955 143 Barnet & Chase Farm Hospital 5 64 22 118 F 80 Muscle invasive TCC Ileal Conduit
1956 143 Barnet & Chase Farm Hospital 5 64 22 118 M 999 999 Ileal Conduit
1957 143 Barnet & Chase Farm Hospital 5 64 22 118 M 78 Other Ileal Conduit
1958 143 Barnet & Chase Farm Hospital 5 64 22 118 M 72 Muscle invasive TCC Ileal Conduit
1959 143 Barnet & Chase Farm Hospital 5 64 22 118 M 77 Salvage after radiotherapy Ileal Conduit
1960 143 Barnet & Chase Farm Hospital 5 64 22 118 M 79 Uncontrolled superficial disease Ileal Conduit
1961 143 Barnet & Chase Farm Hospital 5 64 22 118 M 48 Other Orthotopic
1962 143 North Middlesex Hospital 39 2 22 118 M 57 Muscle invasive TCC Orthotopic
1963 144 Basildon Hospital 6 12 38 164 M 60 Muscle invasive TCC Ileal Conduit
1964 144 Basildon Hospital 6 12 38 164 M 69 Salvage after radiotherapy Ileal Conduit
1965 144 Basildon Hospital 6 12 38 164 M 76 Primary CIS Ileal Conduit
1966 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 63 Muscle invasive TCC Ileal Conduit
1967 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 69 Muscle invasive TCC Ileal Conduit
1968 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 71 Muscle invasive TCC Ileal Conduit
1969 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 50 Muscle invasive TCC Ileal Conduit
1970 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 49 Muscle invasive TCC Ileal Conduit
1971 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 54 Muscle invasive TCC Ileal Conduit
1972 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 65 Muscle invasive TCC Ileal Conduit
1973 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 70 Uncontrolled superficial disease Ileal Conduit
1974 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 76 Muscle invasive TCC Ileal Conduit
1975 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 60 Muscle invasive TCC Ileal Conduit
1976 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 999 Muscle invasive TCC Ileal Conduit
1977 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 68 Primary CIS Ileal Conduit
1978 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 76 Squamous cell Ca Ileal Conduit
1979 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 72 Muscle invasive TCC Ileal Conduit
1980 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 73 Squamous cell Ca Ileal Conduit
1981 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 61 Muscle invasive TCC Ileal Conduit
1982 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 73 Muscle invasive TCC Ileal Conduit
1983 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 66 Salvage after radiotherapy Ileal Conduit
1984 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 69 Muscle invasive TCC Ileal Conduit
1985 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 71 Muscle invasive TCC Ileal Conduit
1986 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 73 Muscle invasive TCC Ileal Conduit
1987 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 69 Muscle invasive TCC Ileal Conduit
1988 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 55 Uncontrolled superficial disease Ileal Conduit
1989 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 64 999 Ileal Conduit
1990 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 74 Muscle invasive TCC Ileal Conduit
1991 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 75 Muscle invasive TCC Ileal Conduit
1992 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 81 Uncontrolled superficial disease Ileal Conduit
1993 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 63 Muscle invasive TCC Ileal Conduit
1994 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 81 Muscle invasive TCC Ileal Conduit
1995 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 38 Muscle invasive TCC Ileal Conduit
1996 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 71 Primary CIS Ileal Conduit
1997 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 73 Muscle invasive TCC Ileal Conduit
1998 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 70 Squamous cell Ca Ileal Conduit
1999 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 66 Muscle invasive TCC Ileal Conduit
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2000 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 70 Muscle invasive TCC Ileal Conduit
2001 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 72 Muscle invasive TCC Ileal Conduit
2002 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 62 Muscle invasive TCC Ileal Conduit
2003 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 56 Muscle invasive TCC Ileal Conduit
2004 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 77 Muscle invasive TCC Ileal Conduit
2005 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 72 Muscle invasive TCC Ileal Conduit
2006 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 48 Muscle invasive TCC Ileal Conduit
2007 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 63 Muscle invasive TCC Ileal Conduit
2008 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 75 Muscle invasive TCC Ileal Conduit
2009 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 60 Muscle invasive TCC Ileal Conduit
2010 144 Southend University Hospital NHS Foundation Trust65 84 38 164 M 72 Muscle invasive TCC Ileal Conduit
2011 144 Southend University Hospital NHS Foundation Trust65 84 38 164 F 62 Muscle invasive TCC Ileal Conduit
2012 145 Bristol Oncology Centre; United Bristol Health Care Trust8 7 28 351 F 81 Uncontrolled superficial disease Ileal Conduit
  
Appendix 17 – Patient Questionnaire Survey Raw Results 
 
 
 
 
RemovalMonths RemovalYears AgeGroup Gender UrineDiversion BothMethodsAvailable UBenefits URisks URecovery UPeerSupport UDailyCare UAppliances UEmployment ULeisure UAppearance USexual SBBenefits SBRisks SBRecovery SBPeerSupport SBDailyCare SBAppliances SBEmployment SBLeisure SBAppearance SBSexual Information
3 6 4 1 2 1 1 2 3 666 1 2 3 2 2 3 1 2 3 666 1 2 3 2 2 3 2
0 12 4 1 2 1 1 1 999 1 1 2 999 2 2 3 1 2 2 2 1 2 2 2 1 3
8 4 5 1 1 2 2 2 3 2 2 3 3 2 3 6 6 6 6 6 6 6 6 6 6 6 1
6 5 4 1 1 2
6 4 3 1 1 2
0 6 3 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1
1 4 5 1 1 2
4 5 2 1 2
0 4 2 1 2 1 1 1 1 1 1 1 1 1 3 1 1 1 1 1 1 1 1 1 4 1 2
4 4 1 1 2
10 3 4 1 1 1 1 1 1 1 1 1 1 1 1 4 1 1 1 1 1 999 1 1 1 5 2
9 4 4 1 1 2
11 15 4 1 2 1 999 999 999 999 999 999 999 999 999 999 2 2 2 3 2 3 3 3 3 2 2
3 5 2 1 999 1 2 2 1 2 2
2 3 5 1 1 2
8 3 3 1 1 999 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 1
0 3 4 2 1 1 2 2 2 2 2 2 999 2 2 2 2 2 2 3 3 2 2 2 2 2 2
2 4 1 1 2
3 5 2 999 2 1 1 2 1 3 2 6 6 1 1 1 1 1 6 3 6
0 3 4 1 1 1 2 2 2 2 3 2 2 2 3 4 2 2 2 2 3 2 2 2 2 3 1
10 2 5 1 1 2 2 2 2 3 2 2 2 2 2 2 2
3 4 1 1 2
8 2 3 1 1 2
7 2 5 1 1 2
3 5 1 1 2
0 3 3 1 1 1 1 1 2 3 1 2 3 2 2 2 1 1 1 2 1 1 2 1 1 1 2
5 2 3 1 2 1 3 2 3 4 3 3 3 3 4 5 1 2 4 2 4 3 2 1 1 5 2
5 3 5 1 1 1 1 1 1 1 1 1 1 1 1 3 2 2 2 999 999 999 999 999 999 999 2
0 2 3 1 1 1 1 2 2 1 1 1 2 2 2 3 999 999 999 999 999 999 999 999 999 999 2
0 2 4 1 1 1 1 1 1 3 2 2 2 2 2 2 2 1 2 3 3 3 2 2 2 2 2
0 2 4 1 1 1 2 2 2 3 2 2 2 3 3 3 2 2 2 2 2 2 2 3 3 3 2
10 1 4 1 1 2
10 1 3 1 2 1 3 3 2 3 3 2 3 3 3 4 2 2 2 2 3 3 3 2 2 3 2
9 1 5 1 1 2
9 1 5 1 1 1 1 1 1 1 1 1 999 999 2 2 1 1 1 2 1 1 999 999 2 2 2
10 1 4 2 2 1 2 2 1 3 1 3 3 2 2 2 2 2 2 3 2 2 2 2 2 2 2
5 1 5 1 1 2 3 2 2 2 3 3 2 3 2 3 2 2 2 2 2 2 2 2 2 2
6 1 4 1 1 1 1 1 1 2 1 1 1 1 2 1 1 1 1 1 999 999 999 999 999 999 2
6 1 4 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
  
 
 
 
 
 
 
  
 
 
 
 
 
6 5 4 2 1 2
3 4 5 1 1 2
8 5 3 1 1 1 2 2 2 2 1 1 2 3 3 3 2 2 3 3 3 666 2 3 2 3
999 999 2 1 2 1 999 999 999 999 999 999 999 999 999 999 2 1 2 1 1 1 1 2 2 2
5 4 1 1 2 2 2 2 2 2 2 2 2 2 6 3 3 3 3 3 3 3 3 3 6
0 5 3 1 2 1 2 2 2 2 4 4 4 3 2 2 1 2 3 2 4 5 3 3 2 2
5 5 1 1 2
5 2 1 2
4 4 3 2 1 2
9 3 4 1 1 1 1 2 1 2 3 2 3 2 666 666 1 1 1 666 666 666 666 666 666 666
0 5 4 2 1 1 1 1 1 1 1 1 999 1 1 4 999 999 999 999 999 999 999 999 999 999
2 5 2 1 2
3 4 2 1 2
6 2 3 1 2 1 3 2 2 2 2 2 3 3 4 4 3 2 2 3 2 3 3 3 4 4
7 2 5 1 1 2
0 2 5 1 1 1 1 1 1 1 1 1 1 1 1 666 999 999 999 999 999 999 999 999 999 999
2 4 2 1 2
1 1 5 1 1 1 1 1 1 1 1 1 3 3 2 666 3 1 3 3 1 1 3 3 3 666
7 1 5 2 1 2
6 1 4 2 2 1 1 2 1 2 3 2 2 2 2 2 1 2 2 666 666 3 2 2 2 2
1 1 5 1 1 2
1 1 4 2 1 2
999 999 5 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
1 5 2 1 2 1 1 1 1 3 1 3 1 3 6
5 5 1 1 2
0 5 5 1 1 1 2 2 1 1 1 1 2 2 1 3 2 2 666 666 666 666 666 666 666 666
9 4 3 1 2 1 1 3 1 3 1 1 3 1 1 1 1 1 1 1 1 1 1 1 1 2
2 3 5 1 1 2
8 4 4 1 2 1 1 1 1 1 1 2 2 2 2 3 1 1 1 1 1 2 2 2 2 4
0 5 4 1 2 1 1 1 1 999 1 1 1 1 1 2 1 1 1 999 1 1 1 1 1 2
0 4 2 1 1 1 3 3 2 2 2 2 1 3 3 5 3 3 3 3 3 3 2 2 3 3
0 4 4 1 2 1 2 2 2 3 3 2 3 3 3 3 2 2 2 3 2 2 2 2 3 3
10 3 3 1 2 2
8 3 4 1 2 1 999 999 999 999 999 999 999 999 999 999 666 999 999 999 999 1 999 999 1 666
8 1 3 1 1 2
6 1 4 1 1 1 2 2 2 666 2 3 3 666 2 5 2 2 2 666 2 3 666 666 2 5
9 4 5 1 1 2
8 4 4 1 1 2
7 4 5 1 1 2 2 1 1 1 1 6 6 6
7 1 5 1 1 2 1 1 1 1 1 1 1 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 1 4 1 1 2
4 1 1 2
6 1 4 1 1 2
3 1 4 1 1 1 1 1 1 999 1 1 999 1 1 1 1 1 1 999 999 1 999 1 1 1 2
4 1 4 2 1 1 2 1 2 1 2 1 999 2 4 666 2 2 2 1 2 2 999 2 4 666 1
3 1 5 1 1 2
1 1 5 1 1 1 2 1 2 5 1 3 2 2 4 2 2 2 3 5 2 5 3 3 3 3 1
9 5 4 1 2 1 2 2 666 666 666 2 666 2 2 666 2 1 1 2 2 2 666 2 666 666 2
8 5 3 1 1 2
6 5 4 2 1 2
4 4 1 2 2 1 1 1 1 1 1 1 1 1 3 2
0 4 4 1 2 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 2 2
9 3 2 2 1 1 1 2 1 666 2 4 666 666 666 666 666 3 666 666 666 666 666 666 2 666
3 5 2 1 2
0 3 3 1 2 1 1 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2
7 3 5 1 1 2 1 1 1 1 1 1 1 1 2
3 4 1 1 2
1 3 5 1 1 2
2 2 4 1 2 1 999 999 999 999 999 999 999 999 999 999 2 2 2 1 2 2 2 2 2 2 1
2 5 1 1 2
8 1 4 1 1 2
8 1 999 2 1 1 1 1 2 1 1 2 999 2 1 999 999 999 999 999 999 999 999 999 999 999 2
13 4 1 1 2 3 3 3 2 1 1 1 2 2 3 2
4 1 1 2
7 6 4 1 1 1 2 2 2 2 1 1 1 1 2 3 2 1 1 3 3 3 3 3 3 3 2
5 1 1 2 2 2 2 2 2 2 2 2 2 6
999 2 1 2
5 999 1 1 2
0 3 5 1 1 1 2 2 2 3 2 2 3 3 3 999 3 3 2 3 2 3 3 3 3 999 1
6 5 5 1 1 1 1 2 1 1 1 1 2 2 1 2 1 1 1 1 1 1 1 1 1 2 1
10 5 4 1 2 1 2 2 2 2 2 2 2 3 2 3 1 2 2 1 1 2 2 3 2 3 2
6 5 1 1 2
4 4 1 1 2
1 4 4 2 2 1 1 999 999 999 1 2 999 2 2 999 1 999 1 999 999 999 999 1 1 999
0 5 4 2 1 1 2 2 2 999 2 2 999 2 2 2 2 999 666 999 3 999 3 3 3 3 1
6 4 1 1 2 5 5 5 5 5 5 5 5 5 5 1
4 5 3 1 2 1 1 1 1 1 2 1 1 1 1 3 1 1 1 3 3 1 1 1 1 4 2
3 5 3 2 2 1 1 1 1 1 1 1 2 2 1 2 1 1 1 1 1 1 2 2 1 2 2
5 5 1 1 2 2 2 2 1 2 1 2 2 6
9 4 3 1 2 1 1 1 1 1 1 1 1 3 1 3 1 1 1 1 1 1 1 3 1 3 2
  
 
 
 
 
 
 
 
 
 
 
9 4 4 1 2 1 2 2 1 1 1 2 1 1 1 2 1 1 1 1 1 1 1 1 1 2 2
8 4 4 1 2 1 1 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2
7 4 5 1 2 1 1 1 1 2 1 1 2 3 1 2 1 2 1 1 1 1 2 3 1 2 2
999 999 4 2 1 1 2 1 1 1 1 1 666 666 1 666 999 999 999 999 999 999 999 999 999 999 2
6 3 3 1 2 1 1 1 1 1 1 666 3 2 1 3 1 1 1 1 1 666 2 2 1 3 2
0 3 4 1 2 1 999 999 999 999 999 999 999 999 999 999 1 1 1 1 1 1 1 1 1 1 2
3 5 2 1 2
0 3 4 1 2 1 3 3 999 2 2 5 999 3 2 666 2 2 2 999 1 999 3 2 2 666
999 999 4 1 2 1 2 2 2 2 2 2 2 2 2 2 1 1 1 1 1 1 1 1 1 666 1
999 999 5 1 1 1 999 999 1 999 1 1 999 999 1 999 999 999 999 999 999 999 999 999 999 999
9 2 3 1 2 1 2 2 2 2 2 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1 2
6 5 2 1 2
6 5 2 1 2 2 2 2 2 2 2 2 2 2 2
6 5 5 1 1 2 1 1 1 3 1 1 6 1 3 1
5 3 1 1 2
3 5 4 2 1 1 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 2
5 5 1 1 2 2 2 2 3 3 2 3 3 2 3 6 6 6 6 6 6 6 6 6 6 2
4 1 2 2 2 2 2 3 2 1 2 3 2 6 2
5 5 1 1 2
1 5 5 1 1 2 1 1 1 1 1 1 1 1 1 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix 18 – Clinician Questionnaire Raw Results (Surgeons) 
 
  
 
Are you male or female? (Please choose below)Could you t ll us your age? (Please enter below)What is your designation? (Please choose a response below)How many y ars have you been a consultant for?  (Please choose one response below)Ove  the past year, how many pati nts did you see f r surgical consultation as radical cystectomy candidates?  (Please enter below)H  many of the following urinary div rsi n did you erform with radical cystectomy in the pas  year?  (Please nter for each type of diversion below)How often do you c v r th f llowing opics when you di uss ILEAL CONDUIT with your pati nt during the pre-surgery consultation?  (Please choose one response for each topic below)Do you cover any other topics?  (Please comment below)How often do y u cover the foll wing topics hen you discuss ORTHOTOPIC NEOBLADDER with your patient during the pre-surgery consultation?  (Please choose one response for each topic below)Do ou cover any other topics?  (Pleas comment below)Apart fr m yourself, who el d  y u think helps a atient choose between the two urinary diversion methods? (Please choose as many as applicable below)Do you use any f the following materials to help your patient choose a diversion m thod? If so, how helpful are they? (Please choose one reponse for each material listed below)Please t ll us more about why, apart from unavailability, that you did not us  some of the materials listed in the previous question.  (Please comment below) D  y u ny oth r materials and how useful are they?(Please comment below)In rd r o lp future patients choose a diversion that suits th m best, we are hoping to develop decision support which provides information on the two urinary diversion options and determines what is important to patients.  Which is your most preferred format of support? (Please choose one response below)Which one  the following t men would you most agree with?  (Pl ase choose one response below)Any ddi i nal comments? (Please provide below)We would lik  o invite y u to participate further in nother study, as an independent healthcare professional involved in the decision making about urinary diversion with radical cy tectomy for bladder cancer.      In this other study, we hold intervi ws with healthcare professionals and patients to explore the factors taken into account by both parties, when choosing a urinary diversion with cancer cystectomy.  The findings from these interviews will be used in designing decision support to help future patients choose the most individually suitable urine diversion.  Your participation involves an individual telephone interview which lasts for about 45 minutes or less, with a member of our research team.    If you are interested in participating in this interiew study, or would like to learn more about it before deciding to participate - please tick below and provide us with your contact details on the next page.  We will then forward you the study documentation for your further consideration.    
ResponseOpen-Ended ResponseResponseResponseOpen-Ended ResponseIleal ConduitOrthotopic NeobladderTechnical description of ileal conduit formationB nefits of hav ng ileal conduit Advers  outcomes f ileal conduitPr bab lities of btaining the benefits of ileal conduitP obabili ies of adverse outc mes of ileal conduitCo rse of r covery in hospitalCourse of rec very after discharge from hospitalCourse of recovery in hospitalD ily care after d scharge from hospitalEmploymentLeisure activities/Sports/TravelBodily appearance after surgerySexual mattersOp n-End d ResponseTechnical description of orthotopic neobladder formationBenefits of having rthotopic neobladdeAdverse ou c mes of orthotopic ne bladderPr babilities of btaining the benefits of orthotopic neobladderProbabili i s of advers  outc mes f orthotopic neobladderCourse of r covery in hospitalCourse of rec very after discharge from hospitalDaily care after discharge from hospitalEmpl yme tL isure activities/Sports/TravelBodily appearance after surgerySexual mattersOp n-End d ResponseSpecialist/Stoma NurseSpouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support Groups (e.g. Uro tomy Association)Other (Please state relati nship/r le/pr fession)Intern t (Web ites)L aflets/BookletsDVDs/VideosAudio CDsModels/AppliancesPictures Audio CDsInternet (Websites)L aflets/BookletsDVDs/VidoesAudio CDsModels/AppliancesPictures Open-Ended ResponseResponseOther (can be combination of above, please state below)ResponseOpen-Ended ResponseResponse
Male 56 Consultant16 to 20 years 10 8 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery time SometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimes Specialist/Stoma Nurse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Neutral Helpful Neutral Neutral Helpful Helpful Leaflets/Booklets I would prefer that my patient makes the decision about the diversion, after seriously considering my opinionYes - I a  interested.
Male 59 Consultant999 999 999 999
Male 44 Consultant6 to 10 years 40 26 10 Every timeEvery timeEvery timeVery often Very often Every timeVery often Very often SometimesSometimesVery often Every time Every timeEvery timeEvery timeVery often Every timeEvery timeEvery timeVery often SometimesVery often Every timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryDon't use - material not availableHelpful Don't use - material not availableDon't use - m teri l not availableNeu ra Helpful Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointly
Male 47 Consultant11 to 15 years 12 8 4 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeVery often Very often Every timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Every timeEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryNeutral Helpful Helpful Don't use - material not availableHelpful Very helpful variable quality on information DVD/Videos I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 41 Consultant999 999 999 999
Male 53 Consultant16 to 20 years 0 0 6 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimes SometimesNot discussedEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimesEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Don't use - material n t availableVery helpfulDon'  use - material not availableDon't use - m teri l not availableDon't use - m teri l not availableVery helpful Internet (Websites) I would prefer to leave the decision about the diversion to my patientYes - I am interested.
Male 53 Consultant16 to 20 years 18 15 3 Very often Every timeEvery timeVery often Very often Every timeVery often Every timeEvery timeEvery timeEvery timeEvery timeSatisfaction at one year    Variety of stoma bags    Meeting with stoma nurse and a patient with a stoma if wantedEvery tim Every timeEvery ti eEvery tim Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeAbsolute necessity of ability to self catheterise    Absolute essential to empty every 4 hours    Emphasise these things as the patients sole responsibilitySpecialist/Stoma Nursepouse Other patients who had und rgone similar surgeryUrol gy ca c r specialty nursesNeutral Helpf l Helpful Don't use - mat rial not availablDon't use - m teri l not availableHelpful difficult to access in the clinic DVD/Videos I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 57 Consultant999 999 999 999
Male 47 Consultant11 to 15 years 0 0 0 Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Don't use - oth r rea n(s)Don't use - other reason(s)Don'  use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s) As stated, I do not personally carry out radical cystectomy and hence do not counsel patients about diversion etc.Leaflets/Booklets I believe that if the patient is suitable for either procedure, then after appropriate counselling, the patient should make their own decision.
Male 39 Consultant0 to 5 years 60 37 3 Not very oftenNot very oftenVery often SometimesEvery timeEvery timeEvery time Every timeVery often Very often Very often Very often Not very oftenVery often Every timeVery often Every timeEvery timeEvery timeEvery timeVery often Very often Very often Very often Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Very helpfulVery helpfulVery helpfulHelpful Helpful Helpful BAUS regional guidesregional guides DVD/Videos I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 61 Consultantover 20 years 0 0 0
Male 53 Consultant16 to 20 years 0 0 0
Male 45 Consultant6 to 10 years 15 11 4 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time SometimesNot discussedV ry often Every timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeNot discussedV ry often Every timeEvery time Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Clinical ncology nu e speciali tHelpful Hel ful Don'  use - material not availableDon't use - m teri l not availableVery helpfulVery helpful I have none availableNot sure how this would help! DVD/Videos I would prefer to leave the decision about the diversion to my patientYes - I am interested.
Male 46 Consultant6 to 10 years 0 0 0
Male 45 Consultant0 to 5 years 20 0 0 Every timeEvery timeVery often Very often Very often Every timeEvery time SometimesVery often Very often Very often Very often no Every timeEvery timeEvery timeVery often Very often Very often Very often Very often Every timeEvery timeEvery timeEvery timeno Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Helpful Helpful Neutral Don't use - material not availableDon't use - m teri l not availableHelpful Leaflets/Booklets I would prefer to leave the decision about the diversion to my patientYes - I am interested.
Male 63 Consultant999 999 999 999
Male 51 Consultant6 to 10 years 18 18 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Not very oftenNot discussedV ry often Very often Every timeEnsure that stoma therapist input is always available.Every timeEvery t meEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeNot very oftenEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryNeutral Helpful Don't use - material not availableDon't use - m teri l not availableDon't use - m teri l not availableVery helpful DVD/Videos I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 54 Consultant16 to 20 years 30 25 5 Every timeEvery timeEvery timeVery often Every timeEvery timeEvery time Every timeVery often Very often Every timeEvery timeRisk of serious complications and operative mortality    Need for blood transfusion where required    Domestic circumstances / help at home    Tissue banking for researchEvery ti eEvery timeEvery timeEvery timeEvery timeEvery imeEvery timeEvery tim Very ften Very often Every timeEvery ti eNeed for IS Catheterisation  Nocturnal Incontinence  Diurnal incontinence  Complications   Domestic circumstances / help at home  Tissue banking for researchSpecialist/Stom ursepouse Relatives/frie dsOth r patients who had undergone simil r surgeryPatient Support G oups (e.g. Ur stom  Association)Helpful Very helpfulNeutral Neutral Neutral Very helpful Used with caveats about variability of the quality / accuracy of some sitesno available Other (can be combination of above, please state below)Combination f leaflets, DVD videos and the InternetI w uld prefer that my patie t and I make he decision about the diversion jointlyYe  - I am inter st d.
Male 47 Consultant6 to 10 years 6 6 0
Male 40 Consultant0 to 5 years 0 0 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeSometimesSometimesVery often Sometimes Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Specialist/Stoma Nurse Other patients who had undergone similar surgeryHelpful Helpful Helpful DVD/Videos I would prefer to leave the decision about the diversion to my patient
Male 55 Consultant16 to 20 years 0 0 0 Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed I refer all patients who need this form of surgery to 1 of 2 Consultant colleagues. However my impression is that in Cardiff most patients have an ileal conduit diversion.Don'  use - other reason(s)Don't use - ther reason(s)Don't use - other reason(s)Don't use - other reaso (s)Don't use - other r son(s)Don't use - other reason(s) I do not advi e patients on this subjectOther (ca  be combination of above, please state below)none I w uld prefer to m k the decision about the diversion, after seriously considering my patient's opinionI think the 4th option above would be be t
Male 44 Consultant0 to 5 years 4 0 0
Male 62 Consultant16 to 20 years 12 6 2 Every timeEvery timeVery often Very often Very often Every timeEvery time Very often SometimesSometimesEvery timeVery often Patient under the age of 70 who are motivated enough and  with good renal function, always discuss neobladder if the prostatic urethral biopsy in the male and bladder neck in the female is negative.Every tim Every timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Very often SometimesEvery timeVery often regularly provide at east u ilateral n rv  spar ng cys ectomy in selected patients. I try and infuse enthuasism into these patients so that after the initial 6 months of hard work their quality of life improves. I always ask if they would be happy to speak to the next oatient deciding to have a neo bladder. Every patient have agreed to do this.Specialist/Stoma Nursepo s Relati s/friendsOther patients who had undergon  simila  surgeryPatient Support G oups (e.g. Urostom  Association)ur logy n rs  specisli s.Helpful Very helpfulVery helpfulNeutral Neu ral Very helpful patients now a days are internet savvy !They can take thes  away and read further in the comfort of their homes.upda  the visible xperienceI don't hav  this avail blelimited availabilityvery resourceful and practical.DVD/Videos I would prefer tha my patient and I make the ecision about the diversion join lyYes - I am interested.
Male 44 Consultant6 to 10 years 15 12 0 Very often Very often Very often Very often Very often Every timeEvery time Every timeVery often Every timeEvery timeEvery timeRisks of major pelvic surgery. ITU and post operative care. Implications on quality of life and impact .S metimesVe y often Very often Very often Very often Very often Very often Very often Very often Very often Very often Very often Will tend to refer for neobladderSpecialist/St ma Nursepouse Relatives/friends Don't use - other reason(s)Don't use - material not availableNot particularly helpfulNot p rtic arly helpfulHe pful Helpful Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointly
Male 56 Consultant16 to 20 years 2 2 999 Very often Very often Very often Very often Very often Very often Sometimes SometimesSometimesSometimesSometimesNot very often SometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimes Specialist/Stoma NurseRelatives/friends Not particularly helpfulNeutral Neutral Neutral Neutral Neutral Tends to be US based and extremist Other (can be combination of above, please state below)Dis ussio  with the c nsultant UrologistI uld prefer that my patient and I make the decision about the diversion jointly
Male 43 Consultant6 to 10 years 25 23 2 Every timeEvery timeVery often Very often Very often Every timeEvery time SometimesNot very oftenNot very oftenNot very oftenVery often Just To clarify the above question, Our stoma nurse sees patient and discusses daily care after discharge, complications, lesiure activities, bodily apperance etcEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEv ry timeEv ry timeEvery timeEvery timeEvery tim Every time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Oncology ur  specialistVery helpfulVery helpful Very helpful Christie hospitalStoma booklet stoma bags shown by stoma nurseRoutinely advise patients interested in orthotopic bladder to talk to someone who had surgeryInternet (Webs tes) I would prefer that my patient and I make the decision about the diversion jointlyYes - I m interested.
Male 44 Consultant6 to 10 years 17 14 3 Very often Very often Very often Very often Very often Very often Very often SometimesSometimesSometimesVery often SometimesPossible need for revision. Risk of uretero-ileal stricture and need for intervention, revision, re-implaqntation.Very oft n Very often Very often Very often Very oft n Very oft n Very oft n S metimesSometimesSometimesVery often SometimesNeed for patient to relearn how to void/empty neo-bladder. Ability to perform ISC.  Importance of regular emptying and timed voiding.  Pelvic floor exercises to help recover continence.  Risk of upper tract deterioration.  risk of metabolic acidosis and symptoms of same. Possible need to take Sodium bicarbonate to counter acidosis.  Need for urethral surveillance.Specialist/Stoma Nursepouse Oth r patients who had undergone similar surgeryPatient Support G oups (e g. Ur stom  Association)Helpful Helpful Helpful Not particularly helpfulHe pful Helpful equires visual cues as well as verbalSurgical Atlas from BJUI 2004, Professor Studers excellent illustrati n of formation of orthotopic ne bladderOther (c n be combination f ab ve, please tate below)DVD and explanatory bookletI w uld p efer that my patient makes the decis on about e diversi n, fter seriously considering my opinionYe  - I a  interested.
Male 63 Consultantover 20 years 0 0 3
Male 53 Consultant16 to 20 years 999 999 999
Male 52 Consultant11 to 15 years 25 19 2 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimes SometimesNot very oftenSometimesSometimesEvery time Every timeEvery timeEvery timeEvery timeEvery timeVery often Very often SometimesNot very oftenSometimesVery often Every time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryNeutral Very helpfulNeutral Don't use - material not availableDon't use - m teri l not availableVery helpful DVD/Videos I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 38 Consultantover 20 years 40 20 2
Male 50 Consultant11 to 15 years 20 14 6 Every timeVery often Very often Very often Very often Very often Sometimes SometimesSometimesNot very oftenNot very oftenVery often Every timeEvery timeEvery timeEvery timeEvery timeVery often Very often Very often SometimesSometimesSometimesVery often Specialist/Stoma Nurse Other patients who had undergone similar surgeryHelpful Very helpfulHelpful Helpful Helpful Helpful encourge patients to use itdo use themDont have themNot availableNot availableSometimes use themDVD/Videos I would prefer to make the decision about the diversion, after seriously considering my patient's opinionYes - I am interested.
Male 57 Consultant999 999 999 999
Male 40 Consultant0 to 5 years 0 0 0 Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Specialist/Stoma Nurse Other patients who had undergone similar surgeryDon't use - oth r reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s) Internet (Websites)
Male 44 Consultant6 to 10 years 25 8 5
Male 57 Consultant11 to 15 years 0 0 0
Male 57 Consultantover 20 years 30 25 5 SometimesEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Very often Not very oftenSometimesSometimesEvery time SometimesEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often SometimesSometimesSometimesEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgery
Male 50 Consultant16 to 20 years 21 21 0 Every timeEvery timeEvery timeVery often Very often Every timeEvery time Every timeEvery timeEvery timeEvery timeVery often Risks of mucous and bacterial colonisation often labelled by GP's as infection  Follow up in terms of imaging and renal function  Potential changes in stoma in relation to future changes in body habitusSometimesSom t mesS metimesSometim sSometimesSometimesSometimesSome ime S metimesSometimesSometimesSometimesAlways di cuss reconstruction as a possibility an  outline what is involved and the need for referral to regional centre. If the patient is interested all of the above would be coveredSpecialist/St ma N rse Other patients ho had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Neu ral Helpful Neutral Don't us  - material not availableDon't use - m teri l not availableNeu ra Other (can be combination of above, please state below)Leaflets/booklets could also be on he internet along with DVD/VideosI w uld prefer that my pati nt makes the decision about the diversion, after seriously considering my opinion
Male 49 Consultant11 to 15 years 10 0 0 Every timeEvery timeEvery timeEvery timeEvery timeSometimesSometimes SometimesSometimesSometimesEvery timeEvery time
Male 47 Consultant6 to 10 years 35 28 7 SometimesVery often Very often Not very oftenSometimesEvery timeEvery time SometimesSometimesSometimesSometimesEvery time Very often Very often Very often Very often Very often Very often Every timeVery often SometimesSometimesSometimesEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Helpful Helpful Helpful Neutral Helpful Helpful The Nurse Specialist deals with thisLeaflets/Booklets I would prefer that my patient makes the decision about the diversion, after seriously considering my opinionI leave the final decision to the patient together with our nurse specialistYes - I a  interest d.
Female 46 Consultant6 to 10 years 0 0 0
Male 52 Consultant11 to 15 years 7 0 0 Every timeEvery timeVery often Every timeEvery timeEvery timeVery often Very often Very often Very often Very often Very often Very often Every timeEvery timeEvery timeEvery timeEvery timeVery often Very often Very often Very often Every timeVery often Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryHelpful Helpful Helpful Neutral Neutral Helpful Internet (Websites) I would prefer that my patient makes the decision about the diversion, after seriously considering my opinionYes - I a  interested.
Male 53 Consultant11 to 15 years 0 0 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeNot very oftenVery often Every timeSometimesI only do ileal conduit diversion for benign disease (BPS/IC).Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedI don't do cystectomy.Specialist/Stoma Nurse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Helpful Helpful Don'  use - material not availableDon't use - m teri l not availableDon't use - m teri l not availableHelpful I don't do cystectomy.  I only do an occasional ileal conduit diversion for benign disease.Ditto Ditto Other (can be c m i ation of bove, please state below)Patient support groups and other pati nts who have had ileal conduit are my most useful methods.I w uld prefer that my tie t makes the decision about the diversion, after seriously considering my opinion
Male 45 Consultant0 to 5 years 5 3 2 Very often Every timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeVery often Very often Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Specialist/Stoma Nurse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Very helpfulVery helpfulDon'  use - material not availableDon't use - m teri l not availableHelpful Very helpful Other (can be combination of above, please state below)both we  b sed and booklet/leaflet informationI w uld prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 42 Consultant0 to 5 years 12 11 1 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Very often Very often Very often Every timeVery often Natural history of living with ileal conduitEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Very often Every timeEvery timeI discuss Possible sequelae- no neccessarily a complicationSpeciali t/Stoma Nursepouse Other patients who had undergone similar surgeryNot particula ly helpfulVer Very helpfulNot particularly helpfulNeutral Helpful My own hand drawn picturesDVD/Videos I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 44 Consultant6 to 10 years 20 12 3 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeSelf cath  Mucous  Night time incontinence   Annual cystoscopy  May not be possible to create orthotopicSpecialist/Stoma Nursepouse Other patients who had undergone sim lar surgeryPatient Support G oups (e.g. Urostom  Association)Helpful Helpful Neutral Don't use - material not availableHelpful Very helpful Other (can be combination of above, please state below)All bar audioI w uld prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 45 Consultant6 to 10 years 6 4 999 Every timeEvery timeVery often Very often Very often Every timeSometimes SometimesNot very oftenSometimesSometimesNot very often SometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesNot very oftenNot very oftenNot very oftenSometimes Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Helpful Internet (Websites) I would prefer that my patient makes the decision about the diversion, after seriously considering my opinionYes - I a  interested.
Male 50 Consultant999 999 999 999
Male 54 Consultant999 999 999 999
Male 59 Consultant11 to 15 years 8 6 2 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeNot very oftenVery often Every timeSometimes Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Every timeEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Very helpfulVery helpfulVery helpfulNot particularly helpfulNot partic arly helpfulVer Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointly
Male 40 Consultant0 to 5 years 28 24 4 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryDon't use - material not availableVery helpfulDon't use - material not availableDon't use - m teri l not availableVery helpfulVery helpful Enhanced recovery literatureDVD/Videos I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 54 Consultant16 to 20 years 5 0 0 Every timeEvery timeVery often Very often Very often Every timeVery often Very often SometimesEvery timeVery often Every time Every timeEvery timeEvery timeVery often Very often Very often Very often Every timeSometimesEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Relatives/friends Neutral Helpful Neutral Neutral Helpful Neutral Some of my patients have no internet accesssNot sure what is availableNot ure what is available Internet (Websites) I would prefer that my patient makes the decision about the diversion, after seriously considering my opinion
Male 53 Consultant16 to 20 years 60 35 25 Every timeEvery timeEvery timeVery often Every timeEvery timeEvery time Every timeSometimesEvery timeEvery timeEvery timeThey all see a stoma nurse in OP  Many of these issues are also cover by the CNS   It is supplemented with written informationEvery ti eEvery timeEvery timeEv ry timeEvery timeEvery timeEvery timeEvery timeSometimesEvery timeEvery timeEvery timeThey all see a stoma nurse in OP  I offer a meeting with an expert patient  It is supplemented with written informationSpecialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surg rythe w b Helpful Neutral Don'  use - material not availableDon't use - m teri l not availableHelpful Helpful Other (can be combination of above, please state below)internet leaflets/ books and DVDI w uld prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 61 Consultantover 20 years 15 10 2
Male 61 Consultantover 20 years 10 7 3 Every timeEvery timeEvery timeEvery timeVery often Every timeEvery time SometimesEvery timeSometimesVery often Every time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimesEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryNeutral Helpful Don't use - material not availableDon't use - m teri l not availableDon't use - m teri l not availableDon't use - m teri l not available Most useful assistance is patient "buddy".  We are in the process of making a video / CD for patients.DVD/Videos I woul  prefer that my patient and I make the decision about the diversion jointlyY s - I am interested.
Male 55 Consultant16 to 20 years 0 999 999
Male 43 Consultant6 to 10 years 10 9 1 Every timeVery often Every timeEvery timeEvery timeEvery timeVery often SometimesVery often Very often SometimesSometimes Every timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Very often SometimesVery often Very often Very often Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Neutral Very helpfulNeutral Not particularly helpfulHe pful Very helpful Need visualisation Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointly
Male 43 Consultant6 to 10 years 0 0 0 Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedPatients for cystectomy are referred to specialist centreNot dis ussedNot discussNot discussedNot discuss dNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Neutral Very helpfulVery helpfulNeutral Very helpfulVery helpful Leaflets/Booklets I would prefer to make the decision about the diversion, after seriously considering my patient's opinionI do not do urinary diversions but I hope the answers I have provided are hel ful!
Male 41 Consultant0 to 5 years 2 0 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Very often Very often Very often Very often SometimesMy patients are transplant patients and I discuss implications of their urinary drainage on their transplant as wellNot discu sedV ry often Very often Very often Very often Not discussedNot discussedNot discussedNot discu sedNot discussedNot discussedNot discussedMy patients are transplant patients and I discuss implications of their urinary drainage on their transplant as well - we have not done any orthotopic neobladders in transplant patients yet so the above answers dont really applySpecialist/Stoma Nursepouse Rel tives/friendsOther patients who had undergone similar surgeryP e t Support G oups (e.g. Urostom  Association)Helpful Helpful N utral they meet the stoma nurse with me and see what appliances are  and how they would fit etcL aflets/Bookl ts I woul  prefer that my pati nt and I make the decision about the diversion jointly
Male 55 Consultant999 999 999 999
Male 64 Consultantover 20 years 20 10 2 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeVery often The difficulty with this questionaire is that you only offer 2 alternatives when there are actually 4 - I also offer Mainz 2 and Mitrofanoff. I decide on which of these is reasonable for the patient and then counsel on those. Pts are also counselled by a CNS. My numbers in this survey are, therefore, meaningless.Every timeEvery timeEvery timeEvery timeEvery timeE ry timeEv y timeEvery timeEvery tim Every timeEvery timeVery often Ma y of evacuation; possibility of CIC; man g me t of inconti ence especially at night.Specialist/Stoma Nursepouse Other patients who had u dergone similar surgeryPatie t Supp rt G oups (e.g. Uro tom  Association)Very helpfulVery helpful Very helpfulVery h lpful DVD/Videos I would prefer that my patient and I make the decision about the diversion jointly
Male 42 Consultant6 to 10 years 30 20 3 Very often Every timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeVery often Every timeEvery timeEvery timeOffer them the chance to speak to a previous patient with an ICVery often Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Every timeEvery timeEvery timeOffer them the chance to speak to/meet a previous patient with neobladderSp cialist/St ma Nursepous Other patients who had undergone similar surgeryGP has influenced choice in a number of patientsN utral Not particularly helpfulDon't use - ma erial not availableDo 't use - m teri l not availableHelpful Helpful Patients. Nothing can substitute for previous experienceLeaflets/Booklets I would prefer that my patient makes the decision about the diversion, after seriously considering my opinionYes - I a  interested.
Male 52 Consultant11 to 15 years 75 48 4 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeVery often What we think governs the decisions of the patients who we see    The benefits of seeing a specialist nurse and having discussions with, or meetings with patients who have had these proceduresEvery timeEvery timeEvery tim Every timeEvery tim Every timeEvery tim Every timeEvery tim Every timeEvery timeVery often As for Q 8 Specialist/Stoma Nursepouse Relativ /friendsOther patients who had undergone similar surgeryDon't use - oth r reason(s)Neutral Don't use - other reason(s)Don't use - other reason(s)Helpful Helpful We use our own counselling and patient information, as well as nurses and former patientsWe use our own counselling and patient informatio , as well as nurses and former patientsWe use our ow  coun elling a d patient information, as w ll s nurses and former patientsOth r (c  be combi ation of bove, please state below)Possibly all of the above. I s e a very mixed group of patients, who I suspect might individually prefer each of these.I w uld re e  to v the decision about the diversion to my atientTh  atient hould ch ose the diversion having been nformed, rather than persu ded, provided that both options look reasonable and sensible to us.Y s - I am interest .
Male 46 Consultant6 to 10 years 6 6 999 Every timeEvery timeNot discussedEvery timeNot discussedEvery timeEvery time Every timeEvery timeEvery timeEvery timeNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Specialist/Stoma Nurse Other patients who had undergone similar surgeryVery helpful Very helpfulVery helpful Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 60 Consultantover 20 years 0 0 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Very often Very often Every timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Very often Very often Every timeEvery timerevision rate  mortalitySpecialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Neutral Very helpfulHelpful Helpful Helpful Very helpful ignorance don't have oneditto Internet (Websites) I would prefer that my patient makes the decision about the diversion, after seriously considering my opinion
Female 47 Consultant16 to 20 years 0 0 0 Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedI am involved in Urogynaelogy and incontince and not seeing radical cyctectomy pts.Not discussedNot discussedNot discussedNot discus dNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Specialist/Stoma Nurse Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s) Audiotapes/CDs I would prefer that my patient and I make the decision about the diversion jointly
Male 43 Consultant0 to 5 years 0 0 0
Male 41 Consultant0 to 5 years 15 15 0 Every timeEvery timeVery often Very often Every timeEvery timeEvery time Very often Not very oftenVery often Every timeNot very often Every timeEvery timeEvery timeVery often Every timeEvery timeVery often Very often Not very oftenVery often Very often Very often Specialist/Stoma Nurse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)G.P. Don't use - material n t availableVery helpfulDon'  use - material not availableDon't use - m teri l not availableVery helpfulVery helpful Internet (Websites) I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 53 Consultant11 to 15 years 0 0 0
Male 47 Consultant11 to 15 years 20 15 5 Every timeEvery timeEvery timeVery often Very often Every timeEvery time Very often SometimesSometimesEvery timeVery often Every timeEvery timeEvery timeVery often Very often Every timeEvery timeEvery timeVery often Very often Every timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryVery helpfulVery helpfulHelpful Neutral Neutral Helpful Internet (Websites) I would prefer that my patient makes the decision about the diversion, after seriously considering my opinionYes - I a  interested.
Male 39 Consultant0 to 5 years 14 10 4 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeSometimesSometimesEvery timeVery often Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Every timeVery often Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryCancer specialist nurseDon't use - material not availableDon't use - m teri l not availableDon't use - m teri l not availableDon't use - m teri l not availableDon't use - m teri l not availableVery helpful
Female 48 Consultant11 to 15 years 15 15 999 Every timeEvery timeEvery timeNot discussedV ry often Every timeEvery time Every timeEvery timeEvery timeEvery timeEvery timePatients often ask about the ease of care of each option if they are incapable of own personal care in the futureEvery timeEvery timeEvery timeNot discussedEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryHelpful Very helpfulDon't use - material not availableDon't use - m teri l not availableHelpful Very helpful Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointlyA large proportio  of my cyst ctomy patie ts are elderly +/-not very IT literate so written information needs to be availableYes - I am intere ted.
Female 48 Consultant6 to 10 years 0 0 0
Male 57 Consultantover 20 years 0 0 0 Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed I don't do any cancer surgeryDon't us  - oth  reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s) Other (can be combination of above, please state below)I don't do c ncer surgeryI w uld p efer to v the decision about the diversion to my patientYou should have had a  opt out question right at the b ginning!
Male 55 Consultant999 999 999 999
Male 37 Consultant0 to 5 years 5 5 0 Every timeEvery timeEvery timeVery often Very often Every timeVery often Very often SometimesVery often Very often Very often robotic vs openEvery timeEvery timeEvery timeVery often Very often Every timeVery often Every timeVery often Very often Every timeVery often robotic vs openSpecialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Helpful Very helpfulHelpful Not particularly helpfulHe pful Helpful Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointly
Male 42 Consultant0 to 5 years 10 8 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Very often Very often Very often Very often Very often Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Very often Very often Very often Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Neutral Helpful Don'  use - other reason(s)Don't use - other reason(s)Helpful Helpful Leaflets/Booklets I would prefer that my patient makes the decision about the diversion, after seriously considering my opinion
Female 48 Consultant6 to 10 years 0 0 0
Male 60 Consultantover 20 years 6 6 0 Every timeEvery timeEvery timeSometimesEvery timeEvery timeSometimes SometimesSometimesEvery timeEvery timeEvery timeAlternative of orthotopic bladderEvery timeEvery timeEvery timeSometimesEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeContinence and self catheterisationSpecialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Neutral Helpful Don'  use - material not availableDon't use - m teri l not availableHelpful Helpful Commercial bias Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointly
Male 52 Consultant11 to 15 years 0 0 0
Male 45 Consultant6 to 10 years 10 0 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time SometimesSometimesSometimesEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often SometimesEvery timeEvery time Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryNeutral Very helpfulNeutral Neutral Neutral Very helpful Patients not always able and further serches lead to erroneus informationI don't think this helps patients and is more for the surgeons benefit to demonstrate abilities than anything elseLeaflets/Bo klets I w uld prefer hat y pa ient nd I make the dec sion about the diversion jointly
Male 46 Consultant6 to 10 years 0 0 0 Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed na
Male 62 Consultant999 999 999 999
Male 55 Consultant16 to 20 years 0 0 0 Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedEn ourologist, ttherefore do not deal with these patients.Not discussedNot discuss dNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Specialist/Stoma Nurse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Don't use - oth r rea n(s)Don't use - other reason(s)Don'  use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Practice endourologyditto ditto ditto ditto ditto Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointly
Male 52 Consultant16 to 20 years 30 26 4 Every timeEvery timeEvery timeVery often Every timeEvery timeVery often SometimesVery often Every timeEvery timeVery often Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Relatives/friends Patient Support Groups (e.g. Urostomy Association)Helpful Helpful Helpful Neutral Helpful Helpful better to see than just listen Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointlywhat the patinet woul  like to have and what is appropriate may no  be the same
Male 41 Consultant0 to 5 years 5 1 4 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryVery helpfulVery helpfulVery helpfulDon't use - other reason(s)Don't use - other reason(s)Very helpful dont use as have other aids Internet (Websites) I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 41 Consultant6 to 10 years 2 0 0
Male 38 Consultant0 to 5 years 0 0 0
Male 47 Consultant6 to 10 years 21 18 3 Every timeEvery timeEvery timeNot discussedEvery timeEvery timeEvery time SometimesVery often Very often Every timeVery often Follow up  Adjuvant treatmentsEvery timeEvery timeEvery timeNot discussedEvery timeEvery timeEvery timeEvery timeVery often Very often Every timeSometimesIt rather depends what detail "recovery after hospital and daily care after discharge" means.  We routinely discuss the need for regular voiding to completion, voiding at night with the use of an alarm clock, increased daily fluid intake, daily salt supplementation, expected day and night time continence rates and isc rates, the possible need for oral bicarbonate.Specialist/Stoma Nurse Other p tie ts who h d undergone similar surgeryHelpful Very helpful Availability Other (can be combination of above, pl ase st te below)Different p tie t will find diff rent sources of informatio  useful.I w uld prefer that my patient makes the decision about the diversion, after seriously considering my opinionI  my experienc having acc ss to a bank of p tients willing to s ak to new pati nts consider ng the options is invaluable.Y s - I a  interested.
Female 44 Consultant6 to 10 years 0 0 0
Male 42 Consultant0 to 5 years 20 15 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Very often SometimesVery often Every timeSometimes Not very oftenSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimes Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Don't use - oth r rea n(s)Don't use - other reason(s)Don'  use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s) DVD/Videos I would prefer that my patient makes the decision about the diversion, after seriously considering my opinion
Male 57 Consultant6 to 10 years 4 0 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Not discussedNot discussedEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeNot discussedNot discussedEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Don't use - oth r rea n(s)Don't use - other reason(s)Don'  use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Very helpful Our stoma nurses show them the picturesLeafl ts/B oklets I would prefer that my patient and I make the decision about the diversion jointly
Male 50 Consultant16 to 20 years 18 15 3 Every timeVery often Very often Very often Very often Very often Very often SometimesSometimesVery often SometimesEvery time Every timeEvery timeEvery timeVery often Very often Every timeEvery timeEvery timeVery often Very often Every timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryDon't use - oth r reason(s)Helpful Don't use - other reason(s)Helpful Helpful Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 40 Consultant0 to 5 years 10 9 1 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeI personnally don.t cover the last 5 topics, although I do discuss sexual function. The other 4 are discussed by the specialist colorectal/stoma nurses.Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeI also discuss that I do not perform this operation on a regular basis and if the operation is proving very challenging, I may convert to an ileal conduit. I also offer the patients the opportunity to travel to the major teaching hospital (Edinburgh) which is 200 miles away.Speci list/Stoma Nursep us Relatives/friends Don't use - material not availableDon't use - m teri l not availableDon't use - m teri l not availableDon't use - m teri l not availableVery helpfulVery helpful I d n't specific lly know of any.We have them for IC but not for orth topic.Used regul rly by stoma nursesI use them regularly. Leaflets/Booklets I would prefer that my patient makes the decision about the diversion, after seriously considering my opinionI think leaflets and booklets are st ll the m s applicable as many older people still do not use the internet. However an internet source of information should also be developed as this will obviously turn into the major source of information as time progresses. Pictures and DVD's etc should just be incorporated into the website.    I think it is also important to remember continent diversion as a viable option of diversion for all patients who are not suitable for orthotopic for cancer reasons. This material should be developed at the same time as IC and orthotopic.Yes - I a  int rested.
Male 61 Consultantover 20 years 20 14 2
Male 49 Consultant11 to 15 years 10 8 2 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeNot very oftenEvery timeEvery timeVery often Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Very often SometimesVery often Specialist/Stoma Nurse Other patients who had undergone similar surgeryVery helpful Very helpful DVD/Videos I would prefer that my patient and I make the decision about the diversion jointly
Male 41 Consultant999 999 999 999
Male 44 Consultant6 to 10 years 8 4 0 Not very oftenEvery timeEvery timeEvery timeVery often Every timeSometimes SometimesNot very oftenNot very oftenNot very oftenNot very often Very often Every timeEvery timeEvery timeEvery timeVery often Very often SometimesSometimesSometimesVery often Sometimes Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Neutral Very helpfulHelpful Neutral Neutral Very helpful DVD/Videos I would prefer that my patient and I make the decision about the diversion jointly
Male 57 Consultantover 20 years 55 31 9 Very often Very often Very often Very often Very often Every timeEvery time Every timeNot discussedNot very oftenNot very oftenSometimes Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimesSometimesSometimesSometimesThere is a difference in responses here between orthotopic and conduit, which is explained by the fact that a proportion of patients will never be considered for orthotopic in the first place.Sp cialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryl ts of patient  trawl the internet and can be heavily i fluenced by hat th y findHelpful H lpful Don't use - material ot av ilableDon't use - m ter l not availableHel ful Helpful Why do I ne d a reason other than unavailability - that is the reasonditto DVD/Videos I would prefer to leave the decision about the diversion to my patientI would pr fer to allow the patient to d cide but this is heavily influenced by many factors as well as my opinion and advice - What are the patients own motivators? How much value do they assign to various aspects of their future?    I fear that most patients are still most influenced by what I say - the shift in my own prejudice towards allowing orthotopic to be the default position has been closely mirrored by the increasing proportion of patients submitting themselves for this option.Yes - I am int rested.
Female 43 Consultant6 to 10 years 0 0 0
Female 42 Consultant0 to 5 years 0 0 0 Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussed Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgery
Male 51 Consultant16 to 20 years 8 8 0 Every timeVery often SometimesNot discussedNot discussedEvery timeVery often Not discussedNot discussedSometimesSometimesSometimes Not discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussedNot discussed Specialist/Stoma Nurse Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s) Leaflets/Booklets I would prefer to make the decision about the diversion, after seriously considering my patient's opinion
Male 38 Consultant0 to 5 years 40 25 10 Every timeEvery timeEvery timeSometimesSometimesEvery timeEvery time SometimesSometimesVery often Very often Sometimes Every timeEvery timeEvery timeSometimesSometimesVery often Very often Very often SometimesSometimesSometimesSometimes Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryNot particula ly helpfulHe pful Very helpfulNot particularly helpfulHe pful Helpful DVD/Videos I would prefer that my patient and I make the decision about the diversion jointly
Male 48 Consultant11 to 15 years 15 13 2 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Helpful Helpful Helpful Helpful Neutral Helpful Internet (Websites) I would prefer that my patient makes the decision about the diversion, after seriously considering my opinion
Male 45 Consultant6 to 10 years 0 0 0
Male 49 Consultant6 to 10 years 5 0 0
Male 44 Consultant6 to 10 years 20 10 5 Very often Very often Very often Very often Very often Very often Very often Very often SometimesSometimesSometimesVery often Very often Very often Very often Very often Very often Very often Very often Very often SometimesSometimesSometimesVery often Specialist/Stoma Nurse Other patients who had undergone similar surgeryDon't use - material not availableHelpful Helpful Helpful Neutral Neutral DVD/Videos I would prefer to leave the decision about the diversion to my patientYes - I am interested.
Male 37 Consultant0 to 5 years 30 25 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often SometimesSometimesSometimesSometimesSometimesEnhanced recoverySometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimesSometimes Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Helpful Helpful Neutral Not particularly helpfulHe pful Helpful Excellent BAUS info now on CystectomyI have locally developed infot o xpen iver placed by internetI get patient to wear dummy ileal conduit from a companyInternet (Websites) I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 45 Consultant6 to 10 years 30 8 2 Every timeEvery timeVery often Every timeEvery timeEvery timeEvery time SometimesVery often Very often Every timeVery often Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimesVery often Very often Every timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryHelpful Very helpfulHelpful Not particularly helpfulVer Very helpful need pictures Leaflets/Booklets I would prefer that my patient makes the decision about the diversion, after seriously considering my opinionYes - I a  interested.
Male 55 Consultant11 to 15 years 10 9 1 Every timeEvery timeEvery timeEvery timeEvery timeVery often Very often Very often SometimesSometimesEvery timeEvery time Very often Very often Very often Very often Very often Very often Very often Very often SometimesSometimesSometimesSometimes Specialist/Stoma Nurse Other patients who had undergone similar surgeryOncology CNSVery helpfulVery helpfulHelpful Helpful Helpful Very helpful Internet (Websites) I would prefer that my patient and I make the decision about the diversion jointlyYes - I am interested.
Male 48 Consultant11 to 15 years 6 5 1 Every timeEvery timeEvery timeVery often Every timeEvery timeEvery time SometimesSometimesNot discussedNot very oftenEvery time
Male 40 Consultant0 to 5 years 30 28 2 Every timeEvery timeEvery timeVery often Very often Every timeEvery time Every timeSometimesEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimesEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryNeutral Helpful Neutral Neutral Neutral Neutral Dont know where to lookoften useddont have anydont have anytoo technicaldont have any Leaflets/Booklets I would prefer that my patient and I make the decision about the diversion jointly
Female 40 Consultant0 to 5 years 10 8 0 Very often Very often Very often Very often Every timeVery often Not very often Not discussedSometimesVery often Very often Very often Risks of surgery and other options for treatmentVery often Very ften Very oft n Not very oftenVery often Very often Not very oftenNot discussedSometimesSometimesVery often Very often Referral to colleague as I don't perform this type of reconstructionSpecialist/Stoma Nursepouse Relatives/friendsOth r patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Oncology urNeutral Helpful Helpful Don't use - other reason(s)Don't use - other reason(s)Don't use - other reason(s)Patient choice for accessFr ely available in cancer centreA  above In xperienceAccess Access Drawings useful as patient feels they are individual to themInternet (Websi es) I would prefer that my patient makes the decision about the diversion, after seriously considering my opinionYes - I a  interested.
Male 55 Consultant16 to 20 years 5 0 0
Male 43 Consultant0 to 5 years 20 15 0 SometimesSometimesSometimesSometimesSometimesEvery timeEvery time SometimesNot very oftenNot very oftenNot very oftenNot very often Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimesSometimesSometimesSometimes Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryNeutral Helpful Don't use - material not availableDon't use - m teri l not availableNeu ra Neutra Leaflets/Booklets I would prefer that my patient makes the decision about the diversion, after seriously considering my opinion
Male 56 Consultant16 to 20 years 0 0 0
Male 55 Consultant16 to 20 years 10 8 2 Very often Every timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Neutral Very helpfulVery helpfulHelpful Neutral Very helpful poor quality control not aware of any Internet (Websites) I would prefer that my patient makes the decision about the diversion, after seriously considering my opinion
Male 38 Consultant0 to 5 years 15 5 0 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimes SometimesVery often Very often Every timeSometimesproven track record of many years of useEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeVery often Very often SometimesVery often Very often Sometimes Specialist/Stoma Nursepouse Relatives/friendsOther patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Don't use - material n t availableHelpful Don'  use - material not availableDon't use - m teri l not availableDon't use - other reason(s)Don't use - other reason(s) Internet (Websites) I would prefer that my patient and I make the decision about the diversion jointly
Male 45 Consultant0 to 5 years 10 4 6 Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery time Every timeEvery timeEvery timeEvery timeEvery timethe title of the question refer to both options, but questions only relate to ileal conduit!    I always cover urinary diversion procedures in this sequence; 1. orthotopic, 2. continent cutaneous diversion and 3. ileal conduit.    All above aspects are covered.Every timeEv ry timeEvery imeEvery timeEvery timeEvery tim Every timeEvery timeEvery timeEvery timeEvery timeEvery t mesee previous commentSpecialist/Stoma Nurse Other pat e ts who had undergone similar surgeryPatient Support G oups (e.g. Urostom  A sociation)Helpful Helpful Don'  use - material not availableDon't use - m teri l not availableHelpful Helpful We have a booklet that covers urinary diversion.  I also use website during clinic consultationLeaflets/Booklets I woul  prefer that my patient and I make the decision about the diversion jointlywell designed l afl t /booklets are very val able, but equally impor ant is to have the same information available on websites that are carefully designed in a user friendly way so that lay person find easy.Ye  - I am interes ed.
Male 51 Consultant11 to 15 years 30 24 6 Very often Every timeEvery timeVery often Very often Every timeEvery time Every timeSometimesSometimesVery often Every timeMorbidity and Mortality  Social support  Family supportVery f en Every timeEvery timeVery often Very often Every timeEvery timeEvery timeVery often Every timeEvery timeEvery timeMorbidity and Mortality issues  SOCIAL AND fAMILY SUPPORT  Absolute need for urethral survillance  any family history of alziemers
Male 57 Consultant16 to 20 years 5 0 0
Male 37 Consultant0 to 5 years 0 0 1 Very often Every timeEvery timeEvery timeEvery timeEvery timeVery often Every timeSometimesSometimesVery often Sometimes Every timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeEvery timeSometimesSometimesSometimesSometimes Specialist/Stoma Nursepouse Other patients who had undergone similar surgeryPatient Support G oups (e.g. Urostom  Association)Don't use - material n t availableHelpful Don'  use - material not availableDon't use - m teri l not availableDon't use - m teri l not availableHelpful DVD/Videos I would prefer that my patient makes the decision about the diversion, after seriously considering my opinion
Male 49 Consultant11 to 15 years 5 3 2 Very often Very often SometimesVery often Very often Every timeVery often Very often Very often Not very oftenSometimesEvery timeno SometimesVery often SometimesVery often Every timeVery often SometimesNot very oftenNot very oftenNot discussedNot very oftenSometimesno Specialist/Stoma Nursepouse gp Don't use - material not availableVery helpfulNeutra Neutral Very helpfulVery helpful misleadingcost no access no useful DVD/Videos I would prefer to make the decision about the diversion, after seriously considering my patient's opinionYes - I am interested.
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Appendix 18 – Clinician Questionnaire Survey Raw Results (Nurses) 
 
 
 
Are you male or female? Could you tell us your age? How many years have you 
been a specialist nurse in 
stoma/incontinence care for?  
Over the past year, how many 
patients did you counsel for 
radical cystectomy with 
urinary diversion? 
And in the past year, how 
many of the pre-radical 
cystectomy patients you 
counselled underwent: 
How often do you cover the 
following topics when you 
discuss with your patient 
about ILEAL CONDUIT 
during the pre-surgery 
consultation?  
Do you cover any other 
topics?  
How often do you cover the 
following topics when you 
discuss with your patient 
about ORTHOTOPIC 
NEOBLADDER during the 
pre-surgery consultation?  
Do you cover any other 
topics?  
Apart from yourself, who else 
do you think helps a patient 
choose between the two 
urinary diversion methods? 
Do you use any of the 
following materials to help 
your patient to choose a 
diversion method? If so, how 
helpful are they? 
Please tell us more about 
why, apart from unavailability, 
that you did not use some of 
the materials listed in the 
previous question.
Do you use any other 
material and how useful are 
they?
In order to help future patients 
choose a diversion that suits 
them best, we are hoping to 
develop decision support which 
provides information on the two 
urinary diversion options and 
determines what is important to 
patients.  Which is your most 
preferred format of support? 
Which one of the following 
statements would you most 
agree with? 
Any additional comments? We would like to invite you to 
participate further in another 
study, as an independent 
healthcare professional 
involved in the decision 
making about urinary 
diversion with radical 
cystectomy for bladder 
cancer…
Ileal Conduit Orthotopic Neobladder Technical description of 
ileal conduit formation 
Benefits of having ileal 
conduit  
Adverse outcomes of ileal 
conduit 
Probabilities of obtaining 
the benefits of ileal 
conduit 
Probabilities of adverse 
outcomes of ileal conduit 
Course of recovery in 
hospital
Course of recovery after 
discharge from hospital 
Daily care after discharge 
from hospital 
Employment Leisure 
activities/Sports/Travel 
Bodily appearance after 
surgery 
Sexual matters Technical description of 
orthotopic neobladder 
formation 
Benefits of having 
orthotopic neobladder 
Adverse outcomes of 
orthotopic neobladder 
Probabilities of obtaining 
the benefits of orthotopic 
neobladder 
Probabilities of adverse 
outcomes of orthotopic 
neobladder 
Course of recovery in 
hospital 
Course of recovery after 
discharge from hospital 
Daily care after discharge 
from hospital 
Employment Leisure 
activities/Sports/Travel 
Bodily appearance after 
surgery 
Sexual matters Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups 
(e.g. Urosotmy 
Association)
Other (Please state 
relationship/role/professio
n)
Internet (Websites) Leaflets/Booklets DVDs/Videos Audio CDs Models/Appliances Pictures Internet (Websites) Leaflets/Booklets DVDs/Videos Audio CDs Models/Appliances Pictures
Female 48 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 54 0 to 5 years 10 10 999 Every time Every time Every time Very often Every time Every time Every time Every time Every time Every time Every time Every time 999 Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed we do not offer this in Essex 
area
Operating Surgeon 999 999 999 999 999 Very helpful Very helpful Very helpful Helpful Very helpful Very helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer that my patient 
and I make the decision about 
the diversion jointly
999 Yes, I am interested.
Female 39 6 to 10 years 2 1 1 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 47 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 51 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 50 11 to 15 years 10 3 7 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Offer them a chance to speak 
to some one who has had the 
procedure
Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Offer the chance to speak to 
some one who has been 
through the procedure
Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
999 999 Helpful Very helpful Don't use - material not 
available
Don't use - material not 
available
Helpful Helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999 Yes, I am interested.
Male 40 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 49 6 to 10 years 12 12 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 45 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 33 0 to 5 years 30 28 2 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 40 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 50 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 50 16 to 20 years 6 4 2 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 50 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 50 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 41 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 49 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 45 6 to 10 years 10 5 5 Every time Every time Every time Every time Every time Every time Every time Every time Very often Every time Every time Very often peer support Every time Every time Every time Every time Every time Every time Every time Every time Very often Every time Every time Very often peer support Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
999 stoma nurse Helpful Very helpful Don't use - other reason(s) Don't use - other reason(s) Helpful Very helpful 999 999 no access to these no access to these 999 999 verbal communication it would be useful to have all 
formatis as each patient finds 
different method each helpful    
definatally bookelts and leaflets
I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
it is important that pts have 
the information and your 
experence in order for them 
to make a decision for them
Yes, I am interested.
Female 46 6 to 10 years 32 26 3 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Operating Surgeon 999 999 Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
Stoma Nurse Helpful Very helpful Not particularly helpful Don't use - material not 
available
Very helpful Helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999 Yes, I am interested.
Male 38 0 to 5 years 0 0 0 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Male 37 11 to 15 years 12 11 1 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Operating Surgeon Spouse 999 999 999 999 Helpful Helpful Helpful Don't use - other reason(s) Neutral Very helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
999 Yes, I am interested.
Female 41 0 to 5 years 0 0 0 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 42 6 to 10 years 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 49 6 to 10 years 12 10 0 Every time Every time Very often Every time Very often Every time Very often Very often Every time Every time Every time Every time Finance Every time Every time Every time Very often Very often Every time Every time Every time Every time Every time Every time Every time Finance Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
999 999 Helpful Very helpful Very helpful Very helpful Very helpful Very helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
999
Female 32 0 to 5 years 5 to 7 5 to 7 0 Every time Every time Not very often Not discussed Not discussed Every time Every time Every time Every time Every time Very often Every time Patients have support of 
stoma care nurses.  Offer to 
speak with patients of similar 
situation
Every time Every time Every time Not discussed Not discussed Every time Every time Every time Every time Every time Every time Every time Teaching ISC.  Offer to speak 
with patients of similar 
situation
Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Don't use - material not 
available
Helpful Don't use - material not 
available
Don't use - material not 
available
Don't use - material not 
available
Helpful 999 999 999 999 999 999 999 Leaflets+DVD+Website I would prefer to leave the 
decision about the diversion 
to my patient
999
Female 46 16 to 20 years 12 to 15 12 to 15 8 Every time Every time Every time Every time Every time Every time Every time Every time Sometimes (Many have 
retired)
Every time Every time Every time Use BAUS complications Every time Every time Every time Every time Every time Every time Every time Every time Sometimes (If not retired) Every time Every time Every time We discuss how long this op 
has been available  i.e. 
consultant experience in 
operating
Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery 
(Very occ)
999 Nurse who teaches pre-op 
ISC + pre-op stoma nurse 
visit too.  I am the patients' 
keyworker
Very helpful Helpful Neutral Neutral Neutral Helpful As listed in Cancer Backup Cancer Backup/Own personal 
hospital leaflets
Stoma Video None None From Backup books or self-
drawn
Show equipment i.e. 
catheter/urostomy bags
Keyworker contact/support.  
Many app to see + telephone 
support
I would prefer to leave the 
decision about the diversion 
to my patient (If medically fit 
enough for neobladder)
Some patients do not have a 
choice of neobladder as the 
operation is longer; if not fit 
so would not get to choose
Yes, I am interested.
Female 55 6 to 10 years 28 25 3 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Very often 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
999 999 Neutral Very helpful Helpful Not particularly helpful Very helpful Helpful Access not available at the 
clinic times
999 999 Most patients prefer to see 
what they want
999 999 999 Internet (Websites) + 
Leaflets/Booklets+DVD/Videos
I would prefer that my patient 
and I make the decision about 
the diversion jointly
I have found that there is 
quite some inconsistency in 
the information available 
reagarding post-operative and 
discharge care for patients 
with neobladder 
reconstruction.  Therefore a 
more balanced view and 
information would be helpful
Yes, I am interested.
Female 45 16 to 20 years Approx. 50 35 15 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Not particularly helpful Very helpful Not particularly helpful Helpful Very helpful Very helpful Sometimes too detailed.  UA 
website good
999 Very company orientated 999 999 999 999 Internet (Websites) + 
DVD/Videos
I would prefer to leave the 
decision about the diversion 
to my patient
999 Yes, I am interested.
Female 33 0 to 5 years Approx. 15 Approx. 15 4 Every time Every time Every time Every time Every time Every time Every time Every time Not very often Every time Every time Every time How it affects relationships 
and discuss family and 
friends support
Every time Every time Every time Every time Every time Every time Every time Every time Very often Very often Every time Every time The effects on relationships 
and family and friends 
support
Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Neutral Very helpful Helpful Helpful Very helpful Very helpful As the internet can be 
misleading on correct facts
I go through the leaflets + 
books the?to take
Difficult to assume patient 
has watched
Difficult to assume patient 
has listened
999 999 999 Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
I provide all the advantages 
and disadvantages of the 
procedure, providing leaflets 
and booklets and visual aids 
and when I provided all the 
facts would leave the 
decision with my patient and 
be there to support them in 
whatever they choose
Yes, I am interested.
Female 43 6 to 10 years 12 10 2 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Mood after major surgery Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Again mood after major 
surgery
Operating Surgeon 999 999 Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Don't use - other reason(s) Very helpful Very helpful Don't use - material not 
available
Helpful Helpful Inconsistent unreliable sites Predominantly use Urostomy 
Association leaflets and info 
pack from Coloplast
999 999 999 999 999 Leaflets/Booklets I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
I like to think I offer them all 
the pros and cons and then 
ultimately it is their choice
Yes, I am interested.
Female 48 6 to 10 years 10 8 2 Every time Not discussed Not discussed Sometimes Not discussed Every time Every time Every time Not very often Every time Every time Sometimes 999 Every time Very often Very often Very often Very often Every time Every time Every time Sometimes Every time Every time Every time 999 Operating Surgeon 999 Relatives/friends Other patients who have 
undergone similar surgery
999 999 Very helpful Very helpful Very helpful Very helpful 999 Very helpful 999 999 999 999 Do not have 999 Very useful.  Patient prefers 
this and usually in an anxious 
pre-op
Leaflets/Booklets+DVD/Videos 999 999 Yes, I am interested.
  
 
 
 
 
 
 
 
Are you male or female? Could you tell us your age? How many years have you 
been a specialist nurse in 
stoma/incontinence care for?
Over the past year, how many 
patients did you counsel for 
radical cystectomy with 
urinary diversion?  
And in the past year, how 
many of the pre-radical 
cystectomy patients you 
counselled underwent:
How often do you cover the 
following topics when you 
discuss with your patient 
about ILEAL CONDUIT 
during the pre-surgery 
consultation?  
Do you cover any other 
topics? 
How often do you cover the 
following topics when you 
discuss with your patient 
about ORTHOTOPIC 
NEOBLADDER during the 
pre-surgery consultation? 
Do you cover any other 
topics?  
Apart from yourself, who else 
do you think helps a patient 
choose between the two 
urinary diversion methods? 
Do you use any of the 
following materials to help 
your patient to choose a 
diversion method? If so, how 
helpful are they?
Please tell us more about 
why, apart from unavailability, 
that you did not use some of 
the materials listed in the 
previous question.
Do you use any other 
material and how useful are 
they?
In order to help future 
patients choose a diversion 
that suits them best, we are 
hoping to develop decision 
support which provides 
information on the two urinary 
diversion options and 
determines what is important 
to patients.  Which is your 
most preferred format of 
support? 
Which one of the following 
statements would you most 
agree with? 
Any additional comments?  We would like to invite you to 
participate further in another 
study, as an independent 
healthcare professional 
involved in the decision 
making about urinary 
diversion with radical 
cystectomy for bladder 
cancer…
Ileal Conduit Orthotopic Neobladder Technical description of 
ileal conduit formation
Benefits of having ileal 
conduit
Adverse outcomes of ileal 
conduit
Probabilities of obtaining 
the benefits of ileal 
conduit 
Probabilities of adverse 
outcomes of ileal conduit
Course of recovery in 
hospital
Course of recovery after 
discharge from hospital
Daily care after discharge 
from hospital 
Employment Leisure 
activities/Sports/Travel 
Bodily appearance after 
surgery
Sexual matters Technical description of 
orthotopic neobladder 
formation 
Benefits of having 
orthotopic neobladder
Adverse outcomes of 
orthotopic neobladder 
Probabilities of obtaining 
the benefits of orthotopic 
neobladder
Probabilities of adverse 
outcomes of orthotopic 
neobladder 
Course of recovery in 
hospital 
Course of recovery after 
discharge from hospital
Daily care after discharge 
from hospital
Employment Leisure 
activities/Sports/Travel
Bodily appearance after 
surgery 
Sexual matters Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups 
(e.g. Urosotmy 
Association)
Other (Please state 
relationship/role/professio
n)
Internet (Websites) Leaflets/Booklets DVDs/Videos Audio CDs Models/Appliances Pictures Internet (Websites) Leaflets/Booklets DVDs/Vidoes Audio CDs Models/Appliances Pictures
Female 36 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 55 over 20 years 10 10 0 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time shown types of appliances    
given "stoma trainer" to 
practice before TCI
Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Operating Surgeon 999 999 Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
urology nurse specialist Neutral Very helpful Very helpful Helpful Helpful Very helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
999
Female 44 6 to 10 years 40 38 2 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time meeting or phone call to 
another ostomist
Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time meeting another patient Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Very helpful Very helpful Don't use - other reason(s) Don't use - other reason(s) Very helpful Very helpful 999 999 offered in past but not taken 
up
same 999 999 999 Leaflets/Booklets I would prefer that my patient 
and I make the decision about 
the diversion jointly
999
Female 48 11 to 15 years 8 6 2 Every time Every time Every time Every time Every time Every time Every time Every time Very often Very often Every time Every time Products, QOL, psychological 
aspects of adapting to 
change.
Some times Every time Every time Every time Every time Every time Every time Some times Very often Very often Every time Every time 999 Operating Surgeon 999 999 Other patients who have 
undergone similar surgery
999 Macmillan nurse and urology 
nurse specialist
Neutral Helpful Neutral Don't use - other reason(s) Not particularly helpful Neutral Find a lot of very negative 
information which is daunting 
to pts.very specific re 
websites to look at
Helpful and can take away Daunting for some but do use 
if appropriate
Not available Use Use 999 Website and booklets leaflets I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
Pt must be the one to decide 
but for some the practicalities 
of option may not be suitable 
to all and at this point I would 
want the pt to think hard 
about the decision 
understanding all that is 
involved.
Yes, I am interested.
Female 39 11 to 15 years 10 9 1 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Financial Issues - ? referral 
to social services
Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Financial Support Operating Surgeon Spouse Relatives/friends 999 999 999 Neutral Helpful Helpful Helpful Helpful Very helpful 999 999 999 999 999 999 999 DVD/Videos I would prefer to leave the 
decision about the diversion 
to my patient
Due to the age group of this 
patient group being mostly 
elderly - the internet is not 
always the best way to impart 
this information
Female 51 6 to 10 years 10 10 0 Every time Every time Every time Every time Very often Every time Every time Every time Some times Every time Every time Every time types of appliances  voluntary 
organisations/support groups
Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed counselling for neobladder is 
undertaken by a different 
team, but I do point out that 
they will need to be able to 
self catheterise and that 
mucus can be a problem
Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
999 other uroslogy CNS Helpful Very helpful Very helpful Don't use - material not 
available
Very helpful Very helpful 999 999 999 999 999 999 voluntary visitors leaflets and DVD and 
voluntary visitors
I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
sometimes we are told that a 
patient is deciding between 
diversion options, but has 
never been referred to us as 
the stoma nurses. I do not 
feel that they have been given 
enough information on ileal 
conduit, if they have not met 
us to make a fully informed 
choice.
Yes, I am interested.
Female 48 over 20 years 22 22 0 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time DISCUSS SUPPORT 
NETWORKS, PT 
VISITORS,U/A. SUPPORT 
GROUPS
Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time urology nurse covers above 
topics, we work closely 
together when pts are 
considering surgery
Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Neutral Very helpful Helpful Neutral Very helpful Very helpful pt choice pt choice pt choice pt choice pt choice pt choice no Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
999
Female 999 6 to 10 years 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 56 over 20 years 9 9 0 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Diet  Medication Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Diet  Medication Operating Surgeon 999 999 999 Patient Support Groups (e.g. 
Urosotmy Association)
999 Not particularly helpful Very helpful Helpful Helpful Neutral Very helpful too much conflicting 
information
999 999 999 not usually very useful 999 999 Leaflets/Booklets I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999
Female 60 over 20 years 10 8 1 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Very often Products  Support Groups  
Supply of Products on 
discharge
Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often 999 Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Helpful Very helpful Very helpful Neutral Very helpful Very helpful 999 999 999 999 999 999 Personal trainer to practice 
pouch change
Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
Making an informed choice Yes, I am interested.
Female 48 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 48 16 to 20 years 40 35 5 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Very often pre operative education of 
how to change apliances etc 
with view to accelerated 
surgery
Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not very often Not very often Not discussed Not discussed Not discussed Not discussed i do not see these pts pre 
operatively seen by urology 
nurse specialist but i have 
involvement in their care 
during their hospital stay
Operating Surgeon 999 999 Other patients who have 
undergone similar surgery
999 999 Neutral Very helpful Helpful Don't use - material not 
available
Very helpful Very helpful 999 Dansac and coloplast 
information leaflets
Dansac 999 coloplast pre operative 
education packs
Dansac and coloplast  
information books
no Leaflets/Booklets I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999
Female 33 0 to 5 years 15 10 4 Very often Every time Every time Every time Very often Every time Every time Every time Every time Every time Every time Every time 999 Some times Some times Some times Very often Very often Very often Very often Some times Very often Very often Very often Very often 999 999 Spouse 999 999 999 999 Very helpful Very helpful Very helpful Very helpful Very helpful Very helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999 Yes, I am interested.
Female 38 0 to 5 years 3 999 999 Every time Every time Every time Every time Some times Every time Every time Every time Every time Every time Every time Every time 999 Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed I do not have any experience 
of looking after patients 
undergoing orthotopic 
neobladder so they are 
referred onto the Urology 
Specialist Nurse in 
Southampton where all our 
patients go to have their 
surgery.  However, in the 
past, a patient has also been 
referred to Mr Chris 
Woodhouse, Consultant 
Urologist at The Royal 
Marsden for a second opinion 
and the possibility of 
undergoing pioneering 
surgery where ileal conduit is 
not wanted by the patient and 
orthotopic neobladder is not 
an option for the patient
Operating Surgeon Spouse Relatives/friends 999 999 999 Neutral Very helpful Very helpful Don't use - material not 
available
Very helpful Very helpful 999 999 999 999 999 999 I will also refer patients onto 
other patients who have 
undergone similar surgery if 
they want to talk to someone 
living with an ileal conduit.  
The patient will also be 
referred onto other Specialist 
Nurses at the Specialist 
Centre where they will 
undergo surgery
A combination of 
leaflets/booklets and 
DVD/videos would be most 
useful
I would prefer to leave the 
decision about the diversion 
to my patient
I think it is important that the 
patient is given all the 
required information from the 
different Specialists but 
ultimately, the Surgeon and 
the patient need to discuss 
which option is going to have 
the best outcome for them 
and their future needs.  Also, 
the Surgeon has a lot more 
considerations to think about 
regarding the patients 
performance status.
Yes, I am interested.
Female 33 6 to 10 years 4 3 1 Very often Very often Every time Very often Every time Every time Every time Every time Very often Every time Every time Very often 999 Every time Every time Every time Every time Very often Every time Every time Every time Very often Every time Very often Not discussed 999 Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Helpful Very helpful Helpful Don't use - other reason(s) Helpful Very helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
999
Female 51 11 to 15 years 12 12 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Sexual mattters is a big issue 
so I do spend a long time 
discussing this matter.
Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed 999 Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
999 Urology CNS Very helpful Very helpful Helpful Helpful Very helpful Very helpful 999 999 999 999 999 999 Pre op stoma trainer pack ( 
From Coloplast and Salts)
Speaking with another patient I would prefer to leave the 
decision about the diversion 
to my patient
999 Yes, I am interested.
Female 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 41 11 to 15 years 40 30 10 Every time Every time Very often Every time Very often Every time Every time Every time Very often Very often Very often Every time 999 Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often Not very often We do not go into the 
orthotopic neo bladder in a lot 
of detail as this is done by the 
urology nurse specialist - the 
stoma care nurse will focus 
on the ileal conduit
Operating Surgeon 999 999 999 999 999 Very helpful Very helpful Very helpful Neutral Helpful Helpful 999 999 999 999 999 999 Education packs provided by 
coloplast
Leaflets/Booklets I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999
Female 49 11 to 15 years 10 10 999 Every time Every time Very often Very often Very often Every time Every time Very often Very often Every time Every time Every time 999 Every time Every time Very often Very often Very often Every time Every time Very often Very often Every time Every time Every time 999 Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
Patient fitness and 'wanting 
to lead a normal life'
Helpful Very helpful Very helpful Helpful Helpful Helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer that my patient 
and I make the decision about 
the diversion jointly
To ensure the patient is fully 
informed befor they make a 
decision
Yes, I am interested.
Female 59 16 to 20 years 33 33 0 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 45 6 to 10 years 4 4 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time support groups   Stoma 
buddies  lifting  diet  drinks 
including alcohol
Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed Tick not discussed for all as 
not our patient group
Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
stoma nurse  pree-
assessmenr nurse  internet
Neutral Very helpful Helpful Helpful Very helpful Very helpful depending on the material 
can be quite scary
999 999 999 999 999 stoma buddies Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
Patient to make own decision 
after information given for 
informed decision by patient
Yes, I am interested.
Female 48 0 to 5 years 40 35 5 Every time Some times Some times Some times Some times Every time Every time Every time Every time Every time Every time Every time follow-up support from stoma 
nurse  patient suppport local 
and national organisations  
stoma equipment
Every time Some times Some times Some times Some times Every time Every time Every time Every time Every time Every time Every time 999 Operating Surgeon Spouse 999 999 999 Urology Nurse Specialist Helpful Very helpful Helpful Don't use - other reason(s) Very helpful Very helpful 999 999 999 DVDs more helpful unless 
patient is visually impaired
999 999 999 Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
999
Female 31 0 to 5 years 22 16 4 Every time Every time Very often Very often Very often Every time Every time Every time Every time Every time Every time Every time Diet Advice for post op period  
How to avoid urine infection  
How to obtain supplies in the 
community  Clothing issues 
re belt/braces  Medication 
contraindications
Not very often Not very often Not very often Not discussed Not discussed Not very often Not discussed Not discussed Not discussed Not discussed Not discussed Not discussed These topics are discussed 
during counselling with the 
urology nurse specialist
Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
Clinical Nurse Specialist 
Urology
Neutral Very helpful Very helpful Very helpful Very helpful Very helpful 999 999 999 999 999 999 Pre-operative practice pack 
for practical training of stoma 
care.  Unsure what resources 
the Urology CNS provide the 
patient with
Leaflets/Booklets &  
Audiotapes/CDs/DVD help 
particularly for patients who 
cannot read, are partially 
sighted/blind etc
I would prefer to leave the 
decision about the diversion 
to my patient
The individual patient must 
make an informed decision 
once they have been given all 
the associated information 
and must be supported by 
ourselves, the urology 
specialists and the surgical 
team in enabling the patient 
to make the best decision for 
them.
Female 51 0 to 5 years 15 9 6 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time how to obtain supplies  
dietary advice
Every time Very often Very often Very often Very often Very often Very often Not very often Not very often Not very often Not very often Not very often 999 Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
999 urology specialist nurse. They 
usually cover most of the 
topics for neobladders. I am 
usually only asked to site in 
case of conduit and discuss 
this.
Helpful Very helpful Don't use - material not 
available
Don't use - material not 
available
Very helpful Very helpful 999 999 999 999 999 999 999 DVD/Videos I would prefer to leave the 
decision about the diversion 
to my patient
As befoer, I do not have much 
input with regards to 
neobladders - this is the role 
of the urology nurse 
specialist
Female 45 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 47 6 to 10 years 20 999 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Given stoma care practice 
pack
Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Teaching of CISC Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Not particularly helpful Very helpful Very helpful Don't use - material not 
available
Very helpful Very helpful If patient searching websites 
independantly not all websites 
are accurate and can give 
misinformation
999 999 999 999 999 999 Booklet with DVD 999 999 Yes, I am interested.
Female 55 over 20 years 22 15 6 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Helpful Helpful Helpful Don't use - material not 
available
Helpful Helpful 999 999 999 As far as I am aware there 
are no audio tapes fpr 
orthotopic neobladder
999 999 We have a printed pre op 
proforma which we go 
through with the patient. tick 
box and signed by the CNS. A 
copy ig given to the patient 
and one kept in their notes. 
The patient can then refer to 
this at a later date and 
contact us for a 
reminder.Details specific to 
the patient ca also be logged 
on the form so that the 
medical staff are aware. ie 
medication for depression, 
dependants. I have listed the 
materials as helpful however I 
believe them to be very 
helpful if used with the patient 
and CNS together.
choice would depend on age, 
ethnicity, intellect of the 
patient. All are better if used 
in conjunction with a visit 
to/from th CNS
I would prefer that my patient 
and I make the decision about 
the diversion jointly
999 Yes, I am interested.
Female 48 6 to 10 years 10 10 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Feelings and fears  Weight 
loss  Diet and fluids post op  
Bowel prep  Siting  
Complications  Stoma 
management  Rehabilitation  
Offer visitor
Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Offer visitor  Failure and 
conversion to conduit
Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
999 999 Neutral Very helpful Don't use - material not 
available
Don't use - material not 
available
Very helpful Very helpful Some sites are not 
particulary good and confuse 
the patient
Pts dont always retain all 
information supplied at 
meetings and this is a good 
resource to refer back to
999 999 Good for pts to apply to skin 
and practice using.
good for pt to look at the 
process of the surgery and 
what the stoma looks like
Stoma trainer. Model of a 
stoma that pt attachs to their 
skin and pracices with a 
pouch prior to surgery
Leaflets/Booklets I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999
Female 35 6 to 10 years 15 14 1 Some times Very often Some times Very often Very often Every time Every time Every time Very often Every time Every time Very often 999 Very often Every time Every time Every time Very often Every time Every time Every time Very often Very often Very often Very often 999 Operating Surgeon 999 999 Other patients who have 
undergone similar surgery
999 CNS urology Helpful Very helpful Helpful Helpful Neutral Helpful 999 999 Patients do not seem keen to 
use
Patients do not seem keen to 
use
999 999 999 Internet (Websites) I would prefer that my patient 
and I make the decision about 
the diversion jointly
999
Female 45 11 to 15 years 4 4 999 Every time Every time Every time Every time Every time Every time Every time Every time Very often Every time Every time Every time How to obtain equipment  
Siting of stoma  What the 
operation actually entails
Every time Every time Every time Every time Every time Every time Every time Every time Very often Every time Every time Every time 999 Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
Oncology Urology Nurse 
Specialist
Helpful Very helpful Helpful Don't use - material not 
available
Very helpful Very helpful I only recommend certain 
websites - I ward against 
looking at too many
999 999 999 999 999 999 Leaflets and DVD - DVD of 
ileal conduit can either put 
people at ease or frighten 
them off!
I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
I feel that ultimately it should 
always be the patietns choice 
but they should have full 
information available and 
have spoken to more than 
one health care professional
Female 59 over 20 years 6 5 1 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Some people have other 
issues that are personal to 
them.
Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time As above. Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
999 G.P. Helpful Very helpful Helpful Helpful Very helpful Very helpful 999 999 999 999 999 999 999 Written info is useful but 
nothing beats talking face to 
face.
I would prefer to leave the 
decision about the diversion 
to my patient
We must leave the final 
decision to the patient having 
talked about all the risks, 
benefits etc.
Yes, I am interested.
Female 46 6 to 10 years 16 10 6 Every time Every time Not very often Every time Not discussed Every time Every time Every time Every time Every time Every time Very often 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time 999 Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
999 Not particularly helpful Helpful Helpful Don't use - material not 
available
Helpful Helpful many pts don't have internet 
access. Internet info. re. 
orthotopic bladder surgery 
aimed at pts. is limited in the 
U.K., as far as I've been able 
to establish.
999 Our hospital computers (very 
unhelpfully!) don't permit us 
to play DVD's to our patients, 
yet not all of our patients own 
a DVD player
999 999 999 999 Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
When I first counsel patients 
re the pros & cons of each 
form of surgery, there seems 
to be a lack of awareness 
from them relating to the 
possible complications of neo-
bladder surgery - e.g. 
possibility of incontinence or 
need for self-catheterisation. I 
don't really feel that I should 
be the first person they hear 
this information from. Having 
a urostomy does sometimes 
seem to be presented to 
patients as a less favourable 
option by their surgeon. I 
would certainly prefer it if 
their surgeon gave them a 
more balanced view of both 
types of surgery before they 
came to see me, especially 
since my initial contact with 
them is sometimes only a 
week or two before their 
operation. This leaves 
patients with very little time to 
make an informed decision - 
especially if they then wish to 
make contact with former 
patients to hear their 
experiences first.
Yes, I am interested.
Female 50 11 to 15 years 999 999 999 Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Every time Risk of hernia leaking bags 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999
Female 54 6 to 10 years 10 7 3 Every time Very often Very often Very often Very often Every time Every time Every time Very often Very often Every time Every time 999 Every time Very often Very often Very often Very often Every time Every time Every time Very often Very often Every time Every time 999 Operating Surgeon Spouse Relatives/friends Other patients who have 
undergone similar surgery
999 999 Neutral Very helpful Helpful Neutral Helpful Very helpful 999 999 999 999 999 999 999 DVD/Videos I would prefer that my patient 
makes the decision about the 
diversion, after seriously 
considering my opinion
999
Female 42 16 to 20 years 15 15 10 Every time Every time Every time Every time Very often Every time Every time Very often Every time Every time Every time Every time 999 Every time Every time Every time Every time Every time Every time Every time Very often Every time Every time Every time Every time 999 Operating Surgeon Spouse 999 Other patients who have 
undergone similar surgery
Patient Support Groups (e.g. 
Urosotmy Association)
urology CNS Very helpful Very helpful Very helpful Very helpful Very helpful Very helpful 999 999 999 999 999 999 999 Leaflets/Booklets I would prefer to leave the 
decision about the diversion 
to my patient
999
  
 
 
